Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3003785	s-cea	ug/l (ug/l)	21031	75196	0.00%
3003785	p-cea	ug/l (ug/l)	10935	42488	3.58%
3003785	s-cea	— (—)	9432	22549	100.00%	Distribution not available
3003785	p-cea	— (—)	4940	10504	100.00%	Distribution not available
3003785	s-ceakym	ug/l (—)	118	141	100.00%	Distribution not available
3003785	s-karsinoembryonaalinenantigeeni	ug/l (—)	101	124	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Malignant neoplasm of prostate

1554

3054

3.29

323.01

3.9

1.5

20.55

2.72

ug/l

4.00

1283

2290

Persons encountering health services for other counselling and medical advice, not elsewhere classified

7884

26783

1.67

322.46

4.1

4.0

20.52

27.47

ug/l

0.77

6273

21398

Other septicaemia

3202

15304

2.21

322.46

4.3

3.8

21.81

22.20

ug/l

0.03

2764

12505

Unspecified jaundice

675

1430

6.44

321.67

5.3

4.1

44.82

22.00

ug/l

0.79

619

1187

Malignant neoplasm of prostate, including Hilmo

1577

3126

3.24

318.91

3.9

1.5

23.68

2.71

ug/l

3.68

1301

2343

All pneumoniae

6981

28767

1.70

314.92

3.9

4.0

20.98

25.90

ug/l

0.69

5760

22685

Pneumonias (Asthma/COPD co-morbidities)

6950

28754

1.70

314.55

4.0

21.17

25.91

ug/l

0.65

5740

22672

Adenocarcinoma of pancreas

578

403

31.29

307.65

7.0

1.4

133.55

2.79

ug/l

1.76

552

297

Bacterial infection, other or unspecified

6071

21040

2.78

307.65

4.9

3.9

39.29

23.68

ug/l

1.59

5171

16972

Laparoscopic right hemicolectomy

1762

2198

43.44

307.65

7.5

3.8

5.42

24.26

ug/l

3.15

1579

1801

Nutritional anaemias

4257

21173

2.12

307.65

4.1

3.8

15.24

24.73

ug/l

2.00

3540

17201

Hepatocellular carcinoma, including Hilmo

598

405

30.84

307.65

4.0

1.3

4.44

2.77

ug/l

1.29

509

300

Constipation

6947

28159

1.81

307.65

4.1

4.0

18.26

27.19

ug/l

0.99

5638

22630

Any gastric operation

6593

6374

5.72

307.65

4.4

1.6

29.18

18.70

ug/l

0.86

5265

4469

Personal history of malignant neoplasm

1014

2344

6.20

307.65

2.7

3.8

3.85

23.00

ug/l

2.77

706

1860

Adenocarcinoma and papillary adenocarcinoma of stomach

511

379

23.56

307.65

6.4

1.4

28.74

2.78

ug/l

3.32

478

292

Malignant neoplasm, without specification of site, including Hilmo

615

771

11.06

307.65

3.5

1.3

73.00

2.79

ug/l

4.98

510

573

Malignant neoplasm of respiratory system and intrathoracic organs

2322

3286

7.36

307.65

3.2

1.4

56.78

2.74

ug/l

7.36

2096

2461

Non-small cell lung cancer, including Hilmo

1849

2612

8.66

307.65

3.6

1.4

55.50

2.76

ug/l

5.46

1688

1953

Any reimbursement code in KELA

3278

5462

3.18

307.65

4.5

2.3

32.77

11.14

ug/l

1.14

2547

3864

Malignant neoplasm of small intestine, including Hilmo

486

442

18.47

307.65

4.8

1.4

9.91

2.74

ug/l

1.57

403

333

Malignant neoplasm of breast, including Hilmo

5431

5667

7.86

307.65

3.8

1.5

13.74

2.57

ug/l

10.23

4080

4098

Other bacterial diseases

8574

26419

2.22

307.65

4.6

3.8

30.17

22.88

ug/l

0.81

7127

20743

First line medication for Crohn's disease

8592

23578

2.10

307.65

4.8

3.5

31.94

20.96

ug/l

1.30

7029

18432

Malignant neoplasm of stomach

952

799

20.54

307.65

5.8

1.4

28.47

2.81

ug/l

4.67

859

596

Serous carcinoma of ovary, including Hilmo

550

555

17.04

307.65

1.8

1.4

3.93

2.72

ug/l

0.83

398

411

Other medical care

7824

16329

5.87

307.65

5.5

3.7

63.11

14.68

ug/l

11.48

6912

13066

Ulcerative colitis (strict) with PSC

265

156

131.49

307.65

9.0

4.6

2.46

9.51

ug/l

1.49

208

125

Fever of other and unknown origin

5008

19498

2.51

307.65

5.1

4.0

28.66

23.79

ug/l

0.51

4121

15564

Persons encountering health services for specific procedures and health care

9823

24038

2.69

307.65

4.6

3.7

41.45

14.10

ug/l

6.66

8220

18555

Non-Hodgkin lymphoma, all, including Hilmo

965

2243

4.97

307.65

2.5

1.4

10.30

2.71

ug/l

1.88

704

1661

Malignant neoplasm of colon, including Hilmo

5954

3503

53.77

307.65

8.2

1.4

35.58

2.73

ug/l

11.68

5415

2611

Adenocarcinoma and papilloma adenocarcinoma of rectum

3098

1582

89.42

307.65

9.7

1.4

34.68

2.74

ug/l

2.86

2824

1172

Disorders of gallbladder, biliary tract and pancreas

8972

26997

2.29

307.65

4.2

4.0

19.05

27.51

ug/l

1.52

7373

21439

Malignant neoplasm of ovary

760

778

15.99

307.65

1.9

1.4

6.09

2.64

ug/l

2.07

552

568

Follow-up examination after treatment for malignant neoplasms

1469

4141

4.68

307.65

6.0

4.2

11.38

22.83

ug/l

1.21

1260

3383

Symptoms and signs involving the digestive system and abdomen

7518

19274

2.07

307.65

4.0

29.50

25.65

ug/l

0.27

6105

15400

Secondary uncertain malignant neoplasm

1481

2153

8.89

307.65

3.9

1.4

75.78

2.69

ug/l

6.78

1256

1592

Cholangitis (primary sclerosing, PSC)

1191

1923

10.61

307.65

6.5

4.0

9.84

25.28

ug/l

1.39

1011

1573

Colorectal cancer

8031

4308

66.81

307.65

9.1

1.4

39.31

2.72

ug/l

11.24

7375

3229

malignant neoplasm of female genital organs

1618

2952

6.95

307.65

2.4

1.4

5.55

2.67

ug/l

3.29

1162

2203

Non-small cell lung cancer, adenocarcinoma

793

1016

11.11

307.65

4.2

1.4

101.74

2.76

ug/l

3.99

733

758

L02BG Aromatase inhibitors

3710

12608

3.68

307.65

4.2

3.7

14.18

21.11

ug/l

1.42

2913

10070

Colon adenocarcinoma

3798

2060

71.28

307.65

9.0

1.4

35.28

2.71

ug/l

9.58

3517

1533

Septicaemia

3538

16681

2.17

307.65

4.3

3.8

23.53

23.38

ug/l

0.01

3033

13581

Malignant neoplasm of rectum, including Hilmo

3906

2096

69.05

307.65

8.9

1.4

34.79

2.67

ug/l

3.67

3546

1558

Other bacterial diseases

8418

26799

2.30

307.65

4.6

3.8

31.89

22.81

ug/l

1.07

7038

21211

Other and unspecified anaemias

3960

18346

2.29

307.65

3.8

4.0

32.24

24.56

ug/l

0.41

3305

15138

Malignant neoplasm of small intestine

337

308

18.29

307.65

4.5

1.4

7.43

2.64

ug/l

0.80

273

233

Complications of surgical and medical care, not elsewhere classified

7980

29596

1.97

307.65

4.5

3.8

18.39

26.09

ug/l

0.90

6525

23531

Solid cancers, helper endpoint

11868

9938

8.87

307.65

5.3

1.5

32.19

2.58

ug/l

12.60

9654

7186

malignant neoplasm of male genital organs

1600

3137

3.36

307.65

3.9

1.5

20.09

2.70

ug/l

3.99

1315

2352

General symptoms and signs

7335

22205

1.73

307.65

4.1

4.0

29.32

23.91

ug/l

0.42

5929

17545

Malignant neoplasm of rectosigmoid junction

436

233

68.54

307.65

9.8

1.4

22.68

2.62

ug/l

2.38

390

178

Colitis, primary sclerosing, strict definition

331

223

75.94

307.65

8.2

4.5

2.45

26.10

ug/l

0.66

265

183

All kidney diseases

7074

28699

1.77

307.65

4.2

3.9

17.20

26.54

ug/l

2.28

5815

22651

Malignant neoplasm of stomach, including Hilmo

1100

954

19.53

307.65

5.6

1.4

26.38

2.80

ug/l

5.12

988

719

Iron deficiency anaemia

3626

18072

2.17

307.65

4.0

3.8

15.16

23.17

ug/l

1.29

3002

14632

Abdominal and pelvic pain

7205

19273

1.98

307.65

3.9

4.0

21.37

25.66

ug/l

0.49

5801

15399

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

5026

4469

19.84

307.65

7.6

1.5

78.96

2.67

ug/l

13.32

4579

3329

Ascites

1317

2449

8.55

307.65

4.3

4.0

62.13

28.51

ug/l

0.69

1090

1999

Malignant neoplasm of pancreas, including Hilmo

1924

1415

28.23

307.65

5.7

1.4

62.29

2.76

ug/l

3.22

1793

1053

Colorectal adenocarcinoma

6836

3631

77.54

307.65

9.3

1.4

35.18

2.74

ug/l

8.92

6285

2703

Opioids

6734

19415

1.89

307.65

4.3

3.7

32.79

18.05

ug/l

1.67

5493

15019

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1767

2567

9.03

307.65

5.0

1.5

23.92

2.68

ug/l

5.62

1513

1899

Right hemicolectomy

1198

2132

10.63

307.65

7.4

3.8

14.50

22.40

ug/l

0.64

1081

1771

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

3231

1643

90.42

307.65

9.8

1.4

33.88

2.72

ug/l

2.94

2948

1221

Other anaemias

4000

18467

2.29

307.65

3.8

4.0

31.97

24.58

ug/l

0.39

3338

15234

Family history of malignant neoplasm

1158

3373

4.16

307.65

5.2

3.9

6.62

34.99

ug/l

1.70

877

2624

Malignant neoplasm of liver and intrahepatic bile ducts

576

404

28.40

307.65

4.5

1.3

25.54

2.92

ug/l

1.24

505

302

Malignant neoplasm of rectosigmoid junction, including Hilmo

788

424

63.14

307.65

9.2

1.4

21.16

2.77

ug/l

2.41

692

314

Adenocarcinoma and ductal carcinoma of pancreas

784

514

37.56

307.65

7.7

1.4

101.26

2.76

ug/l

1.84

752

383

Colectomy operation

4199

6390

14.00

307.65

7.5

3.6

9.75

27.12

ug/l

4.53

3731

5195

Malignant neoplasm of ovary, including Hilmo

1108

1088

17.36

307.65

2.4

1.4

6.84

2.62

ug/l

3.82

804

802

Malignant neoplasm of oesophagus, including Hilmo

700

523

25.80

307.65

4.8

1.4

40.01

2.75

ug/l

2.87

641

386

Laparoscopic left hemicolectomy

471

615

30.22

307.65

8.6

4.4

13.54

31.80

ug/l

0.64

428

514

Benign neoplasm: Rectum, anus and anal canal

2070

8716

2.80

307.65

4.7

4.0

10.99

25.35

ug/l

3.24

1741

7184

Hepatocellular carcinoma

416

293

27.96

307.65

3.7

1.4

3.60

2.86

ug/l

1.12

359

219

Other symptoms and signs involving the digestive system and abdomen

1647

5741

3.33

307.65

3.3

3.9

29.97

19.17

ug/l

0.23

1341

4535

Benign neoplasms

6982

19945

2.04

307.65

3.9

4.1

20.00

31.92

ug/l

1.30

5589

15843

Malignant neoplasm of breast

5417

5613

8.02

307.65

3.8

1.5

13.61

2.58

ug/l

10.01

4077

4067

Malignant neoplasm of bronchus and lung, including Hilmo

2505

3439

7.77

307.65

3.3

1.4

57.81

2.73

ug/l

8.03

2284

2582

Non-small cell lung cancer

1191

1711

8.98

307.65

3.6

1.4

72.32

2.79

ug/l

4.30

1097

1269

Malignant neoplasm of breast, ER-negative, including Hilmo

1778

4144

4.76

307.65

3.4

1.5

14.51

2.63

ug/l

4.73

1334

3053

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

6466

26462

2.45

307.65

3.5

4.1

22.14

26.30

ug/l

0.49

5436

21354

Other diseases of intestines

8138

22534

2.19

307.65

4.2

3.9

16.13

30.60

ug/l

4.04

6514

17802

L02BA Anti-estrogens

2121

6495

4.21

307.65

5.0

3.6

15.74

26.56

ug/l

0.87

1618

5122

Benign neoplasm: Rectum

1920

7672

3.00

307.65

4.8

4.1

11.48

24.77

ug/l

2.48

1623

6333

Fentanyl

1257

3683

4.22

307.65

5.7

3.6

30.81

13.05

ug/l

2.22

1115

2982

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2875

7076

2.98

307.65

3.7

1.5

12.63

2.67

ug/l

8.41

2327

5270

Benign neoplasm: Colon

5800

24045

2.65

307.65

4.4

4.0

17.07

28.33

ug/l

1.19

4860

19685

Aplastic and other anaemias

4258

19460

2.27

307.65

3.7

4.0

31.96

25.33

ug/l

0.37

3559

16022

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

4760

3379

32.63

307.65

8.3

1.4

88.79

2.70

ug/l

13.39

4351

2508

Chronic pancreatitis

1740

4106

5.83

307.65

5.6

4.3

16.82

28.05

ug/l

0.96

1585

3395

Neoplasms

5955

4538

7.70

307.65

4.6

1.6

31.23

2.46

ug/l

4.67

4653

3175

Other diseases of pancreas

1395

2820

7.82

307.65

3.4

4.0

5.79

25.26

ug/l

3.83

1154

2282

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

322

246

25.72

307.65

4.5

1.4

138.53

2.75

ug/l

3.08

284

192

Diseases of liver

2968

14234

2.32

307.65

3.5

4.1

9.47

26.61

ug/l

5.06

2414

11544

Diverticular disease of intestine

5915

19908

2.04

307.65

3.4

3.9

14.02

32.65

ug/l

5.27

4781

16147

Diseases of the digestive system

3793

19846

2.07

307.65

4.2

3.9

19.63

25.53

ug/l

0.65

3178

16198

Tramadol

5680

19048

1.94

307.65

3.8

3.7

22.74

18.24

ug/l

0.48

4659

14831

Malignant neoplasm of pancreas

1538

1097

29.89

307.65

5.8

1.3

71.73

2.76

ug/l

2.91

1443

819

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

7278

26455

1.90

307.65

4.2

3.9

16.98

28.31

ug/l

2.64

5773

21036

Paralytic ileus and intestinal obstruction

3111

10063

3.74

307.65

6.1

3.9

14.40

29.43

ug/l

2.75

2639

8275

Complications of procedures, not elsewhere classified

6528

29164

1.99

307.65

4.6

3.8

23.01

25.95

ug/l

0.19

5349

23223

Anaemias

1790

1407

9.36

307.65

4.4

1.9

30.99

2.23

ug/l

3.07

1440

922

Medicines for HER+ breast cancer

4605

14135

3.85

307.65

3.9

3.7

13.96

24.99

ug/l

2.15

3511

11248

Malignant neoplasm of breast, HER2-negative, including Hilmo

5429

5667

7.86

307.65

3.8

1.5

13.74

2.57

ug/l

10.23

4079

4098

Oxycodone

6072

14408

5.00

307.65

5.8

3.8

54.27

19.20

ug/l

6.10

5405

11576

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

483

292

42.16

307.65

6.9

1.3

46.44

2.73

ug/l

1.75

451

214

Renal tubulo-interstitial diseases

6526

28477

1.81

307.65

4.2

3.9

17.26

26.53

ug/l

2.35

5448

22624

Malignant neoplasm

12075

9996

9.01

307.65

5.3

1.5

32.06

2.58

ug/l

12.88

9815

7220

IBD (strict) with PSC

327

191

124.70

307.65

8.8

4.5

2.42

32.02

ug/l

0.69

256

151

Malignant neoplasm of anus and anal canal, including Hilmo

265

164

37.19

307.65

5.2

1.5

68.29

2.53

ug/l

0.77

225

126

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

1085

758

30.55

307.65

5.2

1.4

31.42

2.79

ug/l

3.25

976

562

Intestinal stricture

3831

13122

3.58

307.65

6.1

3.8

14.09

25.09

ug/l

2.35

3241

10750

Malignant neoplasm of rectum

3041

1585

78.37

307.65

9.6

1.4

42.28

2.73

ug/l

3.46

2782

1183

Any event in cancer register

11892

11826

7.21

307.65

5.3

1.7

29.81

9.72

ug/l

5.27

9640

8638

Secondary malignant neoplasm of respiratory and digestive organs

327

246

27.75

307.65

5.7

1.4

155.50

2.79

ug/l

2.70

306

185

Malignant neoplasm of breast, ER-positive, including Hilmo

4449

5139

8.84

307.65

3.9

1.5

14.16

2.59

ug/l

8.45

3401

3758

Any death

7377

19721

3.21

307.65

5.0

4.0

81.53

3.79

ug/l

20.32

6563

15757

Other diseases of biliary tract

1566

3066

8.17

307.65

5.8

3.9

22.98

28.60

ug/l

0.32

1402

2496

Hernia of abdominal wall, postoperative

1925

2764

8.51

307.65

5.8

1.6

11.22

21.79

ug/l

1.20

1656

2007

Malignant neoplasm of breast, HER-negative

1592

3845

4.75

307.65

3.4

1.5

14.75

2.65

ug/l

4.16

1202

2848

Cholangitis (primary sclerosing, PSC), with reimbursement 202

506

472

35.81

307.65

7.8

4.2

2.92

16.45

ug/l

0.86

401

387

Artificial opening status

1030

1838

9.84

307.65

9.0

4.2

13.54

23.17

ug/l

0.96

903

1537

Malignant neoplasm of oesophagus

518

373

28.15

307.65

4.6

1.4

41.46

2.75

ug/l

2.00

472

276

Malignant neoplasm of breast, HER2-negative

5281

5578

7.87

307.65

3.9

1.5

13.30

2.57

ug/l

9.72

3993

4045

Colitis, primary sclerosing

424

316

61.72

307.65

8.1

4.3

2.51

20.59

ug/l

0.72

337

255

Benign neoplasm of colon, rectum, anus and anal canal

7092

25063

2.85

307.65

4.5

3.9

16.21

27.81

ug/l

1.59

5908

20429

Basal cell carcinoma

2581

6519

2.96

307.65

3.6

1.5

12.74

2.68

ug/l

7.60

2104

4886

Benign neoplasm of other and ill-defined parts of digestive system

1891

7453

3.03

307.65

3.3

4.0

4.72

25.02

ug/l

6.32

1495

6058

Bacterial infection, other or unspecified

5703

20171

2.81

307.65

4.9

3.9

40.47

23.11

ug/l

1.74

4862

16346

Abnormal findings on diagnostic imaging of lung

4726

21090

2.42

307.65

3.5

4.1

19.05

27.80

ug/l

1.42

4046

17247

Liquid cancers, helper endpoint

3385

6466

5.32

307.65

4.0

1.5

17.29

2.66

ug/l

7.28

2739

4808

Malignant neoplasm, wide definition for exclusion

11982

10105

8.65

307.65

5.1

1.5

31.75

2.58

ug/l

12.28

9681

7278

Malignant neoplasm of breast, HER-positive

4324

5101

8.73

307.65

4.0

1.5

13.92

2.59

ug/l

8.23

3313

3731

Pleural effusion

1746

6324

3.36

307.65

3.5

4.1

17.29

20.35

ug/l

0.35

1465

5249

Lung cancer and mesothelioma

2576

7132

3.88

307.65

3.2

4.3

54.07

25.87

ug/l

2.36

2338

5874

Carcinoma in situ of other and unspecified digestive organs

661

1219

10.73

307.65

4.9

4.2

12.26

23.84

ug/l

0.73

550

1013

Nausea and vomiting

2291

8949

2.79

307.65

4.8

3.9

23.31

20.78

ug/l

0.19

1910

7230

Malignant neoplasm of other and unspecified parts of biliary tract

353

201

49.16

307.65

7.0

1.3

42.80

2.72

ug/l

1.89

327

151

Malignant neoplasm of bronchus and lung

2097

2889

7.60

307.65

3.2

1.4

61.69

2.74

ug/l

7.34

1918

2157

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2667

6720

2.94

307.65

3.7

1.5

15.13

2.67

ug/l

7.76

2165

5024

Diseases of oesophagus, stomach and duodenum

7775

27691

1.77

307.65

3.5

4.2

14.76

27.12

ug/l

3.89

6200

22127

Malignant neoplasm of digestive organs

12269

6164

41.53

307.65

7.7

1.5

43.84

2.69

ug/l

17.87

11197

4616

Basal cell carcinoma, including avohilmo

2645

6769

2.90

307.65

3.6

1.5

12.53

2.68

ug/l

7.53

2140

5062

Complications of medical and surgical care

5767

30213

1.87

307.65

4.6

3.8

21.05

25.49

ug/l

0.30

4724

24154

Malignant neoplasm of skin

3002

7311

3.04

307.65

3.7

1.5

13.76

2.66

ug/l

7.86

2409

5438

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8778

28119

2.35

307.65

4.1

3.9

24.21

25.21

ug/l

0.08

7171

22315

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1455

1044

29.54

307.65

5.2

1.4

34.15

2.75

ug/l

3.91

1298

778

GASTRO-related operations

6593

6374

5.72

307.65

4.4

1.6

29.18

18.70

ug/l

0.86

5265

4469

Malignant neoplasm of colon

4729

2678

60.51

307.65

8.8

1.4

39.43

2.74

ug/l

10.36

4368

1984

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

550

467

25.40

307.65

2.0

1.4

6.58

2.73

ug/l

1.01

329

346

Other or unspecified ileus, impaction or obstruction

2396

6883

4.38

307.65

6.3

4.0

16.92

27.65

ug/l

1.65

2046

5700

Malignant neoplasm of other and unspecified female genital organs

312

260

27.74

307.65

1.7

1.4

2.58

2.69

ug/l

0.08

182

199

Ductal carcinoma of pancreas

207

104

104.97

303.80

9.5

1.4

12.09

2.59

ug/l

1.58

201

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6823

28896

1.69

300.63

3.9

4.0

21.43

25.76

ug/l

0.57

5662

22798

Gastrointestinal diseases

3383

8210

2.15

300.06

4.1

3.7

21.10

43.09

ug/l

1.89

2668

6271

Influenza and pneumonia

7130

28370

1.67

299.41

4.0

18.51

26.22

ug/l

1.48

5873

22331

Other and unspecified iron deficiency

2833

13900

2.24

297.68

4.0

3.8

11.71

23.36

ug/l

2.17

2337

11239

Other functional intestinal disorders

3402

16427

2.06

293.62

3.8

13.34

30.94

ug/l

5.14

2738

13240

Explicit Sepsis

3610

17983

2.03

293.36

4.3

4.0

25.00

26.29

ug/l

0.10

3088

14669

Pneumonia, organism unspecified

6388

27571

1.70

293.36

3.9

4.0

19.84

26.61

ug/l

1.17

5312

21818

Persons encountering health services in other circumstances, wide

8108

26925

1.61

286.29

4.0

20.30

27.39

ug/l

0.86

6552

21511

Examination and observation for other reasons

4281

13543

1.93

285.74

3.7

4.4

16.80

33.26

ug/l

2.40

3424

10802

Malaise and fatigue

3913

17179

1.96

285.35

3.5

4.0

33.79

22.90

ug/l

1.02

3191

13872

Acute pancreatitis

1723

7039

2.78

282.99

4.1

9.13

23.45

ug/l

3.85

1430

5741

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

274

247

19.11

280.92

3.0

1.4

3.95

2.66

ug/l

1.10

186

187

Abnormal findings on diagnostic imaging of other body structures

1383

5154

3.19

279.03

3.5

4.0

35.12

24.67

ug/l

0.35

1107

4120

Malignant neoplasm, without specification of site

371

490

10.15

278.73

2.8

1.3

68.32

2.86

ug/l

3.36

313

357

Other diseases of intestine

1395

5211

3.14

277.92

4.7

4.1

16.17

27.71

ug/l

1.19

1131

4295

Other diseases of pleura

3770

18247

1.97

274.60

3.4

4.1

23.68

24.69

ug/l

0.09

3171

15106

Secondary and unspecified malignant neoplasm of lymph nodes

591

1243

5.53

272.04

2.8

1.5

14.96

2.70

ug/l

2.61

455

914

Intestinal adhesions without obstruction

938

2868

4.06

268.48

6.5

3.9

8.91

30.32

ug/l

2.90

791

2343

Other diseases of the digestive system

2720

13686

2.19

267.68

4.1

3.9

23.30

25.02

ug/l

0.11

2276

11314

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6290

23759

1.68

265.74

3.9

4.0

19.42

26.27

ug/l

1.05

5175

18795

6290

23759

1.68

265.74

3.9

4.0

19.42

26.27

ug/l

1.05

5175

18795

Depression medications

1075

1487

3.77

265.21

3.7

1.9

18.03

2.22

ug/l

2.13

828

971

Secondary malignant neoplasm of other and unspecified sites

266

259

17.08

258.51

5.4

1.5

87.97

2.68

ug/l

2.95

250

197

Malignant neoplasm of mesothelium and soft tissue

387

581

8.58

258.27

2.7

1.4

5.68

2.76

ug/l

0.63

288

426

Hypothyroidism (congenital or acquired)

958

1448

3.89

257.37

3.7

1.9

26.59

2.22

ug/l

1.25

730

940

Metabolic disorders

6635

25822

1.64

256.67

3.7

4.1

29.46

23.69

ug/l

0.41

5393

20552

Certain infectious and parasitic diseases

6499

20388

1.66

256.54

4.2

3.9

28.09

25.32

ug/l

0.17

5207

16061

Non-invasive ventilation

1976

7887

2.45

255.09

5.2

4.5

10.23

27.39

ug/l

2.38

1647

6205

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4594

27131

1.78

253.20

4.6

3.8

21.29

25.61

ug/l

0.24

3751

21809

Venous thromboembolism

4297

24446

1.82

252.40

4.8

3.8

32.55

22.38

ug/l

1.28

3561

19966

Hypothyroidism and >3 levothyroxin purchases

947

1445

3.86

251.63

3.6

1.9

26.05

2.22

ug/l

1.18

719

938

Hypothyroidism, levothyroxine purchases

947

1445

3.86

251.63

3.6

1.9

26.05

2.22

ug/l

1.18

719

938

Pulmonary embolism

2561

12929

2.20

251.46

5.3

3.8

32.47

21.44

ug/l

1.34

2154

10626

GI-bleeding

2672

13652

2.15

251.25

4.0

3.9

22.11

25.27

ug/l

0.22

2240

11287

Pulmonary heart disease

2561

12939

2.19

250.92

5.3

3.8

32.47

21.43

ug/l

1.34

2154

10637

Cholelithiasis, broad definition with cholecystitis

6081

25915

1.66

247.96

3.6

3.9

18.81

27.61

ug/l

1.18

4909

20615

Benign neoplasm: Sigmoid colon

1814

8129

2.58

247.45

4.4

4.1

27.18

25.79

ug/l

0.03

1532

6712

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

674

1697

4.53

246.33

3.0

1.4

13.79

2.71

ug/l

1.77

538

1262

DVT of lower extremities and pulmonary embolism

3407

19042

1.93

239.51

5.0

3.8

37.47

23.65

ug/l

1.47

2850

15612

Hypothyroidism, drug reimbursement

682

1125

4.57

239.04

3.8

1.7

19.12

2.26

ug/l

0.73

516

755

Benign neoplasm: Pancreas

472

1003

8.21

236.91

3.6

4.2

2.85

24.42

ug/l

1.92

393

831

Pulmonary heart disease, diseases of pulmonary circulation

2700

14275

2.08

231.10

5.1

3.8

31.26

20.97

ug/l

1.31

2262

11746

Non-small cell lung cancer, adenocarcinoma, helper endpoint

793

2469

4.29

227.31

4.2

4.0

101.74

22.55

ug/l

2.65

733

2061

Malignant neoplasm of bladder, including Hilmo

726

2025

3.96

225.43

3.6

1.4

38.14

2.78

ug/l

1.32

609

1528

Cholelithiasis

5802

25645

1.63

225.28

3.6

3.9

18.67

27.72

ug/l

1.17

4666

20401

Acute pancreatitis (for exclusion)

1723

7804

2.48

224.76

4.1

9.13

25.31

ug/l

3.79

1430

6421

Malignant neoplasm of urinary organs

625

1597

4.44

223.76

3.0

1.4

13.47

2.73

ug/l

1.55

496

1183

Malignant melanoma, including Hilmo

936

3108

3.29

221.51

3.7

1.4

10.67

2.69

ug/l

1.54

738

2305

Agranulocytosis

1089

4050

3.21

221.00

5.8

4.0

25.88

27.85

ug/l

0.09

898

3240

Malignant neoplasm of other and ill-defined digestive organs

175

114

35.57

220.37

3.6

1.4

207.01

2.90

ug/l

2.35

155

Benign neoplasm: Colon, unspecified

2230

11356

2.20

216.37

4.0

4.1

16.41

25.00

ug/l

1.10

1859

9415

Total colectomy operation

501

1177

5.68

210.52

7.1

4.3

8.53

24.29

ug/l

1.27

403

966

Total colectomy

501

1177

5.68

210.52

7.1

4.3

8.53

24.29

ug/l

1.27

403

966

Drug-induced neutropenia

791

2561

3.92

209.24

5.9

4.1

27.24

23.29

ug/l

0.19

657

2069

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4213

25971

1.72

206.43

4.6

3.9

21.52

24.03

ug/l

0.12

3436

20962

Procreative management

2000

8123

2.19

201.63

5.1

3.9

11.72

19.34

ug/l

1.08

1477

6296

L01XE Protein kinase inhibitors

676

2070

4.42

199.83

8.7

4.1

27.39

20.99

ug/l

0.30

607

1703

Malignant melanoma

784

2509

3.43

197.94

3.7

1.4

7.99

2.67

ug/l

3.32

610

1856

Non-small cell lung cancer, squamous

366

668

6.45

197.87

2.6

1.3

7.86

2.91

ug/l

2.39

334

504

Other diseases of anus and rectum

2245

11664

2.07

197.63

4.0

3.9

16.67

28.60

ug/l

1.67

1802

9533

Malignant neoplasm of kidney, except renal pelvis

561

1456

4.37

196.59

3.0

1.4

10.36

2.73

ug/l

1.34

445

1076

Carcinoma in situ of colon

363

734

9.49

195.48

4.8

4.4

6.96

31.32

ug/l

1.37

299

622

Left hemicolectomy

392

835

7.86

194.75

8.3

4.1

11.11

29.80

ug/l

1.04

354

700

Diffuse large B-cell lymphoma, helper endpoint

374

723

6.33

192.11

2.1

1.4

6.70

2.69

ug/l

0.82

253

543

Diffuse large B-cell lymphoma, including Hilmo

374

723

6.33

192.11

2.1

1.4

6.70

2.69

ug/l

0.82

253

543

Diffuse large B-cell lymphoma

374

723

6.33

192.11

2.1

1.4

6.70

2.69

ug/l

0.82

253

543

Benign neoplasm: Caecum

1095

4420

3.00

191.89

4.3

4.1

5.04

21.92

ug/l

5.16

930

3641

Mucinous and mucinous cystic tumor of rectum

133

104.50

191.71

11.7

1.3

15.67

2.59

ug/l

2.31

124

Benign neoplasm: Ascending colon

1325

5810

2.67

191.54

4.4

4.1

7.29

24.06

ug/l

4.83

1131

4762

Fibrosis and cirrhosis of liver

816

2826

3.58

191.44

3.5

4.2

4.67

23.77

ug/l

4.48

689

2318

All chronic kidney diseases

3896

19496

1.73

190.82

4.0

17.47

27.90

ug/l

1.70

3285

15879

Ventral hernia

1987

10170

2.15

187.38

5.6

4.0

24.28

26.36

ug/l

0.10

1689

8294

Hydronephrosis

1062

4275

2.87

182.24

6.3

4.0

26.38

24.63

ug/l

0.08

897

3491

Neuroendocrine tumor and carcinoma of small intestine

192

193

15.98

181.94

3.2

1.4

3.29

2.66

ug/l

1.10

148

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1284

5643

2.61

181.86

3.5

4.4

10.12

23.89

ug/l

2.80

1128

4705

Codeine

5428

19328

1.58

178.98

3.6

3.7

14.94

18.11

ug/l

0.47

4352

14961

Medical observation and evaluation for suspected diseases and conditions

4302

13648

1.67

177.59

3.5

4.3

18.78

33.11

ug/l

1.94

3429

10888

Other pleural conditions

995

3949

2.96

177.44

3.4

4.1

27.07

21.54

ug/l

0.24

822

3277

Implicit Sepsis

5138

25619

1.58

177.12

3.5

4.1

14.91

26.89

ug/l

3.28

4236

20637

Malignant melanoma of skin, including Hilmo

748

2497

3.26

175.38

3.6

1.4

12.10

2.68

ug/l

1.39

585

1841

Inflammatory bowel disease treatment related agents

7297

28625

1.47

174.25

3.6

4.1

22.75

25.62

ug/l

0.30

5855

22743

Attention to artificial openings

453

1139

5.14

173.32

5.7

3.8

33.75

15.31

ug/l

0.58

378

927

Oral corticosteroids

6898

28522

1.48

172.91

3.5

4.1

21.49

25.67

ug/l

0.58

5604

22689

ILD medications: prednisolone, methylprednisolone, prednisone

7015

27408

1.48

171.36

3.6

4.2

20.40

25.47

ug/l

0.73

5663

21767

Bleeding

5706

27601

1.53

170.07

3.8

4.1

17.22

26.79

ug/l

2.17

4717

22352

Dyspnoea

6007

30511

1.51

169.61

3.5

4.1

20.18

26.11

ug/l

0.83

4893

24408

Gastrointestinal stromal tumor and sarcoma

172

165

17.83

169.40

3.2

1.3

4.34

2.66

ug/l

0.70

130

128

Parasetamol

4371

13919

1.64

169.17

4.2

4.0

18.87

30.36

ug/l

1.56

3526

10884

Other diseases of blood and blood-forming organs, wide

1735

8799

2.17

167.92

4.8

4.1

24.34

27.08

ug/l

0.15

1417

7147

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1964

4862

2.10

165.72

4.2

4.4

20.98

24.83

ug/l

0.18

1567

3773

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2797

10119

1.83

163.10

4.3

4.2

17.83

24.92

ug/l

0.58

2258

7725

Factors influencing health status and contact with health services

1801

4356

2.17

162.57

4.3

3.9

19.25

22.78

ug/l

0.21

1485

3431

Other disorders of fluid, electrolyte and acid-base balance

2438

13272

1.89

159.97

3.8

4.1

28.80

23.97

ug/l

0.15

2067

10922

Carcinoma in situ of rectum

246

426

14.16

159.49

5.3

4.4

10.65

36.32

ug/l

0.74

206

358

Cirrhosis of liver, NAS

598

1938

3.96

158.98

3.3

4.2

4.92

22.37

ug/l

2.74

522

1609

Exclusions for E4_PCOS_CONSORTIUM

4320

17469

1.61

158.50

3.2

4.0

18.05

23.63

ug/l

0.63

3259

13634

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

666

2213

3.28

157.05

3.7

1.3

17.41

2.75

ug/l

1.95

543

1663

Any operation in hilmo

177

29.62

156.80

5.0

1.1

47.00

1.86

ug/l

0.63

149

Implicit Sepsis

5361

26755

1.52

156.33

3.5

4.1

15.09

26.83

ug/l

3.23

4386

21440

Malignant neoplasm of corpus uteri, including Hilmo

574

1775

3.64

155.18

3.1

1.4

5.39

2.68

ug/l

1.33

452

1321

Oesophageal varices

476

1365

4.56

153.11

3.8

4.2

5.47

24.09

ug/l

2.12

417

1130

Malignant neoplasm of gallbladder, including Hilmo

136

109

25.93

152.34

6.6

1.3

14.69

2.64

ug/l

1.82

128

Other diseases of liver

1377

6660

2.28

151.28

3.4

4.2

8.61

30.83

ug/l

2.68

1074

5355

Bacterial Sepsis

3397

18250

1.68

151.25

3.6

4.1

23.48

28.10

ug/l

0.35

2868

15009

In situ neoplasms

2837

17196

1.77

151.20

3.8

15.55

23.30

ug/l

1.19

2287

13925

Cholecystectomy

4922

28909

1.53

150.90

4.1

3.9

12.94

25.64

ug/l

3.54

3934

23256

Noninfective enteritis and colitis

2957

18010

1.72

150.08

4.4

3.9

21.57

25.56

ug/l

0.30

2354

14397

Malignant neoplasm of anus and anal canal

111

45.25

149.20

4.3

1.4

5.05

2.84

ug/l

2.22

Malignant neoplasm of other connective and soft tissue, including Hilmo

304

612

5.88

148.13

3.4

1.4

8.44

2.74

ug/l

1.09

231

450

Condition for Implicit Sepsis (Organ dysfunction codes)

5612

26926

1.49

145.86

3.5

4.1

18.21

26.27

ug/l

1.60

4587

21379

Malignant melanoma of skin

569

1824

3.41

143.35

3.6

1.4

9.13

2.69

ug/l

2.72

437

1336

Benign neoplasm: Transverse colon

984

4316

2.67

142.28

4.6

4.1

8.12

22.69

ug/l

3.39

844

3563

Abnormalities of breathing

5448

21865

1.49

141.60

3.5

4.2

21.25

28.00

ug/l

0.84

4328

17381

Malignant neoplasm of retroperitoneum and peritoneum

129

106

22.61

141.00

2.6

1.4

2.88

2.53

ug/l

0.39

Hernia

6001

28525

1.46

140.29

4.1

3.9

18.81

25.94

ug/l

1.16

4913

22757

Certain infectious and parasitic diseases

4716

15783

1.54

140.17

4.2

3.9

30.51

26.87

ug/l

0.16

3823

12483

Benign neoplasm: Liver/bile ducts

314

707

6.01

139.61

2.5

4.2

2.67

24.50

ug/l

1.24

215

576

ILD medications

6988

27453

1.42

137.41

3.5

4.2

21.00

25.45

ug/l

0.59

5643

21788

Gastro-oesophageal reflux disease

4437

26085

1.53

134.62

3.2

4.2

16.92

27.22

ug/l

1.90

3470

21012

Other postsurgical states

601

2119

3.37

134.25

5.6

4.0

4.82

22.57

ug/l

3.05

549

1738

Small cell lung cancer, including Hilmo

207

320

7.89

133.16

2.1

1.4

32.96

2.88

ug/l

1.97

190

243

Small cell lung cancer

207

320

7.89

133.16

2.1

1.4

32.96

2.88

ug/l

1.97

190

243

Malignant neoplasm of corpus uteri

491

1523

3.63

132.25

3.2

1.4

5.70

2.70

ug/l

1.22

387

1134

Pain, not elsewhere classified

1810

9975

1.93

132.24

4.0

3.9

19.40

19.18

ug/l

0.01

1429

7891

Acute tubulo-interstitial nephritis

4111

23921

1.54

131.52

4.1

3.9

15.59

25.76

ug/l

2.37

3393

19114

Malignant neoplasm of other and ill-defined sites, including Hilmo

174

230

10.18

130.93

4.1

1.4

21.23

2.68

ug/l

2.10

136

173

Neuroendocrine tumor and carcinoma of pancreas

116

25.94

130.59

3.6

1.4

7.19

2.51

ug/l

1.35

Erysipelas

4558

23875

1.51

130.54

3.7

3.9

15.20

23.78

ug/l

1.62

3762

19076

Benign neoplasm: Liver

282

620

6.17

129.06

2.5

4.2

2.65

15.15

ug/l

1.11

191

501

Hypertension, essential

4750

18450

1.51

128.16

3.8

4.2

21.26

23.45

ug/l

0.17

3846

14529

Condition for Implicit Sepsis (Organ dysfunction codes)

5401

27014

1.46

128.07

3.5

4.1

16.78

26.38

ug/l

2.23

4427

21592

Appendectomy

3835

24540

1.55

127.97

3.8

4.0

14.04

24.39

ug/l

2.40

2926

19433

Disorders of lipoprotein metabolism and other lipidaemias

5502

24181

1.46

127.39

3.5

4.2

25.37

24.58

ug/l

0.06

4477

19502

Implicit bacterial Sepsis

3199

17851

1.63

127.00

3.5

4.1

21.35

26.87

ug/l

0.47

2704

14717

Asthma, unspecified (mode), excluding more controls

3218

15407

1.63

126.98

3.4

4.3

15.60

26.53

ug/l

1.24

2640

12048

Malignant neoplasm of endocrine gland

378

1011

4.15

126.28

4.1

1.4

20.06

2.61

ug/l

0.88

293

739

Mesothelioma, including Hilmo

150

177

11.89

124.39

2.4

1.3

2.21

2.89

ug/l

2.47

117

131

Heart failure, not strict

5106

24525

1.47

123.75

3.5

4.3

17.55

28.02

ug/l

2.31

4275

19841

Implicit bacterial Sepsis

2950

16719

1.65

123.28

3.5

4.1

22.31

27.18

ug/l

0.36

2503

13806

Renal failure

3268

18922

1.61

122.99

3.5

4.0

24.41

25.15

ug/l

0.05

2780

15678

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

6225

29098

1.41

122.17

4.1

4.0

20.17

26.05

ug/l

0.85

5075

23294

Hernia of abdominal wall

3071

19947

1.62

121.40

5.1

4.0

24.57

25.86

ug/l

0.08

2583

16211

Pure hypercholesterolaemia

5026

23167

1.47

121.30

3.6

4.2

26.02

24.91

ug/l

0.07

4126

18759

Clear cell adenocarcinoma of kidney

298

696

4.98

121.28

3.2

1.4

10.24

2.67

ug/l

0.73

238

520

Asthma, unspecified (mode)

3337

16421

1.59

120.24

3.4

4.3

15.15

26.00

ug/l

1.32

2749

12887

Malignant neoplasm of thyroid gland, including Hilmo

386

1085

3.92

119.79

4.5

1.5

27.83

2.60

ug/l

1.23

297

797

Symptoms and signs involving the urinary system

5032

27256

1.46

119.58

3.8

4.1

20.82

26.44

ug/l

0.55

4126

22078

Gastroduodenal ulcer

1930

11218

1.84

118.69

3.8

4.1

20.94

26.02

ug/l

0.37

1617

9348

Excluding asthma or asthma-COPD overlap

4876

17027

1.48

117.32

4.0

4.3

20.11

25.68

ug/l

0.57

3967

13343

Type 2 diabetes, wide definition

5256

24086

1.45

116.64

3.7

4.1

22.49

26.78

ug/l

0.45

4370

19327

Enlarged lymph nodes

1100

5363

2.22

116.59

3.3

4.1

18.76

23.62

ug/l

0.33

884

4286

Pain in throat and chest

5101

21746

1.45

115.40

3.5

4.2

16.53

28.07

ug/l

1.66

4014

17333

Squamous cell neoplasms and carcinomas of the skin

448

1425

3.45

114.59

3.7

1.3

19.28

2.72

ug/l

1.43

366

1058

Cardiovascular diseases (excluding rheumatic etc)

3029

11094

1.61

113.74

3.9

4.1

20.86

24.13

ug/l

0.21

2323

8291

ILD differential diagnosis

4843

17001

1.47

113.26

4.0

4.3

20.24

25.68

ug/l

0.55

3936

13335

COPD differential diagnosis

4843

17003

1.47

113.21

4.0

4.3

20.25

25.68

ug/l

0.55

3936

13337

Iron deficiency anaemia secondary to blood loss (chronic)

1231

6366

2.12

112.60

3.9

3.8

25.86

24.17

ug/l

0.07

1028

5186

Malignant neoplasm of bladder

374

1075

3.83

112.10

3.2

1.4

49.44

2.82

ug/l

0.83

316

800

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

162

233

8.75

112.06

2.2

1.4

14.47

2.72

ug/l

0.59

129

165

Postprocedural disorders of digestive system, not elsewhere classified

353

1018

4.43

111.82

6.6

4.1

18.04

24.81

ug/l

0.26

303

847

Oedema, not elsewhere classified

2167

13016

1.74

111.74

3.7

3.9

26.77

21.63

ug/l

0.29

1780

10572

Mucosal proctocolitis

812

3565

2.48

111.51

5.4

4.1

5.68

35.55

ug/l

2.32

629

2831

Pain (limb, back, neck, head abdominally)

4396

15200

1.49

111.07

4.0

4.2

18.21

29.40

ug/l

1.48

3531

12301

Ovarian cyst

2214

7619

1.76

110.65

3.0

4.1

14.30

31.30

ug/l

1.72

1643

5945

COPD (mode)

2235

10768

1.73

109.09

3.0

4.4

30.46

26.82

ug/l

0.20

1988

8821

Malignant neoplasm of thyroid gland

342

958

3.94

106.83

4.2

1.4

22.16

2.62

ug/l

0.88

262

705

Use of hypnotics and sedatives

6611

28473

1.37

106.15

4.0

21.66

26.11

ug/l

0.57

5404

22653

Dental caries

1713

9539

1.83

105.84

4.6

4.4

21.57

27.82

ug/l

0.37

1440

7707

Care involving use of rehabilitation procedures

3572

22522

1.51

104.74

3.5

3.7

15.97

14.64

ug/l

0.12

2895

17584

Benign neoplasm: Descending colon

647

2713

2.82

104.05

5.3

4.1

5.53

23.06

ug/l

3.64

552

2249

Non-Hodgkin lymphoma, all

271

663

4.67

103.38

2.2

1.3

3.61

2.87

ug/l

0.96

209

492

Mesothelioma

117

129

13.14

102.56

2.2

1.3

2.05

2.90

ug/l

3.30

Benzodiazepine use

6133

31631

1.37

102.42

3.6

4.0

21.94

25.25

ug/l

0.37

4937

25234

Other pulmonary diagnosis

4769

17027

1.44

101.55

4.0

4.3

20.24

25.68

ug/l

0.55

3853

13343

Symptoms and signs concerning food and fluid intake

780

3533

2.43

100.44

2.7

3.9

11.33

22.10

ug/l

1.07

643

2852

Misadventures to patients during surgical and medical care

1045

5319

2.15

100.01

4.6

3.9

19.17

25.65

ug/l

0.22

860

4268

Caries of dentine

1523

8445

1.87

99.95

4.6

4.4

23.35

25.41

ug/l

0.10

1284

6824

Acute renal failure

1588

9240

1.85

99.35

3.9

4.0

30.46

23.21

ug/l

0.34

1359

7692

Malignant neoplasm of heart, mediastinum and pleura

127

161

10.39

98.57

2.1

1.3

3.48

2.79

ug/l

0.29

103

114

Colorectal neuroendocrine tumor and carcinoma

133

178

9.74

98.57

4.5

1.5

9.04

2.62

ug/l

0.85

111

133

Hypertensive diseases (excluding secondary)

2765

10427

1.59

96.95

3.7

4.2

16.65

24.98

ug/l

0.68

2204

7929

Endometroid carcinoma of ovary, including Hilmo

118

146

12.30

95.58

3.2

1.4

4.04

2.66

ug/l

0.67

111

Ulcerative colitis

1463

8347

1.85

95.41

4.6

4.1

13.06

27.19

ug/l

1.36

1151

6698

COPD/asthma related infections

6295

23759

1.36

94.97

3.9

4.0

17.87

26.27

ug/l

1.56

5053

18795

COPD/asthma/ILD related infections

6295

23759

1.36

94.97

3.9

4.0

17.87

26.27

ug/l

1.56

5053

18795

Inflammatory bowel disease

1833

11132

1.73

94.78

4.3

4.0

16.53

23.92

ug/l

0.50

1439

8908

General examination and investigation of persons without complaint and reported diagnosis

3756

13619

1.48

92.69

3.6

4.3

21.84

33.12

ug/l

1.19

3047

10867

Dysphagia

1567

9223

1.80

92.10

3.2

4.0

14.99

20.62

ug/l

0.72

1271

7544

Hypertension

4555

18582

1.42

92.04

3.8

4.2

21.45

23.35

ug/l

0.15

3699

14604

Hypertensive diseases

4554

18585

1.42

91.92

3.8

4.2

21.46

23.35

ug/l

0.15

3698

14607

Hypokalaemia

921

4630

2.19

91.73

4.2

4.1

19.18

24.41

ug/l

0.29

783

3749

Malignant neoplasm of head and neck

383

1266

3.28

91.55

3.3

1.4

11.21

2.77

ug/l

1.43

321

939

Insulin medication

3717

22156

1.46

91.17

3.9

4.1

20.18

25.34

ug/l

0.62

3216

17856

Gastric ulcer

1303

7352

1.91

90.33

3.7

4.1

22.37

26.92

ug/l

0.23

1084

6115

Other heart diseases

2434

10241

1.60

90.09

3.6

4.2

23.46

25.31

ug/l

0.09

1920

7798

Pain in limb

4854

23966

1.39

89.11

3.6

4.2

13.12

28.61

ug/l

4.57

3821

19161

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

281

787

4.03

88.71

2.3

1.4

3.57

2.74

ug/l

1.46

228

586

Diarrhoea and gastroenteritis of presumed infectious origin

4019

26208

1.42

86.73

4.0

3.9

18.59

24.17

ug/l

0.72

3187

20920

Provisional assignment of new diseases of uncertain etiology

3098

21546

1.49

85.44

4.0

3.9

12.17

23.89

ug/l

2.44

2527

17249

Codes for special purposes

3101

21578

1.49

85.28

4.0

3.9

12.16

24.13

ug/l

2.53

2530

17272

Erysipelas

3419

21415

1.46

85.08

3.7

3.9

17.84

23.11

ug/l

0.59

2831

17325

Insulin, intermediate and long-acting

3407

23522

1.46

84.52

3.9

4.0

19.83

26.88

ug/l

0.90

2942

19061

IBD patients in KELA-register

1255

7090

1.86

84.23

4.7

4.1

16.15

29.80

ug/l

0.77

978

5611

Cardiovascular diseases

2624

9295

1.55

83.27

3.9

4.2

20.99

26.74

ug/l

0.34

1996

6906

Ulcerative colitis, NAS

847

4245

2.14

83.13

4.8

4.1

7.17

32.39

ug/l

2.16

668

3376

Other noninfective gastroenteritis and colitis

1507

9014

1.76

83.06

4.4

4.0

24.88

28.97

ug/l

0.20

1210

7271

Other soft tissue disorders, not elsewhere classified

5447

24181

1.35

81.92

3.6

4.2

11.92

28.48

ug/l

6.56

4302

19312

Other inflammatory liver diseases

509

2129

2.72

80.30

4.2

7.14

23.17

ug/l

2.41

407

1729

Other disorders of urethra and urinary system

4331

23124

1.39

79.90

3.7

4.0

14.13

27.58

ug/l

3.60

3426

18533

Inflammatory bowel disease, strict (require KELA)

1255

7202

1.83

79.87

4.7

4.1

16.15

29.33

ug/l

0.74

978

5721

Hypo-osmolality and hyponatraemia

1276

7384

1.85

79.81

3.4

4.0

13.14

23.80

ug/l

2.37

1079

6074

Diaphragmatic hernia

2454

16660

1.55

79.54

3.3

3.9

19.40

24.84

ug/l

0.34

1980

13584

Prophylactic surgery

111

160

10.58

79.44

3.0

3.8

5.14

7.12

ug/l

0.24

126

Multiple myeloma, including Hilmo

254

719

3.97

78.90

2.7

1.4

5.43

2.80

ug/l

1.64

201

533

Diabetes, insulin treatment (Kela reimbursement)

6113

28640

1.32

78.20

3.7

4.0

22.78

24.78

ug/l

0.21

5098

22703

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5710

26472

1.33

77.44

3.7

4.1

23.06

25.32

ug/l

0.22

4748

20923

Other gastritis (incl. Duodenitis)

1512

9279

1.73

76.69

3.4

4.2

24.08

28.10

ug/l

0.18

1251

7669

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3756

22037

1.42

76.69

3.5

4.1

24.24

24.28

ug/l

0.00

3174

18003

Mucinous and mucinous cystic tumor, including Hilmo

13.56

76.60

2.7

1.4

12.77

2.71

ug/l

1.49

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

904

4763

2.02

76.31

5.1

4.2

8.90

31.61

ug/l

2.10

702

3781

Fitting and adjustment of other devices

2220

13364

1.57

76.22

3.4

3.7

19.88

13.86

ug/l

0.46

1836

10820

Portal vein thrombosis

200

516

5.34

75.84

5.0

4.2

4.52

39.01

ug/l

1.48

169

439

Persons encountering health services for examination and investigation

3781

13652

1.42

75.78

3.9

4.3

26.36

33.10

ug/l

0.48

3059

10890

5-aminosalicylic acid

1203

6930

1.83

75.65

4.7

4.2

14.71

26.27

ug/l

0.61

936

5489

Diabetes, varying definitions

5939

27006

1.32

75.20

3.7

4.1

24.05

25.04

ug/l

0.09

4922

21234

Covid-19 confirmed case

2275

15390

1.55

74.15

4.2

3.9

7.80

25.48

ug/l

7.29

1875

12525

Malignant neoplasm of other connective and soft tissue

158

329

5.60

74.05

3.3

1.4

9.95

2.70

ug/l

0.68

123

246

Need for other prophylactic measures

436

1763

2.81

73.88

4.6

4.3

14.32

21.97

ug/l

0.35

355

1447

Crohn's disease (strict) with PSC

82.82

73.54

7.1

4.1

2.08

2.55

ug/l

0.48

Diabetes mellitus

5942

27027

1.31

73.32

3.7

4.1

24.10

25.01

ug/l

0.08

4929

21241

Intestinal infectious diseases

6800

30782

1.29

72.14

3.9

4.0

17.83

26.48

ug/l

1.97

5392

24649

Ulcerative colitis (strict definition, require KELA)

920

4977

1.96

71.58

5.1

4.1

8.77

30.99

ug/l

2.16

715

3958

Insulin, combination of fast acting with intermediate-acting or long-acting

3721

25172

1.39

71.06

3.9

4.0

20.18

26.80

ug/l

0.91

3218

20372

Speech therapy

1745

11298

1.63

70.93

3.4

4.0

14.51

25.52

ug/l

1.45

1455

9170

Intestinal infectious diseases

5407

31847

1.32

70.91

3.9

4.0

18.49

26.16

ug/l

1.39

4293

25437

Functional dyspepsia

1650

10533

1.65

70.39

3.1

4.1

15.06

24.95

ug/l

1.05

1285

8463

Endometroid carcinoma of ovary

13.56

70.12

2.7

1.5

3.15

2.63

ug/l

0.51

Infections, IBD-co-morbidities

1108

4486

1.87

70.12

3.7

5.0

22.61

42.98

ug/l

0.95

909

3600

Diabetes medication

6037

28089

1.30

69.99

3.7

4.0

24.65

24.52

ug/l

0.01

4987

22138

Chronic gastritis

1871

12357

1.60

69.40

3.2

4.1

14.26

25.32

ug/l

1.59

1496

10243

Benign neoplasm: Small intestine

378

1501

3.04

68.93

3.6

4.2

7.69

21.10

ug/l

1.31

311

1243

Other special examinations and investigations of persons without complaint or reported diagnosis

3696

13651

1.40

68.70

3.7

4.3

22.33

33.10

ug/l

0.98

3017

10889

Follow-up examination after treatment for conditions other than malignant neoplasms

2570

11763

1.49

68.69

3.3

4.2

16.73

29.70

ug/l

1.54

2006

9328

Persons encountering health services for specific procedures, not carried out

487

2119

2.49

68.34

4.3

3.8

9.70

13.69

ug/l

0.31

400

1666

Transplanted organ and tissue status

616

2983

2.25

67.22

3.6

4.3

6.18

24.44

ug/l

3.05

510

2453

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

973

5480

1.87

66.39

5.0

4.2

17.87

30.25

ug/l

0.51

759

4363

Codeine or tramadol medication

6644

29004

1.28

66.08

3.6

4.1

15.14

25.32

ug/l

2.97

5336

23121

Other complications of surgical and medical care, not elsewhere classified

645

3201

2.19

65.97

5.3

3.8

59.95

24.44

ug/l

0.32

516

2565

Primary_lymphoid and hematopoietic malignant neoplasms

1601

10349

1.64

65.81

2.8

4.1

9.11

25.43

ug/l

4.97

1200

8596

Other heart diseases, wide

5049

23899

1.32

65.26

3.7

4.2

18.38

27.38

ug/l

1.36

3998

18883

Benign neoplasm: Rectosigmoid junction

375

1524

2.94

64.96

4.7

4.1

10.18

21.19

ug/l

0.99

297

1262

Other diseases of urinary system

5917

26255

1.29

64.78

3.7

4.1

14.77

28.30

ug/l

3.73

4669

21077

Abnormal findings on examination of blood, without diagnosis

2893

19217

1.43

64.61

3.5

4.2

32.77

27.17

ug/l

0.19

2369

15846

Autoimmune diseases excluding thyroid diseases

6023

25996

1.29

64.27

3.8

4.1

23.13

25.34

ug/l

0.19

4857

20740

Autoimmune diseases excluding thyroid diseases, strict definition

5855

25315

1.29

63.48

3.8

4.1

21.96

25.64

ug/l

0.35

4718

20217

Alcoholic liver disease

687

3553

2.12

63.21

3.1

4.5

13.50

28.37

ug/l

1.66

609

2971

Type 2 diabetes

5784

26737

1.29

62.69

3.7

4.1

24.18

25.13

ug/l

0.08

4791

21087

Phlebitis and thrombophlebitis (not including DVT)

1449

9317

1.64

60.59

4.5

4.0

16.64

27.29

ug/l

1.01

1181

7530

Chronic kidney disease

1968

13238

1.53

60.25

3.0

4.0

17.12

23.71

ug/l

0.68

1682

11010

Asthma, excluding more controls

4014

15811

1.35

60.01

3.4

4.3

14.66

26.38

ug/l

1.68

3238

12346

Noninfectious colitis NAS

830

4617

1.92

59.82

4.6

3.9

19.59

32.37

ug/l

0.68

669

3693

Acute peritonitis

466

2134

2.44

59.67

5.0

4.1

46.15

16.42

ug/l

0.96

402

1764

Disorders of mineral metabolism

593

2973

2.19

59.64

3.7

4.1

35.58

24.03

ug/l

0.50

503

2408

Abnormal weight loss

647

3353

2.12

59.52

2.4

4.0

10.33

22.32

ug/l

1.04

523

2737

Diseases of arteries, arterioles and capillaries (FINNGEN)

1478

6537

1.64

59.03

3.4

4.5

29.60

24.06

ug/l

0.24

1237

5241

Weight loss

684

3617

2.07

59.01

2.5

4.0

11.59

21.36

ug/l

0.84

553

2947

Non-follicular lymphoma

695

3712

2.07

58.80

2.3

4.1

9.90

20.74

ug/l

1.42

488

3092

Paralytic ileus

301

1137

3.04

58.79

5.3

4.0

14.65

25.91

ug/l

0.49

257

948

Unspecified haematuria

2658

15945

1.43

58.57

3.8

4.1

22.95

30.81

ug/l

0.47

2177

13220

Asthma

4219

16894

1.34

58.43

3.4

4.3

15.53

25.81

ug/l

1.40

3415

13236

Vitamin B12 deficiency anaemia

743

4053

1.99

58.00

4.7

3.8

13.69

24.00

ug/l

1.19

638

3329

Infections of the skin and subcutaneous tissue

3085

22680

1.38

57.96

3.9

4.1

19.72

25.84

ug/l

0.71

2509

18137

Hepatic failure, not elsewhere classified

309

1203

3.00

57.52

3.2

4.1

10.36

23.43

ug/l

0.87

265

992

Other ulcerative colitis

366

1524

2.65

57.41

5.8

4.2

6.22

23.46

ug/l

1.82

292

1230

Type 2 diabetes, definitions combined

5632

26381

1.28

57.12

3.7

4.1

23.19

25.33

ug/l

0.20

4657

20863

Diseases of peritoneum

692

3723

2.02

56.51

4.5

3.9

41.94

22.57

ug/l

0.66

576

3016

Intestinal malabsorption

333

1346

2.80

56.46

4.3

13.66

21.05

ug/l

0.35

291

1089

Haemorrhage from respiratory passages

2233

14283

1.46

55.84

3.5

4.3

17.04

29.48

ug/l

1.30

1833

11852

Crohn disease

698

3748

1.98

55.80

4.2

4.1

7.98

33.31

ug/l

1.85

536

2961

Benign neoplasm of ovary

1165

7313

1.70

54.92

3.1

3.8

15.07

18.87

ug/l

0.19

902

5783

Endocrine, nutritional and metabolic diseases

4103

15918

1.33

54.85

3.8

4.3

30.23

23.51

ug/l

0.32

3270

12420

Volume depletion

646

3432

2.04

54.48

4.4

4.0

14.47

23.38

ug/l

1.09

553

2847

Symptoms and signs involving the circulatory and respiratory systems

5486

21878

1.28

54.42

3.6

4.2

21.11

27.99

ug/l

0.87

4330

17391

Type 2 diabetes, strict (exclude DM1)

5651

26646

1.27

54.16

3.7

4.1

23.12

25.15

ug/l

0.19

4673

21099

Cardiac arrhythmias

3094

14941

1.38

53.90

3.6

4.2

14.93

25.81

ug/l

1.54

2406

11475

Persons encountering health services in other circumstances

2112

14840

1.46

53.83

3.7

3.9

14.88

28.18

ug/l

2.29

1764

11854

Chronic hepatitis, not elsewhere classified

270

1015

3.08

53.56

4.3

4.1

3.04

21.57

ug/l

2.32

225

826

Later onset COPD, excluding more controls

1452

7376

1.61

53.46

3.0

4.3

32.54

24.31

ug/l

0.42

1285

6106

Atrial fibrillation and flutter

1795

7897

1.53

53.33

3.6

4.4

14.16

24.22

ug/l

0.97

1460

6264

Other diseases of stomach and duodenum

474

2289

2.30

53.14

4.3

9.12

21.72

ug/l

1.59

400

1874

L04AD Calcineurin inhibitors

621

3282

2.03

52.81

3.5

4.3

13.31

26.32

ug/l

0.76

506

2639

Mucinous and mucinous cystic tumor

13.23

52.77

2.2

1.4

15.07

2.44

ug/l

1.27

Ulcerative ileocolitis

270

1027

2.95

51.41

6.2

4.3

13.11

27.14

ug/l

0.56

205

834

Asthma (mode)

4097

17001

1.32

51.24

3.4

4.3

18.40

25.68

ug/l

0.68

3294

13335

Disorders of calcium metabolism

466

2271

2.28

51.07

3.2

4.1

41.77

23.50

ug/l

0.69

397

1846

Autoimmune diseases related-to ILD

4734

32283

1.28

51.04

3.6

4.0

29.65

23.89

ug/l

0.42

3748

25769

Disorders of breast

2716

18341

1.38

50.43

3.5

3.7

13.58

22.00

ug/l

1.47

2067

14181

Type 2 diabetes, definitions combined, including avohilmo

5581

26307

1.26

49.73

3.7

4.1

24.15

25.12

ug/l

0.08

4608

20800

Alcohol use disorder, Swedish definition

2983

20653

1.36

49.71

3.3

4.3

23.56

26.70

ug/l

0.21

2581

16698

Early onset COPD, excluding more controls

1213

7819

1.63

49.62

3.0

4.5

21.69

23.61

ug/l

0.10

1075

6359

Malignant neoplasm of oral cavity, including Hilmo

207

687

3.28

49.55

3.4

1.4

6.02

2.67

ug/l

1.72

187

509

Other embolism and thrombosis

839

4963

1.81

49.48

4.7

3.9

15.87

24.17

ug/l

0.95

713

4026

Other (not insulin) diabetes medications

5721

27580

1.25

49.38

3.6

4.1

24.84

24.74

ug/l

0.01

4702

21855

Nonalcoholic fatty liver disease

591

3149

2.02

49.34

3.0

4.2

4.37

22.96

ug/l

3.53

457

2525

Renal cell carcinoma of kidney

169

499

3.74

49.19

2.7

1.3

14.27

2.79

ug/l

0.90

136

373

Retention of urine

2129

12556

1.45

49.02

3.9

4.1

19.91

28.45

ug/l

0.80

1775

10501

Symptoms and signs involving cognition, perception, emotional state and behaviour

5546

30714

1.25

48.93

3.4

4.1

15.75

26.82

ug/l

2.66

4442

24568

Asthma (only as main-diagnosis), excluding more controls

3599

15811

1.33

48.58

3.3

4.3

21.72

26.38

ug/l

0.31

2922

12346

Sequelae of external causes of morbidity and mortality

1561

10695

1.53

48.30

4.2

4.1

19.03

25.83

ug/l

0.36

1242

8744

Sequelae with surgical and medical care as external cause

1285

8481

1.60

48.18

4.2

4.1

21.63

24.39

ug/l

0.11

1023

6929

Chronic apical periodontitis

6370

29847

1.24

48.15

3.9

4.0

21.61

26.22

ug/l

0.57

5145

23787

Benign neoplasm: Duodenum

249

966

3.16

48.07

3.4

4.3

8.37

25.01

ug/l

1.03

201

816

Syncope and collapse

2549

16178

1.39

47.77

3.4

4.0

17.20

24.32

ug/l

0.81

2055

13138

Fall on same level

6327

28398

1.24

47.61

3.7

4.1

20.87

26.45

ug/l

0.69

5082

22544

Headache

3295

20182

1.33

47.60

3.2

3.9

22.71

22.95

ug/l

0.01

2551

15870

Pain in joint

3026

14566

1.35

47.34

3.3

4.3

15.17

29.22

ug/l

1.81

2334

11772

Biguanides

5640

28035

1.25

47.33

3.6

4.1

24.27

24.61

ug/l

0.03

4634

22308

Papillary adenocarcinoma of thyroid gland

211

727

3.12

47.12

3.6

1.4

8.82

2.65

ug/l

0.56

153

540

Other bacterial intestinal infections

1103

7089

1.64

46.19

3.8

4.0

18.12

31.80

ug/l

1.16

909

5805

Paracetamol or NSAID medication

810

2315

1.81

45.78

4.1

4.0

26.58

37.46

ug/l

0.41

667

1829

Dialysis, with operation codes

760

4470

1.82

45.71

3.1

4.3

10.57

25.17

ug/l

1.99

640

3723

Neuroendocrine tumor and carcinoma of lung

115

8.06

45.67

2.6

1.4

24.14

2.61

ug/l

0.50

COPD

2930

18304

1.35

45.54

3.0

4.2

28.35

25.62

ug/l

0.19

2583

15058

Streptococcal septicaemia

548

2926

2.02

45.53

3.7

3.9

28.35

18.72

ug/l

0.30

447

2404

Osteopathies and chondropathies

3277

23678

1.32

45.48

3.6

4.0

17.32

24.20

ug/l

1.06

2703

19068

Insulin, fast-acting

1953

14035

1.44

45.48

3.8

4.1

18.55

25.82

ug/l

0.63

1669

11339

Viral Sepsis

1196

7857

1.60

45.24

3.2

4.0

8.14

23.79

ug/l

5.35

979

6412

Asthma (only as main-diagnosis)

3742

16894

1.31

45.22

3.3

4.3

21.82

25.81

ug/l

0.27

3050

13236

Cerebrovascular diseases (FINNGEN)

1697

8345

1.48

45.17

3.6

4.3

25.97

28.13

ug/l

0.08

1420

6532

Implicit viral Sepsis

1193

7845

1.59

44.93

3.2

4.0

8.16

23.82

ug/l

5.34

976

6402

Unspecified misadventure during surgical and medical care

384

1828

2.34

44.85

5.1

4.1

38.45

22.81

ug/l

0.20

319

1509

Implicit viral Sepsis

1708

12050

1.47

44.76

3.3

4.0

9.47

26.01

ug/l

4.04

1393

9834

Budesonide

786

4678

1.77

44.58

3.7

4.1

3.95

31.69

ug/l

2.83

597

3699

Other bacterial intestinal infections

1345

9081

1.55

44.52

3.7

4.0

17.98

27.15

ug/l

0.85

1088

7420

Anosmia

115

267

4.58

44.52

3.7

1.7

8.74

2.38

ug/l

1.43

100

196

Ulcerative colitis (strict definition, all Crohn cases excluded)

720

4180

1.81

44.37

4.9

4.1

9.09

33.31

ug/l

1.88

572

3305

Genitourinary diseases

2882

10859

1.36

44.18

4.2

4.5

21.93

41.80

ug/l

2.29

2316

8839

Non-small cell lung cancer, squamous, helper endpoint

366

1723

2.37

43.98

2.6

3.8

7.86

29.20

ug/l

2.57

334

1454

Benign neoplasm: Appendix

136

397

4.69

43.79

3.6

4.0

4.11

38.55

ug/l

1.09

110

340

Hyperlipidaemia, other/unspecified

2469

17083

1.38

43.71

3.5

4.2

33.84

24.36

ug/l

0.32

2015

14113

Diseases of the respiratory system

3774

14814

1.30

43.14

4.0

4.2

19.95

24.13

ug/l

0.37

3037

11671

3076

21496

1.32

43.03

3.4

4.2

23.97

27.17

ug/l

0.22

2663

17332

Carcinoma in situ of breast, intraductal

604

3412

1.94

43.03

3.5

3.8

19.21

22.91

ug/l

0.14

468

2709

Other reaction to severe stress, and adjustment disorders

1678

11834

1.46

42.99

4.1

4.0

25.81

24.20

ug/l

0.08

1330

9071

Abscess of anal and rectal regions

443

2230

2.11

42.96

5.4

4.2

28.05

27.40

ug/l

0.02

351

1818

Alcohol-induced chronic pancreatitis

410

2034

2.21

42.58

3.3

4.6

28.49

23.41

ug/l

0.11

369

1693

3207

21985

1.31

42.47

3.4

4.2

23.50

27.24

ug/l

0.28

2773

17690

Cholecystitis

843

5187

1.72

42.42

4.0

3.9

17.60

23.67

ug/l

0.51

722

4226

Nephropathy related operations

726

4316

1.80

42.11

3.2

4.3

10.82

25.54

ug/l

1.88

609

3582

Heart failure and antihypertensive medication

1496

6738

1.51

41.92

3.2

4.6

13.11

31.42

ug/l

3.28

1253

5438

Malignant neoplasm of cervix uteri, including Hilmo

118

304

4.28

41.84

3.5

1.4

5.10

2.65

ug/l

1.38

222

Other chronic obstructive pulmonary disease

2802

17764

1.34

41.59

3.0

4.2

29.21

25.67

ug/l

0.24

2475

14617

Low back pain

4171

24028

1.27

41.58

3.4

4.3

21.35

26.46

ug/l

0.49

3286

19135

691

4041

1.79

41.53

4.1

3.9

6.69

35.96

ug/l

2.25

534

3169

Bacterial intestinal infections, IBD co-morbidities

1103

7268

1.59

41.39

3.8

4.0

18.21

26.85

ug/l

0.82

905

5925

Morphin

176

607

3.43

41.29

4.8

3.7

14.62

10.72

ug/l

0.28

155

509

Explicit bacterial Sepsis

637

3668

1.85

41.14

3.9

4.1

29.37

27.48

ug/l

0.05

523

3019

Unspecified lump in breast

954

6107

1.65

41.12

3.8

3.7

7.68

26.63

ug/l

2.17

734

4789

Other CVD (FINNGEN)

747

3451

1.78

41.06

3.5

4.5

22.31

27.74

ug/l

0.17

619

2815

Pneumothorax

445

2299

2.10

41.03

4.2

4.3

39.05

25.79

ug/l

0.31

376

1907

Polyarthropathies

3873

20138

1.28

40.99

3.3

4.3

20.54

29.91

ug/l

1.14

3106

16170

Other antidepressants

5900

25043

1.23

40.79

3.6

4.2

22.42

26.91

ug/l

0.32

4737

20048

Heart failure,strict

3331

18482

1.31

40.60

3.1

4.3

14.76

27.03

ug/l

3.16

2792

15261

Periodontitis

5587

30978

1.23

40.50

4.0

18.86

26.09

ug/l

1.22

4564

24796

Haemorrhoids and perianal venous thrombosis

1786

12877

1.43

40.49

3.5

3.9

19.85

29.75

ug/l

0.70

1456

10561

Other Crohn's disease

357

1699

2.25

40.41

4.7

4.2

5.47

16.94

ug/l

1.79

269

1342

DVT of lower extremities

1178

7942

1.56

39.81

4.4

4.0

43.88

26.76

ug/l

0.64

966

6492

Vascular disorders of the intestines

446

2333

2.08

39.69

3.2

3.8

7.42

27.98

ug/l

3.15

368

1941

Chronic periodontitis, including avohilmo

5564

30975

1.23

39.59

4.0

18.93

26.09

ug/l

1.20

4542

24799

Used for control exclusion in common control thyroid runs

5800

24318

1.22

39.18

3.8

4.1

17.92

26.21

ug/l

1.34

4631

19428

Other and unspecified abdominal hernia

304

1397

2.45

39.12

6.7

4.0

10.87

14.72

ug/l

0.32

262

1154

Malignant neoplasm of oral cavity

151

480

3.43

39.01

3.4

1.5

6.38

2.71

ug/l

1.28

135

357

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

529

2933

1.93

38.94

5.3

3.9

69.19

20.50

ug/l

0.39

446

2342

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

170

5.68

38.93

4.4

1.6

44.21

2.60

ug/l

0.78

128

Other disorders of skin and subcutaneous tissue

4078

29395

1.26

38.47

3.4

4.0

14.58

26.44

ug/l

2.90

3299

23768

Other chronic obstructive pulmonary disease, including avohilmo

3336

21887

1.30

38.39

3.0

4.2

33.21

25.18

ug/l

0.69

2930

18001

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

134

402

3.70

38.26

2.1

1.3

4.29

2.81

ug/l

0.56

106

294

Multiple myeloma

134

402

3.70

38.26

2.1

1.3

4.29

2.81

ug/l

0.56

106

294

Cutaneous abscess, furuncle and carbuncle

1298

8950

1.50

38.19

4.0

4.1

19.13

27.24

ug/l

0.63

1072

7170

Chronic lymphocytic leukaemia

139

428

3.59

38.06

3.4

1.4

8.24

2.80

ug/l

0.75

106

310

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

139

428

3.59

38.06

3.4

1.4

8.24

2.80

ug/l

0.75

106

310

Chronic lymphocytic leukaemia, helper endpoint

139

428

3.59

38.06

3.4

1.4

8.24

2.80

ug/l

0.75

106

310

Diseases of the skin and subcutaneous tissue

5714

23822

1.22

38.01

3.7

4.2

24.11

26.56

ug/l

0.18

4560

19021

Azathioprine

754

4633

1.70

37.63

3.9

4.2

12.97

27.29

ug/l

0.94

596

3642

Malignant cancer of tonsil and base of tongue, including Hilmo

117

325

3.99

37.47

3.5

1.4

22.52

2.71

ug/l

0.88

243

Cystitis

4855

23737

1.24

37.44

3.6

4.0

14.50

27.30

ug/l

3.17

3784

19010

Other CVD

1250

8640

1.52

37.39

3.2

3.9

16.74

23.40

ug/l

0.45

1021

7160

Irritable bowel syndrome

1342

9342

1.48

37.36

2.7

3.8

10.50

28.07

ug/l

2.42

1003

7364

Benign neoplasm: Endocrine pancreas

218

6.18

37.20

3.0

4.8

2.86

27.32

ug/l

0.71

186

Symptoms and signs involving the skin and subcutaneous tissue

3908

31057

1.26

36.71

3.5

4.0

11.27

26.16

ug/l

6.28

3127

24830

ILD medications: azathioprine

754

4667

1.69

36.57

3.9

4.2

12.97

27.32

ug/l

0.95

596

3679

Crohn's disease NAS

347

1701

2.19

36.55

4.6

4.2

11.10

24.17

ug/l

1.00

276

1359

COPD, hospital admissions

2806

18582

1.32

36.34

3.0

4.2

28.60

25.21

ug/l

0.24

2473

15382

Insulin, fast-acting or short human

1959

14607

1.38

36.30

3.8

4.0

18.69

26.21

ug/l

0.67

1674

11846

Hypercalcemia

323

1572

2.32

36.24

3.3

4.1

32.56

20.51

ug/l

0.53

276

1303

Dorsalgia

5444

24275

1.22

36.08

3.4

4.3

17.26

26.43

ug/l

1.58

4307

19330

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

492

2746

1.94

35.96

4.2

4.0

8.66

20.31

ug/l

1.80

404

2232

Atrial fibrillation and flutter with reimbursement

1502

6770

1.46

35.89

3.4

4.5

10.48

24.21

ug/l

2.42

1209

5438

Lower back pain or/and sciatica

5821

31966

1.21

35.84

3.3

4.1

19.60

25.60

ug/l

0.82

4601

25568

COPD, early/later onset

2828

18721

1.31

35.82

3.0

4.2

29.17

25.14

ug/l

0.30

2495

15502

Autoimmune diseases

6095

26076

1.21

35.65

3.8

4.1

20.26

25.29

ug/l

0.66

4882

20801

Disorders of eyelid, lacrimal system and orbit

4912

30989

1.23

35.60

3.5

4.0

15.54

26.09

ug/l

2.27

3913

24889

Dizziness and giddiness

4367

28455

1.24

35.57

3.3

4.1

17.38

27.37

ug/l

1.71

3495

22932

Malignant neoplasm of brain, including Hilmo

175

636

2.91

35.31

2.8

1.5

36.08

2.68

ug/l

0.62

131

468

Leiomyosarcoma, including Hilmo

131

6.25

35.27

2.2

1.4

2.40

2.60

ug/l

0.23

103

Malignant neoplasm of renal pelvis, including Hilmo

165

5.46

35.17

3.4

1.3

32.44

2.81

ug/l

0.57

128

Benign neoplasm: Adrenal gland

516

2953

1.90

35.10

3.5

4.1

28.49

21.97

ug/l

0.16

435

2416

Asthma (diagnoses ohter than nonallergic)

4711

32414

1.22

34.85

3.3

4.0

14.37

26.12

ug/l

2.63

3859

25782

Malignant neoplasm of eye, brain and central nervous system

159

554

3.06

34.77

2.5

1.6

2.98

2.76

ug/l

0.28

113

410

Rare circulating lymphoid malignancy, including Hilmo

123

370

3.60

34.65

3.1

1.4

15.64

2.70

ug/l

0.53

272

Other other unspecified disorders of the circulatory system

273

1265

2.43

34.55

3.5

4.2

11.27

24.79

ug/l

1.05

214

1046

Small cell lung cancer, helper endpoint

207

853

2.80

34.45

2.1

4.0

32.96

29.77

ug/l

0.08

190

731

Benign neoplasm: Stomach

647

3961

1.76

34.27

3.3

4.0

4.21

25.12

ug/l

4.67

518

3212

Other and unspecified drugs and medicaments

503

2882

1.87

33.42

5.4

4.0

72.57

20.89

ug/l

0.40

424

2309

Malignant neoplasm of bone and articular cartilage

126

6.11

33.35

4.4

1.7

3.99

2.63

ug/l

0.68

Anaemia in chronic diseases classified elsewhere

188

755

2.89

33.12

2.8

4.1

184.69

27.21

ug/l

0.54

161

626

Carcinoid syndrome

113

352

4.35

33.10

3.5

4.5

12.47

45.32

ug/l

0.79

301

Suppurative and necrotic conditions of lower respiratory tract

362

1886

2.10

32.99

3.1

4.2

8.14

30.46

ug/l

2.54

309

1578

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

589

3557

1.77

32.43

4.5

4.0

13.92

22.17

ug/l

0.38

483

2880

Myelodysplastic syndrome, including Hilmo

137

460

3.25

32.43

2.6

1.4

12.70

2.82

ug/l

0.56

105

342

Follow-up care involving plastic surgery

247

1123

2.42

32.17

3.7

3.5

23.79

17.32

ug/l

0.17

183

884

Primary biliary cholangitis (PBC)

191

792

2.83

31.82

3.9

4.1

3.39

25.01

ug/l

1.42

144

645

Leiomyoma of uterus

3487

15986

1.26

31.80

3.4

3.7

19.65

22.24

ug/l

0.20

2652

12471

Marginal zone B-cell lymphoma, including Hilmo

240

4.32

31.74

2.3

1.4

2.98

2.67

ug/l

0.21

183

Enterocolitis due to Clostridium difficile

655

4084

1.70

31.68

3.4

3.8

22.94

23.46

ug/l

0.02

542

3340

Malignant neoplasm of eye and adnexa, including Hilmo

231

4.35

31.63

3.3

1.4

31.91

2.80

ug/l

0.61

177

Other metabolic disorders

722

4593

1.65

31.63

3.5

4.0

72.87

21.43

ug/l

0.53

555

3598

Bacterial pneumoniae

2280

15588

1.32

31.60

3.8

4.0

29.09

28.98

ug/l

0.01

1923

12673

Malignant neoplasm of tongue, including Hilmo

118

370

3.49

31.32

3.5

1.5

5.22

2.77

ug/l

1.88

108

276

Asthma-related pneumonia or sepsis

2074

15941

1.33

30.98

3.3

3.9

11.15

23.15

ug/l

3.29

1760

12928

Asthma, hospital admissions 3, pneumonia

2074

15941

1.33

30.98

3.3

3.9

11.15

23.15

ug/l

3.29

1760

12928

Asthma-related pneumonia

2071

15919

1.33

30.94

3.3

3.9

11.16

23.14

ug/l

3.27

1758

12910

Exposure to unspecified factor

5342

32547

1.20

30.86

3.8

4.0

15.81

26.26

ug/l

2.28

4240

25986

Other infectious diseases

532

3165

1.79

30.86

4.3

4.0

29.47

19.23

ug/l

0.39

438

2595

Heart failure, strict

3649

21102

1.25

30.81

3.1

4.2

17.28

26.67

ug/l

1.40

3065

17499

Malignant neoplasm of testis, including Hilmo

173

4.71

30.67

5.4

2.0

4.20

2.49

ug/l

1.93

136

Alcohol-induced acute pancreatitis

236

1078

2.44

30.65

3.2

4.6

5.32

26.47

ug/l

1.88

203

901

All-cause Heart Failure

3606

20862

1.25

30.60

3.1

4.2

17.18

26.67

ug/l

1.40

3025

17303

Duodenal ulcer

663

4179

1.68

30.58

3.7

4.2

17.32

23.81

ug/l

0.34

566

3492

Smoking dependency

495

2895

1.82

30.57

2.9

4.2

8.65

27.96

ug/l

2.67

444

2343

Mental and behavioural disorders due to tobacco

495

2896

1.82

30.53

2.9

4.2

8.65

27.94

ug/l

2.67

444

2349

N06DA Anticholinesterases

1312

14189

0.71

30.52

2.8

3.8

13.57

21.88

ug/l

0.90

1053

11882

Use of anticholinesterases

1312

14189

0.71

30.52

2.8

3.8

13.57

21.88

ug/l

0.90

1053

11882

Liposarcoma, including Hilmo

141

5.50

30.35

3.5

1.5

3.19

2.61

ug/l

0.60

109

Diarrhoea and gastroenteritis of presumed infectious origin

5489

30758

1.19

29.86

3.9

4.0

16.94

26.52

ug/l

2.09

4309

24589

Coagulation defects, purpura and other haemorrhagic conditions

1019

7059

1.50

29.75

3.7

4.0

12.55

28.19

ug/l

1.67

807

5695

Adjustment and management of implanted device

982

6757

1.51

29.75

2.9

3.7

18.73

12.74

ug/l

0.46

768

5538

Bacterial pneumonia, not elsewhere classified

2170

14853

1.32

29.62

3.8

4.0

26.12

27.37

ug/l

0.06

1831

12077

Ulcerative enterocolitis

194

825

2.60

29.47

5.3

4.3

4.00

27.12

ug/l

1.55

148

678

Spondylopathies

4654

23333

1.21

29.32

3.2

4.3

27.93

27.02

ug/l

0.04

3794

18784

Hyperkalaemia

370

2026

1.98

28.92

4.3

4.0

89.93

28.24

ug/l

0.34

316

1675

Purpura and other haemorrhagic conditions

730

4760

1.61

28.90

3.8

4.0

15.48

23.12

ug/l

0.66

599

3873

Disorders of lens

4026

20876

1.23

28.84

3.9

4.2

18.28

30.00

ug/l

1.91

3296

16954

Heartburn

541

3280

1.73

28.66

3.6

4.0

7.05

22.84

ug/l

2.17

421

2617

ILD medications: immunosuppressive drugs

3294

25031

1.24

28.64

3.3

4.2

27.70

23.86

ug/l

0.21

2609

19844

Other symptoms and signs involving the urinary system

603

3777

1.69

28.62

3.6

4.3

20.52

25.94

ug/l

0.18

531

3130

External causes of morbidity and mortality

3624

14850

1.24

28.52

3.9

4.0

28.35

30.65

ug/l

0.08

2871

11743

Barrett oesophagus

328

1742

2.07

28.50

3.5

4.4

8.97

24.32

ug/l

1.49

267

1434

Other arrhythmias

3508

21753

1.24

28.46

3.5

4.2

13.01

28.13

ug/l

4.03

2764

17414

Congenital malformations of gallbladder, bile ducts and liver

284

4.16

28.12

3.1

4.2

3.83

24.20

ug/l

0.77

238

Postprocedural endocrine and metabolic disorders, not elsewhere classified

663

4255

1.63

28.05

3.7

4.0

78.78

21.53

ug/l

0.55

511

3329

Malignant neoplasm of testis

148

4.86

28.00

5.7

2.0

4.46

2.47

ug/l

2.03

120

Mantle cell lymphoma, including Hilmo

193

4.45

27.88

3.1

1.5

22.11

2.69

ug/l

0.52

150

6441

28726

1.17

27.79

3.8

4.0

21.46

25.71

ug/l

0.42

5111

22946

Leiomyosarcoma

6.43

27.69

2.2

1.5

2.62

2.53

ug/l

0.08

All influenza

1282

9345

1.41

27.68

3.8

4.0

19.59

28.53

ug/l

0.52

1059

7590

Chronic lower respiratory diseases

6478

29815

1.17

27.53

3.3

4.2

20.17

25.21

ug/l

0.68

5329

23506

Faecal incontinence

526

3221

1.73

27.36

3.7

3.9

7.15

20.81

ug/l

1.94

408

2609

Endometriosis

1714

7583

1.36

27.12

3.3

4.1

15.43

31.36

ug/l

1.45

1280

5931

Asthma-related infections

3066

24548

1.24

27.05

3.2

4.0

12.14

24.62

ug/l

3.32

2545

19578

Asthma, hospital admission 2, infections

3066

24548

1.24

27.05

3.2

4.0

12.14

24.62

ug/l

3.32

2545

19578

Other diseases of pericardium

305

1611

2.07

26.90

3.5

4.5

15.64

28.99

ug/l

0.72

249

1332

Crohn's disease of large intestine

264

1313

2.15

26.90

4.6

4.3

3.10

23.08

ug/l

2.11

212

1055

Drug-induced polyneuropathy

290

4.14

26.81

6.1

4.1

4.50

23.09

ug/l

0.69

241

Senile cataract

3817

19474

1.23

26.77

3.9

4.2

18.35

29.39

ug/l

1.76

3150

15919

Vocal cord dysfunction

779

4672

1.55

26.72

4.1

4.6

8.67

34.60

ug/l

2.47

643

3670

Other disorders of kidney and ureter

754

5053

1.57

26.62

3.2

4.1

32.98

25.45

ug/l

0.18

608

4144

Colorectal squamous cell carcinoma

69.06

26.61

3.2

1.5

2.14

3.36

ug/l

0.72

Substance abuse, excluding more controls

2868

19854

1.25

26.53

3.2

4.3

24.52

26.88

ug/l

0.14

2479

15960

Other congenital malformations of the digestive system

249

1210

2.18

26.38

3.4

4.1

3.76

24.79

ug/l

2.19

186

978

Malignant neoplasm of larynx, including Hilmo

266

3.69

26.27

3.5

1.4

8.99

2.67

ug/l

1.75

197

Polyp of the female genital tract

1704

7427

1.35

26.21

3.5

4.1

16.04

31.68

ug/l

1.22

1287

5868

Other infectious diseases

446

2651

1.79

26.10

4.4

4.0

22.57

21.53

ug/l

0.04

362

2188

Adenocarcinoma and Papillary adenocarcinoma of kidney

139

5.02

25.82

3.4

1.4

3.16

2.68

ug/l

0.34

100

Malignant cancer of tonsil and base of tongue

276

3.62

25.62

3.6

1.5

23.52

2.70

ug/l

0.69

209

Thrombocytopenia, unspecified

419

2468

1.82

25.49

3.9

4.1

20.28

24.19

ug/l

0.16

342

2026

Unspecific neurodegenerative disorder

1777

15591

0.76

25.48

2.9

3.9

12.97

25.36

ug/l

2.01

1442

13071

Cough

2248

16933

1.28

25.47

3.5

4.3

13.37

27.13

ug/l

2.12

1762

13694

Abnormal serum enzyme levels

1705

12825

1.34

25.44

3.7

4.3

20.61

28.26

ug/l

0.65

1409

10788

Marginal zone B-cell lymphoma

142

5.07

25.40

2.1

1.4

2.46

2.69

ug/l

0.32

109

Diseases of spleen

138

545

2.93

25.25

3.1

4.5

24.47

32.01

ug/l

0.12

113

456

Other congenital malformations of the digestive system

213

993

2.28

25.21

3.6

4.2

3.86

26.29

ug/l

1.83

161

803

Benign neoplasm: Other and unspecified parts of small intestine

142

575

2.95

25.20

3.9

4.1

6.02

33.83

ug/l

1.26

122

487

Malignant neoplasm of thymus, including Hilmo

8.39

25.15

3.1

1.7

2.11

2.26

ug/l

0.23

Fissure and fistula of anal and rectal regions

1160

8459

1.41

25.01

3.8

4.0

18.68

29.47

ug/l

0.78

893

6806

Collagenous colitis

519

3246

1.69

24.95

4.1

4.0

11.13

23.66

ug/l

1.14

401

2606

Diseases of arteries, arterioles and capillaries

3964

24687

1.21

24.90

3.4

4.1

23.31

25.11

ug/l

0.15

3353

20240

Osteoporosis

1620

11653

1.35

24.83

3.4

3.8

12.15

21.80

ug/l

2.11

1354

9531

Fistulae involving female genital tract

135

536

2.94

24.55

5.9

4.2

8.45

29.83

ug/l

0.52

112

442

Non-ischemic cardiomyopathy

1958

12433

1.31

24.25

3.4

4.3

23.27

27.28

ug/l

0.23

1665

10328

Malignant neoplasm of ureter, including Hilmo

118

5.38

24.25

3.8

1.3

54.00

2.84

ug/l

0.80

Polyneuropathies and other disorders of the peripheral nervous system

1235

9180

1.40

24.25

3.3

4.2

57.36

22.96

ug/l

0.73

1015

7613

Candidiasis

1445

10968

1.35

24.09

3.4

4.0

35.85

24.47

ug/l

0.32

1148

8716

Other dorsopathies, not elsewhere classified

5389

24285

1.17

24.07

3.4

4.3

16.86

26.43

ug/l

1.78

4275

19336

Malignant neoplasm of larynx

200

4.02

23.94

3.3

1.4

9.36

2.81

ug/l

1.33

151

Care involving dialysis

386

2252

1.81

23.92

2.7

3.9

10.91

12.07

ug/l

0.06

329

1828

Secondary hypertension

405

2362

1.78

23.85

2.8

4.4

5.19

22.03

ug/l

3.14

321

1906

Pyothorax

270

1426

2.07

23.82

3.0

4.3

9.58

21.93

ug/l

1.06

229

1191

Mental and behavioural disorders due to psychoactive substance use

2953

22564

1.23

23.80

3.3

4.2

24.31

26.16

ug/l

0.12

2553

18113

Substance use, excluding alcohol

850

5922

1.48

23.75

2.8

4.4

8.82

28.89

ug/l

2.43

733

4677

Dementia

1868

16252

0.77

23.68

2.9

4.0

14.39

25.56

ug/l

1.65

1523

13607

Malignant neoplasm of oropharynx, including Hilmo

290

3.43

23.66

3.4

1.5

28.43

2.64

ug/l

0.84

223

Substance abuse

2868

22179

1.24

23.66

3.2

4.2

24.52

26.10

ug/l

0.09

2479

17808

Continuous positive airway pressure

1032

6267

1.43

23.52

3.2

4.6

22.19

23.44

ug/l

0.04

853

5041

Unspecified kidney failure

611

4025

1.60

23.50

3.3

3.9

37.16

25.00

ug/l

0.32

525

3365

Disorders of choroid and retina

4661

28409

1.18

23.50

3.6

4.1

22.10

26.89

ug/l

0.53

3799

23098

Benign neoplasm of other and unspecified endocrine glands

731

4994

1.53

23.43

3.6

4.0

28.67

24.04

ug/l

0.14

603

4025

Granulosa cell carcinoma of ovary

8.14

23.38

1.3

1.7

6.62

2.19

ug/l

0.50

Malignant neoplasm of cervix uteri

185

4.09

23.30

3.5

1.4

6.18

2.72

ug/l

0.99

133

Convulsions, not elsewhere classified

1009

7168

1.42

23.29

3.8

4.0

12.73

25.06

ug/l

1.83

834

5713

Fungal Sepsis

257

1349

2.08

23.10

3.9

4.1

68.99

27.10

ug/l

0.41

211

1106

Malignant neoplasm of eye and adnexa

119

5.20

23.01

2.6

1.4

3.18

2.62

ug/l

0.49

Other diseases of gallbladder

275

1477

2.02

22.93

3.6

4.1

10.72

22.19

ug/l

0.84

216

1213

Presence of other functional implants

3453

20087

1.22

22.85

3.7

4.0

24.02

30.39

ug/l

0.54

2815

16507

Malignant neoplasm of tongue

261

3.52

22.76

3.6

1.5

4.81

2.76

ug/l

1.46

195

Gout

1668

11451

1.32

22.69

3.3

4.4

22.27

31.45

ug/l

0.58

1381

9673

Paroxysmal tachycardia

1096

6707

1.40

22.67

3.7

4.4

10.65

26.28

ug/l

1.60

868

5274

Injury, poisoning and certain other consequences of external causes

2940

12099

1.24

22.43

3.9

4.1

34.88

32.02

ug/l

0.08

2340

9531

Liposarcoma

5.65

22.30

3.6

1.7

3.45

2.59

ug/l

0.82

Viral infections characterized by skin and mucous membrane lesions

4449

32671

1.18

22.21

3.8

4.0

20.95

25.17

ug/l

0.22

3528

26057

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

119

5.15

22.14

2.8

1.3

2.63

2.79

ug/l

0.15

Brain meningioma, including Hilmo

177

809

2.30

22.14

3.6

1.4

25.07

2.72

ug/l

0.60

143

597

Dementia, including avohilmo

2010

17193

0.78

22.12

2.9

4.0

14.98

24.82

ug/l

1.49

1651

14395

Injuries to the thorax

2419

19749

1.25

22.01

3.5

4.1

21.82

24.16

ug/l

0.16

1999

16159

Implicit fungal Sepsis

402

2441

1.76

21.96

3.4

4.0

52.51

22.88

ug/l

0.44

323

1977

Early onset COPD

1213

9130

1.37

21.85

3.0

4.4

21.69

24.93

ug/l

0.19

1075

7530

COPD related to multimorbidity

2340

16112

1.26

21.65

2.9

4.1

22.82

26.33

ug/l

0.31

2050

13367

Abnormal results of function studies

432

2674

1.70

21.44

3.7

4.1

11.85

20.71

ug/l

0.83

354

2148

Congenital malformation of biliary tract

9.43

21.40

3.8

4.2

3.59

11.32

ug/l

0.84

Bacterial pneumonia (organism specified)

2447

18185

1.24

21.31

3.8

4.0

28.26

24.84

ug/l

0.20

2054

14852

Haemorrhage, not elsewhere classified

246

1307

2.04

21.30

4.3

3.9

8.18

21.07

ug/l

1.30

200

1078

Valvular heart disease excluding rheumatic fever

2727

16275

1.23

21.29

3.5

4.4

26.23

27.47

ug/l

0.07

2214

13439

Alzheimer disease, including avohilmo

1509

13602

0.76

21.28

2.9

3.8

16.89

23.40

ug/l

0.60

1225

11393

Other disorders of ear

5144

29284

1.16

21.24

3.6

4.1

14.11

28.09

ug/l

3.92

4161

23520

Mantle cell lymphoma

114

5.02

21.20

2.1

1.4

2.84

2.60

ug/l

0.16

Polycythaemia vera

128

520

2.62

21.07

2.8

1.4

20.46

2.79

ug/l

0.53

102

381

Brain meningioma

169

774

2.30

21.06

3.4

1.4

26.13

2.71

ug/l

0.59

135

570

Essential (haemorrhagic) thrombocythaemia

135

562

2.55

21.04

2.9

1.4

4.26

2.72

ug/l

0.93

418

Malignant neoplasm of tonsil, including Hilmo

239

3.54

20.98

3.3

1.5

32.77

2.68

ug/l

0.83

186

Implicit fungal Sepsis

234

1233

2.07

20.86

3.8

4.1

72.33

19.37

ug/l

0.49

188

1012

Injuries to the head

5883

31733

1.15

20.84

3.6

4.0

9.00

27.68

ug/l

13.16

4740

25250

Abnormalities of heart beat

1895

14859

1.28

20.82

3.4

4.2

17.05

26.72

ug/l

1.11

1482

12017

Heart failure and bmi 25plus

1978

10702

1.28

20.81

3.2

4.2

16.67

24.21

ug/l

1.08

1641

8824

Non-rheumatic valve diseases

2717

16237

1.23

20.79

3.5

4.4

26.31

27.49

ug/l

0.07

2206

13417

Fracture of rib(s), sternum and thoracic spine

1637

12909

1.30

20.67

3.4

4.1

21.37

24.29

ug/l

0.16

1347

10650

Other and unspecified types of non-Hodgkin lymphoma, hilmo

273

1521

1.96

20.63

2.6

4.1

10.11

21.82

ug/l

0.89

213

1263

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

6.20

20.59

5.8

1.7

4.97

2.68

ug/l

0.78

Congenital ovarian cysts

191

930

2.18

20.56

2.9

3.6

5.64

13.54

ug/l

0.78

144

683

Scar conditions and fibrosis of skin

225

1170

2.07

20.55

3.5

4.2

3.31

26.48

ug/l

2.17

168

934

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

299

3.19

20.53

3.6

1.5

5.79

2.68

ug/l

1.76

223

Viral pneumonia

651

4454

1.52

20.46

3.4

4.1

8.78

28.91

ug/l

3.66

527

3638

Candidiasis

696

4828

1.50

20.46

3.7

3.9

34.81

34.77

ug/l

0.00

567

3842

Localized swelling, mass and lump of skin and subcutaneous tissue

1669

13201

1.30

20.46

3.7

4.0

13.90

24.78

ug/l

1.42

1342

10636

Cellulitis

1078

8040

1.38

20.39

3.8

4.1

19.25

27.61

ug/l

0.43

879

6515

Follicular adenocarcinoma of thyroid gland, including Hilmo

139

4.45

20.36

3.3

1.5

4.22

2.53

ug/l

0.44

106

Acute posthaemorrhagic anaemia

217

1123

2.10

20.30

3.1

3.8

7.24

22.04

ug/l

1.23

178

929

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

5.40

20.21

3.4

1.4

9.45

2.76

ug/l

1.35

Diagnoses used for exclusion with ILD

1394

10806

1.33

20.20

3.2

4.0

14.41

27.25

ug/l

1.12

1107

8891

Oesophageal obstruction

226

1192

2.07

20.14

3.9

4.4

86.72

13.99

ug/l

0.66

200

988

Malignant neoplasm of adrenal gland, including Hilmo

5.55

19.96

3.3

1.5

4.39

2.29

ug/l

0.72

Inflammatory diseases of female pelvic organs

2972

18296

1.21

19.92

3.4

3.7

13.49

22.00

ug/l

1.25

2250

14055

Dementia in Alzheimer disease

589

7254

0.66

19.88

2.6

3.7

27.26

26.71

ug/l

0.02

459

6095

Cyst of kidney

431

2740

1.68

19.78

3.1

4.2

34.47

24.46

ug/l

0.18

344

2268

Polyuria

1226

9377

1.35

19.76

3.4

4.1

12.84

28.13

ug/l

2.19

978

7756

Toxic colitis

101

6.25

19.74

6.6

4.2

25.23

7.56

ug/l

0.75

Seminoma of testis, including Hilmo

5.13

19.72

6.3

1.9

4.14

2.52

ug/l

1.26

Shoulder lesions

4412

23100

1.17

19.69

3.4

4.2

19.16

29.21

ug/l

1.43

3581

18665

Degenerative diseases of the nervous system

1439

13474

0.76

19.68

2.8

3.8

17.94

22.10

ug/l

0.33

1167

11265

Osteonecrosis due to drugs

121

512

2.80

19.68

7.0

4.3

27.66

33.85

ug/l

0.11

109

434

Other noninflammatory disorders of uterus, except cervix

1289

6653

1.35

19.52

3.5

4.1

14.39

33.63

ug/l

1.69

1004

5343

Familial hypercholesterolemia

898

6585

1.42

19.44

3.4

4.1

12.10

25.72

ug/l

2.19

773

5471

Any dementia

1665

14474

0.78

19.41

2.8

3.9

17.06

24.47

ug/l

0.77

1369

12099

COPD, hospital admission 2, with asthma infections

1850

12765

1.27

19.36

2.8

4.1

30.03

24.93

ug/l

0.30

1621

10626

Chronic hepatitis NAS

101

392

2.99

19.28

4.1

4.6

3.25

26.69

ug/l

1.20

327

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

697

3438

1.50

19.21

3.2

5.1

25.34

38.44

ug/l

0.45

576

2844

Other noninfective disorders of lymphatic vessels and lymph nodes

217

1145

2.05

19.19

4.0

4.1

7.09

25.96

ug/l

1.51

171

935

Malignant neoplasm of oropharynx

227

3.48

19.16

3.1

1.5

30.27

2.69

ug/l

0.66

174

Disorders of magnesium metabolism

252

3.73

19.16

7.7

5.1

40.65

49.44

ug/l

0.09

214

Covid-19 suspected case

916

6719

1.40

19.06

3.7

3.9

18.45

25.85

ug/l

0.28

731

5188

6-mercaptopurine

140

626

2.37

18.63

3.7

4.5

2.71

36.70

ug/l

1.53

109

501

Soft tissue disorders

5371

24268

1.15

18.47

3.5

4.2

18.22

28.41

ug/l

1.66

4278

19378

Hypotension

988

7427

1.38

18.20

3.1

3.8

18.34

24.82

ug/l

0.34

818

6169

Gout, unspecified

1159

8924

1.34

18.03

3.3

4.2

23.37

22.81

ug/l

0.02

963

7529

Alzheimer disease

1268

11877

0.76

18.00

2.7

3.7

17.57

22.19

ug/l

0.34

1018

9932

Gout, FINNGEN

1668

13386

1.28

17.92

3.3

4.2

22.27

26.28

ug/l

0.22

1381

11254

STROKE

3179

18384

1.19

17.87

3.6

4.4

27.63

25.66

ug/l

0.11

2593

14776

Diseases of pulp and periapical tissues, including avohilmo

5744

26293

1.14

17.86

3.8

4.0

19.71

27.86

ug/l

1.25

4624

20980

Any mental disorder

6107

27137

1.14

17.66

3.5

4.2

22.46

25.73

ug/l

0.36

4956

21627

Oesophagitis

302

1803

1.78

17.59

3.5

4.4

5.69

16.17

ug/l

1.97

244

1485

Other and unspecified polyneuropathies, also in other diseases

1053

8027

1.36

17.59

3.0

4.2

64.86

22.14

ug/l

0.79

867

6669

Congenital malformations of ovaries, fallopian tubes and broad ligaments

236

1304

1.90

17.59

3.2

3.7

5.42

38.47

ug/l

0.65

176

968

Persons encountering health services in circumstances related to reproduction

2463

13790

1.22

17.55

4.6

4.1

17.51

23.06

ug/l

0.51

1916

10853

Pneumonia due to other infectious organisms, not elsewhere classified

197

1038

2.06

17.54

4.4

4.0

14.00

21.17

ug/l

0.25

157

856

Excessive, frequent and irregular menstruation

1756

7700

1.27

17.51

3.3

4.1

20.77

31.10

ug/l

0.66

1343

5998

UC patients in KELA-register (code 208), prior to 1994

257

1476

1.88

17.43

5.4

4.3

6.67

21.14

ug/l

1.55

205

1219

Polycystic ovarian syndrome, consortium definition

3492

17731

1.18

17.25

3.3

3.7

19.14

21.32

ug/l

0.15

2683

13572

Pericarditis

214

1172

1.97

16.91

2.9

4.6

6.34

26.00

ug/l

1.75

168

971

Other abnormal uterine and vaginal bleeding

1214

6736

1.32

16.90

3.1

4.1

21.47

30.30

ug/l

0.35

960

5357

Gout, idiopatic and unspecified

1392

11057

1.30

16.89

3.3

4.2

20.25

23.73

ug/l

0.17

1158

9327

Acute myeloid leukaemia and myelodysplastic syndromes

288

2.98

16.85

2.8

1.3

3.28

2.66

ug/l

0.53

212

Crohn's disease of small intestine

297

1776

1.75

16.83

3.8

4.2

5.27

21.85

ug/l

2.25

214

1419

Volvulus

158

784

2.19

16.66

3.9

4.0

12.11

33.02

ug/l

1.00

135

646

Gout, strict definition

1019

7813

1.35

16.46

3.3

4.2

15.29

21.98

ug/l

0.41

850

6615

Malignant neoplasm of tonsil

212

3.36

16.43

3.2

1.5

32.86

2.68

ug/l

0.66

160

Hyperplasia of prostate

1913

8863

1.25

16.39

4.1

4.5

22.36

38.04

ug/l

1.30

1594

7554

Other endocrine disorders

203

1045

1.95

16.36

3.6

4.2

9.65

22.70

ug/l

0.84

150

834

Other misadventures during surgical and medical care

153

762

2.22

16.28

4.5

4.2

4.10

31.02

ug/l

1.68

119

638

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2136

17678

1.22

16.23

3.3

4.3

28.69

27.45

ug/l

0.05

1852

14370

Other intervertebral disc disorders

4520

23882

1.15

16.19

3.2

4.3

18.54

26.69

ug/l

1.10

3624

19093

Dentofacial anomalies [including malocclusion]

2323

22235

0.83

16.17

3.3

4.0

11.92

23.05

ug/l

1.26

1734

17353

Gingivitis and periodontal diseases

5704

26180

1.14

16.06

3.9

4.0

22.47

27.76

ug/l

0.53

4552

21042

Neuroendocrine tumor and carcinoma of stomach

5.56

16.03

2.8

1.3

13.40

2.49

ug/l

0.80

Special screening examination for neoplasms

322

2001

1.70

16.01

3.9

4.6

13.70

17.53

ug/l

0.16

266

1644

Haemangioma and lymphangioma, any site

451

3023

1.56

15.98

3.5

4.0

24.04

22.94

ug/l

0.03

352

2415

Seminoma of testis

5.03

15.86

7.2

2.0

4.64

2.31

ug/l

1.70

Intracranial trauma

2970

17827

1.19

15.80

3.5

4.5

11.08

29.89

ug/l

4.70

2378

14142

Invasive ventilation

373

2411

1.63

15.74

3.8

4.2

16.13

24.29

ug/l

0.42

307

1989

Emphysema

414

2742

1.59

15.73

3.0

4.2

13.20

25.94

ug/l

0.86

364

2278

Certain disorders involving the immune mechanism

930

7071

1.35

15.68

3.5

4.2

14.07

28.77

ug/l

1.28

708

5703

Complications following infusion, transfusion and therapeutic injection

102

438

2.62

15.64

5.5

4.0

6.08

20.04

ug/l

0.81

366

Hypertensive heart and/or renal disease

1472

8815

1.28

15.60

2.9

4.4

13.73

22.46

ug/l

1.22

1237

7326

Use of donepezil

706

9142

0.72

15.55

2.7

3.7

11.49

22.83

ug/l

1.91

562

7638

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

282

1700

1.73

15.52

3.8

4.3

10.36

22.55

ug/l

0.83

215

1350

Benign neoplasm: Anus and anal canal

182

979

2.04

15.51

4.3

4.0

3.72

24.65

ug/l

1.77

156

815

Antihypertensive medication - note that there are other indications

2376

10514

1.21

15.40

3.7

4.3

18.87

29.72

ug/l

0.86

1829

7934

Crohn disease (strict definition, require KELA, min 2 HDR)

262

1555

1.76

15.30

3.6

4.2

10.92

22.17

ug/l

0.67

200

1233

Viral and other specified intestinal infections

931

6810

1.34

15.29

3.4

3.9

16.70

25.66

ug/l

0.51

716

5243

Autoimmune hepatitis

290

3.12

15.28

3.8

4.0

3.34

11.34

ug/l

2.63

240

Other diseases of oesophagus

501

3462

1.51

15.25

3.4

4.2

13.50

26.15

ug/l

1.06

426

2845

Viral hepatitis, IBD co-morbidity

242

1404

1.79

15.25

3.2

5.3

9.57

59.01

ug/l

1.14

210

1109

Non-seminoma of testis, including Hilmo

7.12

15.24

2.6

1.7

4.91

2.38

ug/l

1.07

Caries of enamel

3402

28260

0.86

15.22

3.6

4.1

13.81

25.56

ug/l

1.20

2539

22500

Pneumocystosis

134

656

2.31

15.22

5.3

4.3

18.22

34.74

ug/l

0.42

111

557

Menorrhagia

1682

7569

1.26

15.17

3.4

4.1

17.19

31.39

ug/l

1.06

1282

5939

Haemangioma, any site

423

2833

1.56

15.10

3.4

4.0

25.34

22.96

ug/l

0.06

328

2269

Asthma/COPD (KELA code 203)

4900

29798

1.14

15.08

3.3

4.2

19.58

25.21

ug/l

0.64

4069

23495

COPD, hospital admissions 3, with asthma pneumonia sepsis

1541

10694

1.26

14.98

2.8

4.1

29.73

23.58

ug/l

0.36

1356

8940

Chronic periodontitis, complicated

2975

25423

1.18

14.97

4.0

4.1

25.32

25.57

ug/l

0.01

2513

20595

Undetermined asthma, excluding more controls

632

4555

1.43

14.94

3.3

4.2

25.93

30.77

ug/l

0.09

514

3606

Dental pulpitis, including avohilmo

3408

25461

0.86

14.94

3.6

4.1

13.26

26.02

ug/l

2.62

2604

20100

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

447

3043

1.54

14.93

2.7

3.9

9.16

20.03

ug/l

1.56

363

2487

Crohn disease (strict definition, require KELA)

262

1567

1.74

14.88

3.6

4.2

10.92

21.99

ug/l

0.66

200

1244

Postmenopausal bleeding

1597

6904

1.27

14.84

3.6

4.1

16.57

28.50

ug/l

0.93

1235

5552

Malignant neoplasm of renal pelvis

5.38

14.80

2.2

1.3

73.94

2.63

ug/l

0.51

Presence of cardiac and vascular implants and grafts

2486

15684

1.20

14.74

3.0

4.0

18.61

30.45

ug/l

1.29

2029

13090

Other/unspecified dorsalgia

1947

16072

1.22

14.71

3.1

4.2

14.66

26.80

ug/l

1.93

1516

12868

Other viral hepatitis

231

1337

1.80

14.69

3.3

4.5

8.65

22.28

ug/l

0.99

201

1045

Protozoal diseases

176

955

2.01

14.55

5.1

4.5

15.40

27.86

ug/l

0.43

143

798

Hypertensive Heart Disease

1327

8320

1.28

14.51

3.0

4.3

14.87

23.11

ug/l

0.99

1113

6922

Other external causes of accidental injury

4444

19615

1.15

14.48

3.8

4.2

13.76

31.11

ug/l

4.50

3557

15608

Other obstructive and reflux uropathy

207

1171

1.86

14.48

5.6

4.0

6.14

24.69

ug/l

1.56

176

948

Falls/tendency to fall

5635

25223

1.13

14.46

3.7

4.1

17.96

27.75

ug/l

1.99

4534

19974

Elevated blood glucose level

405

2712

1.56

14.46

3.8

4.2

36.36

25.82

ug/l

0.23

334

2213

Malignant neoplasm of parotid gland, including Hilmo

131

3.88

14.44

3.3

1.4

25.09

2.70

ug/l

1.18

Alzheimer’s disease, strict definition

958

10152

0.76

14.42

2.7

3.7

20.54

22.90

ug/l

0.11

766

8505

Malignant neoplasm of vulva, including Hilmo

213

3.19

14.42

4.0

1.4

14.24

2.65

ug/l

0.65

163

L02BX Other hormone antagonists and related agents

325

2095

1.66

14.39

2.9

4.3

20.45

28.06

ug/l

0.35

265

1791

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

5.83

14.24

3.7

1.4

2.90

2.76

ug/l

0.08

Malignant neoplasm of brain

422

2.42

14.20

2.3

1.6

2.94

2.68

ug/l

0.25

308

Malignant neoplasm of bone and articular cartilage of limbs

6.58

14.18

2.2

1.4

2.19

3.16

ug/l

1.60

Other acute lower respiratory infections

2567

20906

1.19

14.15

3.6

3.9

16.91

25.66

ug/l

0.98

2102

16848

Viral infections characterized by skin and mucous membrane lesions

2001

16751

1.21

14.15

3.8

4.0

29.08

22.49

ug/l

0.16

1608

13432

Undetermined asthma

632

4600

1.41

14.12

3.3

4.1

25.93

30.45

ug/l

0.08

514

3653

Alcohol use disorder, ICD-based

1948

16288

1.22

14.08

3.2

4.3

29.80

28.23

ug/l

0.06

1691

13252

Accidents

4436

19615

1.14

14.08

3.8

4.2

13.81

31.11

ug/l

4.46

3549

15608

Other diseases of appendix

380

2.68

14.05

3.9

4.2

3.69

20.36

ug/l

0.83

307

Persons with potential health hazards related to communicable diseases

1304

10352

1.27

14.04

4.3

3.9

16.15

24.51

ug/l

0.59

1004

7843

Other retinal disorders

3601

24583

1.16

14.02

3.5

4.0

22.01

26.44

ug/l

0.39

2972

20168

Malignant neoplasm of thymus

6.73

14.02

2.3

1.8

1.99

2.26

ug/l

0.36

Inguinal hernia

2896

16660

1.18

13.97

4.0

4.1

16.42

29.99

ug/l

2.59

2413

13638

Secondary thrombocytopenia

413

2.61

13.96

3.8

4.5

16.10

23.99

ug/l

0.24

347

Use of memantine

1064

11132

0.77

13.83

2.7

3.7

11.61

23.39

ug/l

2.28

857

9321

Use of other anti-dementia drugs

1064

11132

0.77

13.83

2.7

3.7

11.61

23.39

ug/l

2.28

857

9321

Zoster [herpes zoster]

984

7683

1.32

13.80

3.8

3.9

10.45

26.44

ug/l

2.97

806

6273

Diseases of pulp and periapical tissues and dental caries

3939

17720

1.15

13.78

3.9

4.0

25.06

28.99

ug/l

0.29

3199

14319

Mycoses

1312

10589

1.27

13.70

3.6

4.1

26.29

26.19

ug/l

0.00

1061

8599

Viral hepatitis

281

1749

1.67

13.65

3.3

4.3

8.76

21.84

ug/l

1.26

241

1386

Abscess of lung

104

480

2.42

13.56

3.0

4.8

4.84

33.65

ug/l

1.08

406

Colonic or urogenital fistula

1336

10818

1.26

13.55

4.0

4.1

19.06

26.15

ug/l

0.54

1038

8800

Malignant neoplasm of vagina, including Hilmo

6.28

13.41

3.9

1.3

4.52

2.84

ug/l

0.64

Pruritus

543

3902

1.44

13.32

3.4

3.8

5.80

31.98

ug/l

2.12

435

3081

Diseases of oral cavity, salivary glands and jaws

3521

15824

1.16

13.30

3.8

4.1

23.33

28.97

ug/l

0.46

2852

12861

Other specified/unspecified bacterial intestinal infections

342

2256

1.59

13.28

4.2

4.1

13.00

17.55

ug/l

0.30

288

1850

Problems related to lifestyle

402

2724

1.52

13.25

2.7

4.2

25.54

34.54

ug/l

0.22

358

2187

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

124

3.80

13.23

4.1

1.4

64.55

2.66

ug/l

0.55

Conductive and sensorineural hearing loss

4508

27094

1.14

13.23

3.6

4.1

14.59

29.05

ug/l

3.55

3692

22005

Salpingitis and oophoritis

910

7074

1.32

13.21

3.8

3.9

20.00

24.54

ug/l

0.17

697

5508

Disorders of skin appendages

2116

17900

1.20

13.14

3.6

4.0

15.92

23.85

ug/l

0.89

1660

14133

Any dementia, excluding more controls

1571

13057

0.81

13.14

2.9

4.0

16.53

25.01

ug/l

0.87

1295

10906

Myelodysplastic syndrome

145

3.54

13.04

2.3

1.4

3.25

2.78

ug/l

0.25

116

Malignant neoplasm of other and unspecified parts of tongue

203

3.09

13.01

3.4

1.4

4.91

2.59

ug/l

1.14

151

Benign neoplasm: Ill-defined sites within the digestive system

217

3.37

13.01

4.4

4.3

13.93

9.26

ug/l

0.33

187

ILD, hospital admission 2, with pulmonary infections

535

3862

1.44

12.96

3.2

4.0

12.29

25.95

ug/l

1.69

438

3221

Mental and behavioural disorders due to alcohol

2415

19896

1.18

12.93

3.3

4.3

27.76

26.74

ug/l

0.05

2092

16043

Sarcoidosis

658

4909

1.38

12.84

3.4

4.1

10.27

25.44

ug/l

1.79

495

3961

Vitamin deficiency

245

1507

1.71

12.82

3.3

4.1

7.04

20.40

ug/l

1.53

201

1227

Vitamin deficiency, wide

245

1507

1.71

12.82

3.3

4.1

7.04

20.40

ug/l

1.53

201

1227

Disorders of other endocrine glands

2076

17311

1.20

12.82

3.2

3.9

17.15

22.16

ug/l

0.42

1631

13839

Disorders of thyroid, IBD co-morbidities

898

4868

1.32

12.81

3.2

4.9

9.22

39.36

ug/l

2.78

688

3810

Disorders of the thyroid gland

4962

28962

1.13

12.81

3.6

4.0

18.95

25.71

ug/l

0.91

3897

23225

Use of rivastigmine

500

6881

0.70

12.73

2.8

3.7

7.51

25.12

ug/l

5.32

396

5727

Ulcerative proctitis

262

1636

1.67

12.69

3.1

4.2

17.80

23.49

ug/l

0.19

184

1309

Finngen Rheumatological endpoints

4926

25085

1.13

12.66

3.5

4.2

20.64

26.16

ug/l

0.60

3913

19921

Urolithiasis

1654

13788

1.22

12.61

4.2

4.1

17.83

28.70

ug/l

1.20

1352

11433

Cystic disease of liver

238

3.17

12.56

2.7

4.4

3.90

27.13

ug/l

0.73

200

Diseases of male genital organs

2287

9796

1.19

12.48

4.2

4.6

20.37

36.74

ug/l

1.85

1899

8245

Congenital malformations of genital organs

310

2002

1.58

12.43

3.1

3.7

4.87

43.56

ug/l

1.33

224

1479

Chromophobe cell carcinoma of kidney

4.78

12.36

3.1

1.4

50.28

2.46

ug/l

0.51

Myocardial infarction, unclassifiable

792

9124

0.76

12.32

3.3

3.8

10.66

24.78

ug/l

3.94

669

7642

Other cataract

2504

16343

1.18

12.32

3.7

4.1

14.58

28.21

ug/l

2.52

2030

13399

Depression or dysthymia

3751

18275

1.14

12.30

3.5

4.4

19.45

28.45

ug/l

1.04

3006

14735

Caries of dentine, including avohilmo

4552

20758

1.13

12.29

3.9

4.0

25.44

27.90

ug/l

0.16

3694

16707

Acute bronchitis

1997

16620

1.20

12.17

3.4

3.9

17.38

23.62

ug/l

0.47

1628

13433

Infarction of spleen

213

3.25

12.12

3.3

4.5

10.72

26.32

ug/l

0.36

180

ILD, hospital admissions 3, with pneumonia sepsis

463

3302

1.46

12.12

3.1

4.0

11.00

23.83

ug/l

1.38

379

2748

Ulcer of oesophagus

365

2491

1.53

12.10

3.4

4.3

5.12

21.18

ug/l

3.47

310

2071

Dorsopathies

5310

24300

1.12

12.09

3.5

4.3

17.81

26.42

ug/l

1.39

4249

19343

Zoster [herpes zoster]

2712

23244

1.17

12.06

3.9

4.0

11.23

23.95

ug/l

5.32

2196

18884

Unspecified privation

500

3614

1.43

11.89

4.0

4.1

17.35

21.63

ug/l

0.22

407

2923

Magnesium deficiency

110

4.56

11.85

7.2

4.4

6.48

12.29

ug/l

0.64

Acute gastritis

380

2621

1.51

11.83

2.9

4.1

6.69

21.27

ug/l

2.87

320

2137

Extracorporeal dialysis

301

1985

1.59

11.79

2.5

4.3

12.32

22.30

ug/l

0.52

255

1645

Follicular cysts of skin and subcutaneous tissue

862

6750

1.31

11.76

3.8

4.2

25.62

30.19

ug/l

0.15

696

5464

Other specific joint derangements/joint disorders

3536

20179

1.14

11.73

3.3

4.3

18.35

29.63

ug/l

1.39

2723

16061

Other maternal disorders predominantly related to pregnancy

1893

14007

0.84

11.66

3.5

3.8

18.99

22.02

ug/l

0.17

1394

10566

Ulcerative rectosigmoiditis

348

2360

1.53

11.64

4.1

4.2

5.54

20.56

ug/l

2.48

267

1893

Spondylopathies in diseases classified elsewhere

455

2.38

11.62

4.3

4.4

19.26

36.91

ug/l

0.41

369

Myalgia

1126

9113

1.26

11.48

3.1

4.2

15.49

25.70

ug/l

0.74

862

7202

Sensorineural hearing loss

4328

26346

1.13

11.43

3.6

4.1

14.25

29.24

ug/l

3.65

3558

21470

Coronary artery bypass grafting

1095

10050

0.79

11.39

3.1

4.4

11.60

29.11

ug/l

4.55

909

8504

Neuroendocrine tumor and carcinoma of rectum

5.28

11.34

3.8

1.4

25.15

2.77

ug/l

0.49

Dental operations

3665

16685

1.14

11.25

4.0

4.1

25.85

30.27

ug/l

0.31

2962

13574

Benign mammary dysplasia

751

5832

1.33

11.19

3.4

3.7

15.59

21.39

ug/l

0.42

588

4655

Dental caries, including avohilmo

4309

19728

1.13

11.16

3.9

4.0

26.42

28.80

ug/l

0.15

3498

15953

Gestational diabetes (for exclusion)

725

6551

0.76

11.13

3.5

13.40

19.70

ug/l

0.29

507

4561

Injuries to the abdomen, lower back, lumbar spine and pelvis

1937

16371

1.19

11.02

3.5

3.9

17.51

23.14

ug/l

0.42

1582

13281

Viral and other specified intestinal infections

633

4658

1.34

11.01

3.6

3.8

19.67

25.40

ug/l

0.19

490

3567

Other abnormalities of plasma proteins

105

531

2.20

10.95

3.3

4.3

307.83

35.60

ug/l

0.46

450

Nerve, nerve root and plexus disorders

5666

31577

1.11

10.94

3.4

4.1

17.07

26.19

ug/l

1.72

4587

25211

Serous carcinoma of ovary

111

3.75

10.92

3.3

1.3

10.54

2.80

ug/l

0.69

Wilms' tumor, including Hilmo

4.43

10.88

1.6

1.4

3.23

2.65

ug/l

0.35

Migraine, single triptan purchase ok & required. ICD-code if available is included

2736

21157

0.87

10.88

3.4

4.1

16.71

24.28

ug/l

0.76

2035

16559

Triptan medication for migraine, single purchase ok

2736

21157

0.87

10.88

3.4

4.1

16.71

24.28

ug/l

0.76

2035

16559

Presence of other devices

1298

10695

1.23

10.87

3.2

3.8

9.65

25.47

ug/l

3.70

1086

8847

Coeliac disease

529

3913

1.39

10.87

3.6

3.9

6.37

22.82

ug/l

3.15

434

3093

Mycoses

4224

33019

1.12

10.85

3.4

4.1

24.62

24.64

ug/l

0.00

3302

26394

Toxic liver disease

435

2.29

10.84

3.7

4.2

25.79

17.97

ug/l

0.12

354

Other benign neoplasms of skin

1967

16872

1.19

10.84

3.6

4.0

14.57

23.70

ug/l

1.28

1598

13718

Other and unspecified local infections of skin and subcutaneous tissue

443

3190

1.43

10.83

3.8

4.0

20.66

22.94

ug/l

0.06

357

2584

Pain associated with micturition

558

4171

1.38

10.80

2.9

3.9

4.33

25.76

ug/l

4.85

428

3344

Calculus of kidney and ureter

1507

12649

1.21

10.76

4.2

4.1

19.06

29.31

ug/l

0.96

1226

10477

Bronchitis

5569

31913

1.11

10.76

3.8

4.0

16.66

25.89

ug/l

1.92

4454

25458

Reimbursement for rheumatic diseases

2935

25776

1.15

10.75

3.8

4.0

28.62

23.08

ug/l

0.28

2312

20673

Fracture of femur

1486

11294

1.22

10.70

3.5

3.8

23.10

22.87

ug/l

0.01

1280

9321

Alzheimer’s disease (Late onset)

902

9461

0.78

10.61

2.7

3.6

21.10

23.51

ug/l

0.11

724

7957

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1411

11776

1.22

10.59

3.3

4.1

8.97

25.94

ug/l

3.93

1138

9486

Fibrosis of liver

234

2.92

10.56

3.6

4.2

3.13

25.97

ug/l

0.68

193

Vascular diseases of the intestine

225

1430

1.67

10.55

3.2

4.0

7.77

22.38

ug/l

1.30

189

1197

Other/unspecified cytomegaloviral diseases

106

542

2.13

10.54

3.3

4.3

28.76

33.37

ug/l

0.07

447

Chronic viral hepatitis

179

1063

1.74

10.52

2.9

4.7

9.92

26.28

ug/l

0.93

161

836

Oxicams

1227

5701

1.24

10.44

3.3

4.3

20.31

25.61

ug/l

0.44

995

4725

Hypocalcemia

130

716

1.97

10.39

3.3

4.2

75.47

31.02

ug/l

0.53

113

588

Other local infections of skin and subcutaneous tissue

468

3425

1.41

10.39

3.8

4.0

19.70

22.27

ug/l

0.07

377

2774

Other respiratory disorders and diseases

1061

8646

1.26

10.38

3.0

4.0

17.35

23.84

ug/l

0.56

893

7186

Other diseases of the respiratory system

1061

8646

1.26

10.38

3.0

4.0

17.35

23.84

ug/l

0.56

893

7186

Chronic diseases of tonsils and adenoids

3099

22122

0.88

10.36

3.6

4.2

32.26

23.75

ug/l

0.34

2362

17569

Colitis due to radiation

362

2.46

10.33

4.1

4.4

3.33

42.55

ug/l

1.14

308

Lung diseases due to external agents

706

5490

1.32

10.33

3.1

4.0

7.93

22.45

ug/l

4.66

585

4556

Other disorders of lacrimal gland

1798

15382

1.19

10.27

3.2

4.0

15.42

23.04

ug/l

0.52

1409

12359

Dermatitis

3153

27912

1.14

10.25

3.6

4.0

15.05

24.98

ug/l

2.41

2549

22391

1982

16918

1.18

10.23

3.2

4.0

11.64

24.28

ug/l

2.04

1623

13394

Conduction disorders

1631

11202

1.20

10.23

3.3

4.4

18.23

26.69

ug/l

0.66

1314

9326

Diabetes mellitus in pregnancy

607

5111

0.75

10.19

3.1

3.5

31.94

20.59

ug/l

0.23

435

3504

Tonsillectomy and adenotomy

1438

11953

0.83

10.19

3.6

4.0

23.44

21.95

ug/l

0.06

1020

9062

Organic, including symptomatic, mental disorders

2366

19263

0.86

10.18

3.0

4.1

14.46

25.45

ug/l

2.05

1945

16099

Spondylosis

3031

21897

1.14

10.13

3.2

4.4

25.56

27.11

ug/l

0.05

2471

17762

Cytomegalovirus infection, IBD co-morbidity

118

634

2.00

10.11

3.3

4.6

25.79

31.05

ug/l

0.10

100

527

Spinal stenosis

2987

20093

1.14

10.04

3.1

4.3

23.74

26.34

ug/l

0.10

2462

16496

All influenza (not pneumonia)

611

4666

1.34

10.02

3.8

4.1

25.54

25.59

ug/l

0.00

500

3790

Degeneration of macula and posterior pole

2836

19956

1.15

9.98

3.5

4.0

19.32

23.85

ug/l

0.46

2338

16581

Primary hyperparathyroidism

594

4549

1.35

9.98

3.3

3.9

7.96

25.83

ug/l

2.13

475

3672

Hodgkin lymphoma, hilmo

139

787

1.88

9.98

3.0

4.5

38.90

29.01

ug/l

0.20

116

659

Benign neoplasm: Extrahepatic bile ducts

107

4.19

9.97

2.2

4.5

2.85

12.30

ug/l

1.41

Oter anti-inflammatory and antirheumatic agents, non-steroids

1225

5558

1.24

9.96

3.7

4.3

29.70

25.92

ug/l

0.14

989

4643

Sequelae of other external causes

263

1747

1.57

9.95

4.4

4.1

5.80

20.04

ug/l

2.03

211

1430

Osteosarcoma, including Hilmo

5.68

9.91

3.6

1.7

28.71

2.54

ug/l

0.49

COPD-related respiratory insufficiency

621

4786

1.34

9.88

2.8

4.1

22.16

20.97

ug/l

0.05

537

3995

Other viral diseases

1063

8654

1.24

9.85

3.8

4.1

19.65

26.76

ug/l

0.32

832

6714

Fibrosarcoma, including Hilmo

118

3.42

9.83

4.2

1.4

4.37

2.60

ug/l

0.43

Cytomegaloviral disease

120

654

1.97

9.83

3.3

4.5

25.31

29.74

ug/l

0.09

102

540

Impotence

265

1771

1.57

9.83

4.1

4.7

31.69

30.22

ug/l

0.03

213

1531

Behavioural syndromes associated with physiological disturbances and physical factors

3757

29633

0.89

9.81

3.2

4.1

12.43

24.63

ug/l

3.18

2850

23636

Acetic acid derivatives and related substances

1353

5825

1.22

9.79

3.5

4.3

21.60

25.26

ug/l

0.19

1060

4799

Respiratory insufficiency

408

2949

1.43

9.68

2.7

4.0

21.32

23.15

ug/l

0.05

337

2437

Other and unspecified dermatitis

2606

22976

1.15

9.67

3.7

4.0

15.27

24.60

ug/l

1.86

2105

18375

Osteopathy in diseases classified elsewhere

251

2.75

9.64

6.0

4.2

6.22

25.96

ug/l

0.62

211

Fracture of shoulder and upper arm

1803

15485

1.18

9.61

3.6

4.0

18.27

23.42

ug/l

0.41

1491

12589

Malignant neoplasm of hypopharynx, including Hilmo

3.98

9.59

2.4

1.4

2.38

2.73

ug/l

0.60

Osteonecrosis

320

2234

1.50

9.59

4.9

4.2

20.91

16.18

ug/l

0.23

265

1823

Viral pneumonia (unknown virus, not influenza)

294

2011

1.51

9.56

3.5

4.2

4.98

17.80

ug/l

2.21

231

1639

Other surgical follow-up care

133

749

1.86

9.56

3.8

7.29

19.38

ug/l

0.59

108

590

Somatoform disorder

717

5639

1.30

9.50

2.8

4.0

5.32

30.62

ug/l

3.01

545

4438

Other disorders of adrenal gland

205

1303

1.65

9.47

3.3

4.2

20.48

21.95

ug/l

0.04

172

1052

Concussion

2469

17687

1.15

9.43

3.4

4.5

11.62

29.98

ug/l

3.84

1980

14042

Fracture of lumbar spine and pelvis

1138

9423

1.23

9.37

3.6

3.9

10.12

22.43

ug/l

3.02

941

7731

Sleep disorders

3595

28880

0.89

9.36

3.2

4.1

12.00

24.36

ug/l

3.16

2712

23012

Type of accident

1302

10921

1.21

9.33

3.3

4.1

9.22

26.57

ug/l

3.62

1049

8827

Triptan medication for migraine, min. 3 purchases

1713

15232

0.85

9.24

3.3

3.9

13.61

22.48

ug/l

0.83

1240

11514

Other disorders of breast

582

4482

1.33

9.19

3.6

3.8

11.59

27.68

ug/l

0.94

429

3472

Nosocomial condition (hospital)

165

3.09

9.17

3.7

4.3

4.51

49.04

ug/l

0.59

144

Other aneurysm

288

1988

1.52

9.17

4.0

4.2

4.94

23.78

ug/l

3.04

242

1659

Open wound of head

2690

22974

1.14

9.14

3.6

4.1

11.91

30.05

ug/l

5.02

2213

18702

Pneumonitis due to solids and liquids

408

2991

1.41

9.10

3.1

3.9

5.25

24.40

ug/l

4.49

335

2505

Small fibre neuropathy

163

997

1.75

9.08

3.5

4.3

176.29

24.95

ug/l

0.43

138

831

Torsion of ovary, ovarian pedicle and fallopian tube

104

553

1.99

9.07

3.2

4.0

53.55

77.89

ug/l

0.12

427

Insomnia

3459

28021

0.89

9.05

3.2

4.1

12.04

24.08

ug/l

2.85

2593

22279

Other ill-defined and unspecified causes of mortality

405

2974

1.41

9.04

4.3

3.9

45.76

22.90

ug/l

0.54

353

2503

Other disorders of glucose regulation and pancreatic internal secretion

360

2584

1.44

9.01

3.2

4.1

21.98

18.74

ug/l

0.12

308

2102

Umbilical hernia

1229

10294

1.21

9.01

3.8

4.2

37.65

30.38

ug/l

0.26

1002

8393

Disorders of oesophagus in diseases classified elsewhere

126

721

1.89

8.99

3.6

4.3

106.02

17.68

ug/l

0.46

106

596

Other disorders of bladder

603

4688

1.32

8.98

3.7

4.3

10.81

25.95

ug/l

2.15

487

3904

Selective serotonin reuptake inhibitors

5249

25061

1.10

8.94

3.5

4.2

16.83

26.90

ug/l

1.87

4191

20058

Adrenocortical insufficiency

175

1089

1.69

8.93

3.3

4.3

9.31

24.55

ug/l

1.03

146

882

Later onset COPD

1634

11177

1.19

8.92

2.9

4.0

34.52

24.51

ug/l

0.59

1435

9359

Pyoderma gangrenosum

221

2.72

8.90

4.2

4.3

4.34

9.88

ug/l

1.30

181

Hypothyroidism, other/unspecified

4571

27386

1.11

8.83

3.6

4.0

20.59

24.39

ug/l

0.37

3569

21937

Endometriosis of ovary

761

5935

1.28

8.80

3.3

4.2

19.49

30.20

ug/l

0.48

555

4654

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1601

13752

1.18

8.72

3.5

4.0

17.60

22.06

ug/l

0.28

1241

10966

Anxiety disorders, excluding more controls

4111

24254

1.11

8.69

3.5

4.2

19.84

25.26

ug/l

0.62

3228

19177

Coxibs

1324

5840

1.21

8.69

3.5

4.3

20.52

25.22

ug/l

0.27

1059

4806

Parkinson's disease, excluding more controls

524

6388

0.75

8.67

2.8

4.6

10.70

30.75

ug/l

2.13

417

5394

Carcinoma in situ of other and unspecified sites

207

1359

1.62

8.64

3.7

4.2

22.79

30.47

ug/l

0.22

175

1153

1739

13108

1.18

8.63

3.3

3.8

19.96

22.19

ug/l

0.16

1445

10940

L04AA Selective immunosuppressants

996

8216

1.23

8.63

3.2

4.1

32.76

27.33

ug/l

0.18

809

6569

Combinations of oral blood glucose lowering drugs

1486

12731

1.19

8.53

3.9

4.3

34.68

24.04

ug/l

0.52

1253

10529

Malignant neoplasm of vulva

158

2.90

8.44

4.2

1.4

6.05

2.71

ug/l

0.62

124

Other skin changes

934

7694

1.24

8.36

3.4

4.1

6.22

32.22

ug/l

4.79

768

6285

Other diseases of peritoneum

228

1533

1.56

8.34

3.5

4.2

32.03

18.63

ug/l

0.20

176

1255

Parkinson's disease, strict definition, excluding more controls

486

6011

0.75

8.32

2.8

4.6

10.49

28.25

ug/l

1.73

384

5073

Adverse effects, not elsewhere classified

797

6446

1.26

8.31

3.8

3.9

20.73

28.98

ug/l

0.27

618

5034

Visual disturbances and blindness

2593

23083

1.14

8.27

3.3

4.0

28.19

23.09

ug/l

0.27

2060

18633

Chondrosarcoma

5.36

8.23

2.1

1.9

1.88

3.14

ug/l

1.62

Carcinoma in situ, bladder

193

1263

1.63

8.23

3.8

4.3

22.91

27.03

ug/l

0.10

163

1073

Personal history of other diseases and conditions

342

2452

1.41

8.23

4.0

3.8

8.52

31.58

ug/l

0.93

260

1840

Parkinson's disease

524

6727

0.76

8.20

2.8

4.0

10.70

25.00

ug/l

1.51

417

5592

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

177

2.95

8.18

3.0

4.2

5.73

8.82

ug/l

0.47

142

Panic disorder

470

3559

1.34

8.18

3.1

4.0

17.19

29.57

ug/l

0.44

362

2681

Hepatomegaly and splenomegaly, not elsewhere classified

222

2.56

8.14

2.7

4.4

4.06

40.35

ug/l

0.63

184

Peripheral artery disease

2469

17470

1.14

8.07

3.0

4.1

28.00

24.45

ug/l

0.24

2131

14516

Alcohol dependence

1209

10217

1.20

8.06

3.1

4.4

35.06

25.65

ug/l

0.36

1041

8385

Hypothyroidism, strict autoimmune

3791

22628

1.11

7.99

3.5

4.0

19.26

24.18

ug/l

0.49

2969

18084

212

3125

0.66

7.97

2.5

4.2

15.00

25.40

ug/l

0.78

185

2627

Fenamates

735

3997

1.27

7.95

3.5

4.2

7.05

21.72

ug/l

4.70

571

3268

Thiazolidinediones

600

4747

1.30

7.91

4.0

4.3

50.30

22.11

ug/l

0.83

523

3971

Pleural plaque

501

3876

1.34

7.90

2.9

4.2

19.97

22.96

ug/l

0.14

436

3284

Leisure time condition

781

6345

1.25

7.89

3.3

4.0

5.81

28.86

ug/l

3.58

617

5122

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

893

7250

1.23

7.86

3.6

3.8

20.79

22.93

ug/l

0.09

673

5422

ILD, hospital admissions

791

6458

1.26

7.85

3.3

4.0

13.31

24.47

ug/l

1.64

652

5362

Injuries to the elbow and forearm

3413

27167

1.11

7.82

3.7

4.0

18.36

24.40

ug/l

0.86

2723

21667

Abnormal findings on diagnostic imaging of breast

480

2.03

7.79

4.5

3.8

49.72

8.44

ug/l

0.64

384

Impaction of intestines

179

2.75

7.75

4.5

3.5

4.07

45.73

ug/l

0.57

150

Chondrosarcoma, including Hilmo

3.95

7.75

2.5

1.7

1.90

2.81

ug/l

1.95

Parkinson's disease, strict definition

486

6249

0.76

7.74

2.8

4.0

10.49

24.04

ug/l

1.29

384

5211

Alzheimer’s disease (Early onset), excluding more controls

1552

0.54

7.71

2.2

4.2

16.13

24.23

ug/l

0.31

1305

Parkinson's disease, including avohilmo

559

7061

0.77

7.69

2.8

4.0

10.18

24.68

ug/l

1.71

448

5881

Status post-ami

1146

10294

0.83

7.60

3.0

4.3

20.76

29.60

ug/l

0.64

962

8679

Hypothyreosis and Thyroxine purchase for inclusion criteria

4734

28542

1.10

7.60

3.6

4.0

21.34

23.41

ug/l

0.18

3691

22851

Crohn disease (strict definition, all UC cases excluded)

190

1248

1.57

7.58

3.4

4.3

5.92

21.01

ug/l

1.67

150

997

Alzheimer’s disease (Early onset)

1638

0.55

7.57

2.2

3.6

16.13

21.12

ug/l

0.18

1367

Unspecified/other endometriosis

306

2200

1.42

7.52

2.8

4.1

3.22

43.17

ug/l

1.44

208

1649

Tobacco use

222

1514

1.52

7.48

2.6

4.3

20.44

20.04

ug/l

0.01

207

1222

Respiratory conditions due to other external agents

125

755

1.79

7.46

3.1

3.9

6.73

30.44

ug/l

1.41

103

628

Other respiratory diseases principally affecting the interstitium

933

7779

1.23

7.46

3.2

4.0

19.69

26.59

ug/l

0.34

776

6452

Other and unspecified effects of external causes

1070

9008

1.20

7.41

3.8

4.0

17.43

25.25

ug/l

0.37

840

7056

Malignant neoplasm of parotid gland

106

3.16

7.38

3.8

1.4

13.77

2.65

ug/l

0.73

Haemolytic anaemias

166

1071

1.63

7.37

3.7

4.1

7.76

25.38

ug/l

1.20

142

880

Urticaria and erythema

1548

13431

1.17

7.36

3.5

3.9

24.78

22.73

ug/l

0.10

1212

10587

Other interstitial pulmonary diseases

797

6560

1.24

7.34

3.2

4.0

13.24

26.91

ug/l

1.88

657

5455

Use of levodopa decarboxylase inhibitor

474

6069

0.76

7.33

2.7

4.0

10.92

23.75

ug/l

1.15

370

5057

Follicular lymphoma, hilmo

231

1605

1.52

7.33

3.0

4.2

24.57

20.41

ug/l

0.13

182

1335

Other and unspecified glaucoma

382

2881

1.38

7.32

3.8

3.9

20.13

21.57

ug/l

0.06

319

2373

Interstitial lung disease endpoints

797

6563

1.24

7.30

3.2

4.0

13.24

24.28

ug/l

1.64

657

5450

Interstitial lung disease

797

6563

1.24

7.30

3.2

4.0

13.24

24.28

ug/l

1.64

657

5450

Arthropathy in ulcerative colitis

340

2.16

7.29

3.1

4.5

4.48

19.41

ug/l

0.61

275

Other degenerative diseases of the nervous system

1232

10749

0.84

7.24

3.0

4.4

13.06

33.21

ug/l

3.21

994

8868

Fibrosarcoma

102

3.19

7.24

4.8

1.5

4.74

2.57

ug/l

0.45

Congenital malformations, deformations and chromosomal abnormalities

2381

20226

1.13

7.23

3.5

4.0

15.61

23.81

ug/l

0.80

1805

15836

Benign neoplasm of urinary organs

246

1731

1.49

7.22

3.5

4.1

4.10

20.38

ug/l

2.61

181

1428

Multiple myeloma and malignant plasma cell neoplasms

255

1809

1.48

7.20

2.8

4.1

5.39

19.78

ug/l

2.25

202

1506

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1474

14778

0.86

7.19

3.2

3.8

12.78

21.55

ug/l

0.95

1083

11128

Pregnancy hypertension

1250

13069

0.85

7.19

3.2

3.7

11.40

21.52

ug/l

1.17

909

9756

Psychiatric diseases

5374

24881

1.09

7.19

3.5

4.3

22.16

27.04

ug/l

0.54

4352

19906

Melanocytic naevi of trunk

501

3914

1.31

7.18

3.7

4.0

4.87

31.22

ug/l

2.37

383

3127

Other inflammation of eyelid

639

5144

1.27

7.18

3.3

4.0

5.25

24.41

ug/l

4.10

490

4140

Malignant neoplasm of gum, including Hilmo

130

2.88

7.17

3.3

1.4

3.60

2.68

ug/l

0.38

Non-allergic asthma (mode), excluding more controls

847

6943

1.23

7.11

3.3

4.2

40.92

25.57

ug/l

0.41

696

5521

Other viral diseases, not elsewhere classified

686

5539

1.25

7.11

4.0

23.73

26.46

ug/l

0.07

542

4342

Tubulo-interstitial nephritis, not specified as acute or chronic

319

2344

1.40

7.09

3.7

3.8

25.94

22.38

ug/l

0.10

263

1928

Alzheimer’s disease (Late onset), excluding more controls

684

5503

0.80

7.06

3.0

4.4

21.62

31.31

ug/l

0.40

556

4649

Other diseases of hard tissues of teeth

3339

15661

1.11

7.04

3.8

4.1

26.47

29.11

ug/l

0.09

2654

12728

Deficiency of other B group vitamins

114

680

1.79

7.04

3.7

4.0

9.78

27.22

ug/l

0.79

566

1210

9749

1.19

7.03

3.1

3.8

18.49

21.95

ug/l

0.28

1010

8096

Injuries to the knee and lower leg

6080

31388

1.08

7.02

3.6

4.0

18.13

26.07

ug/l

1.22

4831

25070

Malignant neoplasm of gum

3.91

7.01

3.0

1.4

2.81

2.65

ug/l

0.13

Disorder of lipoprotein metabolism, unspecified

685

5577

1.26

7.00

3.2

4.2

8.25

24.10

ug/l

4.44

573

4628

Obstructed labour due to malposition and malpresentation of fetus

468

5601

0.77

6.99

3.5

3.6

26.17

21.88

ug/l

0.12

323

3957

Disorders resulting from impaired renal tubular function

176

1167

1.58

6.97

2.9

4.3

4.52

23.89

ug/l

1.90

145

970

Acidosis

113

675

1.79

6.97

4.6

4.4

5.43

30.56

ug/l

1.29

558

Normal-pressure hydrocephalus

124

1973

0.60

6.96

3.6

4.0

4.79

25.06

ug/l

3.04

100

1651

COPD, hospital admissions 1, only main diagnosis

1868

14123

1.15

6.93

2.8

4.1

21.06

24.64

ug/l

0.30

1620

11790

Unspecified acute lower respiratory infection

621

4995

1.27

6.93

4.0

4.1

14.44

28.68

ug/l

0.98

521

4073

Respiratory tuberculosis, confirmed

102

593

1.84

6.90

2.7

4.4

22.55

28.84

ug/l

0.13

509

Enteropathic arthropathies

104

606

1.81

6.87

3.6

4.5

4.05

24.33

ug/l

1.02

501

Benign neoplasm: Skin of other and unspecified parts of face

519

4115

1.29

6.73

3.7

3.9

23.46

22.85

ug/l

0.02

427

3351

Dementia due to Parkinsons disease, excluding more controls

947

0.45

6.72

3.7

4.6

3.13

35.36

ug/l

2.65

807

Dermatitis and eczema

5601

32276

1.08

6.71

3.6

4.0

19.42

25.73

ug/l

0.78

4471

25759

Additional codes for the location of defect, injury or illness

253

1809

1.45

6.69

3.0

4.2

6.87

19.51

ug/l

1.44

192

1473

Disorders of lacrimal system

2173

19371

1.13

6.68

3.3

4.0

15.00

23.55

ug/l

0.78

1711

15594

Cerebrovascular diseases

4124

26670

1.10

6.67

3.5

4.1

27.89

25.64

ug/l

0.11

3436

21757

Other viral diseases

1323

11337

1.17

6.66

3.6

4.0

16.71

23.83

ug/l

0.42

1017

8768

Superficial injury of head

1065

9058

1.19

6.65

3.3

4.0

9.90

30.49

ug/l

3.26

847

7315

Malignant neoplasm of lip, including Hilmo

135

2.74

6.65

4.5

1.4

4.84

2.68

ug/l

0.73

Other disorders of bone

808

6708

1.22

6.64

3.6

4.2

28.25

29.44

ug/l

0.03

660

5329

Benign neoplasm: Oesophagus

420

2.01

6.62

2.8

4.4

7.11

39.99

ug/l

1.01

353

Diseases of appendix

3503

28875

1.10

6.61

4.0

4.1

17.07

25.13

ug/l

1.47

2782

22960

Benign neoplasm of mouth and pharynx

514

4082

1.29

6.58

3.5

4.0

10.82

24.95

ug/l

1.81

413

3306

Complications of other internal prosthetic devices, implants and grafts

197

1353

1.52

6.56

3.9

4.0

9.01

18.82

ug/l

0.85

157

1114

Other disorders of skin and subcutaneous tissue, not elsewhere classified

693

5688

1.24

6.54

3.1

4.1

9.01

27.76

ug/l

2.28

571

4645

Rotator cuff syndrome

3387

22191

1.10

6.54

3.4

4.3

17.22

29.47

ug/l

2.01

2754

18024

Injuries to the hip and thigh

2456

20021

1.12

6.53

3.5

3.9

17.86

24.33

ug/l

0.74

2053

16398

Phobic anxiety disorders

364

2745

1.34

6.53

3.2

4.1

22.35

30.17

ug/l

0.19

266

2046

Infection of intervertebral disc (pyogenic)

458

1.95

6.51

4.6

14.31

33.34

ug/l

0.49

383

Respiratory tuberculosis, bacteriologically and histologically confirmed

103

611

1.79

6.50

2.7

4.4

22.30

28.08

ug/l

0.12

525

Other disorders of veins

2037

18067

1.13

6.49

3.5

3.9

18.96

24.82

ug/l

0.46

1563

14457

Dementia in other diseases classified elsewhere

109

1760

0.59

6.48

3.0

4.0

8.37

24.39

ug/l

1.49

1468

Non-allergic asthma (mode)

847

7010

1.21

6.48

3.3

4.2

40.92

25.66

ug/l

0.40

696

5585

Pain in thoracic spine

700

5753

1.24

6.45

3.4

4.3

6.31

31.99

ug/l

3.20

546

4565

Single delivery by forceps and vacuum extractor

223

1912

0.69

6.45

3.1

3.3

34.28

6.81

ug/l

0.57

147

1257

Ill-defined and unknown causes of mortality

427

3327

1.32

6.44

4.3

3.9

47.89

22.60

ug/l

0.65

372

2801

Adenocarcinomas of cervix

4.03

6.43

3.6

1.6

2.91

3.14

ug/l

0.11

Intracranial injury

2802

24031

1.11

6.41

3.4

4.0

6.93

28.48

ug/l

13.78

2261

19439

Convalescence

220

1546

1.47

6.39

3.0

3.6

6.39

15.42

ug/l

0.85

174

1221

Neurotic, stress-related and somatoform disorders

4180

26960

1.09

6.34

3.5

4.1

19.59

24.05

ug/l

0.52

3268

21312

Injuries to unspecified part of trunk, limb or body region

438

3424

1.31

6.33

3.4

4.0

20.00

23.15

ug/l

0.10

338

2777

Missing teeth due to accident, extraction or parodontitis

3206

27613

1.10

6.32

3.7

4.1

17.65

26.28

ug/l

1.01

2632

22477

Acute pharyngitis

435

3355

1.30

6.31

3.8

4.3

4.92

29.77

ug/l

1.70

305

2615

Dementia due to Parkinson's disease

925

0.46

6.29

3.7

3.9

3.13

27.39

ug/l

2.00

796

Hypoglycaemia, other or unspecified

272

1987

1.41

6.28

3.2

4.1

27.01

20.37

ug/l

0.19

231

1603

Asthma, hospital admissions , main diagnosis only

3956

32158

1.09

6.26

3.2

4.0

21.05

24.31

ug/l

0.25

3229

25550

Injuries to the shoulder and upper arm

4269

31792

1.09

6.24

3.5

4.1

16.61

26.54

ug/l

2.11

3476

25581

Abnormal findings in nipple discharge synovial fluid wound secretions

425

1.94

6.23

4.5

4.1

4.41

32.43

ug/l

0.89

360

Other joint disorders

4259

20703

1.09

6.23

3.6

4.3

19.97

29.45

ug/l

1.26

3347

16501

Benign neoplasm: Kidney

183

1257

1.53

6.21

3.4

4.0

3.92

21.91

ug/l

2.01

133

1036

Use of galantamine

245

3348

0.71

6.17

2.7

3.7

29.36

21.97

ug/l

0.12

201

2798

Hypothyroidism, strict autoimmune, 3 medication purchases required

4282

26728

1.09

6.14

3.5

4.0

20.45

23.29

ug/l

0.26

3342

21354

Other and unspecified injuries of head

307

2298

1.37

6.13

3.5

4.2

5.80

21.66

ug/l

2.79

261

1863

Malignant neoplasm of lip

3.16

6.12

2.6

1.3

3.49

2.80

ug/l

0.50

Herpesviral [herpes simplex] infections

494

3938

1.28

6.08

4.3

3.9

84.66

25.70

ug/l

0.43

400

3126

Alcoholic gastritis

429

1.92

6.07

2.7

4.9

13.43

20.52

ug/l

0.22

354

Immunodeficiencies

200

1397

1.48

6.07

3.7

4.2

13.08

22.58

ug/l

0.42

154

1127

Procedures for purposes other than remedying health state

105

636

1.73

6.06

3.4

3.3

3.04

16.27

ug/l

0.61

493

Acquired haemolytic anaemia

124

788

1.66

6.03

3.7

4.3

8.52

26.96

ug/l

0.91

108

663

Visual disturbances

2347

21188

1.12

6.03

3.4

4.0

27.21

23.07

ug/l

0.20

1859

17071

Kidney transplant status

207

1456

1.47

6.03

2.5

4.5

4.73

20.32

ug/l

1.90

171

1189

Malnutrition

104

632

1.74

6.02

3.4

3.8

6.17

28.03

ug/l

1.04

524

Abnormal findings on diagnostic imaging of central nervous system

190

1315

1.49

6.01

3.2

4.3

5.39

21.79

ug/l

1.65

150

1058

Osteoporosis with pathological fracture (FG)

415

3262

1.32

6.01

2.9

4.0

11.33

22.94

ug/l

1.14

350

2664

Asthma, including avohilmo

5992

31477

1.07

6.00

3.3

4.1

18.66

26.06

ug/l

1.06

4858

25007

Inflammatory disease of uterus

509

4073

1.27

5.98

3.1

3.7

17.08

29.76

ug/l

0.41

360

3034

Hydrocele

520

4178

1.27

5.98

4.2

4.4

20.30

27.80

ug/l

0.30

433

3591

Unspecified dementia

377

4358

0.76

5.97

2.3

3.5

17.54

22.73

ug/l

0.26

319

3649

L02BB Anti-androgens

470

3745

1.29

5.97

3.3

4.1

26.32

27.56

ug/l

0.04

390

3176

Acute appendicitis, with complications

885

7492

1.20

5.96

4.3

4.1

17.81

28.72

ug/l

0.84

715

6092

Atherosclerosis, excluding cerebral and coronary sclerosis

2304

16455

1.12

5.95

3.0

4.1

28.88

24.94

ug/l

0.25

1980

13693

ILD, hospital admissions 1, main diag only

693

5755

1.23

5.94

3.2

4.0

13.86

22.65

ug/l

1.03

567

4771

Endometriosis ASRM stages 3,4

994

8500

1.19

5.92

3.2

3.7

19.97

22.49

ug/l

0.11

733

6536

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

321

2.11

5.91

2.5

4.5

43.76

43.33

ug/l

0.00

273

therapeutic use

163

1107

1.55

5.88

3.6

4.1

6.05

24.09

ug/l

1.52

131

913

Other female pelvic inflammatory diseases

732

6108

1.22

5.86

3.2

3.8

12.55

23.94

ug/l

0.87

558

4744

Melanocytic naevi

1269

11057

1.16

5.85

3.5

4.0

9.44

23.45

ug/l

1.91

972

8798

Anxiety disorders

4225

27258

1.09

5.81

3.5

4.1

19.42

24.47

ug/l

0.62

3309

21553

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

133

2.62

5.80

3.6

1.5

3.35

2.44

ug/l

0.41

Foreign body in alimentary tract

228

1644

1.43

5.79

4.0

4.1

22.94

20.37

ug/l

0.06

186

1347

Other coagulation defects

298

2239

1.37

5.79

3.3

4.0

3.96

35.07

ug/l

1.37

218

1782

Unspecified fall

2406

21470

1.11

5.77

3.4

3.9

10.97

24.06

ug/l

4.34

1944

17429

Ulcer of lower limb, not elsewhere classified

720

6016

1.22

5.75

3.0

4.1

21.33

26.06

ug/l

0.26

606

4995

Use of selegiline

109

1706

0.61

5.72

2.8

4.1

42.34

22.69

ug/l

0.29

1437

Dermatitis due to substances taken internally

232

1682

1.42

5.70

4.9

4.1

17.84

20.77

ug/l

0.15

190

1364

Bacterial, viral and other infectious agents

321

2442

1.34

5.67

3.8

4.3

21.22

18.87

ug/l

0.08

252

1965

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1322

8882

0.87

5.66

3.6

3.7

23.38

24.98

ug/l

0.06

951

6554

Inguinal of femoral hernia, unilateral

139

920

1.59

5.66

3.9

4.1

5.16

17.34

ug/l

1.45

116

760

Femoral hernia, unilateral

139

920

1.59

5.66

3.9

4.1

5.16

17.34

ug/l

1.45

116

760

Inguinal hernia, unilateral

139

920

1.59

5.66

3.9

4.1

5.16

17.34

ug/l

1.45

116

760

Sciatica+with lumbago

2562

21427

1.11

5.66

3.1

4.3

12.64

26.11

ug/l

2.74

2023

17108

Urticaria

1198

10419

1.16

5.64

3.5

3.9

27.67

24.03

ug/l

0.14

931

8122

Congenital malformations of the urinary system

227

1641

1.42

5.63

2.9

4.3

4.94

19.37

ug/l

1.86

176

1322

Varicose veins

3373

23436

1.10

5.62

3.8

3.9

25.95

25.46

ug/l

0.03

2730

18969

Fracture of skull and facial bones

885

7528

1.19

5.60

3.5

4.3

11.17

29.56

ug/l

2.76

707

6090

Congenital malformations of the urinary system

211

1508

1.44

5.60

2.9

4.3

3.58

20.41

ug/l

2.18

163

1219

Subjective visual disturbances

1163

10113

1.17

5.60

3.3

4.0

13.48

23.99

ug/l

0.75

896

8121

Orchitis and epididymitis

377

2939

1.31

5.59

4.0

4.6

9.32

26.28

ug/l

2.58

317

2518

Other general symptoms and signs

181

1245

1.48

5.58

4.3

3.8

7.90

11.96

ug/l

0.57

146

981

Congenital malformations, deformations and chromosomal abnormalities

2665

22370

1.10

5.53

3.5

4.0

17.59

24.63

ug/l

0.62

2016

17590

Disorders of parathyroid gland

1081

9257

1.17

5.51

3.1

3.8

15.88

22.82

ug/l

0.39

869

7523

Other viral diseases, not elsewhere classified

924

7846

1.18

5.51

3.7

4.0

19.02

24.93

ug/l

0.23

705

6062

Alcohol withdrawal state with delirium

297

2252

1.36

5.51

3.0

4.5

17.96

25.82

ug/l

0.39

256

1882

Disorders of continuity of bone

402

3170

1.30

5.48

3.8

4.1

10.09

22.85

ug/l

1.54

322

2492

Drug-induced osteoporosis with pathological fracture

591

1.75

5.47

3.2

3.9

4.55

17.51

ug/l

1.11

491

Drug-induced adrenocortical insufficiency

542

1.76

5.46

3.1

4.2

11.57

28.42

ug/l

0.49

443

Other anxiety disorders

1688

13012

1.13

5.45

3.1

4.0

11.90

23.58

ug/l

2.04

1296

10011

Rash and other nonspecific skin eruption

433

3451

1.28

5.44

3.5

4.0

9.46

20.63

ug/l

1.36

352

2766

Hydrocephalus

217

2960

0.71

5.41

3.8

4.0

12.32

21.94

ug/l

0.62

177

2444

Inflammatory disorders of breast

219

1583

1.42

5.41

3.4

3.7

8.75

34.68

ug/l

0.61

170

1191

Other neurological diseases

3869

28184

1.09

5.39

3.4

4.0

25.61

25.65

ug/l

0.00

3176

22916

AV-block

949

7141

1.18

5.39

3.0

4.4

17.35

27.77

ug/l

0.93

766

6032

Alzheimer disease, excluding more controls

855

6601

0.84

5.38

2.9

4.5

9.48

28.40

ug/l

3.74

686

5552

Benign lipomatous neoplasm of other sites/unspecified

423

3372

1.29

5.38

3.3

4.0

8.03

24.66

ug/l

2.88

347

2763

Gastrojejunal ulcer

380

1.92

5.37

5.4

4.4

17.02

18.54

ug/l

0.03

317

Pilonidal cyst

251

1855

1.38

5.34

3.6

4.5

14.12

20.90

ug/l

0.42

189

1462

Open wound of lower leg

644

5357

1.22

5.33

3.0

4.0

12.33

32.24

ug/l

1.61

532

4352

Alcohol abuse, main dg, excluding more controls

563

4617

1.24

5.33

3.2

4.6

21.17

31.57

ug/l

0.52

482

3734

Diseases of the eye and adnexa

3681

17005

1.09

5.32

3.8

4.3

22.63

30.88

ug/l

0.77

2905

13423

Other abnormal findings of blood chemistry

200

1435

1.44

5.31

3.4

4.2

28.57

21.76

ug/l

0.14

151

1171

Acute myeloid leukaemia, including Hilmo

139

2.50

5.31

3.6

1.4

3.31

2.72

ug/l

0.31

101

Acute myeloid leukaemia

139

2.50

5.31

3.6

1.4

3.31

2.72

ug/l

0.31

101

Acute myeloid leukaemia, helper endpoint

139

2.50

5.31

3.6

1.4

3.31

2.72

ug/l

0.31

101

Complications of internal orthopaedic prosthetic devices, implants and grafts

1151

10056

1.16

5.29

3.3

3.8

9.67

23.58

ug/l

3.65

943

8252

Injury of unspecified body region

326

2518

1.33

5.27

3.6

4.1

25.52

24.66

ug/l

0.02

251

2046

Diseases of middle ear and mastoid

1841

16779

0.89

5.27

3.6

4.0

14.85

22.42

ug/l

1.06

1387

13186

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

119

771

1.60

5.26

2.7

4.0

4.97

72.73

ug/l

0.85

600

Acute appendicitis

3187

27434

1.09

5.25

4.1

18.22

25.12

ug/l

1.04

2533

21779

Other and unspecified disorders of skin and subcutaneous tissue

301

2308

1.34

5.22

3.3

4.1

8.19

21.32

ug/l

1.92

242

1880

Other problems related to primary support group, including family circumstances

319

2383

1.32

5.20

4.8

3.9

13.44

35.63

ug/l

0.75

243

1784

Other complications of labour and delivery, not elsewhere classified

111

1577

0.64

5.20

2.6

3.5

6.24

32.52

ug/l

0.50

998

Other shoulder lesions

409

3255

1.28

5.19

3.0

4.4

4.61

25.26

ug/l

5.40

317

2597

Undefined dementia

379

4405

0.78

5.18

2.3

3.4

17.49

21.41

ug/l

0.19

320

3668

Visual impairment including blindness (binocular or monocular)

312

2405

1.33

5.17

2.9

3.9

30.36

17.69

ug/l

0.24

251

1975

Appendicitis, broad definition

3432

28697

1.09

5.15

4.0

4.1

17.37

25.23

ug/l

1.38

2721

22820

Poisoning by drugs, medicaments and biological substances

833

7101

1.19

5.12

3.3

4.0

13.74

27.25

ug/l

1.20

707

5496

Other disorders of white blood cells

240

1786

1.39

5.11

2.9

4.2

40.00

17.44

ug/l

0.40

191

1455

Nontoxic goitre/thyroid nodule

1533

13672

1.14

5.11

3.5

3.8

16.06

23.37

ug/l

0.56

1227

10967

Chronic laryngitis and laryngotracheitis

681

5729

1.21

5.08

3.3

4.2

21.13

30.09

ug/l

0.28

550

4666

Redundant prepuce, phimosis and paraphimosis

717

5979

1.20

5.08

4.2

4.6

11.29

31.10

ug/l

4.25

588

5013

Immunodeficiency with predominantly antibody defects

110

707

1.62

5.08

3.1

4.1

17.99

24.63

ug/l

0.14

572

Acute lymphadenitis

202

1458

1.42

5.07

3.5

4.1

16.15

21.10

ug/l

0.22

168

1145

Systemic lupus erythematosus

153

1055

1.51

5.07

3.1

4.0

9.52

14.86

ug/l

0.43

115

831

Arterial embolism and thrombosis

279

2124

1.35

5.07

3.4

4.0

40.44

23.20

ug/l

0.29

232

1772

Hyperparathyroidism

948

8103

1.18

5.06

3.1

3.8

9.11

23.08

ug/l

2.88

758

6596

Nephrotic syndrome

132

885

1.55

5.03

3.4

4.3

3.68

26.24

ug/l

1.69

103

738

Bacterial, viral and other infectious agents

298

2285

1.33

5.03

3.8

4.3

22.71

19.42

ug/l

0.11

233

1833

Coxarthrosis

2898

17577

1.10

5.03

3.7

4.3

18.20

32.22

ug/l

1.86

2397

14435

Atrophic disorders of skin

695

5865

1.21

5.01

3.5

4.0

4.59

29.68

ug/l

3.31

523

4680

Systemic connective tissue disorders

1752

15752

1.12

5.00

2.9

3.9

10.84

22.62

ug/l

2.36

1381

12722

Diabetic retinopathy, strict definition

532

5682

0.81

4.96

3.2

3.8

21.10

22.69

ug/l

0.05

435

4749

Nonorganic sleeping disorders, excluding more controls

702

5921

1.20

4.93

3.1

4.2

6.40

29.20

ug/l

2.68

542

4584

Other nutritional deficiencies

2981

25856

1.09

4.93

3.4

4.1

22.33

23.89

ug/l

0.11

2361

20403

Complications of labour and delivery

2366

14443

0.90

4.92

3.7

3.8

17.01

21.57

ug/l

0.34

1790

11025

Fibromyalgia

383

3049

1.28

4.87

2.4

4.1

4.12

27.06

ug/l

1.32

289

2319

Nontraumatic intracranial haemmorrhage

768

8972

0.84

4.84

3.2

4.0

21.96

24.72

ug/l

0.15

650

7409

Fracture of lower leg, including ankle

2696

24517

1.10

4.84

3.6

4.1

25.54

24.92

ug/l

0.03

2173

19730

Follicular adenocarcinoma of thyroid gland

2.89

4.84

3.8

1.4

2.58

2.64

ug/l

0.03

Other congenital malformations

265

2009

1.34

4.81

3.2

4.0

10.11

19.91

ug/l

0.83

184

1554

Disturbances of skin sensation

1127

9883

1.15

4.81

3.3

4.0

10.74

24.16

ug/l

2.01

867

7749

Nonpyogenic thrombosis of intracranial venous system

235

2.10

4.77

5.9

3.9

6.62

37.52

ug/l

0.51

184

Failure and rejection of transplanted organs and tissues

327

1.91

4.77

2.7

4.8

2.86

20.45

ug/l

0.73

264

Other symptoms and signs involving the circulatory and respiratory systems

287

2212

1.33

4.75

2.9

4.2

15.07

25.31

ug/l

0.56

238

1790

Cerebral palsy and other paralytic syndromes

457

3724

1.25

4.72

2.7

4.0

84.87

20.04

ug/l

0.46

343

2991

Other diseases of arteries and capillaries

415

3353

1.27

4.71

4.0

4.1

6.83

19.43

ug/l

2.86

343

2749

Delivery, wide proxy

1299

7798

0.87

4.71

4.0

3.5

16.55

17.42

ug/l

0.07

1029

6082

Other acute viral hepatitis

299

1.95

4.71

3.9

4.3

14.44

21.98

ug/l

0.17

244

Fracture of forearm

2676

22537

1.10

4.69

3.8

3.9

18.72

23.76

ug/l

0.54

2137

18025

Wet age-related macular degeneration

948

8002

1.17

4.69

3.3

3.7

21.23

21.81

ug/l

0.02

776

6650

Melanoma of uvea

362

1.90

4.69

3.6

4.3

8.82

37.49

ug/l

0.71

304

Outcome of delivery

437

2169

1.26

4.68

3.2

108.93

10.00

ug/l

0.55

284

1512

Hard cardiovascular diseases

4440

24768

1.08

4.67

3.5

4.3

23.40

26.96

ug/l

0.30

3616

19916

Disorders of porphyrin and bilirubin metabolism

286

1.97

4.67

3.1

4.5

3.15

43.16

ug/l

0.84

240

Malignant immunoproliferative diseases

363

1.89

4.66

2.8

4.3

8.41

44.49

ug/l

0.92

309

Brain glioblastoma

194

2.15

4.64

2.3

1.4

3.45

2.55

ug/l

0.56

150

Inflammatory diseases of prostate (prostatitis)

546

4541

1.22

4.63

3.6

4.6

15.81

31.17

ug/l

1.04

436

3881

Coxarthrosis [arthrosis of hip](FG)

3167

20631

1.09

4.63

3.7

4.2

20.23

27.48

ug/l

0.69

2617

16876

Other and unspecified disorders of white blood cells

180

1304

1.43

4.60

2.9

4.2

16.48

19.73

ug/l

0.09

142

1060

Prolonged pregnancy

240

2774

0.75

4.60

3.2

3.4

7.15

22.14

ug/l

0.53

165

1845

Other congenital malformations of intestine

325

1.91

4.59

3.7

4.1

3.03

21.25

ug/l

0.79

270

Arterial embolism and thrombosis of lower extremity artery

174

1254

1.44

4.59

3.5

4.0

59.90

22.15

ug/l

0.42

141

1063

Single spontaneous delivery

1585

9365

0.89

4.59

3.9

3.5

23.00

16.70

ug/l

0.44

1241

7311

Obesity related asthma

1612

14500

1.12

4.58

3.1

4.1

23.05

25.79

ug/l

0.12

1310

11622

Noninflammatory disorders of female genital tract

1713

7709

1.12

4.58

3.4

4.1

11.75

31.07

ug/l

2.45

1291

6004

Femoral hernia

209

1555

1.39

4.54

3.6

4.0

25.79

18.70

ug/l

0.16

170

1288

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

958

8301

1.16

4.53

3.1

4.2

15.44

25.68

ug/l

0.86

782

6357

Mood disorders, excluding more controls

4726

26467

1.07

4.52

3.3

4.2

22.93

24.78

ug/l

0.15

3762

21074

Carcinoma in situ of skin

437

3576

1.26

4.52

3.6

3.9

25.50

21.23

ug/l

0.13

339

2962

Poisoning by medicine

735

6274

1.18

4.51

3.2

4.1

12.20

24.70

ug/l

1.07

622

4849

Exclusions for E4_PCOS_BROAD

649

5487

1.20

4.49

3.3

4.1

34.56

26.81

ug/l

0.19

511

4346

Stomatitis and related lesions

798

6869

1.18

4.48

3.8

4.0

19.59

28.81

ug/l

0.35

648

5478

Diseases of salivary glands

1452

13003

1.13

4.48

3.5

4.0

17.16

23.71

ug/l

0.55

1170

10381

Seborrhoeic dermatitis

408

3308

1.26

4.48

3.4

4.2

7.26

25.78

ug/l

2.89

329

2702

Hypertrophy of breast in women and men

809

6972

1.18

4.48

3.5

3.8

20.88

24.48

ug/l

0.14

621

5397

Hemiplegia

211

1573

1.38

4.45

2.8

4.0

26.66

21.06

ug/l

0.13

154

1285

Other and unspecified diseases of spleen

135

2.52

4.45

1.9

4.4

4.56

5.00

ug/l

0.07

114

Alzheimer’s disease (Atypical or mixed)

350

4323

0.79

4.44

2.7

3.6

9.42

23.49

ug/l

2.17

278

3637

Other and unspecified visual disturbances

450

3693

1.24

4.42

3.6

4.1

15.66

21.00

ug/l

0.21

363

2964

SLE, ICD10

144

1010

1.48

4.42

3.2

4.0

10.23

14.38

ug/l

0.29

106

804

SLE, strict definition

144

1010

1.48

4.42

3.2

4.0

10.23

14.38

ug/l

0.29

106

804

Preparatory care for dialysis

197

1460

1.40

4.41

2.7

4.3

4.79

21.11

ug/l

2.03

171

1218

Carcinoma in situ of breast, lobular

282

2.01

4.39

4.4

3.9

4.91

11.50

ug/l

1.57

239

Idiopathic gout

444

3651

1.25

4.35

3.3

4.3

10.41

21.64

ug/l

1.26

373

3092

Anti-inflammatory and antirheumatic products, non-steroids

1320

5879

1.14

4.35

4.0

4.3

20.67

25.13

ug/l

0.25

1086

4825

Chondrocostal junction syndrome [Tietze]

155

1105

1.45

4.34

3.1

4.0

35.32

13.16

ug/l

0.31

120

898

Benign neoplasm of breast

557

4677

1.21

4.34

3.9

3.7

9.81

28.78

ug/l

1.40

437

3672

Ocular pain

321

2541

1.29

4.34

3.1

4.1

16.02

24.66

ug/l

0.37

229

2010

Vitamin D deficiency

450

1.72

4.32

2.6

4.2

3.71

32.19

ug/l

0.98

376

Carbimazole or st.post thyroidectomy, condition for graves disease

920

8030

1.16

4.32

3.5

3.9

11.01

25.93

ug/l

1.87

703

6315

Carcinoma in situ of skin of lower limb, including hip

120

824

1.54

4.30

3.0

4.1

10.82

28.67

ug/l

0.86

695

Diseases of inner ear

2835

25390

1.09

4.29

3.4

4.0

15.94

24.23

ug/l

1.21

2227

20682

Other and unspecified urticaria

765

6586

1.18

4.29

3.4

3.9

15.70

28.13

ug/l

0.90

601

5159

Kela-code for severe mental illness

1176

13247

0.88

4.27

3.0

4.1

20.01

23.98

ug/l

0.21

971

10532

Intussusception

593

1.62

4.27

4.2

3.9

4.51

23.53

ug/l

0.94

477

Delivery

1600

9372

0.89

4.26

3.9

3.5

22.95

16.69

ug/l

0.44

1246

7315

Discitis, unspecified

573

1.65

4.25

3.5

4.5

17.59

28.87

ug/l

0.30

467

Other congenital malformations

420

3428

1.24

4.23

3.4

4.0

27.56

30.42

ug/l

0.05

305

2650

Unstable angina pectoris

1760

15273

0.90

4.21

3.2

4.3

11.50

29.80

ug/l

5.21

1468

12781

Benign neoplasm: Long bones of lower limb

121

828

1.51

4.20

3.5

4.5

36.54

24.29

ug/l

0.14

674

Benign neoplasm: Bronchus and lung

450

1.73

4.20

4.5

4.3

51.17

31.41

ug/l

0.17

379

Hypertrophic disorders of skin

201

1502

1.37

4.16

3.2

4.2

8.49

26.21

ug/l

1.58

147

1177

Spondyloarthritis

726

6241

1.18

4.16

3.4

4.1

75.30

27.48

ug/l

0.82

581

5016

Cyclic neutropenia

3.51

4.15

11.5

4.7

26.28

5.00

ug/l

0.43

Other and unspecified aplastic anaemias

321

1.86

4.14

2.2

4.4

4.64

20.54

ug/l

0.65

268

Unspecified urinary incontinence

426

3507

1.24

4.13

3.2

3.8

14.99

25.97

ug/l

0.54

338

2822

Other and unspecified erythematous conditions

142

1009

1.46

4.12

3.6

4.2

15.28

27.96

ug/l

0.40

119

824

Calcific aortic valvular stenosis

1571

13778

1.12

4.11

3.3

3.9

21.60

23.28

ug/l

0.09

1306

11524

Calcific aortic valvular stenosis, operated

1571

13778

1.12

4.11

3.3

3.9

21.60

23.28

ug/l

0.09

1306

11524

Other disorders of eye and adnexa

553

4657

1.21

4.10

3.3

3.9

11.83

29.57

ug/l

1.19

402

3676

Propionic acid derivatives

1315

5879

1.13

4.10

4.0

4.3

17.19

25.13

ug/l

0.64

1078

4825

Operations 2 for CAVS

1570

13770

1.12

4.10

3.3

3.9

21.60

23.28

ug/l

0.09

1306

11520

Calcific aortic valvular stenosis, diagnosis (helper)

1570

13770

1.12

4.10

3.3

3.9

21.60

23.28

ug/l

0.09

1306

11520

Viral pneumonia (known virus, not influenza)

123

853

1.50

4.09

4.0

4.2

4.87

24.35

ug/l

1.33

108

718

Right bundle-branch block

179

1324

1.40

4.09

4.0

4.5

51.75

30.97

ug/l

0.19

154

1099

Scabies

154

1106

1.43

4.08

3.9

4.4

23.11

19.98

ug/l

0.10

128

894

Inflammatory disease of cervix uteri

291

2302

1.30

4.07

3.1

3.8

7.07

20.11

ug/l

1.29

237

1816

Ectropion of eyelid

204

1541

1.37

4.07

3.6

3.8

10.13

23.15

ug/l

1.01

179

1294

Other specified/unspecified arthritis

1305

11691

1.13

4.06

3.4

4.3

11.96

30.17

ug/l

3.30

1020

9480

Generalized skin eruption due to drugs and medicaments

161

1170

1.42

4.06

4.7

4.1

16.76

21.75

ug/l

0.21

129

943

Atopic dermatitis

1957

17556

0.91

4.06

3.4

4.0

29.63

22.67

ug/l

0.26

1499

13555

Listeriosis

147

2.35

4.05

6.3

4.3

17.98

6.30

ug/l

0.53

129

Other and unspecified coagulation defects

185

1373

1.38

4.05

3.3

4.2

4.58

25.12

ug/l

2.09

131

1084

Benign lipomatous neoplasm

1410

12693

1.12

4.04

3.4

4.1

16.36

24.88

ug/l

0.78

1132

10296

Folate deficiency anaemia

295

1.90

4.03

2.7

4.6

5.32

24.50

ug/l

0.71

239

Ovarian dysfunction

177

1299

1.38

4.03

2.9

3.5

7.95

40.95

ug/l

0.60

123

920

Premature rupture of membranes

431

3747

0.82

4.03

3.4

3.5

4.38

22.44

ug/l

1.05

282

2611

Labour and delivery complicated by fetal stress [distress]

408

3267

0.81

4.01

3.0

3.4

22.37

20.14

ug/l

0.04

251

2151

Long labour

561

5680

0.84

4.00

3.2

3.6

46.55

23.63

ug/l

0.32

394

4080

Other/unspecified reactive arthropathies

253

1967

1.32

4.00

3.4

4.2

14.82

21.44

ug/l

0.28

188

1592

Sequelae of poliomyelitis

343

1.84

3.97

4.5

4.0

17.30

49.69

ug/l

0.62

296

Calcific aortic valvular stenosis, including rheumatic fever

1573

13812

1.12

3.96

3.3

3.9

21.57

23.33

ug/l

0.10

1308

11555

Other congenital malformations of intestine

223

2.02

3.96

4.3

4.4

2.84

10.42

ug/l

2.29

179

Other disorders of penis

359

2910

1.26

3.95

3.8

4.7

11.70

25.46

ug/l

1.23

279

2488

Other arthritis (FG)

1494

13505

1.12

3.94

3.4

4.2

11.46

26.49

ug/l

3.10

1177

10913

Diseases of external ear

1533

13875

1.12

3.94

3.4

4.0

17.32

24.46

ug/l

0.55

1174

11297

Pleural plaque with presence of asbestos

366

2988

1.26

3.93

3.1

4.3

24.69

27.31

ug/l

0.09

318

2553

Drug-induced cataract

109

745

1.53

3.93

2.9

4.3

10.21

25.72

ug/l

0.70

622

Endometriosis of pelvic peritoneum

607

4926

1.19

3.91

3.0

4.2

6.34

35.34

ug/l

2.66

446

3784

Alzheimer’s disease (Atypical or mixed), excluding more controls

336

3298

0.79

3.91

2.7

4.2

9.69

29.12

ug/l

2.97

267

2802

Primary ovarian failure

408

1.70

3.90

3.5

4.1

6.99

21.03

ug/l

0.59

304

Other diseases of blood and blood-forming organs

298

2376

1.28

3.90

3.3

4.1

3.83

16.11

ug/l

2.95

241

1952

Chronic conjunctivitis

127

894

1.47

3.88

2.5

4.1

11.92

27.50

ug/l

0.69

726

Social phobias

200

1505

1.35

3.87

3.3

4.2

16.68

39.35

ug/l

0.39

145

1115

Hidradenitis suppurativa

116

800

1.49

3.86

2.6

4.3

8.87

21.92

ug/l

0.78

614

SLE (Finngen)

153

1114

1.42

3.85

3.1

4.2

9.52

22.52

ug/l

1.02

115

874

Other disorders of nervous system

303

2426

1.28

3.85

3.2

4.3

105.88

23.89

ug/l

0.43

256

1990

Symptoms and signs involving emotional state

110

753

1.51

3.83

2.8

4.2

22.17

30.32

ug/l

0.16

612

Carcinoma in situ of bronchus and lung

3.93

3.83

8.2

4.8

3.59

91.78

ug/l

0.52

Postmenopausal atrophic vaginitis

1389

6889

1.13

3.83

3.3

4.2

6.01

33.33

ug/l

4.27

1050

5522

Circumscribed brain atrophy

784

0.55

3.83

3.3

4.2

16.07

33.24

ug/l

0.59

657

Other erythematous conditions

155

1134

1.41

3.81

3.5

4.2

14.24

26.49

ug/l

0.43

130

930

Endometriosis diagnosis and infertility diagnosis occurring together

340

2750

1.25

3.81

3.3

3.6

13.08

28.99

ug/l

0.52

246

1998

Postpartum haemorrhage

572

5662

0.84

3.80

3.3

3.6

18.55

21.37

ug/l

0.09

385

4044

Moderate visual impairment, binocular

139

999

1.44

3.80

3.1

3.6

55.31

18.79

ug/l

0.34

115

834

Other specified disorders of kidney and ureter

146

1059

1.43

3.79

3.7

4.3

66.20

22.51

ug/l

0.37

120

880

126

894

1.48

3.79

3.1

4.3

4.35

28.07

ug/l

1.81

114

758

Acquired absence of organs, not elsewhere classified

384

1.74

3.79

4.1

4.3

43.90

21.44

ug/l

0.25

324

Systemic lupus erythematosus, unspecified

122

857

1.47

3.78

3.3

4.0

10.99

14.94

ug/l

0.24

685

Achalasia of cardia

532

1.61

3.77

3.1

4.6

3.42

18.33

ug/l

1.19

449

Cachexia

165

2.20

3.77

3.8

4.6

960.89

10.53

ug/l

0.50

139

Acute upper respiratory infections of multiple and unspecified sites

3477

24119

1.07

3.76

3.9

4.0

16.71

24.42

ug/l

1.18

2718

19155

Other disorders of eyelid

2436

21486

1.09

3.75

3.5

4.0

16.38

24.22

ug/l

1.20

1983

17632

Unknown and unspecified causes of morbidity

276

2187

1.29

3.74

3.6

3.9

8.95

19.05

ug/l

1.01

221

1732

Aneurysms, operations, SAH

602

7008

0.85

3.74

3.4

4.1

18.58

25.91

ug/l

0.50

514

5713

Obesity due to excess calories

2004

18409

1.10

3.73

3.3

4.1

19.12

24.19

ug/l

0.39

1597

14493

Congenital iodine-deficiency syndrome/hypothyroidism

138

995

1.44

3.73

3.6

4.0

24.14

22.16

ug/l

0.03

105

819

Pneumonia due to Streptococcus pneumoniae

164

1212

1.39

3.73

3.4

4.2

66.78

20.06

ug/l

0.44

135

999

Nonhereditary hypogammaglobulinemia

317

1.82

3.73

3.2

4.2

3.64

6.77

ug/l

1.07

262

Postmenopausal osteoporosis with pathological fracture

337

2749

1.26

3.72

2.8

3.6

12.85

18.57

ug/l

0.38

283

2233

Entropion and trichiasis of eyelid

427

3560

1.23

3.70

3.7

3.9

21.56

22.50

ug/l

0.02

358

2959

Unspecified event, undetermined intent

621

1.55

3.69

3.8

4.3

2.97

29.92

ug/l

1.32

510

Second line medication for Crohn's disease

2654

24666

1.08

3.67

3.3

4.1

19.12

24.97

ug/l

0.51

2068

19700

Diseases of the ear and mastoid process

5776

27528

1.06

3.67

3.6

4.1

17.60

28.22

ug/l

2.00

4526

21971

Pediculosis, acariasis and other infestations

207

1586

1.33

3.66

3.8

4.3

21.38

22.92

ug/l

0.05

173

1280

Disorders of vestibular function (Vertigo)

2426

22130

1.09

3.64

3.3

4.0

15.59

23.57

ug/l

0.98

1898

18021

Other headache syndromes

1983

18216

1.10

3.63

3.1

4.1

25.15

24.84

ug/l

0.01

1558

14436

Other factor of the environment

357

1.75

3.63

3.0

4.5

3.96

39.54

ug/l

0.95

296

Other follicular disorders

247

1939

1.30

3.62

3.7

4.1

7.06

21.26

ug/l

1.86

201

1530

Decubitus ulcer and pressure area

285

2284

1.28

3.62

2.8

3.9

11.67

23.82

ug/l

0.99

235

1909

Use of levodopa decarbox-comt-inhibitor

1222

0.65

3.61

3.2

4.1

3.15

23.71

ug/l

2.30

1029

Accessory breast

139

2.23

3.61

3.1

3.9

4.51

6.34

ug/l

0.28

106

Calculus of lower urinary tract

240

1886

1.31

3.60

4.4

4.2

4.98

26.97

ug/l

3.00

197

1595

Carcinoma in situ of skin of other and unspecified parts of face

433

3629

1.22

3.60

3.3

3.8

31.41

24.28

ug/l

0.19

332

3024

Shock, not elsewhere classified

283

1.84

3.58

4.1

4.6

51.24

10.13

ug/l

0.40

237

Agoraphobia

502

1.59

3.58

3.2

4.4

17.07

25.47

ug/l

0.22

385

Familial hypercholesterolemia, with ischemic heart disease

503

4274

1.20

3.58

3.2

4.2

10.11

22.83

ug/l

1.41

429

3590

Complications of genitourinary prosthetic devices, implants and grafts

109

759

1.49

3.57

4.3

4.1

5.05

25.10

ug/l

1.16

611

False labour

665

4806

0.86

3.57

3.1

3.5

12.01

22.67

ug/l

0.55

450

3353

Diabetic retinopathy, excluding more controls

1160

5813

1.13

3.55

3.5

4.0

20.23

27.78

ug/l

0.47

957

4786

Cysts of oral region, not elsewhere classified

232

1817

1.31

3.53

3.4

4.3

10.42

19.56

ug/l

0.88

189

1475

Anomalies of dental arch relationship, including avohilmo

445

4780

0.83

3.53

3.3

4.1

9.82

27.36

ug/l

1.39

326

3693

Drug-induced hypoglycaemia without coma

453

1.64

3.52

2.5

4.3

8.21

41.00

ug/l

1.07

379

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

2.46

3.52

1.5

1.4

4.04

2.46

ug/l

0.47

Rheumatism, unspecified

691

6018

1.17

3.50

3.0

4.1

7.50

26.19

ug/l

2.17

553

4767

Nonorganic sleeping disorders

702

6105

1.16

3.50

3.1

4.0

6.40

26.69

ug/l

2.72

542

4744

Horner syndrome

377

1.71

3.50

3.4

4.3

2.97

18.80

ug/l

0.80

313

Assault

358

2937

1.23

3.49

3.4

4.4

36.69

28.69

ug/l

0.11

290

2299

Endocarditis

161

1204

1.38

3.47

3.2

4.6

14.32

27.37

ug/l

0.69

131

1004

209

1610

1.31

3.47

3.3

3.4

33.82

32.42

ug/l

0.01

132

1053

Sequelae of injuries of lower limb

356

2929

1.24

3.47

3.5

4.2

55.96

19.81

ug/l

0.34

286

2370

Other blood glucose lowering drugs, excl. Insulins

808

7117

1.15

3.47

3.4

4.1

15.85

25.24

ug/l

0.80

682

5892

Type 1 diabetes

931

8241

1.14

3.47

3.7

4.2

27.99

27.41

ug/l

0.02

792

6551

Melanocytic naevi of lower limb, including hip

173

1306

1.36

3.47

3.8

4.2

3.21

21.77

ug/l

2.19

139

1061

Alcohol abuse, main dg

563

4822

1.18

3.47

3.2

4.4

21.17

32.26

ug/l

0.58

482

3934

Respiratory tuberculosis, confirmed and not-confirmed

247

1957

1.29

3.46

3.1

3.8

57.40

20.86

ug/l

0.53

208

1640

Meniscus derangement

2983

18779

1.08

3.45

3.9

4.4

13.94

30.77

ug/l

4.27

2417

15275

Respiratory tuberculosis

247

1958

1.29

3.44

3.1

3.8

57.40

20.84

ug/l

0.53

208

1641

351

1.70

3.44

3.6

4.3

2.89

22.00

ug/l

0.85

271

Retinal vascular disorders

608

5256

1.18

3.44

3.5

4.0

16.21

23.17

ug/l

0.56

501

4390

Myocarditis

168

1261

1.36

3.43

4.0

4.5

9.35

23.60

ug/l

1.18

137

1017

Personal history of certain other diseases

239

1.85

3.42

4.5

3.9

3.65

6.02

ug/l

0.90

180

Abnormal findings in peritoneal fluid saliva

124

2.35

3.41

4.0

4.2

5.28

9.71

ug/l

0.71

100

Pyogenic arthritis

299

2425

1.26

3.40

3.0

4.5

20.10

28.22

ug/l

0.36

252

2041

Diabetic maculopathy

374

4229

0.82

3.40

3.6

3.7

48.88

21.82

ug/l

0.45

317

3549

Presbycusis

717

6216

1.16

3.39

3.4

3.7

12.18

26.69

ug/l

2.48

574

5178

Other diseases of upper respiratory tract

5787

28710

1.05

3.38

3.7

4.1

19.88

24.31

ug/l

0.63

4617

23133

Pain and other conditions associated with female genital organs and menstrual cycle

659

5251

1.16

3.38

2.7

4.2

13.10

34.44

ug/l

1.37

468

3967

Other otitis externa (chronic)

263

2105

1.28

3.37

2.8

4.2

51.18

20.36

ug/l

0.48

199

1713

Localized skin eruption due to drugs and medicaments

342

1.73

3.37

6.6

4.1

11.94

40.06

ug/l

0.60

278

Cushing syndrome

350

1.73

3.36

2.0

4.1

11.97

19.95

ug/l

0.25

291

Diplopia

573

4936

1.18

3.36

3.2

4.0

46.00

21.72

ug/l

0.48

467

3995

Radiodermatitis

2.76

3.35

3.9

4.8

5.74

5.98

ug/l

0.02

Encephalopathy

336

1.75

3.34

3.0

4.4

20.34

44.06

ug/l

0.41

279

Retinal vascular occlusion

597

5168

1.18

3.34

3.5

4.0

16.46

23.38

ug/l

0.54

491

4314

Other salmonella infections

168

1270

1.36

3.33

4.5

4.2

29.51

21.73

ug/l

0.18

132

1044

Personality disorders, excluding more controls

845

7461

1.14

3.33

3.0

4.3

11.82

26.47

ug/l

1.65

672

5723

Subarachnoid haemorrhage

342

4131

0.81

3.33

3.2

4.0

23.39

21.88

ug/l

0.05

293

3374

Brain glioblastoma and astrocytoma

227

1.86

3.32

2.2

1.5

3.45

2.73

ug/l

0.42

174

Sequelae of poliomyelitis

292

1.82

3.32

5.0

4.1

19.98

43.96

ug/l

0.36

255

Bronchitis, not specified as acute or chronic

352

2909

1.23

3.31

3.2

4.2

32.13

19.87

ug/l

0.22

295

2357

Hypersplenism

132

2.26

3.31

2.6

5.1

2.27

37.80

ug/l

0.61

114

Otitis externa

900

8004

1.14

3.26

3.4

4.1

21.87

26.71

ug/l

0.18

700

6462

Benign neoplasm of bone and articular cartilage

310

2534

1.24

3.25

3.6

4.1

33.75

20.46

ug/l

0.34

243

2027

Tuberculosis, IBD comorbidity

325

2674

1.24

3.25

3.0

3.9

47.15

20.66

ug/l

0.49

269

2231

Other dermatomyositis

161

2.12

3.25

2.6

4.5

3.52

77.44

ug/l

0.86

133

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

594

4983

1.17

3.24

3.1

4.2

6.65

29.23

ug/l

2.47

458

3975

Tuberculosis, wide

335

2767

1.24

3.22

3.1

3.8

45.73

21.77

ug/l

0.44

278

2311

Other infective otitis externa

235

1867

1.29

3.22

3.2

4.2

15.33

21.17

ug/l

0.22

188

1517

Other peripheral vertigo

425

3592

1.21

3.21

3.1

4.0

11.07

26.36

ug/l

1.50

337

2922

Spontaneous abortion

1627

11969

0.91

3.21

3.8

3.7

28.86

21.95

ug/l

0.21

1242

9000

Recurrent aphthous stomatitis , including avohilmo

574

4962

1.17

3.20

3.7

3.9

25.35

27.18

ug/l

0.04

456

3960

Persistent mood disorders

804

7110

1.14

3.20

2.9

4.1

12.56

25.61

ug/l

1.34

655

5681

Other arthrosis

2847

18458

1.08

3.20

3.3

4.4

11.24

31.02

ug/l

5.82

2284

15043

Other menopausal disorders

1076

6751

0.89

3.20

3.2

4.2

16.46

33.69

ug/l

0.95

794

5350

Superficial injury of wrist and hand

702

6149

1.15

3.19

3.2

4.1

8.97

28.18

ug/l

2.31

520

4820

Other abnormal findings in urine

523

1.57

3.18

3.4

4.4

96.38

33.27

ug/l

0.44

442

Other hearing loss

1445

12917

1.11

3.18

3.5

3.9

9.19

25.41

ug/l

6.22

1150

10707

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

183

2.01

3.18

4.4

4.7

21.50

31.85

ug/l

0.15

152

Thyrotoxicosis with toxic multinodular goitre

294

2405

1.25

3.18

3.2

3.9

4.32

17.57

ug/l

3.00

241

1945

Maternal care for known or suspected abnormality of pelvic organs

584

4602

0.86

3.18

3.2

3.6

31.37

20.50

ug/l

0.21

392

3267

Unspecified mental disorder

1339

14707

0.90

3.17

3.1

4.0

23.37

24.70

ug/l

0.05

1094

11628

Benign neoplasm: Skin of trunk

173

1326

1.34

3.17

3.7

4.1

5.15

24.51

ug/l

2.01

138

1092

Viral agents as the cause of diseases classified to other chapters

660

1.49

3.16

3.5

4.4

20.80

18.25

ug/l

0.05

537

Cluster headache, strict

128

936

1.40

3.16

3.2

4.6

11.13

29.44

ug/l

0.78

103

756

Maternal care for other known or suspected fetal problems

433

3252

0.84

3.15

3.0

3.4

21.97

20.24

ug/l

0.03

278

2164

Reactive arthropathies, FINNGEN

284

2310

1.25

3.15

3.4

4.4

13.86

28.95

ug/l

0.90

211

1868

Other diseases of lip and oral mucosa

1855

17134

1.09

3.15

3.5

4.0

13.16

23.19

ug/l

1.19

1477

13768

Biliary cirrhosis, NAS

123

2.35

3.14

3.8

4.7

2.93

10.38

ug/l

1.37

104

Osteomyelitis

265

2143

1.26

3.13

2.8

4.3

8.75

22.12

ug/l

1.59

219

1784

Disorders of plasma-protein metabolism, not elsewhere classified

198

1.95

3.13

2.8

4.8

4.05

61.34

ug/l

0.81

164

Arthropathies in other diseases classified elsewhere

160

1216

1.35

3.13

3.5

4.6

60.12

26.47

ug/l

0.28

126

1013

ILD-related respiratory insufficiency

159

1211

1.36

3.12

3.5

4.0

16.17

23.69

ug/l

0.26

140

1018

Other specified/unspecified deforming dorsopathies

499

1.56

3.11

3.1

4.3

14.43

7.98

ug/l

0.32

389

Malignant neoplasm of nasal cavity and sinuses

2.42

3.10

3.4

1.5

4.28

2.42

ug/l

0.54

Nontoxic multinodular goitre

1014

9124

1.13

3.10

3.6

3.9

7.88

24.43

ug/l

3.19

823

7387

Benign neoplasm of other and unspecified intrathoracic organs

375

1.67

3.09

3.1

4.2

4.04

45.54

ug/l

1.22

316

Acute generalized exanthematous pustulosis

179

1383

1.33

3.09

4.4

4.2

25.47

19.77

ug/l

0.18

143

1122

Polymyalgia rheumatica

674

5926

1.16

3.06

2.9

3.9

9.07

26.01

ug/l

3.74

545

4898

Exclusion endpoint for clefts

324

1.68

3.05

3.4

4.3

4.44

19.61

ug/l

0.57

256

Phakomatoses, not elsewhere classified

258

1.79

3.04

2.4

4.3

8.88

23.63

ug/l

0.40

209

Lack of expected normal physiological development

2.36

3.04

2.8

3.3

2.19

1.82

ug/l

0.42

Peripheral arterial reconstruction

844

7527

1.14

3.02

3.0

4.0

26.99

21.73

ug/l

0.22

723

6329

Other hereditary haemolytic anaemias

150

2.07

3.02

3.9

4.6

2.67

6.90

ug/l

1.30

121

Hypertrophy of breast

684

6014

1.15

3.01

3.4

3.7

20.05

24.02

ug/l

0.14

511

4586

Other disorders of conjunctiva

660

5800

1.15

3.00

3.4

4.1

12.25

29.30

ug/l

2.02

523

4782

Other maltreatment syndromes

624

1.48

2.99

3.7

4.9

14.23

22.01

ug/l

0.31

498

Endometriosis of rectovaginal septum and vagina

330

2744

1.22

2.98

3.3

4.1

21.00

37.56

ug/l

0.45

248

2176

Other specified congenital malformation syndromes affecting multiple systems

258

1.76

2.98

3.2

4.3

4.95

21.56

ug/l

0.48

205

Abnormal findings on examination of urine, without diagnosis

174

1347

1.32

2.98

3.2

4.2

48.43

20.99

ug/l

0.39

147

1118

Tuberculosis

282

2311

1.25

2.97

3.1

3.7

58.57

22.42

ug/l

0.61

241

1936

Panniculitis affecting regions of neck and back

153

1164

1.35

2.97

2.8

4.6

3.06

21.94

ug/l

1.71

119

941

Diseases of tongue

288

2367

1.24

2.96

3.5

4.2

32.15

27.43

ug/l

0.07

247

1918

Abnormalities of gait and mobility

561

4883

1.17

2.95

2.8

4.1

10.73

25.51

ug/l

1.89

454

4025

Lifestyle-related condition

340

1.67

2.91

2.9

4.5

3.93

41.07

ug/l

0.94

281

Disorders of conjunctiva

3802

28908

1.06

2.91

3.4

4.0

12.60

24.92

ug/l

3.56

2868

22995

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

546

4586

1.17

2.91

3.2

4.2

5.40

29.57

ug/l

2.48

423

3650

Endovascular or surgical operations to intracerebral aneurysms

178

2267

0.77

2.90

3.5

4.1

27.07

19.80

ug/l

0.22

160

1825

Allergic urticaria

280

2294

1.24

2.90

3.6

4.1

11.67

33.05

ug/l

0.77

216

1805

Carcinoma in situ of skin of scalp and neck

128

958

1.39

2.89

3.8

4.0

8.69

27.90

ug/l

1.34

812

Migraine

1770

15518

0.92

2.89

3.1

4.1

12.97

23.29

ug/l

0.98

1283

12012

Thyrotoxicosis

1140

10352

1.11

2.89

3.2

3.8

10.24

24.60

ug/l

2.55

894

8197

Cluster headache, strict, including avohilmo

160

1228

1.33

2.88

3.2

4.3

9.66

26.56

ug/l

0.94

124

973

Single delivery by caesarean section

384

2617

0.83

2.87

3.4

4.97

8.28

ug/l

1.16

261

1799

Communicating hydrocephalus

712

0.60

2.87

3.3

4.1

4.21

25.88

ug/l

1.27

602

Benign neoplasm: Skin, unspecified

166

1286

1.33

2.86

2.9

4.1

3.96

23.08

ug/l

2.11

132

1047

Senility

285

1.71

2.86

2.2

3.4

5.34

7.18

ug/l

0.45

240

Generalized anxiety disorder

438

3737

1.18

2.85

3.2

4.0

6.55

28.69

ug/l

1.47

339

2801

Viral agents as the cause of diseases classified to other chapters

600

1.48

2.85

3.6

4.4

22.86

19.37

ug/l

0.06

496

Other and unspecified vascular occlusions

461

3968

1.18

2.85

3.5

4.0

19.33

19.72

ug/l

0.02

377

3323

Superficial injury of thorax

605

5300

1.16

2.85

3.4

4.2

20.77

29.24

ug/l

0.36

506

4312

Other noninflammatory disorders of vagina

325

2711

1.22

2.85

3.5

4.2

5.17

38.59

ug/l

1.61

247

2131

Benign neoplasm of other and unspecified sites

143

1087

1.36

2.84

3.7

4.2

59.75

26.07

ug/l

0.26

116

893

Other and unspecified haemorrhagic conditions

487

1.54

2.83

3.6

4.2

27.28

22.17

ug/l

0.10

410

Use of ropinirole

1347

0.70

2.83

3.1

4.3

3.92

22.55

ug/l

2.17

1114

Acute appendicitis, no complications

2302

21415

1.08

2.83

4.0

4.1

18.38

25.81

ug/l

0.86

1818

16891

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1688

13805

0.92

2.83

3.6

3.7

14.92

21.75

ug/l

0.53

1232

10380

Medical abortion

2924

14906

1.07

2.82

3.7

14.43

21.06

ug/l

0.98

2296

11438

Symptoms and signs involving speech and voice

1590

14675

1.09

2.82

3.4

4.0

10.87

23.72

ug/l

2.90

1246

11856

Impacted cerumen

443

3802

1.18

2.82

3.2

4.0

9.17

22.63

ug/l

1.89

310

3132

Peptic ulcer

304

1.70

2.82

3.4

4.2

3.35

21.37

ug/l

0.71

253

Herpesviral [herpes simplex] infections

948

8533

1.12

2.82

3.7

3.9

48.79

23.61

ug/l

0.31

731

6621

Pneumonia derived septicemia

139

1053

1.36

2.81

3.7

4.3

14.71

23.48

ug/l

0.36

117

873

Other and unspecified hypertrophic disorders of skin

176

1.94

2.80

2.7

4.7

2.81

6.39

ug/l

1.39

138

Degenerative macular diseases

601

5280

1.16

2.80

3.5

3.9

26.65

20.37

ug/l

0.18

482

4376

Glomerulonephritis

390

3312

1.20

2.80

3.4

4.1

7.57

22.53

ug/l

2.64

310

2717

Perforation of oesophagus

148

2.05

2.79

3.4

5.3

3.80

34.26

ug/l

0.57

126

Herpesviral keratitis and keratoconjunctivitis

182

1433

1.30

2.77

3.5

4.3

5.69

20.26

ug/l

1.55

154

1189

Cluster headache, wide

138

1045

1.35

2.76

3.1

4.5

72.42

29.64

ug/l

0.30

110

841

Injury of muscle and tendon at shoulder and upper arm level

1486

16113

0.91

2.75

3.7

4.3

13.58

28.74

ug/l

2.31

1208

13280

Other and unspecified diseases of blood and blood-forming organs

116

860

1.40

2.75

3.0

4.1

3.42

24.66

ug/l

1.49

708

Gestational [pregnancy-induced] hypertension

666

7516

0.88

2.75

3.3

3.7

4.48

21.41

ug/l

2.38

483

5501

Other and unspecified injuries of lower leg

256

2092

1.24

2.74

3.4

4.0

11.74

21.36

ug/l

0.52

198

1658

Palmar fascial fibromatosis [Dupuytren]

762

6800

1.13

2.74

4.0

4.3

23.53

26.22

ug/l

0.12

638

5718

Other and/or unspecified nontoxic goitre

392

3345

1.19

2.72

3.4

3.9

28.63

20.07

ug/l

0.16

311

2685

Polycystic kidney disease

104

758

1.42

2.72

2.2

4.4

3.26

32.94

ug/l

1.89

627

Other specified and unspecified personality disorders

290

2402

1.22

2.71

2.6

4.2

10.56

33.73

ug/l

0.92

235

1885

Glomerular diseases

760

6781

1.13

2.71

3.2

4.2

10.94

24.10

ug/l

1.99

633

5581

Other systemic involvement of connective tissue

1315

12066

1.10

2.70

2.9

3.9

8.50

24.69

ug/l

3.68

1040

9695

Otalgia

297

2470

1.22

2.70

3.2

4.0

14.04

20.38

ug/l

0.31

226

1948

Other orthopaedic follow-up care

201

1604

1.28

2.70

3.7

3.6

44.27

13.10

ug/l

0.45

169

1275

Adenomyosis (Endometriosis of uterus)

601

5288

1.15

2.70

3.3

4.2

14.34

32.48

ug/l

1.12

464

4223

Benign neoplasm of eye and adnexa

458

3958

1.18

2.69

4.3

3.9

11.67

22.05

ug/l

1.11

379

3196

Superficial injury of hip and thigh

638

5633

1.15

2.68

3.1

3.9

10.49

21.27

ug/l

1.50

519

4616

Flatulence and related conditions

253

1.74

2.68

3.3

4.2

2.90

10.83

ug/l

2.38

208

Meralgia paraesthetica

142

1088

1.34

2.68

3.2

4.3

11.88

24.52

ug/l

0.54

118

873

Carrier of infectious disease

633

1.45

2.66

4.4

4.12

31.64

ug/l

1.38

517

Dislocation of lens

519

1.51

2.66

3.2

4.1

27.79

24.44

ug/l

0.05

443

Lesion of lateral popliteal nerve

199

1592

1.28

2.66

3.3

4.4

10.42

19.68

ug/l

0.61

169

1312

Obsessive-compulsive disorder

142

1082

1.33

2.65

3.0

4.2

12.96

52.34

ug/l

0.61

108

796

Chronic ulcer of skin, not elsewhere classified

308

2579

1.22

2.65

2.8

4.1

9.90

23.15

ug/l

1.82

263

2133

Other mental disorders due to brain damage and dysfunction and to physical disease

425

4927

0.85

2.65

3.1

4.0

5.14

27.55

ug/l

7.18

351

4073

Other and unspecified psoriasis

279

2315

1.23

2.64

4.2

4.53

23.83

ug/l

3.38

235

1889

Dislocation, sprain and strain of joints and ligaments of knee

2254

22165

0.93

2.64

3.8

4.2

11.26

26.62

ug/l

4.52

1752

17455

Glaucoma suspect

1634

17612

0.92

2.64

4.0

3.9

17.98

23.52

ug/l

0.33

1336

14445

Algoneurodystrophy

114

846

1.38

2.64

3.1

4.3

4.90

21.94

ug/l

1.35

666

Benign neoplasm of major salivary glands

432

3724

1.18

2.63

3.8

4.0

27.67

22.95

ug/l

0.11

375

3043

Maternal care for known or suspected malpresentation of fetus

332

2861

0.83

2.62

3.5

3.4

3.18

21.36

ug/l

0.73

212

1897

Thyrotoxicosis, other and/or unspecified

883

7962

1.12

2.61

3.1

3.9

9.70

25.91

ug/l

2.30

690

6304

Benign neoplasm: Skin of eyelid, including canthus

731

6530

1.13

2.61

3.6

4.0

14.22

26.47

ug/l

1.19

590

5317

Scoliosis

303

2532

1.21

2.61

2.9

4.2

15.62

22.20

ug/l

0.21

232

1986

Diseases of the musculoskeletal system and connective tissue

2458

11545

1.07

2.60

3.7

4.6

16.96

31.78

ug/l

1.88

1932

9157

Sulfasalazine

1254

11499

1.10

2.59

3.4

4.2

40.90

24.29

ug/l

0.48

992

9182

Other secondary coxarthrosis

152

1183

1.32

2.59

4.4

4.3

17.58

24.64

ug/l

0.20

126

969

Benign leiomyoma with endometriosis

755

6764

1.13

2.58

3.3

3.8

23.77

25.31

ug/l

0.05

583

5359

Cervicalgia

965

8750

1.11

2.57

3.0

4.3

11.29

27.01

ug/l

2.39

771

7015

Fracture of foot, except ankle

918

8296

1.12

2.57

3.5

4.1

23.59

27.08

ug/l

0.12

732

6562

Suicide or other Intentional self-harm

863

7772

1.12

2.57

3.2

4.1

16.37

27.84

ug/l

0.92

730

6081

Alcoholic cardiomyopathy

160

0.29

2.56

3.2

4.2

2.90

88.63

ug/l

—

138

All anxiety disorders

2402

17816

1.07

2.54

3.2

4.1

13.62

23.49

ug/l

1.96

1859

13809

Acute nasopharyngitis (common cold)

372

3148

1.19

2.54

4.1

4.6

5.17

24.91

ug/l

4.29

300

2561

Atypical facial pain

217

1764

1.26

2.54

3.0

4.2

7.11

25.40

ug/l

2.05

157

1400

Vulvovaginal ulceration/inflammation in other diseases

172

1357

1.29

2.53

2.8

3.8

3.12

37.28

ug/l

0.72

125

998

Hypertrophic scar

173

1368

1.29

2.52

3.4

4.2

9.25

23.74

ug/l

1.11

129

1077

Cluster headache, wide,, including avohilmo

170

1342

1.29

2.51

3.1

4.3

61.20

27.02

ug/l

0.28

131

1061

Cerebral cysts

192

1538

1.27

2.51

2.7

4.2

11.35

23.79

ug/l

0.92

155

1237

2245

19330

1.07

2.51

3.4

4.0

16.70

24.65

ug/l

0.74

1793

16137

Lagophthalmos

445

1.54

2.49

3.9

4.3

3.07

32.63

ug/l

1.03

376

Extrapyramidal and movement disorders

1656

17800

0.92

2.49

3.1

4.0

10.92

24.29

ug/l

3.08

1312

14614

Lumbar disc prolapse

3154

22917

1.06

2.49

3.2

4.4

19.96

26.57

ug/l

0.60

2511

18337

Other renal tubulo-interstitial diseases

685

1.41

2.48

4.1

3.9

6.32

23.76

ug/l

0.84

560

Hypertrichosis

392

1.54

2.48

2.2

3.8

21.93

19.38

ug/l

0.05

289

Corticotropin deficiency

245

1.73

2.47

2.9

4.1

3.05

27.76

ug/l

0.76

193

Non-selective monoamine reuptake inhibitors

1913

17231

1.08

2.46

3.0

4.1

21.40

27.04

ug/l

0.38

1549

13915

Heart failure and coronary heart disease

2351

15659

1.07

2.46

2.8

4.3

8.70

29.31

ug/l

8.00

1969

13102

Drug-induced osteoporosis

430

1.54

2.45

3.7

4.1

10.60

32.25

ug/l

0.61

365

Use of rasagiline

989

0.68

2.45

3.1

4.3

2.76

27.42

ug/l

2.17

826

D07AA Corticosteroids, weak (group I)

489

4260

1.16

2.45

5.5

3.9

33.08

28.67

ug/l

0.12

397

3324

Benign neoplasm: Parotid gland

339

2886

1.20

2.45

3.8

4.1

31.43

24.70

ug/l

0.13

297

2361

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

503

4398

1.15

2.45

3.1

4.1

21.39

26.52

ug/l

0.18

426

3374

Benign neoplasm: Tongue

123

939

1.35

2.44

3.8

4.4

8.12

25.33

ug/l

1.08

104

776

Fall on and from stairs and steps

1132

10371

1.10

2.44

3.4

4.0

9.62

26.96

ug/l

3.42

902

8390

Infections with a predominantly sexual mode of transmission

944

8551

1.11

2.43

3.6

3.9

19.66

22.47

ug/l

0.10

718

6428

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

391

3369

1.18

2.43

3.6

4.1

32.92

20.73

ug/l

0.27

319

2740

Varicella [chickenpox]

131

1004

1.33

2.43

3.9

4.6

15.22

25.07

ug/l

0.44

106

807

Delirium, not induced by alcohol and other psychoactive substances

569

5023

1.15

2.42

3.3

3.9

13.81

21.63

ug/l

0.63

472

4187

Impetigo

123

935

1.34

2.41

3.8

4.3

42.58

23.51

ug/l

0.33

735

Other immunodeficiencies

285

1.65

2.41

4.0

4.1

10.43

46.42

ug/l

0.66

233

Personal history of allergy to drugs, medicaments and biological substances

269

1.66

2.40

4.0

4.2

29.06

24.37

ug/l

0.07

224

Vitiligo

301

1.63

2.39

3.1

4.5

3.20

21.52

ug/l

0.71

248

Perforation of tympanic membrane

394

3398

1.18

2.39

3.5

4.1

28.86

24.13

ug/l

0.14

316

2760

Monoamine oxidase A inhibitors

522

4594

1.15

2.39

3.6

4.3

38.68

35.72

ug/l

0.05

410

3700

Bronchiectasis

381

3285

1.18

2.38

3.2

4.0

17.21

23.17

ug/l

0.25

328

2671

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

334

1.59

2.38

4.9

4.0

16.74

43.82

ug/l

0.52

272

Gonarthrosis, primary, with knee surgery

2942

24691

0.94

2.37

3.4

4.1

20.12

25.36

ug/l

0.45

2343

20320

Stroke, excluding SAH

3270

22679

1.06

2.37

3.5

4.1

32.36

25.47

ug/l

0.30

2740

18713

Chondropathies

556

4911

1.14

2.37

3.4

4.1

37.70

26.15

ug/l

0.28

450

3899

Deep endometriosis

364

3123

1.18

2.36

3.1

3.7

19.70

29.89

ug/l

0.30

266

2412

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

349

1.57

2.36

4.1

3.9

2.58

41.14

ug/l

0.98

278

Deep bite

220

2350

0.81

2.36

3.7

4.1

12.11

21.51

ug/l

0.70

171

1824

Other systemic involvement of connective tissue (FG)

1285

11704

1.09

2.36

2.9

4.1

8.62

23.24

ug/l

3.21

1015

9457

Other autoimmune haemolytic anaemias

451

1.52

2.36

4.0

4.3

3.23

39.98

ug/l

1.33

381

Obesity and other hyperalimentation

2760

25159

1.06

2.35

3.3

4.1

26.95

23.72

ug/l

0.22

2185

19848

Benign neoplasm: salivary glands, exclude unknown (D119)

378

3258

1.18

2.35

3.8

4.0

29.11

25.20

ug/l

0.08

330

2645

Glomerular disorders in diseases classified elsewhere

469

4103

1.16

2.35

2.9

4.3

14.11

22.36

ug/l

0.64

403

3412

Other necrotizing vasculopathies

322

2742

1.20

2.35

2.7

4.1

19.53

23.05

ug/l

0.10

255

2244

Obesity

2742

25030

1.06

2.34

3.3

4.1

27.09

23.68

ug/l

0.23

2170

19739

Viral haemorrhagic fevers, not elsewhere classified/unspecified

645

5753

1.13

2.34

4.2

4.1

14.38

27.13

ug/l

1.31

522

4657

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

679

1.41

2.33

3.4

4.1

8.15

30.33

ug/l

1.06

581

Other disorders of the genitourinary system

615

5484

1.14

2.33

3.0

3.9

13.87

27.07

ug/l

1.02

496

4421

Other protozoal intestinal diseases

351

1.56

2.32

2.8

4.4

3.21

19.67

ug/l

0.74

285

Neuromuscular dysfunction of bladder

380

3278

1.18

2.32

3.0

4.1

9.75

28.89

ug/l

2.17

304

2680

Secondary right heart disease

180

1451

1.27

2.32

2.4

3.9

21.83

23.60

ug/l

0.05

137

1209

Use of disulfiram, acamprosate or naltrexone

292

2463

1.20

2.31

3.1

4.6

12.58

20.44

ug/l

0.74

253

2010

Pediculosis, acariasis and other infestations

503

4418

1.15

2.31

3.3

4.1

11.96

27.30

ug/l

1.02

391

3452

Crushed, pushed or stepped on by crowd or human stampede

185

1489

1.26

2.31

3.3

4.3

20.01

23.13

ug/l

0.10

143

1169

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

512

1.45

2.31

3.3

4.3

42.88

15.47

ug/l

0.31

402

Central retinal artery occlusion

104

783

1.38

2.31

2.9

4.1

5.30

17.40

ug/l

1.24

670

Whooping cough

2.24

2.31

4.5

3.7

5.51

2.94

ug/l

0.63

Other pulmonary heart/vessel disease

199

1623

1.25

2.31

2.5

3.9

19.88

21.66

ug/l

0.05

153

1354

Mental and behavioural disorders due to sedatives or hypnotics

216

1771

1.24

2.30

2.7

4.3

6.17

21.19

ug/l

1.76

184

1416

Special screening examination for infectious and parasitic diseases

694

4565

1.12

2.30

3.5

4.4

7.92

31.04

ug/l

1.84

485

3411

Melanocytic naevi, other sites/unspecified

292

2466

1.20

2.30

3.6

4.1

4.87

21.28

ug/l

3.22

224

1968

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

958

8728

1.10

2.29

3.1

4.0

15.44

25.85

ug/l

0.90

782

6695

Pregnancy, childbirth and the puerperium

1167

6639

0.91

2.29

3.7

3.4

15.09

16.87

ug/l

0.20

925

5152

Speech disturbances, not elsewhere classified

388

3359

1.17

2.28

3.1

4.0

18.91

20.72

ug/l

0.07

306

2756

L04AX Other immunosuppressants

2555

24150

1.06

2.28

3.3

4.1

19.72

25.00

ug/l

0.42

1994

19310

Urethral stricture

248

2069

1.22

2.28

3.4

4.4

21.79

29.77

ug/l

0.18

190

1747

Abdominal aortic aneurysm (AAA)

459

3986

1.16

2.27

3.7

3.9

40.51

20.58

ug/l

0.72

401

3378

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

549

4858

1.14

2.27

3.2

3.7

5.81

26.60

ug/l

1.71

431

3648

Acute upper respiratory infections

5277

31225

1.04

2.27

3.8

4.0

22.51

24.80

ug/l

0.17

4124

25047

Sequelae of infectious and parasitic diseases

281

2369

1.20

2.26

3.9

4.0

30.41

19.31

ug/l

0.32

236

1927

Fibroblastic disorders

1154

10628

1.10

2.25

3.7

4.3

28.29

30.69

ug/l

0.07

929

8765

Anxiety (asthma-related co-morbidities)

2393

17450

1.06

2.25

3.2

4.2

13.63

23.61

ug/l

1.98

1857

13452

Sequelae of injuries, of poisoning and of other consequences of external causes

929

8469

1.11

2.25

3.4

4.2

33.63

27.19

ug/l

0.13

734

6829

Recurrent or chronic depression

1719

11275

1.08

2.23

3.3

4.4

14.56

28.08

ug/l

1.82

1318

8825

Melanoma in situ

202

1659

1.25

2.23

3.8

4.0

3.81

20.59

ug/l

2.58

166

1371

Other inflammation of vagina/vulva

105

791

1.35

2.23

3.3

4.0

8.90

52.06

ug/l

0.50

603

Carcinoma in situ of cervix uteri

248

2066

1.21

2.23

3.6

3.5

10.65

30.12

ug/l

0.54

195

1493

Stroke, including SAH

3426

23681

1.05

2.23

3.5

4.1

31.99

24.92

ug/l

0.33

2876

19477

Intracranial and intraspinal abscess and granuloma

365

1.55

2.22

2.6

4.4

5.18

36.33

ug/l

0.84

310

Congenital malformations and deformations of the musculoskeletal system

293

2465

1.19

2.21

3.5

4.0

3.33

34.25

ug/l

1.50

207

1904

Endometriosis of intestine

274

1.61

2.20

2.1

3.9

1.84

160.01

ug/l

0.62

194

Temporal arteritis

176

1428

1.27

2.20

2.9

4.1

8.22

23.56

ug/l

1.34

144

1185

Motor neuron disease (with DMD)

701

0.65

2.19

2.6

5.0

12.80

42.06

ug/l

1.02

591

Intracerebral haemorrhage

471

5339

0.87

2.18

3.2

4.0

19.77

23.34

ug/l

0.15

395

4417

Other disorders of prostate

143

1131

1.29

2.18

3.5

4.4

8.05

33.76

ug/l

2.06

120

975

Ulcer of vagina/vulva

693

1.38

2.17

2.9

3.8

12.01

10.08

ug/l

0.10

544

Myocardial infarction, strict

2265

17077

0.94

2.17

3.4

4.4

14.54

27.73

ug/l

2.47

1872

14248

Radiculopathy

781

7084

1.11

2.15

3.1

4.3

12.82

30.88

ug/l

2.08

611

5811

Hyperhidrosis

718

1.36

2.15

2.6

3.9

4.22

8.71

ug/l

1.22

556

Type 1 diabetes, wide definition, subgroup 1

687

6173

1.12

2.15

3.6

4.2

24.71

29.97

ug/l

0.14

582

4872

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1247

11475

1.09

2.15

3.5

4.0

6.81

23.74

ug/l

4.19

930

8874

Findings of drugs and other substances, not normally found in blood

133

1.95

2.14

2.2

4.8

3.11

87.53

ug/l

0.86

116

Defect, injury or illness of neck

132

1.92

2.14

4.0

4.3

10.38

38.83

ug/l

0.43

112

Allergic rhinitis

835

9077

0.90

2.14

3.2

4.0

30.81

23.03

ug/l

0.20

632

6937

Other mycoses, not elsewhere classified/unspecified

475

1.46

2.13

3.6

4.5

57.07

35.30

ug/l

0.16

400

Other salmonella infections

144

1143

1.29

2.13

4.4

4.2

34.06

23.83

ug/l

0.21

113

937

Emergency coronary revascularization (for ACS)

4609

26891

1.05

2.13

3.3

4.2

17.79

27.92

ug/l

1.80

3740

21856

Hypertensive Renal Disease

157

1260

1.27

2.12

2.5

4.2

7.27

22.79

ug/l

1.51

137

1053

Nail disorders

301

2569

1.19

2.12

3.7

4.1

6.97

24.40

ug/l

2.15

230

2065

Benign neoplasm: Other/unspecified site

519

1.44

2.12

3.2

4.1

106.84

33.72

ug/l

0.32

438

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

115

886

1.32

2.12

2.4

4.4

7.18

26.11

ug/l

1.15

712

Superficial injury of forearm

318

2724

1.18

2.12

3.3

4.0

7.19

18.10

ug/l

1.57

243

2152

Uterine polyps

428

3755

1.16

2.11

3.2

4.2

23.99

32.81

ug/l

0.26

318

2973

Motor neuron disease

694

0.66

2.11

2.6

5.0

12.80

42.40

ug/l

1.03

586

Other bacterial agents as the cause of diseases classified to other chapters

369

1.53

2.11

3.6

4.0

53.32

37.71

ug/l

0.12

308

Aortic aneurysm

1114

10083

1.09

2.10

3.7

4.2

26.48

23.09

ug/l

0.19

922

8496

Injury of intra-abdominal organs

628

1.39

2.10

3.5

4.6

30.79

26.00

ug/l

0.06

530

Diabetic nephropathy, excluding more controls

618

4558

1.13

2.09

3.0

4.0

14.29

31.57

ug/l

1.75

530

3783

Delayed milestone in childhood

2.17

2.09

2.6

2.4

1.92

1.71

ug/l

—

Seborrhoeic keratosis

1128

10425

1.09

2.08

3.7

4.0

18.22

23.17

ug/l

0.26

931

8571

Charcot foot

554

1.42

2.08

3.0

4.9

13.97

25.89

ug/l

0.38

457

Arthropod-borne viral fevers and viral haemorrhagic fevers

730

6606

1.11

2.08

4.2

4.1

13.01

27.11

ug/l

1.81

593

5347

Neurological diseases, wide definition

1155

5331

1.09

2.08

3.6

4.9

11.86

38.46

ug/l

2.46

908

4145

Asthma mixed form (mode), excluding more controls

190

1557

1.24

2.07

3.3

3.8

5.12

45.43

ug/l

1.16

166

1243

Pleural plaque without asbestos

172

1402

1.26

2.07

2.3

4.0

6.62

31.16

ug/l

2.33

151

1189

Septal defects

176

1400

1.25

2.07

3.0

4.2

4.87

26.05

ug/l

2.24

138

1108

Carcinoma in situ of breast, other/unspecified

532

1.44

2.06

4.9

4.0

4.28

10.41

ug/l

1.87

437

Pre-eclampsia or eclampsia

652

7236

0.89

2.06

3.2

3.7

17.74

22.82

ug/l

0.22

470

5440

Other nonscarring hair loss

241

1.64

2.06

2.7

3.9

5.14

9.68

ug/l

0.74

190

Allergic asthma (mode), excluding more controls

768

6815

1.11

2.05

3.1

4.1

11.73

25.87

ug/l

1.16

601

5196

Dislocation, sprain and strain of joints and ligaments of thorax

123

962

1.31

2.05

4.0

4.2

59.20

21.61

ug/l

0.43

790

Open wound of forearm

341

2947

1.17

2.05

3.3

4.1

33.54

22.73

ug/l

0.33

284

2395

Giant cell arteritis with polymyalgia rheumatica

176

1441

1.25

2.05

2.9

4.0

8.22

22.20

ug/l

1.19

144

1200

Pre-eclampsia

585

6527

0.89

2.04

3.2

3.7

18.08

23.15

ug/l

0.19

422

4875

Progressive vascular leukoencephalopathy

185

1523

1.25

2.04

2.6

3.8

2.94

29.18

ug/l

3.69

146

1278

Retinal detachments and breaks

1819

17108

1.07

2.04

3.8

4.1

22.71

23.31

ug/l

0.04

1461

14119

Other zoonotic bacterial diseases, not elsewhere classified

128

1.93

2.03

1.8

4.1

3.46

41.56

ug/l

0.63

110

Postpartum hemorraghe, parous women as controls

572

5447

0.89

2.03

3.3

3.6

18.55

22.24

ug/l

0.12

385

3899

Dysplasia of cervi uteri

853

5624

1.10

2.03

3.3

4.2

15.59

32.82

ug/l

0.93

643

4301

Tongue abnormality

262

2225

1.20

2.03

3.8

4.0

34.56

19.14

ug/l

0.25

227

1807

Endometriosis ASRM stages 1,2

624

5609

1.12

2.03

3.0

3.7

6.31

24.68

ug/l

1.68

459

4211

Neuralgia and neuritis, unspecified

211

1756

1.22

2.02

3.2

4.3

9.16

25.32

ug/l

1.63

173

1411

Mental and behavioural disorders due to opioids

621

1.37

2.02

3.0

4.9

26.88

27.56

ug/l

0.01

487

Open wound of abdomen, lower back and pelvis

101

770

1.34

2.02

2.7

4.7

29.87

32.08

ug/l

0.04

631

Congenital malformations and deformations of the musculoskeletal system

216

1785

1.22

2.02

3.8

4.1

3.51

22.48

ug/l

2.68

157

1371

Other protozoal intestinal diseases

504

1.42

2.02

3.1

4.5

3.22

29.85

ug/l

1.36

414

Vasomotor and allergic rhinitis

1254

13257

0.92

2.02

3.3

4.1

24.33

24.34

ug/l

0.00

965

10369

Malignant neoplasm of meninges, including Hilmo

2.48

2.01

8.9

1.6

5.66

2.67

ug/l

0.54

Eosinophilic disease (BM)

422

1.47

2.01

3.4

4.0

108.21

37.45

ug/l

0.32

337

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

205

1699

1.22

2.01

3.3

4.1

7.47

21.49

ug/l

1.40

171

1362

Event of undetermined intent

193

1591

1.23

2.00

3.7

4.4

4.75

23.48

ug/l

2.30

161

1284

Other specified and unspecified retinal disorders

152

1227

1.27

1.99

3.4

4.2

7.67

17.39

ug/l

1.11

121

1017

Asthma mixed form (mode)

190

1565

1.23

1.99

3.3

3.8

5.12

45.02

ug/l

1.16

166

1258

Inflammatory diseases of the central nervous system

308

2651

1.18

1.98

3.7

4.1

8.34

21.72

ug/l

1.46

235

2146

Focal epilepsy, mode (most common among epilepsy diagnosis)

753

6845

1.11

1.98

4.0

4.1

14.11

27.71

ug/l

1.29

619

5568

Melanocytic naevi of other and unspecified parts of face

215

1796

1.22

1.98

3.4

4.1

27.94

21.14

ug/l

0.12

162

1431

Congenital malformations of breast

282

1.56

1.98

3.2

3.8

11.53

6.42

ug/l

0.37

208

Lung transplant status

221

1.67

1.97

2.4

4.5

19.23

39.47

ug/l

0.34

176

Cystic kidney disease

119

933

1.31

1.97

2.3

4.4

3.32

28.09

ug/l

1.98

775

Lung transplantation

221

1.67

1.97

2.4

4.5

19.23

39.47

ug/l

0.34

176

Vascular dementia

335

3717

0.86

1.97

2.7

3.6

11.09

22.75

ug/l

0.85

277

3117

Viral meningitis

109

843

1.32

1.97

4.1

4.2

8.88

18.36

ug/l

0.60

676

Type1 diabetes, definitions combined, early onset

760

0.69

1.97

3.7

4.3

11.23

14.10

ug/l

0.11

525

Other/unspecified seropositive rheumatoid arthritis

1107

11951

0.92

1.97

3.0

3.9

27.99

24.41

ug/l

0.11

904

9665

Other specified/unspecified hearing loss

375

3281

1.16

1.96

3.6

3.9

6.28

27.12

ug/l

3.79

295

2689

Disorders of muscles

409

3596

1.15

1.96

3.0

4.4

10.82

33.20

ug/l

1.52

322

2899

Pneumococcal septicemia

129

1023

1.29

1.96

3.6

4.2

15.77

25.37

ug/l

0.38

107

855

Other and unspecified acquired haemolytic anaemias

302

1.56

1.95

3.1

4.0

3.10

46.27

ug/l

1.00

252

Conjunctivitis (acute, non atopic)

1077

9915

1.09

1.95

3.4

4.1

10.44

25.56

ug/l

2.52

838

7881

Voice disturbances

1217

11310

1.08

1.95

3.4

4.0

8.18

24.80

ug/l

4.00

952

9045

Monoarthritis, not elsewhere classified

169

1383

1.25

1.93

3.5

4.5

14.66

27.39

ug/l

0.47

144

1129

Other primary thrombocytopenia

108

1.99

1.93

3.2

4.6

2.75

10.27

ug/l

1.02

Seropositive rheumatoid arthritis, wide

1120

12076

0.92

1.93

3.0

3.9

27.74

24.27

ug/l

0.11

913

9766

Nontoxic single thyroid nodule

317

2746

1.17

1.92

3.5

4.0

22.25

19.02

ug/l

0.11

243

2192

Intestinal helminthiases, other/unspecified

102

2.06

1.92

3.8

4.2

1.78

51.55

ug/l

0.64

Marfan's syndrome

115

1.93

1.92

2.9

5.0

4.93

47.14

ug/l

0.53

Giant cell arteritis

196

1634

1.23

1.92

2.9

4.0

7.74

21.49

ug/l

1.35

157

1345

LSIL lesion of the vulva

109

849

1.31

1.91

3.7

3.45

15.54

ug/l

1.47

663

Viral warts

328

2844

1.17

1.91

2.9

4.1

9.22

21.95

ug/l

1.84

263

2271

Cervicocranial syndrome

465

4132

1.14

1.90

3.0

4.2

14.51

33.81

ug/l

0.91

364

3298

Other infestations

573

1.39

1.90

3.4

4.2

3.09

19.61

ug/l

1.24

475

Carcinoma in situ of skin of trunk

153

1246

1.26

1.90

2.8

3.9

11.06

28.58

ug/l

1.08

123

1049

Female infertility

1045

5845

1.09

1.90

3.4

4.2

9.28

33.54

ug/l

2.43

766

4451

Other condition

523

4677

1.13

1.90

3.3

4.1

13.92

30.18

ug/l

1.07

439

3757

Benign neoplasm: Choroid

268

2296

1.19

1.89

4.6

4.1

17.29

21.18

ug/l

0.18

225

1879

Soft tissue disorders related to use, overuse and pressure

1310

12221

1.08

1.89

3.1

4.3

24.24

27.07

ug/l

0.11

1031

9930

Hirsutism in women

326

1.50

1.89

2.1

3.8

27.41

22.96

ug/l

0.07

235

Disorders of purine and pyrimidine metabolism

193

1.71

1.88

4.1

4.6

3.05

60.00

ug/l

0.81

165

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

333

2899

1.17

1.88

3.3

4.1

32.81

22.51

ug/l

0.22

275

2339

Percutaneous Coronary Intervention

4198

24725

1.04

1.88

3.3

4.3

17.07

28.09

ug/l

1.89

3385

20065

Lactose intolerance

103

797

1.32

1.88

3.6

4.2

3.79

25.92

ug/l

1.45

646

Cystic fibrosis with intestinal manifestations

3.05

1.88

2.9

4.5

2.04

8.77

ug/l

—

Gingival hyperplasia

129

1029

1.28

1.87

3.5

4.3

6.29

24.47

ug/l

1.36

101

846

Other appendicitis

321

2787

1.17

1.86

3.6

4.1

7.42

24.11

ug/l

2.16

250

2227

Atopic conjunctivitis

139

1117

1.26

1.86

3.6

4.1

18.56

18.79

ug/l

0.01

109

880

Reactive arthropathies

355

3105

1.16

1.86

3.4

4.4

15.60

28.98

ug/l

0.85

265

2535

conjunctival haemorrhage

341

2979

1.16

1.86

3.2

4.0

7.40

23.66

ug/l

2.91

270

2443

Use of entacapone

284

0.50

1.86

2.7

4.3

2.91

51.14

ug/l

—

246

Type 1 diabetes, strict definition

1107

0.75

1.85

3.7

4.5

8.69

39.69

ug/l

0.45

779

Cystic kidney disease

128

1022

1.28

1.85

2.4

4.4

5.82

26.24

ug/l

1.57

839

Bacterial meningitis

128

1022

1.28

1.85

4.1

4.5

13.11

22.59

ug/l

0.34

841

Idiopathic thrombocytopenic purpura

113

889

1.30

1.85

3.8

4.3

18.80

25.17

ug/l

0.19

732

Other arterial embolism and thrombosis

122

970

1.29

1.85

3.2

4.0

9.83

26.64

ug/l

1.02

105

814

Campylobacter enteritis

102

792

1.32

1.84

3.4

4.4

3.41

26.66

ug/l

1.50

653

Allergic asthma (mode)

768

6859

1.10

1.84

3.1

4.1

11.73

25.40

ug/l

1.11

601

5236

Dermatopolymyositis, unspecified

171

1.75

1.83

2.5

4.7

3.05

32.52

ug/l

0.66

146

MS-disease / Multiple Sclerosis

153

1872

0.81

1.83

3.9

4.1

4.31

34.30

ug/l

0.98

120

1440

Systemic atrophies primarily affecting the central nervous system

117

1468

0.78

1.83

3.1

4.2

12.44

21.45

ug/l

0.52

1220

Respiratory tuberculosis, clinically confirmed

406

1.46

1.82

2.9

4.3

8.95

45.98

ug/l

1.09

338

Ischemic heart diseases

4374

25278

1.04

1.82

3.5

4.3

17.78

27.78

ug/l

1.63

3531

20453

Special screening examination for other diseases and disorders

407

3592

1.14

1.82

3.6

4.4

28.75

34.48

ug/l

0.08

319

2898

Selective deficiency of immunoglobulin G [IgG] subclasses

210

1.66

1.82

3.3

4.0

3.95

27.70

ug/l

0.62

173

Demyelinating diseases of the central nervous system

195

2329

0.83

1.82

3.8

4.0

5.10

38.71

ug/l

1.44

150

1788

Benign neoplasm of middle ear and respiratory system

322

2805

1.16

1.81

3.7

4.1

43.64

24.16

ug/l

0.33

267

2309

Benign neoplasm: Connective and other soft tissue of pelvis

2.25

1.81

2.1

4.6

2.74

11.74

ug/l

—

Inflammation of lacrimal passages (chronic)

553

0.65

1.81

2.4

4.1

7.50

29.62

ug/l

0.89

463

Hordeolum and other deep inflammation of eyelid

201

1684

1.21

1.81

3.6

4.3

2.77

21.99

ug/l

2.84

157

1355

Injuries to the wrist and hand

4484

32227

0.96

1.81

3.7

4.1

16.20

25.96

ug/l

1.76

3566

25669

Other congenital malformations of skin

260

2226

1.18

1.81

3.6

4.1

38.21

20.43

ug/l

0.27

200

1766

Other symptoms and signs involving the nervous and musculoskeletal systems

1667

17691

0.94

1.81

3.0

4.0

9.00

24.34

ug/l

6.12

1287

14199

Chronic thyroiditis

126

1.88

1.80

3.3

3.9

27.07

6.83

ug/l

0.41

102

Other/unspecified soft tissue disorders related to use, overuse and pressure

113

892

1.30

1.80

3.4

4.5

2.59

28.19

ug/l

1.92

723

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

388

1.45

1.80

3.5

4.2

3.89

17.93

ug/l

0.68

314

Seropositive rheumatoid arthritis

1120

11991

0.92

1.80

3.0

4.1

27.74

24.64

ug/l

0.09

913

9734

Other necrotizing vasculopathies (FG)

281

2428

1.18

1.80

2.7

4.3

21.70

24.33

ug/l

0.06

224

2004

Ménière disease

422

3747

1.14

1.80

3.4

4.0

11.94

26.47

ug/l

1.17

340

3047

Hypertrophy of tongue papillae

382

1.47

1.80

4.4

4.6

4.68

17.50

ug/l

0.61

319

Car occupant injured in noncollision transport accident

109

855

1.30

1.80

3.9

4.4

9.73

24.08

ug/l

0.66

696

Blindness, monocular

300

1.54

1.79

3.5

3.9

3.07

14.21

ug/l

1.49

257

Perineal laceration during delivery

285

2764

0.86

1.79

3.0

3.5

9.01

27.37

ug/l

0.65

194

1865

Injury of other and unspecified intrathoracic organs

250

2139

1.19

1.79

3.7

4.3

49.46

27.80

ug/l

0.40

216

1778

Nontoxic diffuse goitre

144

1173

1.26

1.78

3.1

3.9

12.84

23.17

ug/l

0.48

116

945

Other specified and unspecified disorders of eye and adnexa

146

1189

1.25

1.78

3.2

4.1

18.59

22.12

ug/l

0.08

105

979

Multiple delivery

231

2710

0.84

1.78

3.5

22.54

10.23

ug/l

0.46

169

2021

Idiopathic urticaria

491

1.40

1.78

4.3

3.9

60.96

29.87

ug/l

0.33

393

Melanoma in situ of trunk

564

1.38

1.78

4.4

4.5

4.16

32.78

ug/l

1.30

478

Gilbert syndrome

195

1.66

1.78

2.5

4.6

2.69

27.71

ug/l

0.61

163

Dissociative [conversion] disorders

101

785

1.31

1.77

2.9

4.1

39.99

18.67

ug/l

0.44

616

Lesion of radial nerve

146

1190

1.25

1.77

3.0

4.4

5.54

22.07

ug/l

1.50

110

972

Actinic keratosis

2056

18055

1.06

1.77

3.4

3.9

17.60

24.83

ug/l

0.58

1644

15103

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2405

22235

1.06

1.77

3.6

4.3

15.40

24.45

ug/l

0.98

1885

17926

Other and unspecified myopathies

363

3196

1.15

1.76

3.1

4.0

14.25

21.99

ug/l

0.72

283

2646

Focal epilepsy, strict definition

796

7302

1.10

1.76

4.0

4.1

12.64

28.76

ug/l

1.81

649

5943

Varicose veins of other sites

236

2012

1.19

1.76

4.5

4.4

9.60

23.58

ug/l

1.40

207

1667

Thiamine deficiency

189

1.69

1.75

3.6

5.1

3.87

65.40

ug/l

0.84

156

Meningitis

176

1462

1.22

1.75

4.0

4.2

10.85

19.05

ug/l

0.42

132

1190

Disease of hard tissues of teeth, NOS

2747

15067

0.95

1.75

3.6

4.2

5.52

29.10

ug/l

12.69

2144

12239

Helminthiases

111

876

1.29

1.75

3.2

4.2

3.12

26.86

ug/l

1.69

694

Transient ischemic attack

2830

21891

1.05

1.75

3.4

4.1

20.78

24.09

ug/l

0.25

2324

18045

Suggestive for eosinophilic asthma

382

3377

1.15

1.74

3.8

4.1

44.72

27.23

ug/l

0.23

317

2737

Car occupant injured in other and unspecified transport accidents

633

5747

1.11

1.74

3.4

4.1

12.12

28.14

ug/l

1.29

496

4506

Assault by bodily force

189

1578

1.21

1.74

3.0

4.5

7.57

19.48

ug/l

1.25

146

1245

Chronic tubulo-interstitial nephritis

153

1256

1.24

1.73

3.9

4.0

3.46

21.24

ug/l

1.98

132

1032

All dysplastic lesions of the cervix uteri

758

6880

1.10

1.73

3.3

3.6

17.65

23.00

ug/l

0.21

562

4941

Other disorders originating in the perinatal period

1.95

1.73

4.6

3.7

2.59

6.51

ug/l

—

Other bacterial agents as the cause of diseases classified to other chapters

319

1.50

1.73

3.6

3.9

60.66

40.11

ug/l

0.14

270

Examination and encounter for administrative purposes

187

1566

1.21

1.72

3.6

4.5

4.05

18.44

ug/l

4.66

155

1281

Radial styloid tenosynovitis [de Quervain]

210

1776

1.20

1.72

2.7

4.3

3.40

22.87

ug/l

2.82

153

1388

Whooping cough

219

1.59

1.72

3.1

3.8

6.32

3.44

ug/l

0.46

173

Skin changes due to chronic exposure to nonionizing radiation

2111

18493

1.06

1.72

3.4

4.0

17.55

24.74

ug/l

0.59

1684

15460

Late syphilis

505

1.39

1.72

3.0

4.9

22.10

35.75

ug/l

0.34

429

Late syphilis

420

1.43

1.72

2.8

4.8

21.03

42.47

ug/l

0.48

351

Contusion of other and unspecified parts of foot

139

1128

1.25

1.72

3.1

4.3

4.65

24.84

ug/l

1.62

110

888

Disorders of adult personality and behaviour

893

8240

1.09

1.70

2.9

4.1

12.44

26.72

ug/l

1.76

704

6328

Other abnormal immunological findings in serum

513

1.38

1.70

4.2

4.1

3.65

33.94

ug/l

1.21

417

Tic and related disorders

149

1.71

1.70

3.2

4.8

6.51

5.27

ug/l

0.12

119

Benign neoplasm: Other parts of oropharynx

279

1.53

1.69

2.5

4.4

3.97

23.74

ug/l

0.70

228

Other bursopathies

594

5393

1.11

1.69

3.2

4.4

12.03

25.64

ug/l

1.33

480

4435

Granuloma annulare

429

1.42

1.69

3.3

3.9

9.03

18.72

ug/l

0.40

353

Pedestrian injured in transport accident

249

2140

1.18

1.69

3.1

4.2

12.21

18.61

ug/l

0.34

193

1738

Chronic rhinitis, nasopharyngitis and pharyngitis

1373

12883

1.07

1.69

3.2

4.1

7.90

25.36

ug/l

4.85

1052

10255

Hallux rigidus

604

6632

0.90

1.67

3.2

4.3

12.98

27.11

ug/l

1.51

478

5488

Focal epilepsy

847

7810

1.09

1.67

4.0

4.1

13.52

30.42

ug/l

1.93

690

6336

Female infertility, cervical, vaginal, other or unspecified origin

957

5753

1.09

1.67

3.5

4.2

9.24

32.32

ug/l

2.24

695

4387

Alcohol abuse counselling and surveillance

421

1.42

1.67

1.9

4.9

4.22

38.41

ug/l

1.08

351

Fall involving bed

142

1165

1.25

1.66

3.0

3.8

15.34

22.69

ug/l

0.23

120

980

Congenital malformations of breast

294

1.49

1.66

3.2

3.7

11.53

6.49

ug/l

0.36

216

Bilateral sagittal split ramus osteotomy operation

745

0.71

1.66

3.8

4.4

29.10

20.37

ug/l

0.17

572

Other disorders of Eustachian tube

110

876

1.28

1.66

4.3

6.20

24.94

ug/l

1.23

722

Protein-energy malnutrition of moderate and mild degree

264

1.54

1.65

3.5

4.1

7.55

49.60

ug/l

0.79

221

Complications of cardiac and vascular prosthetic devices, implants and grafts

692

1.32

1.65

3.2

4.0

21.97

28.27

ug/l

0.11

579

Psychotic depression

216

1838

1.19

1.65

3.1

4.3

13.35

44.39

ug/l

0.92

169

1465

Congenital malformations of cardiac septa

185

1502

1.21

1.65

3.0

4.2

5.63

24.41

ug/l

2.06

146

1190

Lymphoid leukaemia

230

1973

1.19

1.64

3.1

4.1

6.31

23.20

ug/l

2.31

169

1646

Cervical disc disorders

1791

16966

1.06

1.64

3.1

4.4

9.50

28.19

ug/l

6.67

1476

13740

Left bundle-branch block

336

2962

1.15

1.64

3.8

4.3

5.72

27.43

ug/l

4.05

266

2441

Superficial injury of lower leg

980

9100

1.08

1.64

3.3

4.0

9.21

28.02

ug/l

2.78

769

7237

Ischaemic Stroke, excluding all haemorrhages

3041

21700

1.05

1.62

3.4

4.1

34.31

25.47

ug/l

0.38

2543

17956

Cardiomyopathy

782

7204

1.09

1.62

3.2

4.5

9.66

27.36

ug/l

5.08

647

6030

Cardiac murmurs and other cardiac sounds

305

2636

1.15

1.62

3.7

4.0

31.13

26.52

ug/l

0.09

239

2070

Habit and impulse disorders

313

1.47

1.62

2.8

5.2

4.26

29.55

ug/l

0.93

255

Metabolic disorder, other/unspecified

2.17

1.61

2.2

4.6

8.84

76.35

ug/l

—

Open wound of shoulder and upper arm

518

1.36

1.61

2.9

4.6

4.98

31.10

ug/l

1.03

432

Prurigo nodularis

109

873

1.28

1.61

2.9

4.3

4.55

27.25

ug/l

1.71

737

Asthma and opportunity respiratory infection

209

1785

1.19

1.60

3.0

4.0

3.97

20.66

ug/l

2.82

184

1462

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2319

19246

0.95

1.60

3.7

3.9

13.10

22.82

ug/l

1.39

1748

15010

Effects of foreign body entering through natural orifice

878

8128

1.09

1.59

3.5

4.3

19.41

27.86

ug/l

0.48

705

6629

Pre-eclampsia or poor fetal growth

845

9106

0.92

1.59

3.3

3.6

15.47

20.70

ug/l

0.30

607

6674

Motor- or nonmotor-vehicle accident in traffic area

138

1.73

1.57

2.3

4.5

2.13

8.16

ug/l

2.01

110

Seropositive rheumatoid arthritis, strict definition

561

6161

0.90

1.57

3.2

4.0

23.84

25.37

ug/l

0.06

460

4941

Exposure to other and unspecified inanimate mechanical forces

231

1987

1.18

1.56

4.2

21.85

22.90

ug/l

0.02

181

1598

Thyroiditis, ILD-related definition

429

3847

1.13

1.56

3.1

3.9

50.59

30.90

ug/l

0.35

327

3001

Scabies

377

3351

1.13

1.55

3.3

4.1

13.14

28.74

ug/l

0.74

286

2582

Diseases of the myoneural junction and muscle

504

4564

1.12

1.54

3.1

4.0

14.05

25.69

ug/l

1.33

391

3747

Complications predominantly related to the puerperium

754

8176

0.92

1.53

3.6

3.7

43.46

21.96

ug/l

0.54

556

6098

Hereditary deficiency of other clotting factors

227

1.55

1.53

3.1

4.1

2.30

8.08

ug/l

1.79

181

Shoulder region

455

1.38

1.53

2.4

4.1

3.20

33.95

ug/l

1.07

377

Other epidermal thickening

171

1440

1.21

1.53

3.3

4.3

8.50

19.92

ug/l

1.05

137

1187

Pure hyperglyceridaemia

682

1.31

1.52

3.6

4.5

5.63

31.06

ug/l

1.34

566

Papilloedema, unspecified

567

1.33

1.52

4.5

4.3

131.02

34.50

ug/l

0.36

466

Benign neoplasm: Conjunctiva

128

1050

1.24

1.52

4.2

4.3

3.46

22.05

ug/l

1.64

104

866

Habitual aborter

300

1.46

1.52

3.7

4.0

26.31

156.28

ug/l

0.50

205

Injury of muscle and tendon at hip and thigh level

287

3267

0.87

1.52

4.5

4.2

16.60

24.63

ug/l

0.34

227

2641

Abnormal blood-pressure reading, without diagnosis

177

1496

1.20

1.51

3.6

4.4

11.05

21.98

ug/l

0.63

124

1186

Gonarthrosis [arthrosis of knee](FG)

4134

23203

1.04

1.51

3.6

4.2

22.83

27.12

ug/l

0.43

3327

18768

Residual foreign body in soft tissue

179

1514

1.20

1.51

4.1

4.5

13.12

24.24

ug/l

0.78

139

1229

Other/unspecified enthesopathies, not elsewhere classified

366

3264

1.13

1.49

3.1

4.2

36.67

24.78

ug/l

0.16

295

2652

Atrial septal defect

108

863

1.26

1.49

2.8

4.3

3.65

16.64

ug/l

1.51

696

HSIL lesion of the cervix uteri

507

4594

1.11

1.49

3.2

3.6

6.09

21.94

ug/l

1.17

373

3276

Other abnormal products of conception

837

5986

0.92

1.49

3.4

3.6

11.49

24.54

ug/l

0.92

578

4211

Artificial joint operation, meniscal resection

4821

30309

1.04

1.49

3.7

4.1

15.35

26.91

ug/l

3.44

3849

24646

Other and unspecified tonsillitis

917

7159

1.08

1.48

4.2

4.3

42.14

26.46

ug/l

0.31

693

5460

Fall on same level involving ice and snow

2666

25569

1.05

1.48

3.7

4.0

29.12

23.55

ug/l

0.28

2129

20558

Bursitis of shoulder

104

837

1.27

1.48

3.6

4.4

6.87

23.91

ug/l

1.02

680

Viral warts

730

6732

1.09

1.48

3.2

4.1

22.48

25.25

ug/l

0.08

569

5290

Mixed and other personality disorders

229

1978

1.17

1.47

3.1

4.3

8.10

17.68

ug/l

1.19

186

1544

Other specified/unspecified disorders of bone/cartilage

103

828

1.27

1.47

3.8

4.2

12.04

15.78

ug/l

0.17

676

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1101

11738

0.93

1.47

3.0

3.9

16.94

24.75

ug/l

0.66

898

9485

Foreign body entering into or through eye or natural orifice

259

2260

1.16

1.46

3.3

4.3

19.56

25.94

ug/l

0.19

203

1839

Xerosis cutis

529

1.35

1.46

3.4

4.4

5.35

30.17

ug/l

1.05

456

Oral lichen planus, including avohilmo , including avohilmo

211

2443

0.85

1.46

3.0

4.1

3.86

26.10

ug/l

2.83

164

1968

Superficial injury of abdomen, lower back and pelvis

536

4880

1.11

1.46

3.4

4.0

34.53

29.54

ug/l

0.09

433

3893

Benign neoplasm: Lip

723

1.29

1.46

2.6

4.3

4.32

28.33

ug/l

1.40

608

Idiopathic pulmonary fibrosis

347

3094

1.14

1.45

3.1

4.0

18.20

23.39

ug/l

0.30

294

2589

Hypoparathyroidism

151

1266

1.22

1.45

3.2

4.0

54.86

21.68

ug/l

0.28

127

1025

Crystal arthropathies, rheuma endpoint

734

1.29

1.45

2.4

4.3

24.55

33.28

ug/l

0.14

631

Ventricular septal defect, a heart condition

336

1.42

1.45

2.9

4.0

10.18

20.86

ug/l

0.33

258

L01XX Other antineoplastic agents

257

2250

1.16

1.45

2.7

4.1

22.46

20.92

ug/l

0.05

206

1877

Prolapse and hernia of ovary and fallopian tube

176

1482

1.20

1.44

3.5

3.7

6.41

16.14

ug/l

1.83

140

1227

Aspergillosis

290

1.48

1.44

4.3

4.6

4.14

56.41

ug/l

1.18

244

Nummular dermatitis

330

2933

1.14

1.44

3.8

4.2

15.71

25.39

ug/l

0.64

273

2401

Other and unspecified follicular disorders

129

1064

1.23

1.44

4.7

4.2

7.62

25.50

ug/l

1.30

103

854

223

1.54

1.44

1.9

4.1

2.60

7.19

ug/l

2.03

181

Oral leukoplakia, including avohilmo

112

913

1.25

1.43

3.2

4.3

76.19

24.64

ug/l

0.36

756

Anorexia

356

1.41

1.43

3.4

3.9

26.72

20.74

ug/l

0.13

288

Benign neoplasm: Skin of upper limb, including shoulder

609

1.31

1.43

3.2

4.5

18.45

31.40

ug/l

0.31

515

Benign neoplasm: Lower jaw bone

112

1.79

1.43

2.5

4.0

4.11

11.20

ug/l

0.98

Astigmatism

183

1556

1.19

1.42

3.7

4.1

4.93

20.90

ug/l

1.95

134

1243

Varicella [chickenpox]

135

1117

1.22

1.42

3.9

4.6

14.97

28.92

ug/l

0.70

108

898

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

261

2288

1.16

1.42

3.8

4.2

11.15

20.16

ug/l

0.90

209

1871

Gonococcal infection

120

985

1.24

1.42

3.4

4.3

10.47

11.67

ug/l

0.06

798

Dermatopolymyositis

470

1.36

1.42

2.4

4.2

3.13

36.48

ug/l

1.21

389

Hypotension due to drugs

497

1.35

1.42

3.8

4.3

3.56

36.85

ug/l

1.34

423

Benign neoplasm: Peripheral nerves and autonomic nervous system

514

1.34

1.41

4.2

4.0

3.68

34.25

ug/l

1.20

424

Synovial cyst of popliteal space [Baker]

329

2929

1.14

1.41

3.3

4.2

6.49

22.68

ug/l

3.35

259

2380

All dysplastic lesions of the vulva

158

1333

1.20

1.41

3.6

3.8

3.59

13.05

ug/l

1.92

124

1039

Cardiomyopathy, other and unspecified

329

2929

1.14

1.41

2.9

4.6

7.40

24.61

ug/l

2.78

268

2426

Acquired absence of limb

308

1.45

1.40

3.2

4.8

27.22

31.50

ug/l

0.06

261

Antenatal screening

619

3178

1.10

1.40

3.7

3.4

25.70

16.33

ug/l

0.33

434

2277

Gout due to impairment of renal function

360

1.41

1.39

2.4

4.5

3.73

49.34

ug/l

1.31

305

Sequelae of other accidents

476

0.68

1.39

2.3

4.2

2.16

33.63

ug/l

1.22

401

LSIL lesion of the cervix uteri, vagina or vulva

435

3930

1.11

1.39

3.5

3.6

24.73

24.34

ug/l

0.01

329

2880

Congenital lactase deficiency

2.26

1.39

4.8

3.4

2.38

6.38

ug/l

—

Chronic Coagulation defects

584

1.31

1.39

2.7

4.2

2.93

38.67

ug/l

1.51

472

Benign neoplasm: Other and unspecified parts of mouth

136

1135

1.22

1.39

3.8

4.3

22.24

22.92

ug/l

0.02

107

941

Ovarian dysfunction, other/unspecified

144

1.67

1.39

3.0

4.2

22.75

9.01

ug/l

0.28

113

Asthma and allergy

346

3044

1.13

1.38

3.0

3.9

16.78

31.90

ug/l

0.42

260

2244

Artificial joint re-operation

255

2897

0.87

1.38

3.0

4.0

9.39

20.68

ug/l

1.41

203

2375

Secondary polycythaemia

728

1.28

1.38

3.8

4.5

4.46

25.73

ug/l

1.21

614

Other crystal arthropathies

739

1.28

1.38

2.4

4.3

24.55

27.48

ug/l

0.05

630

Other acute skin changes due to ultraviolet radiation

139

1163

1.22

1.38

3.1

4.1

3.52

22.83

ug/l

1.92

114

964

Mandibular retrognathia AND surgery (BSSO)

570

0.71

1.38

3.5

4.3

37.25

24.66

ug/l

0.19

443

Ovarian hyperstimulation (induction)

232

1.49

1.37

4.1

3.6

3.13

28.34

ug/l

0.56

156

Other and unspecified mood [affective] disorders

177

1508

1.18

1.36

2.2

4.2

12.04

41.56

ug/l

0.66

129

1143

Bruxism

428

1.36

3.3

4.1

15.25

18.86

ug/l

0.10

333

Use of amantadine

543

0.70

1.36

3.6

4.1

3.23

28.69

ug/l

1.07

449

Superficial injury of ankle and foot

349

3119

1.13

1.36

3.1

4.1

13.63

33.22

ug/l

0.81

280

2423

Erythema intertrigo

784

1.27

1.36

3.7

4.2

11.75

32.23

ug/l

0.92

664

Asthma and allergy, excluding more controls

346

3048

1.13

1.36

3.0

3.9

16.78

32.94

ug/l

0.46

260

2241

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

254

2234

1.16

1.36

2.9

4.0

51.54

22.06

ug/l

0.27

191

1800

LeFortI or BSSO operation

898

0.77

1.35

3.4

4.3

23.52

20.94

ug/l

0.05

687

Sacroiliitis, not elsewhere classified

128

1061

1.22

1.35

2.8

4.4

4.34

26.47

ug/l

1.57

797

Endocrine disorders, other/unspecified

561

1.31

1.35

3.8

4.4

6.32

28.41

ug/l

0.90

464

Infective dermatitis

460

4181

1.11

1.35

3.6

4.2

18.23

24.29

ug/l

0.42

381

3382

Benign neoplasm of thyroid gland

132

1102

1.22

1.35

4.3

3.9

13.64

19.10

ug/l

0.25

101

895

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

1.96

1.34

4.6

4.1

2.37

95.26

ug/l

0.53

Complications associated with artificial fertilization

258

1.46

1.34

3.9

3.6

3.10

171.75

ug/l

0.60

178

Polyarteritis nodosa and related conditions

396

1.38

1.34

3.1

3.9

10.85

39.85

ug/l

0.74

323

Sequelae of other and unspecified effects of external causes

162

1.62

1.33

3.1

4.2

12.61

34.42

ug/l

0.35

130

Occupational exposure to risk-factors

130

1085

1.22

1.33

3.5

4.4

46.18

25.28

ug/l

0.32

111

899

Depression

4471

29365

1.03

1.33

3.4

4.1

23.33

24.51

ug/l

0.09

3537

23285

Tooth eruption problems

245

2088

1.15

1.33

3.3

3.9

3.72

37.86

ug/l

1.23

177

1506

Other disorders of amniotic fluid and membranes

258

2863

0.87

1.33

3.1

3.5

12.23

22.72

ug/l

0.29

177

1939

Contracture of joint

397

1.37

1.32

3.7

4.4

17.29

31.80

ug/l

0.35

345

Benign neoplasm: Skin of lip

441

1.36

1.32

3.5

4.0

3.48

36.66

ug/l

1.15

367

Other and unspecified mononeuropathies of upper limb

110

903

1.24

1.32

3.4

4.6

7.91

24.82

ug/l

1.04

739

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

576

3992

0.91

1.32

3.3

13.48

18.15

ug/l

0.13

350

2628

Spirochaetal infections, other/unspecified

353

3172

1.13

1.31

3.6

4.0

30.52

30.39

ug/l

0.00

281

2577

Benign neoplasm: other/unspecified salivary gland

115

951

1.24

1.31

3.2

4.1

11.50

28.17

ug/l

0.94

793

Other disorders of peripheral nervous system

229

1.51

1.31

4.2

4.5

28.69

26.57

ug/l

0.02

187

Rheumatoid arthritis, including avohilmo

1675

17577

0.95

1.31

3.2

4.0

24.00

22.70

ug/l

0.05

1353

14217

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

148

1253

1.20

1.30

3.5

4.2

5.41

20.54

ug/l

1.42

122

1029

Conjunctivitis

3278

26421

1.04

1.30

3.4

4.0

12.48

24.77

ug/l

3.06

2453

20898

Otitis externa, unspecified

378

3407

1.12

1.30

3.6

4.1

12.80

23.29

ug/l

0.78

300

2720

Toxic effect of corrosive substances

118

0.41

1.29

3.2

4.8

2.08

9.48

ug/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

924

8518

1.07

1.29

3.4

3.6

14.96

21.15

ug/l

0.32

696

6209

Etanercept

155

1820

0.84

1.29

2.7

4.2

56.66

17.70

ug/l

0.62

115

1425

Coxarthrosis, primary

3244

26526

1.04

1.29

3.7

4.0

16.80

26.01

ug/l

1.32

2688

21808

Other assisted single delivery

303

1.41

1.29

3.4

3.6

9.68

6.77

ug/l

0.25

206

Tic and related disorders

162

1.57

1.28

3.2

4.3

6.51

6.85

ug/l

0.03

127

Carcinoma in situ of skin of upper limb, including shoulder

117

974

1.23

1.28

3.0

4.0

3.31

26.01

ug/l

2.01

819

Necrotizing fasciitis

148

1.63

1.28

4.5

4.7

50.55

55.09

ug/l

0.03

123

Injuries to the neck

790

7361

1.08

1.27

3.5

4.1

14.82

26.41

ug/l

0.82

634

5845

Psoas tendinitis

124

1.69

1.27

3.6

4.5

2.13

42.58

ug/l

0.57

Disorders of synovium and tendon

2507

21106

1.04

1.27

3.4

4.3

16.71

27.81

ug/l

1.02

1988

16878

Allergic conjunctivitis

2342

21904

1.04

1.27

3.3

3.9

12.81

21.94

ug/l

1.28

1720

17110

Other osteochondrodysplasias

288

1.43

1.27

3.6

4.5

4.51

6.50

ug/l

0.37

237

Other and unspecified nail disorders

647

1.28

1.26

3.2

4.3

2.61

30.24

ug/l

1.45

531

Contusion of toe(s) without damage to nail

530

1.30

1.26

3.5

4.1

3.30

19.84

ug/l

1.06

425

Coarctation of the aorta

204

1.51

1.26

4.3

4.7

18.69

27.18

ug/l

0.14

167

Torticollis

356

1.37

1.26

3.3

5.2

2.44

18.74

ug/l

0.73

284

Striae atrophicae

263

1.45

1.26

4.3

4.0

3.46

24.22

ug/l

0.67

211

Intercostal neuropathy

256

1.46

1.25

2.9

4.2

3.10

51.18

ug/l

0.90

211

Bitten or struck by other mammals

350

3149

1.12

1.25

3.8

4.1

29.25

29.43

ug/l

0.00

269

2451

Problems related to social environment

773

1.25

1.24

2.5

3.9

6.03

28.19

ug/l

1.32

640

Hyperaldosteronism

114

948

1.23

1.24

3.3

4.3

10.48

28.33

ug/l

1.09

800

Benign neoplasm: Heart

126

1.70

1.24

2.2

4.3

3.55

40.08

ug/l

0.59

109

Dermatophytosis

526

4836

1.10

1.23

3.4

4.2

18.58

21.80

ug/l

0.20

426

3980

Schizophrenia

448

4909

0.91

1.23

2.9

4.3

27.66

30.80

ug/l

0.06

378

3926

Other and unspecified immunodeficiencies with predominantly antibody defects

333

1.39

1.23

4.0

35.08

20.80

ug/l

0.16

272

Foreign body in respiratory tract

175

1509

1.17

1.23

2.9

4.1

27.57

21.64

ug/l

0.12

136

1215

Carcinoma in situ of skin of ear and external auricular canal

518

1.31

1.23

3.5

4.0

5.16

35.58

ug/l

1.30

441

Evidence of alcohol involvement determined by blood alcohol level

367

1.37

1.22

3.0

5.3

3.50

42.75

ug/l

1.10

310

Unspecified contracted kidney

174

1.56

1.22

4.0

4.5

9.51

33.17

ug/l

0.47

144

Oligomenorrhoea

101

828

1.24

1.22

2.7

4.1

5.81

54.62

ug/l

0.63

637

Obesity, other/unspecified

1315

12470

1.06

1.22

3.2

4.0

35.07

22.06

ug/l

0.68

1022

9735

Sacrococcygeal disorders, not elsewhere classified

107

884

1.23

1.22

3.2

4.3

6.51

24.10

ug/l

0.99

690

Coronary atherosclerosis

3315

21680

0.96

1.22

3.3

4.3

22.93

27.38

ug/l

0.29

2700

17822

Specific personality disorders

721

6708

1.08

1.22

2.8

4.1

14.43

28.02

ug/l

1.24

572

5138

Extreme obesity with alveolar hypoventilation

163

1401

1.18

1.22

3.0

4.2

35.13

21.33

ug/l

0.25

131

1143

Granulomatous disorders of skin and subcutaneous tissue

722

1.26

1.21

3.0

4.2

7.65

28.37

ug/l

1.04

595

Panniculitis, unspecified

343

1.39

1.21

4.1

4.3

3.12

41.36

ug/l

0.98

281

Hereditary spastic paraplegia

0.00

1.21

0.0

4.4

—

5.28

—

Bicipital tendinitis

194

1690

1.16

1.21

3.1

4.6

3.46

28.14

ug/l

3.78

149

1381

LSIL lesion of the cervix uteri

315

2824

1.12

1.20

3.4

3.6

33.60

27.99

ug/l

0.09

232

2064

Other and unspecified disease of Bartholin gland

111

924

1.22

1.20

3.3

4.0

3.14

11.73

ug/l

3.72

737

Pregnancy with abortive outcome

2983

15012

1.04

1.20

3.6

3.7

21.02

20.96

ug/l

0.00

2325

11524

Other cestode infections

112

0.42

1.20

3.2

4.1

2.24

74.11

ug/l

—

Thoracic aortic aneurysm

632

5866

1.09

1.20

3.6

4.5

13.11

19.42

ug/l

0.81

501

4943

Dermatopolymyositis (FG)

484

1.32

1.20

2.4

4.3

3.13

39.50

ug/l

1.44

407

Other injuries of upper limb, level unspecified

326

1.39

1.19

2.5

4.3

3.27

21.86

ug/l

0.83

274

Autoimmune hyperthyroidism

237

2093

1.15

1.19

3.3

4.0

9.91

37.59

ug/l

0.97

180

1633

Juvenile rheumatoid arthirtis

451

0.70

1.19

3.8

4.3

16.22

17.87

ug/l

0.04

355

Personality disorders

845

7913

1.07

1.19

3.0

4.1

11.82

27.10

ug/l

1.88

672

6107

Acute alcohol intoxication, ICD10

703

6544

1.08

1.19

3.2

4.4

28.43

28.82

ug/l

0.01

605

5349

Orthopaedic devices associated with adverse incidents

728

1.26

1.18

2.5

4.2

3.79

29.86

ug/l

1.58

606

Macular hole

270

2411

1.14

1.18

3.5

4.1

8.05

20.03

ug/l

1.86

228

1996

Primary adrenocortical insufficiency

310

1.40

1.18

3.0

3.8

6.28

43.55

ug/l

0.84

259

Other obstetric conditions, not elsewhere classified

607

4178

0.92

1.18

3.3

12.81

18.41

ug/l

0.17

374

2777

Exposure to other and unspecified animate mechanical forces

652

1.26

1.17

4.3

17.24

31.87

ug/l

0.34

526

Mixed hyperlipidaemia

155

1331

1.18

1.17

3.5

4.3

118.11

30.78

ug/l

0.56

127

1113

Ingrowing nail

169

1459

1.17

4.1

4.2

5.82

20.59

ug/l

1.65

126

1186

Speech and linguistic disorders, excluding more controls

153

1229

1.18

1.17

3.5

4.4

62.95

22.34

ug/l

0.31

112

923

Adalimumab

286

2556

1.13

1.17

3.2

4.3

84.55

35.62

ug/l

0.38

214

2005

Amyloidosis, other/unspecified

629

1.27

1.16

2.6

4.3

3.92

34.27

ug/l

1.61

533

Vascular dementia (subcortical)

105

1257

0.82

1.16

2.8

3.7

3.14

28.92

ug/l

2.87

1072

Other and unspecified acute skin changes due to ultraviolet radiation

108

901

1.22

1.16

3.1

4.2

3.46

27.61

ug/l

1.87

757

Lactose intolerance, other/unspecified

708

1.25

1.16

3.4

4.1

3.97

27.25

ug/l

1.32

577

Polyarthrosis

1083

9510

1.06

1.16

3.2

4.2

5.95

27.92

ug/l

9.22

897

7802

Coronary revascularization (ANGIO or CABG)

4159

24728

1.03

1.15

3.3

4.3

17.28

28.09

ug/l

1.81

3358

20067

Other disorders of thyroid

434

1.33

1.15

3.1

3.8

53.52

17.21

ug/l

0.31

366

Suppurative and unspecified otitis media

934

8795

0.94

1.14

3.5

4.0

11.59

23.83

ug/l

1.49

678

6759

Other chondrocalcinosis

462

1.32

1.14

2.1

4.2

3.79

32.64

ug/l

1.08

397

Fluid overload

1.76

1.14

1.9

4.2

3.93

118.66

ug/l

0.84

Lichen simplex chronicus and prurigo

249

2216

1.14

1.13

2.8

4.1

4.90

20.41

ug/l

3.12

208

1807

Cardiodefibrillation

1801

17224

1.05

1.13

3.5

4.1

10.22

26.40

ug/l

6.82

1445

14436

Other/unspecified disorders of vestibular function

166

1439

1.17

1.13

2.6

4.1

64.07

20.06

ug/l

0.37

125

1196

Other peripheral vascular diseases

312

2812

1.12

1.13

3.1

4.1

7.07

23.67

ug/l

2.61

263

2257

Dislocation, sprain and strain of joints and ligaments at neck level

451

4134

1.10

1.13

3.5

4.0

5.59

30.31

ug/l

2.12

350

3219

Benign neoplasm: Retina

178

1.53

1.12

3.2

4.2

5.21

11.29

ug/l

0.97

147

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2252

21062

1.04

1.12

3.3

3.9

13.15

22.55

ug/l

1.25

1644

16468

Vasculitis limited to skin, not elsewhere classified

107

895

1.22

1.12

3.6

4.2

77.31

27.40

ug/l

0.49

742

Melanocytic naevi of upper limb, including shoulder

667

1.25

1.12

2.8

4.2

25.33

27.49

ug/l

0.04

550

Gonococcal infection

120

1013

1.20

1.12

3.3

4.3

10.47

11.42

ug/l

0.05

819

Loose body in joint

737

0.77

1.11

3.9

4.6

8.38

26.64

ug/l

1.02

630

Mood disorders

4892

30820

1.03

1.11

3.4

4.1

22.44

24.00

ug/l

0.13

3880

24542

Mood [affective] disorders

4879

30789

1.03

1.11

3.4

4.1

22.48

24.02

ug/l

0.13

3870

24514

Supervision of high-risk pregnancy

548

3041

1.09

1.11

3.8

3.4

17.18

14.56

ug/l

0.10

388

2174

Deviated nasal septum

1317

13816

0.95

1.10

3.4

4.4

15.68

27.78

ug/l

1.47

1043

11315

Other congenital malformations of tongue, mouth and pharynx

200

1.46

1.10

3.1

4.0

2.39

7.66

ug/l

1.62

151

Disorders of vitreous body

2569

23958

1.04

1.10

3.6

4.1

13.66

25.75

ug/l

2.78

2061

19550

Other disorders of optic [2nd] nerve and visual pathways

220

1946

1.14

1.10

3.8

4.2

48.17

21.80

ug/l

0.27

169

1574

Other and unspecified nonscarring hair loss

178

1.51

1.10

3.2

4.0

3.04

7.13

ug/l

1.04

141

Calcific tendinitis of shoulder

235

2089

1.14

1.10

3.4

4.4

43.14

22.23

ug/l

0.27

196

1679

Benign neoplasm: Orbit, unspecified

187

1.50

1.10

3.8

3.9

2.28

42.22

ug/l

0.58

157

Insulin, fast-acting (human)

362

3980

0.90

1.10

3.2

4.0

10.44

27.70

ug/l

1.21

306

3148

Arthropathy in Crohn disease

271

1.40

1.10

3.6

4.5

3.26

25.14

ug/l

0.74

215

Cauda equina syndrome

384

1.34

1.10

3.2

4.4

4.02

17.76

ug/l

0.66

314

Other specified/unspecified spondylopathies

109

916

1.21

1.10

2.9

4.2

3.05

23.39

ug/l

1.52

752

Pyoderma

534

1.28

1.10

3.4

4.5

8.25

31.03

ug/l

0.82

442

Benign paroxysmal vertigo

1399

13347

1.05

1.09

3.4

4.0

14.60

24.52

ug/l

1.31

1077

10860

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

106

1.70

1.09

2.4

5.3

27.36

48.22

ug/l

0.18

Exposure to other specified factors

3307

29418

1.03

1.09

3.7

4.1

12.95

25.50

ug/l

2.78

2608

23391

Vestibular neuronitis

361

3287

1.11

1.09

3.9

4.1

7.00

24.58

ug/l

3.12

294

2678

Lesion of ulnar nerve

557

5165

1.09

3.2

4.4

43.97

23.39

ug/l

0.47

463

4205

Carcinoma in situ of middle ear and respiratory system

163

1.55

1.09

7.0

4.7

3.76

47.32

ug/l

0.84

137

Other disorders of male genital organs

111

932

1.21

1.09

5.0

4.8

3.73

29.58

ug/l

2.39

795

Bullous disorders

233

2073

1.14

1.08

3.7

4.0

5.13

21.20

ug/l

2.50

187

1718

Other and unspecified disorders of pigmentation

204

1.47

1.08

4.9

4.2

29.12

42.23

ug/l

0.13

167

Drug-induced systemic lupus erythematosus

213

1.47

1.08

1.7

3.9

20.45

10.12

ug/l

0.24

169

Other and unspecified primary disorders of muscles

196

1.48

1.07

1.7

4.4

29.95

28.22

ug/l

0.02

154

Benign neoplasm: Spinal meninges

387

1.34

1.07

3.3

4.0

2.47

20.19

ug/l

1.00

328

Chronic iridocyclitis

174

1520

1.16

1.06

4.1

4.3

25.80

22.33

ug/l

0.08

136

1235

Congenital malformations of trachea and bronchus

308

1.38

1.06

3.2

4.0

5.09

44.29

ug/l

0.89

256

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

466

1.30

1.06

2.7

4.5

2.79

40.56

ug/l

1.35

372

Other and unspecified vasculitis limited to skin

800

1.22

1.06

3.8

4.3

83.09

29.23

ug/l

0.49

666

Nonspecific lymphadenitis

199

1754

1.15

1.06

3.2

4.1

4.19

21.30

ug/l

2.32

148

1387

Ankylosing spondylitis, ICD10

292

2633

1.12

1.06

3.3

4.3

131.01

20.07

ug/l

0.88

230

2124

Aggressive periodontitis

682

1.24

1.06

4.3

4.62

32.71

ug/l

1.53

574

Disorders of vitreous body and globe

2637

24490

1.04

1.05

3.6

4.1

13.40

25.54

ug/l

2.91

2112

19998

Other specified disorders of external ear

149

1290

1.17

1.05

3.7

4.3

17.08

26.90

ug/l

0.30

116

1082

Physical medicine devices associated with adverse incidents

0.00

1.05

0.0

4.9

—

2.67

—

Ankylosing spondylitis

313

2834

1.11

1.05

3.3

4.6

124.78

25.77

ug/l

0.82

245

2287

Epilepsy

1351

12848

1.05

3.8

4.2

15.04

26.67

ug/l

1.77

1111

10482

Gonarthrosis

3471

19182

1.03

1.05

3.5

4.3

22.56

30.51

ug/l

0.93

2785

15585

Benign neoplasm of other and unspecified female genital organs

173

1515

1.16

1.04

3.5

3.8

6.36

13.14

ug/l

1.26

134

1207

Episodal and paroxysmal disorders

5421

26917

1.03

1.04

3.4

4.2

17.05

27.40

ug/l

1.79

4243

21544

conjunctival degenerations and deposits

757

1.23

1.04

3.3

4.2

12.09

26.57

ug/l

0.59

633

Schizophrenia, schizotypal and delusional disorders

1029

10857

0.94

1.04

3.1

4.1

22.44

24.75

ug/l

0.09

836

8657

Atrial septal defect, secundum type

607

1.25

1.04

2.6

4.1

5.67

26.98

ug/l

0.91

487

Erectile dysfunction

335

3051

1.11

1.03

4.9

4.4

7.75

28.97

ug/l

3.12

273

2605

Other and unspecified degenerative diseases of nervous system

958

0.81

1.03

3.3

4.0

34.94

27.58

ug/l

0.10

812

Other degenerative diseases of the basal ganglia

692

0.77

1.03

2.6

4.4

2.71

30.06

ug/l

1.66

595

Erosion and ectropion of cervix uteri

121

1033

1.19

1.03

3.3

4.1

20.29

42.33

ug/l

0.45

833

Hypothyroidism due to medicaments and other exogenous substances

380

1.33

1.03

3.5

4.1

19.97

9.75

ug/l

0.25

312

Myeloid leukaemia

108

914

1.20

1.02

3.4

4.1

14.27

24.85

ug/l

0.35

761

Melanocytic naevi of ear and external auricular canal

165

1.51

1.02

3.3

4.5

2.99

34.21

ug/l

0.66

138

Use of cabergoline

320

0.67

1.02

3.1

4.6

2.07

29.23

ug/l

1.09

264

Polyarteritis nodosa

207

1.45

1.02

3.8

4.3

14.79

58.37

ug/l

0.58

177

Type 1 diabetes, strict definition, subgroup 1

950

0.82

1.02

3.8

4.3

8.89

44.85

ug/l

0.44

664

Dyshidrosis [pompholyx]

388

1.31

1.02

2.9

4.4

3.67

32.78

ug/l

0.91

320

Other nutritional anaemias

301

1.37

1.02

2.8

4.2

16.56

27.08

ug/l

0.23

255

Benign neoplasm of meninges

459

4243

1.09

1.02

3.5

3.9

13.72

23.44

ug/l

0.57

369

3428

Burn and corrosion of shoulder and upper limb, except wrist and hand

549

0.75

1.02

3.1

4.6

2.53

34.91

ug/l

1.41

450

Postpartum hemorraghe, all women as controls

572

6047

0.93

1.01

3.3

3.5

18.55

20.19

ug/l

0.05

385

4277

Acne

166

1445

1.15

1.01

4.2

4.1

6.06

41.78

ug/l

0.77

130

1025

Pedestrian injured in collision with car, pick-up truck or van

694

1.23

1.01

3.1

4.2

25.86

27.47

ug/l

0.02

582

Emotionally unstable personality disorder

296

2676

1.11

1.01

2.9

3.9

12.36

27.75

ug/l

0.56

234

1967

Viral conjunctivitis

504

1.27

1.01

2.7

4.4

2.70

31.17

ug/l

1.05

396

Inguinal or femoral hernia, bilateral

429

3954

1.09

1.01

4.5

4.3

6.36

26.01

ug/l

4.60

349

3363

Sequelae of malnutrition and other nutritional deficiencies

1.90

1.00

2.1

4.7

10.55

75.95

ug/l

—

Benign neoplasm: Mediastinum

109

1.65

1.00

2.9

4.8

2.08

10.57

ug/l

—

Effects of heat and light

208

1.44

0.99

4.4

7.97

59.35

ug/l

0.76

176

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

287

2594

1.12

0.99

3.5

4.0

24.53

23.20

ug/l

0.03

242

2153

Autism spe, excluding more controls

181

1.45

0.99

2.2

4.7

2.71

5.36

ug/l

0.59

134

Arthrosis

3709

19785

1.03

0.98

3.6

4.3

17.06

30.20

ug/l

2.13

2976

15990

Moderate visual impairment, monocular

142

1.55

0.98

2.0

4.6

20.71

8.43

ug/l

0.29

120

Acute alcohol intoxication

993

9420

1.06

0.98

3.2

4.3

27.15

29.24

ug/l

0.08

854

7678

Other specified/unspecified systemic involvement of connective tissue

216

1927

1.13

0.98

3.1

4.1

3.06

22.99

ug/l

3.46

163

1537

Autonomic disorders

697

1.23

0.98

3.1

4.3

2.84

24.71

ug/l

1.23

574

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

148

1285

1.16

0.97

2.3

4.6

7.76

23.79

ug/l

1.12

124

996

Spinal instabilities

105

890

1.20

0.97

3.0

4.4

7.37

21.14

ug/l

1.16

704

Benign neoplasm of brain and other parts of central nervous system

239

2146

1.13

0.97

3.7

4.2

8.97

19.87

ug/l

1.13

195

1752

Family history of other specific disorders

268

1.37

0.97

5.0

4.0

1.80

27.36

ug/l

0.94

218

Speech and linguistic disorders

154

1286

1.15

0.97

3.6

4.1

62.40

19.73

ug/l

0.34

113

975

Benign neoplasm: Cerebral meninges

416

3840

1.09

0.97

3.5

3.9

13.81

22.10

ug/l

0.42

337

3098

Abrasion of teeth

1348

14090

0.95

0.97

3.7

4.1

7.73

24.36

ug/l

5.19

1044

11199

Amyloidosis

763

1.22

0.97

2.8

4.2

3.90

29.89

ug/l

1.67

637

Other and specified injuries of hip and thigh

717

1.22

0.96

3.0

4.1

10.49

28.34

ug/l

0.75

609

Crystalline deposits in vitreous body

323

1.35

0.96

2.9

4.6

21.80

43.53

ug/l

0.31

270

Other/unspecified enthesopathies of lower limb, excluding foot

259

2337

1.12

0.96

3.6

4.4

34.87

19.23

ug/l

0.23

207

1847

Other or ill-defined heart diseases

187

1655

1.14

0.96

3.7

4.4

12.74

24.29

ug/l

0.83

149

1369

Bus occupant injured in other and unspecified transport accidents

193

1.45

0.95

2.4

4.3

2.44

8.80

ug/l

1.84

154

Erythema nodosum

105

892

1.19

0.95

3.5

3.9

17.61

21.38

ug/l

0.08

727

Oral lichen planus and hypothyroidism or thyroxine medication

628

1.24

0.95

2.7

4.0

3.11

8.30

ug/l

3.19

501

Embedded teeth, including avohilmo

177

1559

1.14

0.95

3.3

4.1

4.05

45.84

ug/l

1.14

130

1171

Puerperal sepsis

454

4896

0.92

0.95

3.8

65.74

26.13

ug/l

0.66

350

3814

Inguinal hernia, bilateral

420

3880

1.09

0.95

4.5

4.3

6.44

25.89

ug/l

4.41

341

3303

Sulfonylureas

1795

13752

1.04

0.95

3.4

4.0

35.39

23.97

ug/l

0.61

1524

11464

Eosinophilia

483

1.27

0.94

3.4

4.3

108.21

30.56

ug/l

0.37

401

Dermatitis due to ingested food

292

0.69

0.94

3.2

3.5

3.79

4.88

ug/l

0.28

196

Disorders of eyelid in diseases classified elsewhere

115

986

1.18

0.94

3.8

4.2

17.68

20.75

ug/l

0.08

801

Other congenital malformations of skin

115

985

1.18

0.93

3.6

4.4

13.10

13.17

ug/l

0.00

797

Benign neoplasm: Nasopharynx

289

1.36

0.93

3.5

4.3

3.23

46.98

ug/l

0.95

241

Retinal haemorrhage

104

886

1.20

0.93

3.3

4.0

21.94

17.66

ug/l

0.09

752

Other congenital malformations of tongue, mouth and pharynx

133

1.51

0.93

3.9

3.8

2.61

4.79

ug/l

0.71

Benign neoplasm: Tonsil

386

1.30

0.93

3.4

4.4

12.65

25.03

ug/l

0.44

323

Pacemaker

1656

15264

1.04

0.93

2.9

4.0

14.97

24.59

ug/l

1.54

1330

12764

Deforming dorsopathies

1235

11804

1.05

0.93

3.0

4.3

9.49

26.43

ug/l

3.17

990

9475

Disorders of iron metabolism

430

1.28

0.93

2.5

4.7

3.02

33.77

ug/l

0.98

350

Infectious mononucleosis

150

1309

1.15

0.93

3.7

4.1

5.97

44.82

ug/l

0.77

109

943

Palindromic rheumatism

351

1.32

0.92

2.0

4.2

3.00

34.62

ug/l

0.93

297

Contact with blunt object, undetermined intent

153

0.57

0.92

2.9

4.3

3.32

39.00

ug/l

—

122

Major coronary heart disease event excluding revascularizations

3122

21395

0.97

0.92

3.4

4.3

11.86

27.34

ug/l

4.87

2578

17661

Spinal osteochondrosis

280

1.35

0.92

2.4

5.3

4.47

22.90

ug/l

0.64

228

Infective bursitis

109

933

1.19

0.92

3.1

4.6

5.81

27.13

ug/l

1.54

773

Melanoma in situ of scalp and neck

1.68

0.92

4.7

5.0

3.87

54.23

ug/l

0.57

Certain zoonotic bacterial diseases

106

905

1.19

0.92

3.4

4.4

7.94

28.10

ug/l

1.25

759

Blood alcohol or alcohol intoxication level

556

1.24

0.91

3.1

4.9

7.02

33.54

ug/l

1.04

454

Amputation of toe

294

2681

1.11

0.91

2.9

4.1

4.99

25.26

ug/l

4.25

250

2246

Biological medicines for asthma

472

0.75

0.91

2.4

4.4

2.68

16.74

ug/l

0.89

380

Other specified/unspecified dorsopathies

131

1138

1.17

0.91

2.7

4.4

4.19

27.90

ug/l

2.02

102

913

Congenital malformations of uterus and cervix

359

1.30

0.90

2.0

3.8

3.42

22.01

ug/l

0.74

261

Congenital deformities of hip

350

1.30

0.90

5.1

4.1

2.75

6.46

ug/l

1.71

274

Other forms of systemic lupus erythematosus

238

1.38

0.90

3.5

4.0

6.38

6.72

ug/l

0.04

196

Acquired coagulation factor deficiency

1.91

0.90

8.6

5.1

3.81

11.54

ug/l

—

Maternal care for other conditions predominantly related to pregnancy

497

5231

0.93

0.90

4.0

3.6

6.14

21.33

ug/l

1.27

341

3682

Other neurotic disorders

181

1609

1.14

0.90

2.9

4.2

17.52

20.00

ug/l

0.07

146

1326

Other disorders of optic disc

361

1.30

0.89

4.1

4.2

2.58

36.78

ug/l

0.91

299

Right side

214

1.42

0.89

2.7

4.8

27.83

26.77

ug/l

0.01

185

Abnormal spermatozoa

524

4899

1.08

0.89

4.1

4.5

9.54

25.76

ug/l

3.15

432

4188

Iridocyclitis

922

8761

1.06

0.89

3.6

4.1

68.06

26.08

ug/l

0.93

731

7078

Injury of nerves at wrist and hand level

118

1018

1.17

0.89

3.9

4.6

15.44

28.14

ug/l

0.59

831

Melanocytic naevi of lip

265

1.36

0.89

3.3

3.9

2.21

49.97

ug/l

0.93

216

Viral infections of the central nervous system

235

2120

1.12

0.89

3.7

4.1

10.17

21.29

ug/l

1.07

181

1702

Spermatocele

299

2732

1.10

0.89

4.5

4.6

8.74

26.10

ug/l

2.65

251

2352

Ankylosing spondylitis, strict definition

119

1027

1.17

0.89

3.1

4.6

216.43

19.95

ug/l

0.71

819

Haemophilus septicemia

1.88

0.89

4.9

4.3

3.35

23.28

ug/l

—

Specific development disorders of scholastic skills

372

1.28

0.88

2.4

4.2

227.77

4.86

ug/l

0.49

257

Congenital malformations of the respiratory system

469

1.26

0.88

2.9

4.2

11.18

31.19

ug/l

0.56

391

Other and unspecified nerve root and plexus disorders, also in other diseases

810

7675

1.06

0.88

3.1

4.3

15.68

27.40

ug/l

0.66

636

6179

Ptosis of eyelid

497

4642

1.08

0.88

3.2

4.0

27.09

21.08

ug/l

0.18

398

3787

Amenorrhoea

148

1298

1.15

0.87

2.9

4.0

4.73

48.25

ug/l

0.87

106

952

Other symptoms and signs involving cognitive functions and awareness

2294

20230

1.04

0.87

3.2

4.1

10.65

27.01

ug/l

6.42

1836

16707

Chronic nephritic syndrome

142

1246

1.15

0.87

3.0

4.3

11.50

20.91

ug/l

0.46

115

1025

Use of teriflunomide

191

0.62

0.86

2.8

4.0

1.90

5.64

ug/l

1.63

142

Hyperkinetic disorders, excluding more controls

149

1250

1.14

0.86

2.8

4.0

2.18

41.58

ug/l

0.66

818

Schizophrenia or delusion

1027

10768

0.95

0.86

3.1

4.1

22.43

24.82

ug/l

0.10

833

8582

Preterm labour and delivery

868

9133

0.95

0.86

3.7

3.8

11.07

23.51

ug/l

1.37

655

6909

Cyst of Bartholin Gland

121

1050

1.17

0.86

3.3

3.9

8.95

12.09

ug/l

0.27

806

Gonarthrosis,primary

4852

29231

1.02

0.85

3.5

4.1

20.39

26.41

ug/l

0.77

3904

23759

Hyperosmolality and hypernatraemia

454

1.26

0.85

3.2

4.0

23.71

34.76

ug/l

0.21

382

Systemic sclerosis,strict definition

294

0.69

0.84

2.1

4.1

3.44

7.55

ug/l

1.38

243

Viral infections of the central nervous system

249

2261

1.11

0.84

3.8

4.1

10.04

20.59

ug/l

1.08

193

1802

Traumatic amputation of forearm

0.00

0.84

0.0

4.4

—

14.65

—

Otitis media, unspecified

205

2100

0.89

0.84

3.2

4.1

12.90

35.71

ug/l

0.68

146

1626

Other, unspecified and serous retinal detachments

124

1082

1.16

0.84

4.1

4.2

15.27

17.66

ug/l

0.13

104

895

Other specific arthropathies, wide

701

1.20

0.84

2.8

4.5

2.85

28.88

ug/l

1.50

576

Adhesive capsulitis of shoulder

767

7272

1.06

0.84

3.2

4.3

16.49

23.78

ug/l

0.29

630

5894

Bell's palsy

461

4301

1.08

0.83

3.5

4.1

11.33

24.00

ug/l

1.30

380

3460

Injury of nerves and spinal cord at thorax level

156

1.46

0.83

2.3

5.5

2.85

34.77

ug/l

0.63

130

Pemphigus erythematosus

0.00

0.83

0.0

4.8

—

16.68

—

Pollen allergy

380

4050

0.92

0.82

3.2

4.0

4.71

27.31

ug/l

1.72

269

3008

Paraplegia, diplegia of upper limbs

694

1.20

0.82

2.2

4.3

382.62

25.44

ug/l

0.47

575

Other predominantly sexually transmitted diseases, not elsewhere classified

456

4253

1.08

0.81

3.8

3.9

12.31

26.73

ug/l

0.83

340

3154

Cholesteatoma of middle ear

164

1838

0.88

0.81

3.9

4.1

5.69

20.40

ug/l

2.29

137

1534

Pemphigoid

112

974

1.17

0.81

3.7

3.9

3.74

25.10

ug/l

1.85

824

Syphilis

741

1.19

0.80

2.8

4.8

14.53

27.22

ug/l

0.49

621

Syphilis

741

1.19

0.80

2.8

4.8

14.53

27.22

ug/l

0.49

621

Corns and callosities

264

2414

1.10

0.80

2.8

4.2

5.31

22.01

ug/l

3.13

221

1971

Acute poliomyelitis

431

1.26

0.80

4.8

4.2

27.91

23.76

ug/l

0.07

362

Enterobiasis

277

1.31

0.80

2.8

4.1

4.03

25.36

ug/l

0.63

197

Viral infections of central nervous system, not elsewhere classified/unspecified

405

0.75

0.80

4.3

4.2

6.78

35.25

ug/l

0.81

335

Anogenital herpesviral [herpes simplex] infection

143

1262

1.14

0.80

3.8

4.2

5.56

45.84

ug/l

0.82

111

945

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

153

1719

0.88

0.79

4.0

3.9

12.02

29.77

ug/l

0.65

122

1358

Other superficial mycoses

530

1.22

0.79

3.1

4.4

2.77

32.79

ug/l

1.22

434

Benign neoplasm: Rectum/anal canal icd-9

288

1.32

0.79

3.5

4.0

9.41

35.85

ug/l

0.57

246

Other osteochondropathies

219

1984

1.11

0.79

3.9

4.3

41.04

17.47

ug/l

0.35

184

1595

Other congenital malformations of kidney

1.57

0.79

2.3

4.6

4.53

5.54

ug/l

—

Congenital malformations of the circulatory system

440

3983

1.08

0.78

3.4

4.1

6.84

32.04

ug/l

2.10

338

3167

Acne vulgaris

119

1037

1.15

0.78

3.7

4.2

7.08

50.67

ug/l

0.63

726

Vascular dementia (other)

254

1.34

0.78

3.5

3.7

4.71

55.21

ug/l

1.03

223

Other noninflammatory disorders of vulva and perineum

326

3010

1.09

0.78

3.4

4.1

5.69

35.71

ug/l

1.57

238

2346

Unspecified chronic bronchitis

138

1219

1.14

0.78

3.7

4.0

6.50

22.87

ug/l

1.44

111

997

Other and unspecified injuries of ankle and foot

115

1002

1.16

0.78

3.6

4.3

5.54

24.65

ug/l

1.42

807

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

491

0.78

3.4

4.2

3.02

35.64

ug/l

1.31

421

Traumatic subcutaneous emphysema

1.99

0.78

5.9

5.2

7.27

17.74

ug/l

—

Benign neoplasm: Skin of lower limb, including hip

103

893

1.17

0.77

4.3

4.0

13.54

27.18

ug/l

0.55

736

Use of interferon beta-1a

460

0.77

2.9

4.3

4.65

17.83

ug/l

0.68

355

Ototoxic hearing loss

1.73

0.77

2.2

4.2

7.49

14.68

ug/l

—

Medical treatment for female infertility

493

4592

1.07

0.77

3.2

3.5

4.43

22.39

ug/l

1.34

323

3157

Injury of eye and orbit

456

4265

1.07

0.77

4.0

4.4

11.82

36.08

ug/l

1.73

363

3426

Emotional disorders starting during childhood or adolescence

346

0.74

0.77

3.8

2.97

5.10

ug/l

0.61

228

Defects in the complement system

184

1.40

0.77

3.1

3.6

17.51

7.90

ug/l

0.27

146

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

534

5025

1.07

0.77

3.5

4.0

12.00

30.77

ug/l

1.56

419

4029

Combined immunodeficiencies

334

1.29

0.77

4.3

3.8

3.49

40.08

ug/l

0.95

287

Failed attempted abortion

166

1.40

0.77

2.4

3.4

1.98

3.78

ug/l

1.01

117

Other specified/unspecified soft tissue disorders

198

1790

1.12

0.77

2.9

4.1

4.58

22.74

ug/l

2.80

165

1437

Chloasma

142

1.47

0.77

2.8

3.9

3.13

10.20

ug/l

1.28

110

Fitting and adjustment of external prosthetic device

1.60

0.76

3.2

4.0

8.44

8.12

ug/l

—

Methotrexate

527

5599

0.94

0.76

2.9

4.1

23.95

29.56

ug/l

0.20

422

4439

Other conjunctival vascular disorders and cysts

821

1.18

0.76

3.9

4.2

9.62

31.20

ug/l

1.18

680

Exophthalmic conditions

353

1.28

0.76

4.9

4.1

266.65

37.75

ug/l

0.42

298

Thyroiditis

253

2317

1.10

0.75

3.2

4.0

14.71

24.43

ug/l

0.49

195

1828

Antepartum haemorrhage, not elsewhere classified

166

1852

0.89

0.75

2.6

3.4

7.73

27.27

ug/l

0.46

110

1276

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

2.13

0.75

1.4

6.5

1.92

10.71

ug/l

—

Somnolence, stupor and coma

150

1337

1.13

0.75

3.4

4.3

16.47

24.26

ug/l

0.28

121

1125

Female infertility, tubal origin

156

1393

1.13

0.75

3.4

4.2

3.53

46.62

ug/l

0.98

113

1046

Angina pectoris

2969

20286

0.97

0.75

3.4

4.4

15.92

27.02

ug/l

1.74

2459

16763

Other and unspecified injuries of wrist and hand

112

979

1.15

0.74

3.8

4.4

3.30

22.26

ug/l

1.47

783

Primary open-angle glaucoma, strict

1247

12920

0.96

0.74

3.6

3.9

12.50

22.31

ug/l

1.88

1034

10683

Sexual assault by bodily force

1.86

0.74

3.3

4.5

23.77

8.38

ug/l

—

Cerebral aneurysm, nonruptured

304

3287

0.92

0.74

3.5

4.0

17.27

21.02

ug/l

0.20

261

2626

Other superficial mycoses

289

2662

1.09

0.74

3.3

4.2

8.35

30.68

ug/l

1.02

210

2095

Intentional self-harm by unspecified means

202

1.36

0.74

2.4

4.2

3.21

7.19

ug/l

1.17

149

Mental disorders, not otherwise specified

228

2078

1.10

0.74

3.3

4.1

38.48

33.85

ug/l

0.05

174

1612

Sicca syndrome [Sjögren]

353

3283

1.08

0.74

2.8

4.0

11.59

23.52

ug/l

0.82

278

2607

Transient global amnesia

380

4070

0.93

0.74

3.9

4.1

9.36

27.22

ug/l

2.72

314

3331

Psoriatic and enteropathic arthropathies

463

4345

1.07

0.74

3.2

4.4

11.02

23.07

ug/l

1.48

372

3508

Polyglandular dysfunction, other/unspecified

2.07

0.74

2.0

5.0

2.86

9.11

ug/l

—

Need for immunization against other single viral diseases

554

1.21

0.74

4.7

4.5

4.32

18.61

ug/l

0.95

460

Renal agenesis and other reduction defects of kidney

143

1.44

0.73

4.1

5.1

4.06

38.77

ug/l

0.58

113

Melanocytic naevi of scalp and neck

609

1.20

0.73

4.0

4.3

2.93

31.59

ug/l

1.40

500

Distal bite

498

0.79

0.73

2.6

3.9

4.06

16.51

ug/l

0.69

363

Nonischemic cardiomyopathy

417

3899

1.08

0.73

3.7

4.5

9.28

22.75

ug/l

2.25

351

3248

Benign neoplasm: Bladder

328

1.28

0.73

3.7

4.4

3.96

45.98

ug/l

1.10

281

Cholesteatoma of external ear

266

1.32

0.73

3.8

4.5

6.94

55.57

ug/l

0.95

228

Ehlers-Danlos syndrome

194

1.36

0.73

3.3

4.1

2.38

9.21

ug/l

1.47

145

Exposure to smoke, fire and flames

674

0.82

0.73

3.4

4.4

20.64

29.72

ug/l

0.23

555

Placenta praevia

105

915

1.16

0.72

3.6

3.7

28.48

48.37

ug/l

0.18

647

Iliac crest spur

2.04

0.72

3.2

4.7

2.48

8.50

ug/l

—

Primary coxarthrosis, bilateral

1367

14164

0.96

0.72

3.4

4.0

25.94

21.90

ug/l

0.18

1121

11733

Other retinal disorders in diseases classified elsewhere

1.73

0.72

3.3

4.1

3.02

72.14

ug/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

203

1.35

0.72

4.9

4.7

3.01

62.47

ug/l

0.83

160

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

777

1.17

0.72

2.8

4.5

39.03

28.75

ug/l

0.14

642

Mature T/NK-cell lymphomas, hilmo

474

1.23

0.72

2.0

4.4

3.58

38.74

ug/l

1.36

405

Chromomycosis and phaeomycotic abscess

110

1.51

0.72

2.9

4.4

2.56

46.26

ug/l

0.56

Injury of blood vessels at abdomen, lower back and pelvis level

127

1.47

0.72

3.1

4.9

135.68

58.89

ug/l

0.27

112

Behçet disease

1.63

0.72

1.4

4.4

2.40

7.68

ug/l

—

Other osteochondrodysplasias

195

1.36

0.72

4.0

4.9

5.21

6.45

ug/l

0.15

158

Other nonthrombocytopenic purpura

302

1.29

0.72

3.7

4.3

3.68

41.99

ug/l

0.86

255

Sleep apnoea, including avohilmo

4796

30276

0.98

0.71

3.3

4.2

17.53

26.41

ug/l

1.33

3755

24386

Other noninflammatory disorders of cervix uteri

217

1982

1.11

0.71

3.5

4.2

16.68

27.65

ug/l

0.40

162

1592

Childhood asthma (age<16), excluding more controls

174

1231

1.12

0.71

3.3

3.9

4.16

36.82

ug/l

0.52

107

825

Benign neoplasm: Skin of scalp and neck

788

1.17

0.71

3.4

4.4

7.78

28.99

ug/l

1.23

657

Abnormal findings on antenatal screening of mother

108

1233

0.87

0.71

2.9

3.3

3.89

40.95

ug/l

0.56

768

Childhood asthma (age<16)

174

1232

1.12

0.71

3.3

3.9

4.16

36.72

ug/l

0.52

107

827

Allergic colitis

203

1.34

0.71

4.1

3.7

3.49

8.32

ug/l

0.98

144

Disorders of optic nerve and visual pathways

312

2892

1.09

0.71

3.6

4.1

34.18

18.30

ug/l

0.23

250

2297

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

355

1.25

0.70

3.8

3.9

2.85

110.52

ug/l

0.54

255

Pedestrian injured in collision with pedal cycle

105

920

1.15

0.70

2.8

4.3

6.16

23.97

ug/l

1.22

763

Primary gonarthrosis, bilateral

2648

23246

0.97

0.70

3.3

4.1

22.09

23.70

ug/l

0.10

2108

19118

Sequelae of cerebrovascular disease

1708

15196

0.97

0.69

3.1

4.0

20.37

23.26

ug/l

0.18

1406

12618

Purulent endophthalmitis

206

1.35

0.69

4.5

4.0

3.74

64.53

ug/l

0.90

167

Other disorders of pigmentation

170

1536

1.12

0.69

3.7

4.2

8.72

21.14

ug/l

1.24

140

1261

Sequelae of tuberculosis

623

1.19

0.69

3.2

3.8

75.27

32.02

ug/l

0.39

531

Fracture of neck

225

2061

1.10

0.69

3.2

4.1

36.36

24.54

ug/l

0.26

197

1713

Post-traumatic stress disorder

170

1532

1.11

0.69

2.9

3.9

65.12

36.21

ug/l

0.19

120

1101

Other disorders involving the immune mechanism, not elsewhere classified

846

1.16

0.69

3.0

4.4

36.46

27.93

ug/l

0.13

702

Chondromalacia

828

1.16

0.68

3.0

4.5

60.77

16.91

ug/l

0.52

669

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

163

1.40

0.68

4.0

4.6

3.28

69.70

ug/l

0.79

139

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

1.69

0.68

5.0

5.5

4.66

107.03

ug/l

—

Benign lipomatous neoplasm of spermatic cord

1.69

0.68

2.4

4.7

3.43

8.03

ug/l

—

Lesion of plantar nerve

223

2430

0.91

0.68

3.4

4.1

30.91

20.84

ug/l

0.16

185

1938

Cerebral amyloid angiopathy

181

1.38

0.68

2.5

4.2

6.51

65.83

ug/l

0.77

153

Mild mental retardation

512

1.20

0.68

2.4

4.5

160.87

21.73

ug/l

0.51

413

Olecranon bursitis

239

2198

1.10

0.67

3.4

4.9

16.47

32.40

ug/l

0.76

196

1855

Other hypertrichosis

1.63

0.67

1.7

3.9

1.82

6.50

ug/l

—

Congenital malformations of eye, ear, face and neck

155

1393

1.12

0.67

2.8

4.2

10.75

19.80

ug/l

0.54

115

1101

Vitreous haemorrhage

400

3752

1.07

0.67

3.4

4.1

11.21

24.40

ug/l

1.88

335

3066

Disorder of thyroid, unspecified

441

1.23

0.67

3.2

3.8

56.98

18.85

ug/l

0.31

365

Hallux valgus (acquired)

1750

12203

1.03

0.67

3.5

4.2

13.98

29.30

ug/l

2.47

1372

9843

Arthropathies

4174

20715

1.02

0.67

3.6

4.3

13.93

29.44

ug/l

3.55

3254

16505

Assault by blunt object

286

1.28

0.67

4.6

5.0

5.22

29.90

ug/l

0.81

236

Open wound of ankle and foot

339

3161

1.08

0.67

3.7

4.2

14.68

24.64

ug/l

0.61

274

2560

Vertigo of central origin

552

1.20

0.67

2.7

4.1

3.37

33.53

ug/l

1.36

467

Tic disorders

145

1.39

0.67

3.7

4.4

7.40

5.93

ug/l

0.10

113

Rheumatic valve diseases

731

0.84

0.66

3.6

4.0

9.14

28.90

ug/l

0.97

628

Non-allergic asthma

275

2966

0.92

0.66

3.3

4.0

94.08

22.61

ug/l

0.81

232

2416

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

297

1.28

0.66

3.7

4.3

36.03

43.51

ug/l

0.07

248

Asymptomatic human immunodeficiency virus [HIV] infection status

129

0.61

0.66

5.6

6.2

2.10

39.96

ug/l

—

109

Other and unspecified epidermal thickening

803

1.16

0.66

3.2

4.3

11.56

28.09

ug/l

0.77

659

Chorioretinal inflammation

100

878

1.15

0.66

3.1

4.3

50.81

20.64

ug/l

0.63

717

Postpartum care and examination

238

1642

0.91

0.66

3.2

3.1

7.46

10.28

ug/l

0.34

169

1109

Other benign neoplasms of uterus

239

2204

1.10

0.66

3.2

3.7

4.59

12.51

ug/l

4.48

189

1801

Other benign neoplasms of connective and other soft tissue

370

3465

1.07

0.66

3.9

4.0

37.60

22.82

ug/l

0.26

300

2788

Migraine with aura and triptan purchases

436

4101

1.07

0.66

3.3

3.8

4.84

25.97

ug/l

1.60

320

3024

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

314

1.26

0.65

3.0

4.6

2.79

29.16

ug/l

0.98

253

Metatarsalgia

382

3582

1.07

0.65

2.9

4.2

24.57

24.79

ug/l

0.00

287

2851

Reiter disease

164

1.38

0.65

3.0

5.0

7.15

32.60

ug/l

0.49

136

Thromboangiitis obliterans

130

1.44

0.65

2.1

4.9

3.01

43.67

ug/l

0.71

112

Vasomotor rhinitis (mode)

228

2477

0.91

0.65

3.5

4.1

6.90

19.69

ug/l

1.90

175

1994

Mental and behavioural disorders due to cannabinoids

349

0.77

0.65

2.2

5.1

3.03

9.96

ug/l

0.87

267

Meningitis, viral

104

1.49

0.65

5.4

3.9

2.23

70.72

ug/l

—

Other prurigo

361

1.24

0.64

3.2

4.3

8.53

46.94

ug/l

1.02

306

Other early complications of trauma

0.00

0.64

0.0

6.6

—

6.33

—

Autoimmune thyroiditis

479

1.21

0.64

3.6

4.0

44.86

18.39

ug/l

0.37

389

Microscopic polyangiitis

227

1.32

0.64

2.2

4.7

2.90

24.22

ug/l

0.62

192

Other benign neoplasm of uterus: Cervix uteri

191

1.35

0.64

2.1

3.9

4.89

7.53

ug/l

0.33

153

Diabetic retinopathy

1516

9150

1.04

0.64

3.4

3.8

24.65

24.45

ug/l

0.01

1254

7641

Other disorders of electrolyte and fluid balance, not elsewhere classified

298

1.27

0.64

2.5

4.0

113.79

47.41

ug/l

0.25

251

Lichen ruber planus, wide definition including periferal and oral lichen planus

907

9443

0.96

0.64

3.3

4.0

23.73

21.87

ug/l

0.05

710

7636

Other specified/unspecified diseases of inner ear

165

1.38

0.64

2.9

4.1

2.17

49.69

ug/l

0.61

137

Ankle and foot

253

1.29

0.64

2.9

3.9

2.73

22.67

ug/l

0.62

206

Toxic effect of contact with venomous animals

105

1187

0.88

0.64

4.4

4.3

4.12

21.87

ug/l

1.76

968

Injury of nerves at shoulder and upper arm level

325

1.26

0.64

2.7

4.8

16.54

47.97

ug/l

0.62

275

Open bite that required surgery (Lefort1 or BSSO)

153

0.64

1.3

4.4

142.94

5.10

ug/l

—

119

Lichenoid drug reaction

114

1.48

0.64

3.3

4.4

6.86

12.81

ug/l

0.44

Onycholysis

200

1.34

0.64

3.5

4.4

22.59

40.99

ug/l

0.20

165

HSIL lesion of the cervix uteri, vagina or vulva

569

5401

1.06

0.63

3.3

3.6

5.86

25.60

ug/l

1.75

420

3912

Symptoms and signs involving the nervous and musculoskeletal systems

2584

26446

0.97

0.63

2.9

4.0

9.12

24.22

ug/l

8.61

2029

21362

Disorders of olfactory nerve

1.76

0.63

5.2

3.4

35.22

158.25

ug/l

—

Calcification and ossification of muscle

1.57

0.63

1.2

4.8

1.92

101.69

ug/l

—

Short Achilles tendon (acquired)

888

0.86

0.63

4.1

4.4

2.64

31.81

ug/l

2.19

706

Coalworker pneumoconiosis

0.00

0.63

0.0

5.2

—

12.60

—

Urethritis and urethral syndrome

638

1.17

0.63

3.3

4.2

3.06

27.60

ug/l

1.25

518

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1219

11776

1.04

0.63

3.2

4.3

14.72

26.89

ug/l

0.78

991

9460

Glucagon-like peptide-1 (GLP-1) analogues

1219

11776

1.04

0.63

3.2

4.3

14.72

26.89

ug/l

0.78

991

9460

Juvenile osteochondrosis

637

1.17

0.63

2.8

4.2

4.68

14.96

ug/l

0.82

503

Other and unspecified paralytic syndromes

417

1.22

0.62

2.5

4.3

10.20

37.70

ug/l

0.77

346

Other and unspecified acne

235

1.29

0.62

7.9

4.2

4.42

4.93

ug/l

0.15

182

Pulmonary eosinophilia, not elsewhere classified

427

1.22

0.62

2.4

4.2

139.40

43.67

ug/l

0.31

358

Pathological resorption of teeth

114

1014

1.14

0.62

4.0

4.4

3.06

26.56

ug/l

2.06

838

Acute sinusitis

2061

18573

1.03

0.62

3.6

4.0

27.20

23.28

ug/l

0.17

1587

14567

Cardiomyopathy, Hypertrophic obstructive

628

0.83

0.62

3.0

4.8

4.00

26.59

ug/l

1.26

524

Maltreatment syndromes

106

938

1.14

0.61

3.7

4.5

8.92

21.65

ug/l

0.91

710

Disorders of ocular muscles, binocular movement, accommodation and refraction

1706

17402

0.97

0.61

3.5

4.0

14.33

22.64

ug/l

0.73

1311

13746

Amiodarone users

428

4042

1.07

0.61

3.1

4.2

16.30

22.01

ug/l

0.24

340

3375

Profound mental retardation

0.00

0.61

0.0

3.7

—

10.67

—

Iliotibial band syndrome

327

1.25

0.61

3.4

4.7

2.83

8.25

ug/l

2.40

257

Disturbances of smell and taste

165

1502

1.11

0.61

3.8

4.3

11.43

25.31

ug/l

0.90

143

1232

Erosion of teeth , including avohilmo

797

7639

1.05

0.61

3.6

4.1

6.10

28.34

ug/l

3.69

601

5941

Other disorders starting during childhood or adolecense, excluding more controls

372

1.21

0.61

3.0

4.4

2.67

6.43

ug/l

1.64

255

Pedal cyclist injured in noncollision transport accidents

363

3408

1.07

0.60

3.6

4.2

4.14

22.98

ug/l

3.79

293

2733

Galactorrhea

201

1.31

0.60

3.8

4.0

18.85

7.44

ug/l

0.32

153

Seronegative rheumatoid arthritis

477

5033

0.94

0.60

3.2

4.2

13.34

26.49

ug/l

1.61

392

4088

Trichomoniasis

319

1.25

0.60

2.7

3.9

4.42

7.76

ug/l

1.07

269

Pedestrian injured in other and unspecified transport accidents

364

1.23

0.60

3.2

4.1

3.03

37.88

ug/l

0.97

305

Monoplegia

465

1.20

0.60

3.1

4.4

4.55

30.17

ug/l

0.89

392

Acute drug-induced interstitial lung disorder

274

1.27

0.60

2.5

4.2

10.44

52.74

ug/l

0.83

235

Other enthesopathies

1333

12910

1.04

0.60

3.1

4.3

21.22

27.45

ug/l

0.26

1062

10304

Traumatic subarachnoid haemorrhage

150

1360

1.11

0.60

4.2

4.8

5.29

29.47

ug/l

2.83

116

1142

Traumatic amputation of part of head

1.79

0.60

4.0

3.5

7.12

146.74

ug/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

228

1.29

0.59

4.8

4.5

3.06

55.48

ug/l

0.82

181

Cerebral palsy

265

0.75

0.59

1.8

4.4

10.20

8.99

ug/l

—

209

Mental retardation, excluding more controls

759

1.15

0.59

2.4

4.6

111.17

17.09

ug/l

0.51

595

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

132

1168

1.12

0.59

4.4

4.2

12.76

22.38

ug/l

0.46

102

880

Other congenital malformations of face and neck

651

1.16

0.59

2.7

4.3

5.08

26.53

ug/l

1.01

522

Benign neoplasm: Skin of ear and external auricular canal

148

1343

1.11

0.59

3.2

3.9

4.86

20.07

ug/l

1.70

125

1112

Polycystic ovarian syndrome

781

1.14

0.59

2.4

3.4

5.59

63.85

ug/l

0.62

528

Other infections specific to the perinatal period

0.00

0.58

0.0

3.3

—

6.09

—

Rickettsioses

1.61

0.58

6.6

4.6

4.04

113.22

ug/l

—

Ectopic pregnancy

635

6065

1.05

0.58

3.6

3.8

19.76

20.94

ug/l

0.03

473

4546

Supernumerary ureter

1.73

0.58

4.7

4.6

3.25

8.69

ug/l

—

Abnormality of red blood cells

159

1.36

0.58

2.5

4.2

3.23

37.97

ug/l

0.71

131

Anterior Iridocyclitis

794

7623

1.05

0.58

3.6

4.1

77.69

25.90

ug/l

1.02

632

6152

Exposure to sunlight

1.60

0.58

4.8

4.5

4.22

9.14

ug/l

—

Myeloproliferative diseases

342

3214

1.07

0.58

3.0

4.0

13.52

22.11

ug/l

0.51

262

2633

Striking against or struck by other objects

1117

10781

1.04

0.58

3.6

4.2

7.28

27.05

ug/l

5.09

868

8626

Certain zoonotic bacterial diseases

560

1.18

0.58

3.3

4.4

10.45

33.75

ug/l

0.82

477

Respiratory tuberculosis, not confirmed

160

1459

1.11

0.58

3.4

3.9

73.69

21.85

ug/l

0.49

137

1213

Other bursitis of hip

729

1.15

0.57

3.6

4.5

4.77

32.43

ug/l

1.63

588

Peroneal tendinitis

472

0.82

0.57

2.7

4.5

2.97

16.36

ug/l

0.79

367

Impingement syndrome of shoulder

1132

10948

1.04

0.57

3.4

4.4

20.52

29.83

ug/l

0.66

934

8903

Hypermobility syndrome

127

1143

1.12

0.57

3.0

3.8

3.06

43.95

ug/l

0.72

838

Periapical abscess

1909

18607

1.03

0.57

3.9

4.1

19.22

25.73

ug/l

0.58

1551

14901

Muscular dystrophy

231

1.28

0.56

2.1

4.3

28.82

26.01

ug/l

0.04

193

Viral infections of central nervous system, not elsewhere classified/unspecified

317

0.78

0.56

4.6

3.67

29.92

ug/l

0.65

261

Other and unspecified nonorganic psychotic disorders

493

5189

0.95

0.56

3.1

4.2

23.15

23.79

ug/l

0.01

387

4031

Injuries involving multiple body regions

110

984

1.13

0.56

2.5

4.3

3.73

22.86

ug/l

1.53

806

Schizotypal disorder

504

0.83

0.56

3.6

4.6

68.62

20.96

ug/l

0.42

402

Congenital malformations of anterior segment of eye

213

1.29

0.56

4.7

4.5

2.44

27.21

ug/l

0.68

177

Superficial injury of shoulder and upper arm

353

3748

0.94

0.56

2.9

4.1

21.13

20.49

ug/l

0.02

280

3019

Maternal care for known or suspected disproportion

985

0.88

0.56

3.7

3.6

2.70

44.46

ug/l

0.58

692

Haemorrhagic disorder due to circulating anticoagulants

479

1.19

0.56

3.4

3.9

3.14

33.74

ug/l

1.20

408

Other specified and unspecified disorders of conjunctiva

313

1.24

0.56

2.7

4.0

19.03

20.92

ug/l

0.03

263

Alopecia areata

683

1.15

0.56

3.0

4.2

4.16

16.06

ug/l

1.12

543

Congenital hypothyroidism without goiter

125

1.40

0.56

3.9

3.8

4.21

63.20

ug/l

0.53

100

Congenital malformations of heart and great arteries

373

3408

1.06

0.56

3.4

4.2

51.81

22.15

ug/l

0.46

290

2710

Disorders of myoneural junction and muscle in diseases classified elsewhere

268

1.26

0.55

2.7

4.1

3.41

23.14

ug/l

0.69

226

Unspecified hairloss

1.62

0.55

4.8

4.1

3.20

120.92

ug/l

—

Benign intracranial hypertension

142

1.35

0.55

2.4

4.3

10.51

7.97

ug/l

0.11

109

Hypertension, Pulmonary Arterial

268

1.26

0.55

2.1

4.2

38.27

41.15

ug/l

0.03

220

Anogenital herpesviral [herpes simplex] infection

242

2249

1.08

0.55

3.7

4.0

13.21

31.56

ug/l

0.51

179

1676

Ehlers-Danlos syndrome

160

1.33

0.55

3.8

4.2

2.46

8.25

ug/l

1.23

122

Postdysenteric arthropathy

250

1.26

0.54

3.7

4.3

79.81

24.44

ug/l

0.31

208

Post-traumatic wound infection, not elsewhere classified

779

1.14

0.54

2.7

4.4

3.72

26.59

ug/l

1.46

652

Symptoms and signs involving appearance and behaviour

232

1.27

0.54

3.1

4.6

3.32

9.08

ug/l

1.80

187

Stenosis and insufficiency of lacrimal passages

346

3669

0.94

0.54

3.4

3.9

12.55

21.87

ug/l

0.74

284

2958

Burns and corrosions of multiple and unspecified body regions

577

0.84

0.54

4.4

4.5

20.63

23.90

ug/l

0.07

477

Iridocyclitis in diseases classified elsewhere

573

1.17

0.54

3.6

4.4

4.12

32.80

ug/l

1.29

477

Dysplastic lesion of the vagina of unknown severity

1.59

0.54

2.0

4.0

3.83

5.75

ug/l

—

Complications following abortion and ectopic and molar pregnancy

134

1217

1.11

0.54

3.9

3.8

7.33

13.67

ug/l

1.07

107

956

Anisometropia and aniseikonia

104

931

1.13

0.54

3.7

4.1

91.99

24.03

ug/l

0.38

767

Bicuspidal aortic valve syndrome

1002

0.88

0.54

3.9

4.5

3.15

22.02

ug/l

1.60

834

Dronedarone medication

129

1171

1.12

0.54

3.8

4.5

10.54

29.81

ug/l

1.17

105

974

Lumbosacral root disorders, not elsewhere classified

416

1.20

0.54

3.1

4.7

4.67

18.74

ug/l

0.75

345

Rapidly progressive nephritic syndrome

1.53

0.53

6.9

4.3

3.39

7.01

ug/l

0.76

Chalazion

406

3846

1.06

0.53

4.1

9.07

20.24

ug/l

1.19

317

3077

Degenerative and vascular disorders of ear

1.56

0.53

2.3

4.5

12.85

7.72

ug/l

—

Acute and subacute iridocyclitis

747

7181

1.04

0.53

3.6

4.2

80.26

26.64

ug/l

0.99

595

5803

Other injuries of spine and trunk, level unspecified

251

1.26

0.53

3.9

4.3

5.09

53.41

ug/l

0.88

207

Exposure to other specified electric current

490

0.83

0.53

2.8

4.6

10.16

21.75

ug/l

0.43

390

Benign neoplasm: Vagina

426

1.19

0.53

2.7

4.1

14.17

9.50

ug/l

0.21

354

Abscess of Bartholin gland

630

1.15

0.52

3.3

4.1

3.39

9.97

ug/l

2.74

488

Sleep disorders, other/unspecified

771

1.14

0.52

2.7

4.4

3.69

29.08

ug/l

1.34

596

Caught, crushed, jammed or pinched in or between objects

143

1304

1.10

0.52

3.8

4.5

3.31

25.70

ug/l

2.38

108

1066

Glaucoma secondary to other eye disorders

151

1382

1.10

0.52

2.9

3.9

24.26

22.29

ug/l

0.05

120

1149

Family history of other conditions

251

1.25

0.52

3.7

4.1

2.90

26.62

ug/l

0.73

196

Other disorders of patella

650

6235

1.05

0.52

3.8

4.4

13.02

35.80

ug/l

1.72

507

4923

Disorders of sclera, cornea, iris and ciliary body

2403

23525

1.02

0.51

3.6

4.0

33.11

23.44

ug/l

0.45

1908

18876

Endometriosis of fallopian tube

189

1.29

0.51

3.0

4.0

4.49

5.85

ug/l

0.31

151

Inflammatory disorders of male genital organs, not elsewhere classified

362

1.20

0.51

3.4

5.0

21.71

39.92

ug/l

0.32

313

Other disorders of bone density and structure

679

1.14

0.51

2.9

4.4

7.96

15.75

ug/l

0.56

550

Multifocal fibrosclerosis

226

1.27

0.51

1.8

4.1

3.73

38.00

ug/l

0.61

190

Other symptoms and signs involving general sensations and perceptions

139

1269

1.10

0.51

3.3

4.1

5.97

22.11

ug/l

1.67

113

1063

Dilated cardiomyopathy

436

4581

0.95

0.51

3.2

4.3

9.11

24.41

ug/l

3.00

354

3850

Retinal detachment with retinal break

559

5351

1.05

0.51

4.0

4.2

37.46

23.26

ug/l

0.56

441

4455

Amputation of foot

932

0.88

0.50

2.5

4.3

4.85

27.01

ug/l

1.69

785

244

1.26

0.50

2.5

4.1

5.30

52.90

ug/l

0.88

209

Thyrotoxicosis with diffuse goitre

545

5213

1.05

0.50

3.3

3.9

14.09

26.64

ug/l

0.81

419

4085

Open wound of wrist and hand

1715

16345

1.03

0.50

3.8

4.3

11.17

28.70

ug/l

4.20

1384

13130

Personality and behavioural disorders due to brain disease, damage and dysfunction

474

0.83

0.50

3.1

4.4

3.37

39.66

ug/l

1.39

397

Congenital malformations of the respiratory system

511

1.17

0.50

2.9

4.1

11.01

29.04

ug/l

0.54

424

Peripheral retinal degeneration

112

1013

1.12

0.50

2.8

4.0

38.59

16.03

ug/l

0.28

833

Vaginal lichen planus

199

0.73

0.50

2.9

4.0

2.57

7.85

ug/l

—

164

Complications of the puerperium, not elsewhere classified

775

0.87

0.50

3.4

3.8

7.99

62.73

ug/l

0.59

545

Other dialysis

101

909

1.12

0.49

1.9

4.5

4.57

27.62

ug/l

1.72

760

Other enthesopathy of foot (+metatarsalgia)

404

3839

1.06

0.49

2.8

4.2

23.69

34.57

ug/l

0.25

302

3047

Carcinoma in situ of skin, other sites/unspecified

542

1.16

0.49

2.9

3.8

3.27

31.18

ug/l

1.24

458

Other acquired deformities of ankle and foot

277

0.78

0.49

3.7

4.4

4.09

36.00

ug/l

0.73

234

Mental retardation

789

1.13

0.49

2.4

4.4

111.17

16.87

ug/l

0.51

625

Recurrent and persistent haematuria

245

1.25

0.49

2.6

4.2

3.25

9.19

ug/l

1.81

200

Achilles tendinitis

380

4002

0.95

0.49

3.3

4.5

6.81

30.27

ug/l

3.28

301

3248

Trichomoniasis

310

1.22

0.49

2.8

4.0

4.52

7.90

ug/l

1.05

263

Amputation

416

3957

1.06

0.49

2.8

4.1

6.92

19.64

ug/l

2.87

355

3299

Other/unspecified synovitis and tenosynovitis

454

4329

1.05

0.49

3.5

4.3

37.23

34.70

ug/l

0.03

357

3483

Amputation of ankle bones

750

0.87

0.49

2.2

4.5

4.72

32.48

ug/l

1.72

631

Kyphosis

439

1.18

0.49

3.6

4.3

11.18

34.84

ug/l

0.63

357

Injury of nerves and spinal cord at neck level

702

1.14

0.48

4.1

4.6

3.07

30.02

ug/l

1.60

589

Thyrotropin deficiency

288

0.79

0.48

3.1

3.9

103.18

23.00

ug/l

0.35

233

Irregular menses

1746

13453

1.03

0.48

3.2

3.8

20.52

21.50

ug/l

0.04

1300

10062

Other specified disorders of muscle

102

920

1.12

0.48

3.4

4.4

9.32

29.49

ug/l

1.20

747

Sudden idiopathic hearing loss

415

3951

1.06

0.48

3.7

4.1

6.08

22.42

ug/l

4.54

335

3218

Migraine without aura and triptan purchases

396

4168

0.95

0.48

3.0

3.8

8.74

27.00

ug/l

1.22

273

3059

Burn and corrosion of ankle and foot

386

0.82

0.48

3.1

4.7

15.26

25.64

ug/l

0.29

321

Hypersomnia

386

0.82

0.48

3.6

4.4

5.67

37.03

ug/l

0.83

309

Toxic effect of carbon monoxide

514

1.16

0.48

2.7

4.6

13.66

33.79

ug/l

0.57

430

Contact with machinery

384

3648

1.06

0.48

4.2

4.6

32.37

26.17

ug/l

0.11

318

3078

Sequelae of injuries of upper limb

332

3141

1.06

0.48

3.7

4.3

15.59

23.99

ug/l

0.47

264

2540

Other bullous disorders

883

1.12

0.48

3.4

4.3

6.78

24.87

ug/l

1.07

727

Emotional disorders starting during childhood or adolecense, excluding more controls

314

0.81

0.48

3.8

2.97

4.65

ug/l

0.45

200

Respiratory disorders in diseases classified elsewhere

459

1.17

0.47

2.3

4.1

9.08

30.70

ug/l

0.64

387

Major coronary heart disease event

4408

26198

1.02

0.47

3.4

4.2

17.60

28.55

ug/l

1.96

3568

21252

Other specified and unspecified disorders of eyelid

478

1.17

0.47

4.1

4.4

3.46

33.15

ug/l

1.14

402

Benign neoplasm: Larynx

115

1046

1.11

0.47

3.4

4.3

12.88

25.67

ug/l

0.54

877

Left ventricular outflow tract obstruction (LVOTO), broad definition

320

3026

1.06

0.47

3.7

4.5

36.17

19.43

ug/l

0.29

247

2483

Guillain-Barre syndrome

503

0.84

0.47

2.7

4.4

78.22

29.08

ug/l

0.35

428

Glaucoma, exfoliation

510

4884

1.05

0.47

3.6

3.7

32.25

27.89

ug/l

0.08

433

4027

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

301

1.21

0.47

2.9

4.1

13.97

8.12

ug/l

0.32

234

Mandibular retrognathia

127

1385

0.91

0.46

4.1

14.85

17.75

ug/l

0.12

100

1046

Mental retardation, wide definition

887

1.12

0.46

2.8

4.3

98.97

15.68

ug/l

0.51

714

Cleft lip, lip and palate or palate

265

0.79

0.46

2.8

4.4

141.99

23.81

ug/l

0.38

210

Eccrine sweat disorders

1.50

0.46

4.2

4.4

2.72

64.02

ug/l

—

Infections of breast associated with childbirth

703

1.13

0.46

3.8

3.9

6.07

15.51

ug/l

0.66

505

Dialysis

124

1133

1.10

0.46

2.0

4.3

5.01

22.47

ug/l

1.65

105

942

Other and unspecified injuries of shoulder and upper arm

100

904

1.12

0.46

2.6

4.3

15.20

28.82

ug/l

0.54

743

Unspecified visual impairment (binocular)

460

1.17

0.46

2.5

4.0

4.91

22.66

ug/l

1.01

386

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

149

1373

1.09

0.46

3.0

4.5

7.78

27.91

ug/l

1.67

118

1089

Hypopituitarism

189

1757

1.08

0.46

3.2

4.6

38.55

19.91

ug/l

0.32

141

1431

Sleep apnoea

4581

30073

0.98

0.46

3.3

4.2

19.41

26.20

ug/l

0.80

3600

24246

Keratopathy (bullous aphakic) following cataract surgery

1.74

0.46

4.0

8.48

7.81

ug/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

497

4755

1.05

0.46

3.8

3.9

11.69

25.39

ug/l

0.88

366

3491

Short stature, not elsewhere classified

1.37

0.46

3.4

1.49

3.12

ug/l

—

Exclusion endpoint for supernumerary teeth

183

1.27

0.45

3.0

4.3

124.16

34.14

ug/l

0.32

143

Macular pucker

750

7247

1.04

0.45

4.0

4.1

10.50

24.52

ug/l

2.64

613

6027

Male infertility

732

1.13

0.45

5.8

5.3

49.94

14.50

ug/l

0.35

601

Venous complications and haemorrhoids in the puerperium

318

0.81

0.45

4.7

3.8

3.45

9.27

ug/l

1.81

250

Miliary tuberculosis

1.52

0.45

1.5

3.3

2.40

6.23

ug/l

—

Other lesions of median nerve

109

992

1.11

0.45

2.7

4.2

21.53

27.05

ug/l

0.11

818

Myositis

858

1.12

0.45

2.7

4.4

28.06

27.93

ug/l

0.00

701

Iron deficiency

469

1.16

0.45

3.3

4.0

3.63

37.06

ug/l

1.07

346

Autism spe

210

1.24

0.45

2.2

4.5

2.71

6.84

ug/l

1.04

151

Autism

210

1.24

0.45

2.2

4.5

2.71

6.79

ug/l

1.03

152

Neovascular glaucoma

147

1356

1.09

0.45

2.9

4.0

24.59

21.93

ug/l

0.07

118

1136

Congenital malformations of the nervous system

373

0.83

0.45

2.4

4.2

3.36

20.36

ug/l

0.79

290

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1135

11035

1.03

0.45

3.4

4.2

12.54

28.17

ug/l

2.34

900

8941

Maternal care for known or suspected fetal abnormality and damage

352

2872

1.06

0.45

3.6

3.5

7.93

21.42

ug/l

0.49

212

1941

Disorders of tooth development and eruption

517

4366

0.96

0.45

3.7

4.2

19.43

19.42

ug/l

0.00

406

3420

Congenital deformities of hip

302

1.20

0.45

5.6

3.9

2.72

7.01

ug/l

1.70

236

Contact with heat and hot substances

130

1416

0.91

0.45

4.3

4.2

4.04

22.47

ug/l

2.25

114

1148

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

867

1.11

0.45

3.2

4.4

7.44

13.99

ug/l

0.48

662

Golimumab

791

1.12

0.44

3.2

4.4

183.46

18.88

ug/l

0.43

617

Vascular dementia (undefined)

135

1452

0.91

0.44

2.3

3.5

22.78

30.19

ug/l

0.15

106

1249

Overexertion and strenuous or repetitive movements

319

3023

1.06

0.44

3.5

4.3

7.51

22.04

ug/l

2.64

244

2449

Primary open-angle glaucoma

1566

15492

0.97

0.44

3.7

3.9

18.79

22.58

ug/l

0.21

1302

12854

Contracture of muscle

131

1.33

0.44

1.9

5.3

2.49

27.86

ug/l

—

108

Benign neoplasm: Hypopharynx

158

1.30

0.44

3.6

4.8

14.30

86.06

ug/l

0.82

138

Wide developmental disorders, excluding more controls

243

1.22

0.44

2.1

4.7

2.50

35.54

ug/l

0.54

181

Eustachian salpingitis and obstruction

180

1675

1.08

0.43

3.8

4.1

8.04

41.71

ug/l

0.91

122

1269

Secondary parkinsonism

963

0.89

0.43

2.3

4.2

3.76

28.12

ug/l

2.06

812

Schizoid personality disorder

467

0.85

0.43

2.7

4.9

19.72

28.57

ug/l

0.19

378

Excessive attrition of teeth

2168

22110

0.98

0.43

3.7

4.1

30.52

23.20

ug/l

0.19

1687

17444

Desensitization to allergens

892

0.89

0.43

4.8

4.2

3.47

18.27

ug/l

1.26

660

Benign neoplasm: Vulva

690

1.13

0.43

3.7

3.8

2.98

10.33

ug/l

3.56

555

Phantom limb syndrome

1.44

0.43

5.5

5.3

2.39

56.74

ug/l

0.54

Hypersensitivity angiitis

177

1.28

0.43

2.3

4.6

3.90

69.31

ug/l

0.87

151

Tuberculosis of other organs, strict

843

1.11

0.42

3.2

3.7

49.12

27.64

ug/l

0.22

702

Intentional self-harm by sharp object

369

1.17

0.42

2.4

4.4

7.87

19.19

ug/l

0.42

283

Superficial injuries involving multiple body regions

671

1.13

0.42

2.4

4.4

3.98

26.94

ug/l

1.20

562

Other and unspecified injuries of abdomen, lower back and pelvis

398

1.17

0.42

1.3

4.4

4.20

41.26

ug/l

1.11

331

Benign neoplasm: Parathyroid gland

399

1.17

0.42

3.8

4.3

6.27

17.36

ug/l

0.53

334

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

748

1.12

0.42

3.7

4.3

35.73

28.16

ug/l

0.10

627

Disturbance of activity and attention

143

1293

1.09

0.42

2.8

3.9

2.19

41.12

ug/l

0.68

848

Injury of urinary and pelvic organs

596

1.14

0.42

5.0

4.6

38.20

33.06

ug/l

0.05

498

Female infertility, associated with anovulation

134

1234

1.09

0.42

3.0

3.9

7.27

45.10

ug/l

0.63

839

Thyroiditis, unspecified

455

1.16

0.42

2.2

3.9

2.59

18.66

ug/l

1.01

363

Other contact dermatitis

277

2622

1.06

0.41

3.5

4.0

88.57

19.46

ug/l

0.52

226

2073

Recurrent dislocation of patella

107

976

1.10

0.41

3.2

4.2

3.76

48.83

ug/l

0.66

718

Spondylopathies (FG)

478

4586

1.05

0.41

3.3

4.4

108.52

30.35

ug/l

0.87

370

3647

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

235

2213

1.07

0.41

4.3

3.7

59.63

34.56

ug/l

0.24

179

1643

Juvenile arthritis (FINNGEN)

868

0.89

0.41

3.9

4.4

7.55

31.40

ug/l

1.24

653

Central nervous system disorder causing precocious puberty

0.00

0.41

0.0

2.7

—

1.78

—

Hereditary motor and sensory neuropathy

270

0.80

0.41

3.2

4.5

9.76

23.13

ug/l

0.38

227

Glaucoma secondary to eye inflammation

270

0.80

0.41

2.5

4.5

2.56

8.95

ug/l

2.52

222

Other corneal oedema

307

1.20

0.41

3.1

4.1

3.59

43.10

ug/l

0.94

265

Infections with a predominantly sexual mode of transmission

1112

10082

1.03

0.40

3.6

3.9

19.38

21.89

ug/l

0.10

831

7543

Normotensive glaucoma

368

3850

0.95

0.40

3.6

3.9

7.10

24.09

ug/l

3.68

299

3159

Hypermetropia

178

1902

0.93

0.40

3.9

4.0

2.83

18.47

ug/l

2.77

137

1526

Other obstetric trauma

112

1026

1.10

0.40

3.9

3.8

13.72

42.78

ug/l

0.37

717

Congenital malformations of the musculoskeletal system, not elsewhere classified

334

1.18

0.40

2.7

4.0

2.63

21.62

ug/l

0.75

257

Guttate psoriasis

372

1.17

0.40

4.0

4.4

3.22

18.49

ug/l

0.73

305

Other fall from one level to another

758

7339

1.03

0.40

3.6

4.2

19.22

26.45

ug/l

0.33

628

5955

Other abnormal auditory perceptions

307

1.19

0.40

3.4

4.3

8.44

21.02

ug/l

0.39

252

Chronic myeloproliferative disease

494

0.86

0.40

3.6

4.2

3.09

39.36

ug/l

1.47

415

Rheumatic fever incl heart disease

1000

0.90

0.40

3.3

4.1

7.38

27.79

ug/l

1.49

846

Other and unspecified hydrocephalus

590

0.87

0.40

3.8

4.55

29.26

ug/l

1.15

493

Specific development disorders of speech and language

110

970

1.10

0.40

4.0

4.2

5.22

24.24

ug/l

1.37

764

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

760

1.11

0.40

2.7

4.4

3.65

25.54

ug/l

1.29

621

Other facial nerve disorders

874

0.90

0.40

4.2

4.3

3.71

25.25

ug/l

1.51

712

Carpal tunnel syndrome

2924

26174

0.98

0.39

3.4

4.1

15.05

24.35

ug/l

1.54

2380

20906

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

235

2218

1.06

0.39

4.3

3.7

59.63

33.48

ug/l

0.26

179

1631

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

1.43

0.39

5.6

4.0

1.50

3.10

ug/l

—

Parapsoriasis

571

1.13

0.39

2.4

4.3

109.80

31.62

ug/l

0.39

478

Viral encephalitis, not elsewhere classified/unspecified

609

1.13

0.39

3.3

4.4

3.93

30.21

ug/l

1.28

515

Assault by unspecified means

391

1.16

0.39

3.5

4.7

4.94

18.92

ug/l

0.67

313

Acute laryngitis and tracheitis

250

2324

1.06

0.39

3.0

4.1

9.80

33.31

ug/l

0.86

183

1752

Tularaemia

392

1.16

0.39

2.8

4.5

3.95

41.53

ug/l

1.15

334

Complications following myocardial infarction

279

0.81

0.39

3.0

4.6

8.42

45.02

ug/l

0.77

230

Disorders of psychological development

192

1668

1.07

0.39

3.2

4.1

51.14

20.63

ug/l

0.29

139

1232

Embedded and impacted teeth

458

3938

0.96

0.39

3.7

3.9

3.81

25.10

ug/l

1.55

336

2839

Disorders of synovium and tendon in diseases classified elsewhere

676

1.12

0.39

2.8

4.7

8.80

33.24

ug/l

1.12

550

Lateral epicondylitis

488

5072

0.96

0.39

3.3

4.5

10.37

33.72

ug/l

2.06

405

4059

Secondary parkinsonism+Parkinsonism in other disease

987

0.90

0.39

2.5

4.2

3.78

27.21

ug/l

2.02

833

Hydatidiform mole

317

1.18

0.39

2.9

4.0

3.58

11.46

ug/l

1.39

242

Hyperfunction of pituitary gland

131

1212

1.09

0.39

3.9

4.0

76.17

25.41

ug/l

0.38

106

949

Wegener granulomatosis

493

0.86

0.39

3.0

4.1

9.00

36.87

ug/l

0.90

416

Mixed conductive and sensorineural hearing loss

528

5090

1.04

0.38

3.5

4.0

22.02

31.13

ug/l

0.41

420

4172

Open bite

832

0.90

0.38

2.6

4.2

20.07

22.67

ug/l

0.05

607

Sequelae of injuries of neck and trunk

877

1.10

0.38

2.6

4.4

47.17

26.54

ug/l

0.19

726

Chronic sinusitis

1801

18350

0.98

0.38

3.3

4.1

40.47

24.82

ug/l

0.62

1368

14661

Dependence on enabling machines and devices, not elsewhere classified

299

0.82

0.38

1.9

4.6

108.69

34.17

ug/l

0.32

253

Injury of muscle and tendon at wrist and hand level

439

4570

0.96

0.38

4.1

4.4

28.22

27.34

ug/l

0.01

353

3733

Other retinal artery occlusion

821

1.11

0.38

3.8

4.3

11.87

17.72

ug/l

0.31

697

Tooth agenesis EXCLUDE clefts and syndromes

448

1.14

0.38

3.9

4.0

7.47

18.49

ug/l

0.46

325

Use of biperiden

156

1670

0.93

0.38

2.4

4.3

10.54

20.16

ug/l

0.81

130

1372

Torsion of testis

234

1.20

0.37

5.4

5.7

3.04

34.73

ug/l

0.56

194

Schizoaffective disorder

194

2062

0.94

0.37

2.6

4.2

9.99

21.18

ug/l

1.11

167

1624

Myocardial infarction, without ST-elevation

2020

18073

1.02

0.37

3.3

4.0

8.32

27.71

ug/l

10.94

1672

15125

Phantom limb syndrome with pain

1.29

0.37

3.9

3.6

2.53

162.67

ug/l

—

Embolic stroke

167

1780

0.93

0.37

3.2

4.0

19.04

28.34

ug/l

0.40

137

1492

Disorders of optic nerve, not elsewhere classified

717

1.11

0.37

3.1

4.2

4.12

28.72

ug/l

1.46

608

Psoriatic arthropathies

370

3862

0.95

0.37

3.2

4.4

12.50

32.09

ug/l

1.68

306

3150

Otorrhoea

0.61

0.37

8.4

4.2

2.44

12.07

ug/l

—

Disorders in reading

134

1.28

0.37

3.2

4.1

2.46

7.54

ug/l

—

Glaucoma-related operations

220

2325

0.94

0.37

3.6

3.9

15.72

18.14

ug/l

0.10

182

1914

Tarsal tunnel syndrome

357

1.17

0.37

3.7

3.9

2.55

28.78

ug/l

0.77

294

Other demyelinating diseases of the central nervous system

839

0.90

0.37

3.2

4.4

6.10

18.40

ug/l

0.90

645

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

935

9603

0.97

0.37

3.5

4.1

10.82

25.16

ug/l

1.72

727

7541

Intermittent heterotropia

127

1175

1.08

0.37

3.0

4.2

7.09

23.99

ug/l

1.26

918

Other and unspecified injuries of thorax

498

1.14

0.37

3.0

4.4

9.36

29.66

ug/l

0.62

415

Sequelae of other and unspecified infectious and parasitic diseases

159

1487

1.07

0.36

3.9

4.3

9.84

23.16

ug/l

1.05

128

1189

Melanocytic naevi of eyelid, including canthus

301

1.18

0.36

3.6

4.0

3.78

21.22

ug/l

0.65

246

Sub-endpoint used in defining T1D endpoints

1003

10121

0.97

0.36

3.5

4.0

26.67

24.62

ug/l

0.06

854

8156

Mandibular prognathia

299

0.83

0.36

3.0

4.1

2.79

31.90

ug/l

1.00

232

Trochanteric bursitis

646

6259

1.04

0.36

2.9

4.1

5.29

29.17

ug/l

3.46

490

4996

Ganglion

797

8201

0.97

0.36

3.5

4.3

9.23

27.70

ug/l

2.46

628

6456

Migraine without aura

542

5614

0.96

0.36

2.8

4.0

7.23

26.50

ug/l

1.86

389

4168

Other articular cartilage disorders

804

1.10

0.36

3.7

4.7

64.81

26.40

ug/l

0.28

669

Obstructed labour due to maternal pelvic abnormality

571

5905

0.96

0.36

4.0

3.8

8.25

26.56

ug/l

1.72

448

4574

Cardiac arrest

252

2044

1.06

0.36

3.4

4.6

5.64

22.42

ug/l

2.66

218

1695

Contact with sharp glass

838

0.90

0.36

3.9

4.4

35.78

30.64

ug/l

0.06

670

Injury of nerves at forearm level

329

1.17

0.36

3.8

5.1

8.07

28.58

ug/l

0.70

265

Postzoster neuralgia

547

1.13

0.36

2.5

4.0

4.74

35.14

ug/l

1.31

459

Toxoplasmosis

172

1.25

0.36

1.5

4.2

2.20

33.43

ug/l

0.71

146

Melanoma in situ of other and unspecified parts of face

472

1.14

0.36

3.7

4.2

4.23

32.28

ug/l

1.05

402

Drug-induced tremor

209

1.22

0.36

1.5

4.1

3.26

26.78

ug/l

0.58

166

Acute epiglottitis

426

0.86

0.36

4.7

4.57

31.29

ug/l

0.82

355

Amoebiasis

211

0.79

0.35

3.6

4.2

3.43

41.55

ug/l

0.62

174

Other and unspecified disorders of vitreous body

2115

20505

1.02

0.35

3.7

4.1

14.45

23.88

ug/l

1.64

1677

16713

Lichen planus, including avohilmo

781

8032

0.97

0.35

3.3

4.0

26.76

22.57

ug/l

0.11

613

6528

Spondylolisthesis/Spondylolysis

769

7910

0.97

0.35

3.0

4.3

6.92

28.20

ug/l

3.81

635

6383

Episcleritis

146

1561

0.93

0.35

3.7

4.1

8.29

21.74

ug/l

1.08

114

1251

Psoriasis vulgaris

718

6973

1.03

0.35

3.7

4.3

37.58

23.44

ug/l

0.46

597

5683

Failed induction of labour

868

0.91

0.35

3.4

3.5

2.04

51.43

ug/l

0.57

581

Papulosquamous disorders

1741

17091

1.02

0.35

3.4

4.1

29.56

24.20

ug/l

0.24

1401

13815

Separation of retinal layers (serosa)

138

1288

1.08

0.35

3.9

4.3

7.21

17.20

ug/l

1.28

108

1050

Other sexually transmitted chlamydial diseases

106

1149

0.92

0.35

3.8

4.0

11.11

48.98

ug/l

0.56

768

Airway disease due to specific organic dust

0.66

0.35

8.0

4.4

2.87

90.46

ug/l

—

Other puerperal infections

122

1314

0.93

0.35

3.2

3.4

5.94

40.81

ug/l

0.63

896

Use of antiglaucoma preparations and miotics

319

3332

0.95

0.34

3.5

3.8

21.84

27.43

ug/l

0.19

261

2762

Mixed connective tissue disease

223

2115

1.06

0.34

3.0

4.1

3.11

21.22

ug/l

3.46

174

1693

Tuberculosis of other organs

740

1.11

0.34

2.9

3.8

11.94

29.38

ug/l

0.63

621

Carcinoma in situ of prostate

209

0.80

0.34

5.1

4.7

11.40

26.64

ug/l

0.33

174

Effects of other external causes

586

1.12

0.34

3.2

4.6

9.22

21.69

ug/l

0.64

472

Causalgia

477

0.87

0.34

3.9

4.4

2.89

23.65

ug/l

1.23

378

Presbyopia

206

2175

0.94

0.34

3.7

4.2

62.12

21.09

ug/l

0.44

160

1743

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

586

1.11

0.34

3.8

4.3

13.53

15.00

ug/l

0.04

446

Mouth breathing

1595

16233

0.98

0.34

3.6

4.2

17.03

26.39

ug/l

1.10

1245

13162

Neurofibromatosis, type 1

155

1.24

0.33

1.4

4.0

2.54

38.15

ug/l

0.66

121

Keratitis

1447

14187

1.02

0.33

3.6

4.0

19.59

23.06

ug/l

0.15

1158

11397

Chromosomal abnormalities, not elsewhere classified

274

1.17

0.33

3.2

4.5

2.31

22.68

ug/l

0.66

210

Hereditary retinal dystrophy

402

0.86

0.33

2.5

4.1

11.44

17.65

ug/l

0.19

338

Focal brain injury

228

2398

0.95

0.33

3.2

4.8

7.37

22.73

ug/l

2.80

181

2000

Epiphora

761

1.10

0.33

3.7

4.2

6.18

23.80

ug/l

0.99

628

Spinal enthesopathy

102

941

1.09

0.33

3.0

3.7

21.84

20.79

ug/l

0.03

788

Excessive vomiting in pregnancy

218

2068

1.06

0.33

3.1

3.7

15.47

33.24

ug/l

0.40

140

1527

Oral lichen planus

100

925

1.09

0.33

3.0

4.3

3.58

16.83

ug/l

1.71

750

Measles

229

1.19

0.33

3.8

4.4

5.33

13.65

ug/l

0.57

174

Graves ophthalmopathy

748

0.90

0.33

2.8

4.0

10.99

21.15

ug/l

0.54

598

Other benign neoplasm of uterus: Corpus uteri

286

1.17

0.33

4.8

3.8

2.74

7.36

ug/l

1.85

238

Benign neoplasm: Uterine tubes and ligaments

230

1.20

0.33

3.7

3.9

6.08

8.23

ug/l

0.25

190

Acute nephritic syndrome

627

1.11

0.33

3.8

4.5

23.93

25.41

ug/l

0.03

530

Primary angle-closure glaucoma

184

1741

1.06

0.32

3.3

3.9

12.34

20.83

ug/l

0.53

149

1437

Other sleep disorders

421

4060

1.04

0.32

3.3

4.4

28.97

23.86

ug/l

0.10

350

3327

Other congenital malformations of ear

137

1.25

0.32

1.5

4.3

50.75

4.65

ug/l

0.43

100

Convergent concomitant strabismus

141

1321

1.07

0.32

3.4

4.2

5.10

18.85

ug/l

1.79

114

1024

Nezelof syndrome

138

1.26

0.32

6.1

4.2

3.19

58.79

ug/l

0.58

114

Fourth [trochlear] nerve palsy

753

1.10

0.32

3.6

4.3

6.68

28.09

ug/l

1.22

641

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

100

0.68

0.32

4.9

5.0

2.84

50.96

ug/l

—

Contact with nonpowered hand tool

111

1193

0.93

0.32

4.1

4.5

5.61

23.22

ug/l

1.62

990

Tinnitus

1020

9973

1.03

0.32

3.5

4.2

10.00

29.05

ug/l

3.54

794

8102

IgA nephropathy (IgA glomerulonephritis)

667

1.10

0.31

2.8

4.6

18.74

27.95

ug/l

0.21

553

Thrombotic microangiopathy

175

1.22

0.31

3.0

4.5

3.11

73.94

ug/l

0.91

144

Anoxic brain damage

431

0.87

0.31

2.9

4.7

15.33

36.46

ug/l

0.49

360

Injuries to the ankle and foot

2745

24725

0.99

0.31

3.5

4.1

14.46

24.51

ug/l

1.65

2129

19473

Cytomegaloviral pneumonitis

1.31

0.31

3.4

5.2

2.44

7.82

ug/l

—

Hyperkinetic disorders

149

1370

1.07

0.31

2.8

3.9

2.18

42.66

ug/l

0.78

906

Macular cyst

121

1132

1.08

0.31

3.5

4.3

3.50

16.52

ug/l

2.30

943

Rubella [German measles]

860

1.09

0.31

5.1

4.9

29.20

13.21

ug/l

0.29

718

Leukaemia of unspecified cell type

297

1.16

0.31

4.1

4.4

3.67

59.43

ug/l

1.29

246

Abnormal involuntary movements

481

4968

0.97

0.31

2.9

4.1

5.92

31.16

ug/l

2.95

394

4034

Nasal polyp

767

7867

0.97

0.31

3.7

4.3

41.52

24.94

ug/l

0.39

624

6510

Congenital malformations of the musculoskeletal system, not elsewhere classified

287

1.16

0.30

3.0

4.2

2.70

8.47

ug/l

1.93

226

Other disorders of binocular movement

486

1.12

0.30

3.6

4.2

7.71

31.40

ug/l

0.75

390

Graves disease, strict definition

332

3192

1.04

0.30

3.0

4.0

13.46

32.23

ug/l

0.82

246

2464

Cerebral oedema

1.28

0.30

4.3

4.5

7.67

9.35

ug/l

—

Acute and transient psychotic disorders

340

3534

0.96

0.30

3.1

4.2

5.59

31.19

ug/l

1.85

270

2803

Excessive earwax

2564

25353

0.99

0.30

3.7

4.0

9.44

26.52

ug/l

6.40

2005

20775

Bipolar affective disorders

560

5436

1.03

0.30

3.0

4.2

7.53

27.33

ug/l

2.08

447

4192

Ischaemic heart disease, wide definition

4076

24967

1.01

0.30

3.5

4.3

20.34

26.88

ug/l

0.59

3341

20365

Asymmetry of jaw

292

0.85

0.30

3.4

4.3

3.31

22.31

ug/l

0.68

232

Donors of organs and tissues

269

1.16

0.30

2.8

3.9

122.97

4.98

ug/l

0.48

215

Enthesopathies of lower limb, excluding foot

916

8956

1.02

0.29

3.3

4.3

13.92

28.21

ug/l

0.85

720

7104

Status epilepticus

127

1192

1.07

0.29

3.1

4.4

10.59

23.87

ug/l

0.86

100

990

Allergic contact dermatitis

477

4622

1.03

0.29

3.1

3.9

18.22

27.56

ug/l

0.41

371

3581

Persistent delusional disorders

247

2581

0.95

0.29

3.2

4.1

53.30

17.47

ug/l

0.55

203

2097

Motorcycle rider injured in other and unspecified transport accidents

109

1167

0.93

0.29

3.8

4.7

35.61

24.69

ug/l

0.14

943

Benign neoplasm: Cranial nerves

106

990

1.08

0.29

3.9

4.3

14.93

23.94

ug/l

0.33

823

Type 1 diabetes, wide definition

705

6864

1.03

0.29

3.6

4.2

24.35

29.18

ug/l

0.13

596

5426

Allergic purpura

767

1.09

0.28

4.5

4.2

6.78

22.31

ug/l

0.83

624

Other and unspecified mononeuropathies, also in other diseases

106

990

1.08

0.28

3.8

4.4

8.93

26.90

ug/l

1.17

810

Manic episode

767

1.09

0.28

3.0

4.6

17.21

27.08

ug/l

0.23

618

Carcinoma in situ of other and unspecified genital organs

585

1.10

0.28

3.2

3.8

3.18

9.96

ug/l

3.15

466

Other and unspecified bullous disorders

337

1.14

0.28

3.3

4.1

13.61

32.75

ug/l

0.39

281

Other and unspecified pemphigoid

328

1.15

0.28

3.9

4.3

4.86

41.09

ug/l

0.91

282

Disorders of speech understanding and production

809

1.08

0.28

3.9

5.83

27.02

ug/l

1.26

649

Spasmodic torticollis

104

971

1.08

0.28

4.1

8.98

24.37

ug/l

0.97

785

Postprocedural disorders of nervous system

164

1731

0.94

0.28

3.0

4.1

3.03

37.92

ug/l

1.04

119

1309

Other disorders starting during childhood or adolescence

417

1.12

0.28

3.0

3.7

2.67

6.32

ug/l

1.74

272

Use of pramipexole

1006

9855

1.02

0.28

3.2

4.0

8.93

23.89

ug/l

3.16

804

8066

Corneal degeneration

563

0.90

0.28

4.1

3.79

32.11

ug/l

1.26

473

Brachial plexus disorders

272

2834

0.96

0.28

3.4

4.2

4.62

30.54

ug/l

1.40

215

2191

Nail dystrophy

196

1.19

0.28

3.6

4.6

15.92

27.61

ug/l

0.19

165

Schizophrenia or delusion, excluding more controls

1027

10377

0.98

0.28

3.1

4.2

22.43

25.09

ug/l

0.11

833

8182

Disorders of lacrimal system and orbit in diseases classified elsewhere

740

0.91

0.28

2.8

4.2

10.99

21.92

ug/l

0.58

592

Other diseases caused by chlamydiae

337

1.14

0.28

3.2

3.7

2.80

7.96

ug/l

2.21

260

Other and unspecified intracranial injuries

875

1.08

0.28

3.2

4.3

5.42

27.42

ug/l

1.60

733

Other strabismus

681

6957

0.97

0.27

3.4

4.0

5.94

28.12

ug/l

3.34

522

5465

Kissing spine

0.67

0.27

4.0

5.0

1.62

64.79

ug/l

—

All dysplastic lesions of the vagina

769

1.09

0.27

3.9

3.8

3.12

14.82

ug/l

1.24

604

Patellar tendinitis

332

0.87

0.27

2.6

5.3

2.19

40.81

ug/l

0.93

267

Dislocation, sprain and strain of joints and ligaments of head

104

972

1.07

0.27

3.6

4.4

11.68

26.77

ug/l

0.74

755

677

0.91

0.27

2.6

4.4

7.90

18.11

ug/l

0.60

536

Contact with other hot fluids

729

0.91

0.27

4.9

4.5

4.23

26.00

ug/l

1.19

593

Livedoid vasculitis

132

1.24

0.27

4.8

4.1

2.37

42.34

ug/l

—

112

Congenital ichthyosis

0.69

0.27

1.6

4.7

2.36

11.04

ug/l

—

HSIL lesion of the vulva

520

1.11

0.27

3.4

3.6

3.87

9.40

ug/l

2.47

412

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

547

1.10

0.27

3.1

4.0

2.72

5.80

ug/l

2.12

380

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

263

1.16

0.26

3.8

4.7

20.50

25.72

ug/l

0.09

214

Diabetic maculopathy, excluding more controls

379

3667

1.04

0.26

3.6

4.3

48.31

19.48

ug/l

0.50

321

2997

Periodontal disease, other/unspecified

819

1.08

0.26

3.3

4.2

8.90

20.80

ug/l

0.76

673

Anomalies of pupillary function

520

1.10

0.26

4.3

4.2

10.57

16.14

ug/l

0.21

423

Other disorders of central nervous system

341

0.87

0.26

2.8

4.2

9.75

40.80

ug/l

0.68

276

Mental and behavioural disorders due to hallucinogens

0.69

0.26

3.2

5.7

2.52

60.87

ug/l

—

Disorders of refraction and accommodation

850

8651

0.98

0.26

3.7

4.1

22.88

25.60

ug/l

0.08

627

6807

Other benign neoplasm of uterus: Other parts/unspecified

183

1746

1.05

0.26

3.0

3.5

4.90

13.17

ug/l

3.49

142

1416

Psoriasis

1163

11420

1.02

0.26

3.5

4.1

27.91

24.22

ug/l

0.15

958

9231

Recurrent dislocation and subluxation of joint

192

1831

1.05

0.26

3.0

4.4

16.17

46.56

ug/l

0.79

150

1439

Dacryoadenitis

254

1.16

0.26

2.6

4.3

11.99

26.36

ug/l

0.38

216

Fasciculation

309

0.87

0.26

2.4

4.8

1.93

8.15

ug/l

3.06

255

Secondary parkinsonism, excluding more controls

933

0.93

0.26

2.3

4.8

3.76

36.77

ug/l

2.63

786

Other bursitis of knee

454

1.11

0.26

2.8

4.8

23.83

38.77

ug/l

0.27

374

Molar incisor enamel hypoplasia

271

1.14

0.26

2.5

3.7

2.12

7.56

ug/l

1.49

183

Ankyloglossia

104

1.25

0.26

3.2

3.5

1.56

2.91

ug/l

—

Crowding of teeth, including avohilmo

125

973

1.06

0.26

2.8

4.0

8.34

16.16

ug/l

0.42

704

Hypoplasia of dental enamel , including avohilmo

255

1.14

0.26

2.6

3.8

2.24

7.96

ug/l

1.45

171

Fracture at wrist and hand level

1273

12487

1.02

0.25

3.8

4.2

25.09

26.69

ug/l

0.06

1034

10045

Explosion of other materials

1.22

0.25

5.7

4.4

1.94

14.09

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

146

1384

1.06

0.25

4.7

3.5

35.47

38.46

ug/l

0.03

107

971

Deformity of finger(s)

212

0.84

0.25

2.2

4.5

4.33

23.48

ug/l

0.96

189

Mental and behavioural disorders due to use of other stimulants, including caffeine

349

1.12

0.25

1.8

5.1

19.62

11.06

ug/l

0.22

268

Drug-induced obesity

236

1.16

0.25

4.4

3.9

3.70

27.15

ug/l

0.71

195

Convergence insufficiency and excess

255

0.86

0.25

4.0

4.3

2.43

23.34

ug/l

0.64

202

Other and unspecified iridocyclitis

143

1357

1.06

0.25

3.7

4.3

6.55

23.01

ug/l

1.35

106

1109

Eating disorders

187

1955

0.95

0.25

2.6

3.7

21.08

34.71

ug/l

0.24

135

1422

Dystonia

189

1807

1.05

0.25

3.4

4.0

10.54

20.42

ug/l

0.88

148

1451

Other and unspecified injuries of neck

189

1.18

0.25

1.6

4.4

3.04

9.83

ug/l

1.56

151

Hyperprolactinaemia

783

1.08

0.24

3.7

4.2

4.42

32.18

ug/l

1.48

601

Emotional disorders and disorders of social functioning with onset specific to childhood

365

0.89

0.24

2.6

3.8

3.44

6.31

ug/l

0.88

230

Sequelae of injuries of head

158

1504

1.05

0.24

2.9

4.4

7.69

21.67

ug/l

1.38

121

1225

Biological medication for rheuma

504

4907

1.03

0.24

3.0

4.2

79.42

25.95

ug/l

0.76

379

3817

L04AC Interleukin inhibitors

158

1504

1.05

0.24

2.9

4.4

89.22

23.67

ug/l

0.53

121

1191

Systemic sclerosis, icd10

794

1.08

0.24

2.4

3.9

4.40

25.76

ug/l

1.35

633

Congenital absence, occlusion, or narrowing of the ear canal

1.38

0.24

1.0

4.6

1.98

5.61

ug/l

—

Other bursal cyst

557

0.91

0.24

2.7

4.8

59.58

33.19

ug/l

0.20

455

Retinal breaks without detachment

704

6889

1.02

0.24

3.8

4.2

19.87

23.28

ug/l

0.16

551

5651

Other encephalitis

775

1.08

0.24

3.6

4.3

4.91

27.87

ug/l

1.39

635

Lower leg

190

1.17

0.24

3.5

4.3

5.37

7.85

ug/l

0.35

151

Superficial injury of neck

389

1.11

0.24

3.5

4.6

3.60

19.01

ug/l

0.78

316

Labour and delivery complicated by umbilical cord complications

122

1289

0.94

0.24

3.9

7.27

47.73

ug/l

0.80

970

Crushing injury of wrist and hand

457

1.10

0.23

3.9

4.9

24.26

43.93

ug/l

0.39

388

Eating disorder

120

1267

0.94

0.23

2.5

3.6

27.61

44.76

ug/l

0.18

868

Acute inflammation of orbit

162

1.19

0.23

2.0

4.9

2.63

35.48

ug/l

0.69

135

Congenital malformations of great arteries

335

1.12

0.23

3.7

4.4

13.57

20.64

ug/l

0.17

261

Other diseases of spinal cord

918

0.93

0.23

2.5

4.4

3.78

26.48

ug/l

1.77

756

Burn and corrosion of wrist and hand

892

1.07

0.23

4.0

4.5

7.75

23.63

ug/l

0.93

732

Atypical virus infections of central nervous system

295

1.13

0.23

5.1

4.4

15.64

20.47

ug/l

0.11

249

Raynaud syndrome

280

2705

1.04

0.23

2.8

4.1

5.45

32.10

ug/l

1.40

224

2133

Wide developmental disorders

265

1.13

0.23

2.1

4.2

2.50

5.92

ug/l

1.09

189

Paralytic strabismus

263

2539

1.04

0.23

3.5

4.1

6.04

21.09

ug/l

2.93

222

2098

Syndactyly

1.27

0.23

1.2

4.1

1.92

12.02

ug/l

—

Spontaneous rupture of synovium and tendon

336

3258

1.03

0.23

3.8

4.4

4.21

26.51

ug/l

5.09

266

2649

Bullous pemphigoid

768

1.08

0.23

3.6

4.0

3.84

24.72

ug/l

1.36

655

Left ventricular outflow tract obstruction, narrow definition

131

1244

1.06

0.23

3.3

4.4

67.42

21.60

ug/l

0.34

102

1019

Dissection of aorta

108

1142

0.94

0.22

3.8

4.2

5.77

23.69

ug/l

1.65

960

Other operation for atrial fibrillation

182

1.18

0.22

4.1

4.8

10.31

79.73

ug/l

0.92

157

Crossbite

117

1142

0.94

0.22

3.1

4.2

4.28

22.81

ug/l

1.54

871

Other acquired deformities of musculoskeletal system and connective tissue

150

1431

1.05

0.22

3.6

4.1

58.28

22.61

ug/l

0.29

121

1173

Disorders of globe

854

0.93

0.22

3.5

3.9

2.86

29.88

ug/l

1.96

705

Mosquito-borne viral encephalitis

0.00

0.22

0.0

5.7

—

3.27

—

Other/unspecified rheumatoid arthritis

503

5154

0.97

0.22

3.2

3.8

47.63

25.41

ug/l

0.41

413

4193

Trigger finger

607

5937

1.02

0.22

3.2

4.4

23.14

29.90

ug/l

0.17

500

4767

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

191

1.16

0.22

6.2

3.4

5.36

6.12

ug/l

0.08

138

Polyp of middle ear

1.21

0.22

4.0

4.4

19.06

11.91

ug/l

—

Bicornuate uterus

124

0.80

0.22

1.5

4.4

1.72

9.56

ug/l

—

Myocardial infarction

2534

18006

0.99

0.22

3.5

4.4

12.64

27.43

ug/l

3.58

2091

14975

Injury of nerves at lower leg level

277

1.13

0.22

2.7

4.9

4.48

31.72

ug/l

0.89

230

Vertical strabismus

105

993

1.06

0.22

3.0

4.2

5.41

28.02

ug/l

1.62

808

Other disorders of choroid

450

1.10

0.21

3.5

4.0

33.22

16.72

ug/l

0.22

385

Congenital malformations of aortic and mitral valves

102

1079

0.94

0.21

3.7

4.4

3.09

23.93

ug/l

1.90

888

184

1760

1.05

0.21

3.0

3.5

6.06

22.64

ug/l

2.17

154

1468

LSIL lesion of the vagina

429

0.90

0.21

3.8

3.9

3.19

8.29

ug/l

2.09

347

Muscle strain

925

1.06

0.21

3.1

4.6

6.20

28.09

ug/l

1.44

745

Polyhydramnios

886

1.06

0.21

3.7

3.5

56.90

51.43

ug/l

0.03

614

Felty syndrome

202

1.16

0.21

4.2

3.7

6.74

10.39

ug/l

0.45

172

Amblyopia ex anopsia

935

1.06

0.21

3.3

4.2

2.70

16.97

ug/l

1.90

757

Optic neuritis

112

1062

1.06

0.21

3.2

4.2

5.12

27.74

ug/l

1.73

831

Dysplastic lesion of unknown severity of the cervix uteri

211

1.15

0.21

3.3

4.2

21.18

7.64

ug/l

0.49

167

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

175

1824

0.96

0.21

2.9

3.6

5.75

32.10

ug/l

0.71

126

1298

Chondrolysis

0.00

0.21

0.0

4.1

—

2.01

—

Benign neoplasm: Central nervous system, other parts/unspecified

113

0.78

0.21

2.6

4.0

2.20

48.68

ug/l

—

Toxic effect of ethanol

926

1.06

0.21

3.4

4.5

15.58

25.26

ug/l

0.39

749

Other congenital malformations of peripheral vascular system

297

1.12

0.21

2.2

4.0

3.18

23.68

ug/l

0.80

243

Maternal care for cervical incompetence

112

1179

0.95

0.20

3.4

4.0

88.27

10.92

ug/l

0.46

933

Migraine with aura, drug-induced

292

0.88

0.20

2.7

3.9

3.82

23.48

ug/l

0.73

236

Other melanin hyperpigmentation

809

0.93

0.20

3.4

4.0

4.35

25.33

ug/l

1.42

673

Hyphaema and other vascular disorders of iris and ciliary body

624

0.92

0.20

3.4

4.3

4.98

31.31

ug/l

1.33

531

Congenital deformities of feet

509

1.09

0.20

2.7

4.3

3.66

15.74

ug/l

0.78

407

Graves ophthalmopathy, strict

665

0.93

0.20

3.0

4.1

11.37

15.32

ug/l

0.20

534

Cardiovascular disorders originating in the perinatal period

0.00

0.20

0.0

2.2

—

2.96

—

Osteitis due to dental implant

260

1.13

0.20

4.3

4.4

7.00

23.98

ug/l

0.51

215

Exfoliative dermatitis

346

1.11

0.20

2.5

4.9

4.80

49.69

ug/l

1.20

292

Nonsuppurative otitis media

541

4786

0.98

0.20

3.3

3.9

11.39

30.82

ug/l

1.52

406

3693

Other localized connective tissue disorders

636

1.08

0.20

2.7

3.9

46.04

26.10

ug/l

0.18

521

Dermatographic urticaria

194

1868

1.04

0.20

3.4

4.0

85.17

37.78

ug/l

0.39

148

1446

Anankastic personality disorder

912

0.94

0.20

2.4

4.4

4.79

20.77

ug/l

1.37

709

Psoriasis (vulgaris), strict definition

918

1.06

0.20

3.6

4.6

54.11

16.38

ug/l

0.36

752

Hereditary ataxia

406

0.90

0.20

4.3

4.6

4.32

37.80

ug/l

1.09

350

Venous complications and haemorrhoids in pregnancy

288

1.12

0.20

3.6

3.7

2.79

131.34

ug/l

0.52

208

Glucosamine medication

2599

20538

1.01

0.20

3.5

3.9

24.36

21.90

ug/l

0.17

2098

16923

!Aliquae complicationes praecoces traumatis

134

1280

1.05

0.20

3.1

4.2

3.73

22.11

ug/l

2.01

111

1056

Early complications of trauma

134

1280

1.05

0.20

3.1

4.2

3.73

22.11

ug/l

2.01

111

1056

Tumor necrosis factor alpha inhibitors

442

4314

1.03

0.20

3.1

4.2

58.36

26.80

ug/l

0.38

328

3348

Idiopathic hypercalciuria

184

1.16

0.20

1.6

4.3

5.01

31.24

ug/l

0.59

153

Injury of muscle and tendon at ankle and foot level

675

1.07

0.20

2.8

4.5

14.05

27.92

ug/l

0.43

552

Gluteal tendinitis

142

1359

1.05

0.20

3.4

4.4

5.81

20.76

ug/l

1.87

114

1074

Lesion of sciatic nerve

164

1707

0.96

0.20

4.1

37.05

25.08

ug/l

0.15

145

1416

Transport accidents

1938

16482

1.01

0.19

3.5

4.2

10.81

30.33

ug/l

4.82

1531

13099

Other psoriatic arthropathies

341

3502

0.97

0.19

3.1

4.2

13.31

23.92

ug/l

0.80

281

2822

Other juvenile arthritis

674

0.93

0.19

4.0

4.4

8.64

29.42

ug/l

0.84

517

Strabismus

902

9141

0.98

0.19

3.3

4.0

6.08

27.02

ug/l

4.56

709

7259

Other meningitis

424

1.09

0.19

3.7

4.0

4.34

16.92

ug/l

0.65

342

Maxillary retrognathism

301

0.89

0.19

3.0

4.4

7.56

22.09

ug/l

0.47

236

Certain conditions originating in the perinatal period

106

893

1.05

0.19

3.3

3.9

3.31

12.99

ug/l

1.07

639

Diseases caused by chlamydiae

299

1.11

0.19

3.1

3.6

2.78

6.97

ug/l

1.71

231

Rickettsioses

1.23

0.19

1.6

4.6

1.79

124.59

ug/l

—

Embolism and thrombosis of abdominal aorta

1.23

0.19

3.4

4.2

9.31

133.66

ug/l

—

Exposure to uncontrolled fire, not in building or structure

1.23

0.19

5.9

4.7

43.69

9.84

ug/l

—

Amputation of thigh

1041

0.95

0.19

2.1

3.8

12.74

25.82

ug/l

0.52

883

Allergic contact dermatitis due to drugs in contact with skin

687

1.07

0.18

3.3

4.1

5.62

15.29

ug/l

0.88

562

Cerebral atherosclerosis

444

0.91

0.18

2.8

4.1

2.73

35.07

ug/l

1.18

383

Pedal cyclist injured in collision with motor vehicle

837

0.94

0.18

3.1

4.3

13.08

26.47

ug/l

0.49

686

Injury of muscle and tendon at lower leg level

547

5360

1.02

0.18

4.1

4.4

14.03

24.64

ug/l

1.02

423

4409

Localized scleroderma [morphea]

466

0.92

0.18

2.7

4.0

69.07

18.60

ug/l

0.34

378

Chronic mastoiditis

863

1.06

0.18

3.1

4.2

13.78

26.39

ug/l

0.50

726

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

941

1.06

0.18

3.6

4.2

2.98

24.13

ug/l

1.66

761

Statin medication

3062

17361

0.99

0.18

3.4

4.3

15.34

22.87

ug/l

1.46

2433

13663

Atopic dermatitis, strict definition

783

7541

1.02

0.18

3.4

3.9

52.36

21.44

ug/l

0.59

607

5645

Temporomandibular joint disorders, including avohilmo

1508

15039

0.99

0.18

3.0

4.0

14.88

22.64

ug/l

0.43

1121

11511

Carcinoma in situ of larynx

0.74

0.18

1.4

4.6

5.56

65.80

ug/l

—

Other hammer toe(s) (acquired)

859

8044

0.98

0.18

3.4

4.2

12.44

26.45

ug/l

1.46

686

6626

Pterygium

103

1080

0.95

0.18

3.3

4.2

32.98

26.32

ug/l

0.10

913

Disorders of glossopharyngeal nerve

0.75

0.18

2.4

4.1

2.84

8.37

ug/l

—

Frostbite involving multiple body regions and unspecified frostbite

0.75

0.17

4.4

4.0

2.28

79.12

ug/l

—

Other drug-induced secondary parkinsonism

330

1.10

0.17

2.4

4.7

2.84

27.66

ug/l

1.04

280

Epileptic seizures related to alcohol

186

1.14

0.17

3.0

5.2

18.73

76.94

ug/l

0.70

160

Hypogonadotropic hypogonadism

609

0.93

0.17

3.0

5.2

43.11

19.61

ug/l

0.25

500

Syndactyly

0.75

0.17

1.2

4.3

1.92

10.62

ug/l

—

Fall on and from ladder

274

2666

1.03

0.17

4.2

4.4

12.07

25.83

ug/l

1.42

220

2222

Myocardial infarction, with ST-elevation

736

7479

0.98

0.17

3.5

4.1

13.00

22.95

ug/l

1.23

616

6282

Polycystic ovarian syndrome, broad definition

179

1854

0.96

0.17

2.9

3.4

7.75

32.04

ug/l

0.58

122

1225

Erythema in diseases classified elsewhere

1.18

0.17

1.4

4.1

2.42

7.09

ug/l

—

Systemic sclerosis

807

1.06

0.17

2.4

4.0

4.40

28.97

ug/l

1.58

638

Other specified/unspecified inflammatory spondylopathies

131

1257

1.04

0.17

3.6

4.5

94.02

47.11

ug/l

0.21

100

977

Arthropod-borne viral fevers and viral haemorrhagic fevers

329

3210

1.03

0.17

3.7

4.3

10.74

24.35

ug/l

1.81

266

2631

Melanoma in situ of upper limb, including shoulder

277

0.89

0.17

3.2

4.5

3.01

32.43

ug/l

1.03

234

Sexual dysfunction

381

0.91

0.17

3.7

5.2

3.01

43.27

ug/l

1.16

314

Contact with and exposure to communicable diseases

739

7476

0.98

0.17

4.0

3.9

19.63

21.44

ug/l

0.06

557

5560

Urticaria due to cold and heat

204

0.88

0.16

4.6

4.5

5.57

28.88

ug/l

0.54

160

Injury of blood vessels at shoulder and upper arm level

0.77

0.16

1.5

5.6

4.07

65.11

ug/l

—

Burns and corrosions

396

4048

0.98

0.16

4.1

4.2

18.31

21.56

ug/l

0.11

323

3257

Other vitreous opacities

144

1387

1.04

0.16

3.2

4.2

7.52

22.93

ug/l

1.35

114

1139

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

102

1067

0.95

0.16

3.7

4.0

110.98

27.39

ug/l

0.51

894

Early lumbar disc prolapse operation

210

2166

0.97

0.16

3.5

4.3

9.63

27.71

ug/l

0.55

160

1605

Dermatitis herpetiformis

574

1.07

0.16

3.6

4.2

2.76

32.26

ug/l

1.38

487

Dependent personality disorder

613

1.07

0.16

3.4

4.2

22.31

15.00

ug/l

0.21

489

Exposure to other and unspecified man-made environmental factors

401

0.92

0.16

3.1

4.4

2.48

35.12

ug/l

0.98

329

Heart failure and hypertrophic cardiomyopathy

637

0.94

0.16

2.1

4.2

19.58

30.33

ug/l

0.25

538

Isolated proteinuria

828

1.06

0.16

3.0

4.5

5.07

27.86

ug/l

1.44

682

Neuromyelitis optica

0.75

0.16

6.8

3.9

6.82

5.37

ug/l

—

Prepatellar bursitis

144

1494

0.96

0.16

3.2

4.8

64.65

33.54

ug/l

0.28

115

1252

Peripheral artery operations in Hilmo

532

5221

1.02

0.16

2.9

4.1

7.98

19.41

ug/l

4.07

457

4358

Congenital malformations of ear causing impairment of hearing

0.76

0.16

1.0

4.5

1.82

13.19

ug/l

—

Hereditary corneal dystrophies

130

1251

1.04

0.16

3.9

4.4

4.38

21.67

ug/l

1.88

1033

Operations for atrial fibrillation

544

0.93

0.16

3.4

4.7

5.63

36.15

ug/l

1.32

465

Other and unspecified localized connective tissue disorders

102

1.20

0.16

2.7

4.0

5.03

8.19

ug/l

—

Congenital deformities of feet

858

1.05

0.15

2.9

4.3

3.27

17.31

ug/l

1.64

686

Patent foramen ovale

497

1.07

0.15

3.6

4.5

3.14

21.80

ug/l

1.17

404

Contact with other and unspecified heat and hot substances

159

1.14

0.15

3.9

4.9

3.05

9.61

ug/l

2.01

131

Family history of certain disabilities and chronic diseases leading to disablement

102

976

1.05

0.15

3.4

4.1

16.28

19.89

ug/l

0.12

761

Erythema multiforme

693

1.06

0.15

3.1

4.2

12.79

30.38

ug/l

0.57

572

Suppurative otitis media, unspecified

615

0.94

0.15

2.6

4.0

23.72

32.65

ug/l

0.14

504

Von Willebrand disease

323

1.09

0.15

2.4

4.1

3.64

22.02

ug/l

0.74

255

Generalized epilepsy, strict definition

449

1.07

0.15

4.5

4.2

3.54

41.09

ug/l

1.31

369

Pregnancy examination and test

303

1928

0.98

0.15

3.5

3.2

16.81

10.24

ug/l

0.41

192

1325

Myasthenia gravis

563

0.94

0.15

3.5

4.2

26.03

33.56

ug/l

0.12

476

Premature separation of placenta [abruptio placentae]

498

1.07

0.15

3.3

3.8

3.34

79.86

ug/l

0.55

365

Pneumoconiosis due to asbestos and other mineral fibres

737

0.95

0.15

2.5

3.9

18.10

42.40

ug/l

0.81

612

Other and unspecified mental retardation

244

1.10

0.15

2.7

4.3

7.18

7.59

ug/l

0.03

182

Perichondritis of external ear

606

1.06

0.15

3.6

4.2

11.88

32.40

ug/l

0.76

516

Panhypopituitarism

522

0.93

0.15

3.7

4.5

100.41

36.25

ug/l

0.30

434

Corneal ulcer

630

6398

0.98

0.14

3.6

4.2

10.89

24.03

ug/l

1.30

513

5116

Anorexia (incl.atypical)

113

1175

0.96

0.14

2.8

4.0

7.44

52.30

ug/l

0.83

881

Migraine with aura

809

7980

1.01

0.14

3.1

4.1

5.92

24.68

ug/l

3.11

586

6076

Dislocation, sprain and strain of joint and ligaments of hip

132

1274

1.04

0.14

3.5

4.1

4.20

24.04

ug/l

2.22

111

1050

Osteomalacia

237

1.11

0.14

3.7

4.4

77.40

25.93

ug/l

0.30

190

Benign neoplasm: Short bones of upper limb

431

1.07

0.14

4.1

4.3

13.59

18.92

ug/l

0.16

355

Psoriatic arthropathies, ICD10

354

3613

0.98

0.14

3.1

4.2

12.95

24.19

ug/l

0.91

293

2912

Traumatic subdural haemorrhage

628

5936

1.02

0.14

3.5

4.5

8.39

27.44

ug/l

6.69

521

5022

Retained placenta and membranes, without haemorrhage

426

4182

1.02

0.14

4.3

3.8

15.97

28.33

ug/l

0.57

343

3212

Use of glatiramer acetate

305

0.91

0.14

2.0

4.2

2.47

7.27

ug/l

2.11

230

Postpartum haemorrhage due to retained placenta

280

2736

1.02

0.14

3.4

3.5

11.85

34.29

ug/l

0.85

185

1935

Type 1 diabetes, strict (exclude DM2)

175

1798

0.97

0.14

4.3

17.28

35.08

ug/l

0.38

144

1345

Contact with other hot metals

428

0.93

0.14

3.2

4.6

4.19

38.76

ug/l

1.12

357

Tibial collateral bursitis [Pellegrini-Stieda]

364

1.08

0.13

3.0

4.7

3.54

20.19

ug/l

0.79

294

Rosacea

400

4074

0.98

0.13

3.1

3.9

9.77

30.50

ug/l

1.32

308

3219

Other specified/unspecified necrotizing vasculopathies

452

1.07

0.13

2.4

4.2

85.62

34.19

ug/l

0.27

384

Viral haemorrhagic fevers, not elsewhere classified/unspecified

261

2551

1.03

0.13

3.8

4.2

12.90

23.30

ug/l

0.99

210

2093

Burn and corrosion of head and neck

530

0.94

0.13

5.5

4.9

96.86

13.22

ug/l

0.48

434

Myeloproliferative diseases (CML excluded)

300

2938

1.02

0.13

2.9

4.0

11.53

23.40

ug/l

0.73

224

2416

Shigellosis

161

1.13

0.13

4.2

4.3

20.12

77.84

ug/l

0.57

130

Background retinopathy and retinal vascular changes

658

1.05

0.13

3.0

4.2

139.82

18.00

ug/l

0.43

562

Disorders of orbit

145

1406

1.03

0.13

3.3

4.3

101.16

24.75

ug/l

0.47

115

1144

Other congenital malformations of circulatory system

776

1.05

0.13

4.0

4.5

9.50

26.90

ug/l

0.87

645

Contact with other specified venomous animals

200

1.11

0.13

4.0

3.26

30.16

ug/l

0.68

164

Other disorders of iris and ciliary body

845

0.96

0.13

3.1

4.3

5.41

24.90

ug/l

1.28

707

Hyperkinetic disorders (excl. ADHD)

157

0.88

0.13

1.1

4.5

1.92

5.87

ug/l

—

115

Early lumbar disc prolapse, operated

208

2133

0.97

0.12

3.5

4.6

9.74

31.48

ug/l

0.69

158

1588

Cervicobrachial syndrome

896

9061

0.99

0.12

3.3

4.2

5.13

27.97

ug/l

5.29

736

7191

Otosclerosis

292

2861

1.02

0.12

3.8

4.1

20.96

22.89

ug/l

0.06

248

2325

Personal history of risk-factors, not elsewhere classified

262

0.91

0.12

2.1

4.6

10.80

22.04

ug/l

0.27

209

Lichen simplex chronicus

115

1111

1.04

0.12

3.0

4.1

4.44

26.28

ug/l

2.06

919

Haemorrhage in early pregnancy

953

9175

1.01

0.12

3.3

3.7

12.85

20.89

ug/l

0.69

680

6834

Contusion of toe(s) with damage to nail

268

1.09

0.12

5.2

4.5

3.10

49.26

ug/l

0.87

214

Valvular operations

598

5898

1.02

0.12

3.2

4.5

30.79

25.83

ug/l

0.13

482

4997

Burns and corrosions confined to eye and internal organs

649

1.05

0.12

3.0

4.7

5.05

22.33

ug/l

0.86

527

Other infiltrative disorders of skin and subcutaneous tissue

162

1.12

0.12

3.7

4.5

3.29

12.52

ug/l

2.02

133

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

230

0.90

0.12

3.0

4.8

2.48

61.02

ug/l

1.10

201

Myopia

318

3242

0.98

0.12

3.5

4.1

47.28

26.86

ug/l

0.26

216

2504

Pustular psoriasis

162

1576

1.03

0.12

3.0

4.2

50.53

19.86

ug/l

0.43

130

1283

Pyogenic granuloma

483

1.06

0.12

2.8

4.1

8.00

33.81

ug/l

0.89

404

Pigmented purpuric dermatosis

327

1.08

0.12

3.7

4.4

6.84

9.40

ug/l

0.33

275

Sixth [abducent] nerve palsy

117

1132

1.04

0.12

3.9

4.2

4.10

24.47

ug/l

1.97

101

942

Other (seronegative) rheumatoid arthritis, wide

801

8102

0.99

0.12

3.3

3.9

35.79

29.31

ug/l

0.15

652

6549

Foreign body in ear

487

0.94

0.12

4.4

4.5

5.64

16.17

ug/l

0.62

404

Overjet

286

1.08

0.12

3.0

4.0

22.40

7.50

ug/l

0.34

209

Scleritis and episcleritis

182

1867

0.97

0.12

3.7

4.1

7.17

22.96

ug/l

1.71

139

1484

Acute suppurative otitis media

573

5272

1.01

0.12

3.6

3.9

12.04

22.71

ug/l

0.68

399

3916

Adult respiratory distress syndrome

425

1.06

0.12

2.5

4.2

4.96

37.80

ug/l

1.06

351

Contraceptive management

1360

9451

1.01

0.12

3.7

4.0

23.82

23.94

ug/l

0.00

1024

7377

Migraine, unspecified, drug-induced

209

0.90

0.11

2.4

3.8

2.26

8.68

ug/l

1.88

170

Other and unspecified mononeuropathies of lower limb

956

1.04

0.11

2.9

4.4

8.16

24.67

ug/l

1.07

776

Artrosis, including avohilmo

4122

22665

0.99

0.11

3.6

4.3

16.74

29.20

ug/l

2.24

3277

18251

Generalized epilepsy, mode (most common among epilepsy diagnosis)

690

1.05

0.11

4.4

4.2

20.25

30.06

ug/l

0.27

558

Carcinoma in situ of lip, oral cavity and pharynx

1.18

0.11

3.3

4.5

5.56

130.54

ug/l

—

Disorder of external ear, unspecified

107

1035

1.04

0.11

3.3

4.3

5.72

26.21

ug/l

1.64

861

Viral conjunctivitis

954

0.96

0.11

3.3

4.1

3.14

24.16

ug/l

1.64

761

Other sexually transmitted chlamydial diseases

802

0.96

0.11

3.8

4.2

14.29

64.61

ug/l

0.53

554

Other injuries of lower limb, level unspecified

250

1.09

0.11

2.6

4.5

4.28

24.09

ug/l

0.62

207

Ulcer of oesophagus, drug-induced

163

1.12

0.11

3.3

4.6

4.21

74.33

ug/l

0.85

139

Juvenile Open Angle Glaucoma

136

0.88

0.11

1.5

4.5

2.03

37.99

ug/l

—

113

Infections of genitourinary tract in pregnancy

282

2767

1.02

0.11

3.0

3.7

5.26

38.67

ug/l

1.53

218

2096

Retinoschisis and retinal cysts

861

0.96

0.11

4.2

13.37

20.17

ug/l

0.35

716

Postprocedural musculoskeletal disorders, not elsewhere classified

285

2799

1.02

0.11

2.8

4.1

44.98

18.17

ug/l

0.41

240

2289

HSIL lesion of the vagina

417

1.06

0.10

4.1

3.9

2.72

10.44

ug/l

3.10

334

Unspecified nephritic syndrome

702

1.04

0.10

3.7

4.3

4.56

24.65

ug/l

1.09

587

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

296

3012

0.98

0.10

3.2

3.8

16.81

37.00

ug/l

0.55

222

2327

Carcinoma in situ of oral cavity and pharynx

1.18

0.10

3.8

4.6

3.00

13.80

ug/l

—

Cutaneous lupus erythematosus

801

1.04

0.10

3.7

4.0

8.14

27.41

ug/l

1.03

656

Other and unspecified atrophic disorders of skin

164

1.11

0.10

2.2

3.7

2.40

8.93

ug/l

1.60

135

Injury of muscle and tendon at forearm level

496

1.05

0.10

3.1

4.8

39.43

21.88

ug/l

0.34

404

Struck by thrown, projected or falling objec

138

1344

1.03

0.10

3.9

4.4

4.00

22.91

ug/l

2.20

110

1103

Localized adiposity

164

1.11

0.10

4.9

4.3

6.80

6.86

ug/l

0.00

130

Androgenic alopecia

271

1.08

0.10

2.5

3.8

2.95

9.79

ug/l

1.96

216

Villonodular synovitis (pigmented)

232

1.08

0.10

4.8

4.5

2.68

8.23

ug/l

1.75

202

Aortic valve malfunction, age under 60 years

292

2871

1.02

0.10

3.8

4.5

37.87

19.94

ug/l

0.28

227

2364

Other disorders of cornea

353

3477

1.02

0.10

4.1

5.37

18.76

ug/l

3.50

272

2807

Acute bronchiolitis

659

1.04

0.10

3.3

3.7

3.96

24.52

ug/l

0.92

502

Dermatophytosis

2641

26514

0.99

0.10

3.4

4.1

26.18

24.31

ug/l

0.08

2057

21373

Benign neoplasm: Brain, supratentorial

428

1.06

0.10

3.4

4.3

4.44

34.28

ug/l

0.93

347

Diabetic neuropathy

433

4250

1.01

0.09

3.4

3.8

30.76

20.63

ug/l

0.22

362

3580

Divergent concomitant strabismus

220

2243

0.98

0.09

2.9

4.1

8.70

19.72

ug/l

1.33

158

1784

Melanoma in situ, other sites/unspecified

124

0.88

0.09

1.4

4.6

2.88

43.06

ug/l

—

103

Other keratitis

350

3552

0.98

0.09

3.4

4.1

12.36

28.30

ug/l

0.81

275

2850

Toxic effect of alcohol

584

0.96

0.09

4.0

4.6

4.72

32.75

ug/l

1.25

485

Medial epicondylitis

125

1218

1.03

0.09

3.6

4.5

15.54

30.96

ug/l

0.49

104

968

Thyrotoxicosis with toxic single thyroid nodule

282

1.07

0.09

2.2

4.0

2.83

47.44

ug/l

0.91

228

Burn and corrosion of trunk

857

0.97

0.09

4.4

4.5

7.54

29.00

ug/l

1.29

718

Congenital dislocation of hip, unilateral

134

0.89

0.09

4.2

4.6

2.53

7.37

ug/l

1.66

109

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

137

1338

1.03

0.09

3.7

4.3

64.85

22.47

ug/l

0.32

110

1105

Acute otitis externa, noninfective

522

0.95

0.09

2.9

4.3

3.63

20.91

ug/l

1.16

435

Testicular dysfunction

863

1.03

0.09

4.6

5.0

17.58

23.51

ug/l

0.17

725

Exposure to unspecified smoke, fire and flames

253

1.07

0.09

2.8

4.9

24.76

25.34

ug/l

0.01

212

Certolizumab pegol

349

0.94

0.08

3.5

4.0

3.07

8.07

ug/l

1.92

270

Bulimia nervosa (incl. atypical)

449

1.05

0.08

2.1

3.9

2.04

104.23

ug/l

0.62

303

Calcaneal spur

430

1.05

0.08

2.5

4.5

26.77

25.02

ug/l

0.02

344

Acute alcohol intoxication ICD-9

115

1121

1.03

0.08

3.7

4.4

25.59

23.15

ug/l

0.07

100

924

Polyarthritis, unspecified

127

1240

1.03

0.08

3.4

4.5

10.82

23.28

ug/l

0.65

105

1031

Tularaemia

562

0.96

0.08

2.8

4.4

4.61

32.33

ug/l

1.22

474

Systemic sclerosis (FG)

825

1.03

0.08

2.4

4.6

4.40

28.94

ug/l

1.71

674

Abnormalities of forces of labour

284

2882

0.98

0.08

3.6

3.7

24.50

29.00

ug/l

0.08

204

2108

Deaf mutism, not elsewhere classified

164

0.91

0.08

1.8

4.7

3.05

48.22

ug/l

—

143

Disorders of acoustic nerve

954

1.03

0.08

3.7

4.3

15.17

26.03

ug/l

0.38

797

Embolic stroke with flimmer

915

0.97

0.08

2.6

4.1

16.91

34.90

ug/l

0.52

778

Perioral dermatitis

529

1.04

0.08

1.9

3.8

38.56

7.63

ug/l

0.43

412

Anxious personality disorder

342

1.06

0.08

2.2

4.4

6.34

19.10

ug/l

0.48

271

Varus deformity, not elsewhere classified

362

1.05

0.08

4.1

4.3

3.26

28.21

ug/l

0.75

307

Benign neoplasm: Connective and other soft tissue, unspecified

368

0.95

0.08

4.3

4.0

3.28

20.13

ug/l

0.84

306

Scleritis

362

1.05

0.08

4.3

2.40

22.03

ug/l

0.99

294

Somnolence

317

0.94

0.08

2.7

3.8

3.01

45.46

ug/l

0.98

253

Encephalitis

826

1.03

0.08

3.5

4.3

4.88

26.47

ug/l

1.41

680

Major anomalies of jaw size

672

0.97

0.07

4.2

4.4

3.66

17.81

ug/l

1.16

534

Conductive hearing loss, unspecified

288

2841

1.01

0.07

3.8

4.1

7.99

29.04

ug/l

2.70

231

2291

Restless leg syndrome

508

5130

0.99

0.07

3.3

4.0

5.75

30.31

ug/l

2.94

404

4116

Cramp and spasm

131

1338

0.98

0.07

3.4

4.2

5.62

19.58

ug/l

1.33

108

1079

Other disorders of the musculoskeletal system and connective tissue

588

5828

1.01

0.07

3.0

4.0

38.43

24.86

ug/l

0.29

487

4726

Pulmonary oedema

590

1.04

0.07

3.8

4.2

4.19

33.20

ug/l

1.40

500

Cytomegaloviral hepatitis

0.87

0.07

2.5

4.4

5.05

56.42

ug/l

—

Burns and corrosions of external body surface, specified by site

304

3078

0.99

0.07

4.1

4.2

20.28

20.86

ug/l

0.01

249

2476

Exposure to other and unspecified forces of nature

167

1.08

0.07

3.9

4.0

2.99

76.09

ug/l

0.89

137

Myotonic disorders

224

0.93

0.07

3.0

4.4

8.79

58.21

ug/l

0.76

183

Memory loss

385

3810

1.01

0.07

3.2

4.0

4.37

25.67

ug/l

6.04

292

3156

Type 1 diabetes, definitions combined

178

1805

0.98

0.07

4.2

4.3

16.99

36.83

ug/l

0.44

147

1350

Mixed specific developmental disorders

109

1.10

0.07

2.9

3.4

1.89

2.05

ug/l

—

Pre-eclampsia superimposed on chronic hypertension

0.85

0.07

1.4

3.7

2.42

9.28

ug/l

—

Other secondary gonarthrosis

198

1950

1.02

0.07

3.3

4.3

21.54

21.43

ug/l

0.00

162

1632

Hypothermia

601

1.03

0.06

3.3

4.5

10.59

29.71

ug/l

0.74

508

Abscess of tendon sheath

197

1.07

0.06

3.3

4.7

1.94

7.74

ug/l

1.85

163

Visual field defects

313

3165

0.99

0.06

3.5

4.0

45.53

23.99

ug/l

0.31

257

2601

Internal derangement of knee

1640

16390

1.00

0.06

3.9

4.4

20.23

31.00

ug/l

0.95

1299

13280

Glaucoma

2913

24977

1.00

0.06

3.8

4.0

16.68

26.54

ug/l

1.38

2401

20505

Female genital prolapse

1296

7287

1.01

0.06

3.2

4.1

8.75

32.03

ug/l

3.15

989

5787

Other endophthalmitis

172

0.92

0.06

2.6

3.8

2.48

49.04

ug/l

—

137

Benign neoplasm: Spinal cord

454

1.04

0.06

4.2

3.66

31.73

ug/l

0.97

382

Degeneration of nervous system due to alcohol

761

1.03

0.06

2.4

4.5

10.46

31.28

ug/l

0.94

636

Lichen sclerosus et atrophicus

422

4183

1.01

0.06

3.4

3.9

5.34

25.34

ug/l

3.04

320

3347

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

324

0.95

0.05

4.1

4.4

2.57

22.01

ug/l

0.85

267

Foreign body or object entering through skin

172

1695

1.02

0.05

3.7

4.5

66.08

22.01

ug/l

0.49

141

1389

Unspecified abortion

157

1594

0.98

0.05

3.9

3.8

5.02

17.32

ug/l

0.91

109

1208

Motorcycle rider injured in noncollision transport accidents

617

0.97

0.05

3.3

4.8

3.30

17.83

ug/l

1.08

490

Lyme disease

1282

12764

1.00

0.05

3.7

4.1

13.92

24.20

ug/l

0.67

980

10319

Obstructive hydrocephalus

455

0.96

0.05

4.3

4.1

6.58

31.06

ug/l

0.80

384

Burn and corrosion confined to eye and adnexa

544

1.03

0.05

3.3

4.7

5.80

19.26

ug/l

0.78

443

Flat foot [pes planus] (acquired)

386

3893

0.99

0.05

3.5

4.2

6.14

30.20

ug/l

3.31

300

3154

Other congenital malformations, not elsewhere classified

151

0.92

0.05

3.8

4.2

2.93

10.52

ug/l

—

117

Childhood allergy (age < 16)

783

1.02

0.05

2.7

3.5

3.94

4.36

ug/l

0.08

434

Poor fetal growth

229

2317

0.99

0.05

3.6

3.4

7.48

27.14

ug/l

0.60

160

1547

Aphakia

455

1.03

0.05

3.0

4.2

5.49

21.83

ug/l

0.86

390

Keratoconus

614

1.03

0.05

4.0

4.7

6.94

29.68

ug/l

0.96

500

Foreign body on external eye

438

4347

1.01

0.05

3.4

4.6

15.53

25.18

ug/l

0.47

353

3594

Other and unspecified rosacea

303

3002

1.01

0.05

3.4

4.0

5.67

32.70

ug/l

1.58

230

2392

Cardiomyopathies, Primary/intrinsic

489

4856

1.01

0.05

3.2

4.6

9.66

24.91

ug/l

3.39

400

4111

Disorders of pituitary gland, other and/or unspecified

179

1.07

0.05

4.6

4.0

232.09

7.93

ug/l

0.46

145

343

0.96

0.05

2.6

4.6

5.78

47.11

ug/l

1.04

285

ILD medications: nintedanib

199

1.06

0.05

1.6

5.6

14.06

42.67

ug/l

0.56

170

Benign neoplasm: Pituitary gland, craniopharyngeal duct

156

1539

1.01

0.05

3.7

4.1

94.40

24.32

ug/l

0.58

118

1245

Supervision of normal pregnancy

540

3063

1.01

0.04

3.5

3.4

33.06

15.08

ug/l

0.59

357

2190

severe traumatic brain injury, does not include concussion

929

9331

0.99

0.04

3.5

4.0

7.77

23.94

ug/l

7.16

751

7751

Corneal scars and opacities

893

1.02

0.04

4.1

4.2

152.71

27.21

ug/l

0.48

748

Degeneration of the brain due to alcohol

764

1.02

0.04

2.4

4.6

10.46

31.19

ug/l

0.94

639

Simple and mucopurulent chronic bronchitis

144

1420

1.02

0.04

3.5

3.9

6.78

24.74

ug/l

1.75

124

1192

Cardiomyopathy (excluding other)

501

5042

0.99

0.04

3.2

4.6

9.46

23.85

ug/l

3.28

412

4265

Inflammation of lacrimal passages (acute and unspecified)

556

1.03

0.04

4.1

4.0

12.89

28.08

ug/l

0.44

459

Poisoning by medicine, drug-induced

338

1.04

0.04

3.8

4.2

2.42

19.61

ug/l

0.73

269

Chronic suppurative otitis media

204

2018

1.01

0.04

3.7

4.2

15.99

17.31

ug/l

0.06

153

1649

Caries in Clefts patients

170

0.94

0.04

2.7

4.3

228.43

32.30

ug/l

—

131

Subacute thyroiditis

116

1177

0.98

0.04

3.3

4.1

8.15

23.80

ug/l

1.17

941

Other specified and unspecified strabismus

289

1.04

0.04

3.9

4.4

5.21

6.61

ug/l

0.17

248

Toxic effects of substances chiefly nonmedicinal as to source

329

3314

0.99

0.04

3.7

4.1

7.89

19.85

ug/l

2.19

270

2656

Impacted teeth

287

2532

1.01

0.04

3.9

3.77

31.57

ug/l

1.15

206

1775

Renal tubulo-interstitial disorders in diseases classified elsewhere

309

1.04

0.04

2.3

4.4

3.20

40.67

ug/l

0.88

265

FESS (DNB20)

417

4195

0.99

0.03

3.1

4.2

5.57

31.22

ug/l

2.39

336

3358

Other obstructed labour

229

2310

0.99

0.03

3.4

3.9

53.91

32.11

ug/l

0.19

171

1755

Ankylosing hyperostosis [Forestier]

488

1.03

0.03

3.9

4.8

5.61

37.05

ug/l

1.17

410

Sleep disorders (combined)

5597

29325

1.00

0.03

3.3

4.2

18.31

26.84

ug/l

1.22

4354

23624

Abscess of external ear

361

0.97

0.03

2.7

4.3

4.42

41.65

ug/l

1.01

299

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

359

1.03

0.03

4.1

5.1

5.69

24.94

ug/l

0.76

293

Other overlap syndromes

538

1.02

0.03

2.7

3.9

2.93

17.68

ug/l

1.17

441

Diabetic nephropathy

625

6141

1.00

0.03

2.9

3.8

14.23

23.08

ug/l

0.95

533

5147

Lesion of femoral nerve

270

1.04

0.03

2.4

4.3

4.24

7.15

ug/l

0.64

222

Other and unspecified corneal deformities and disorders

100

986

1.02

0.03

4.6

4.3

6.45

26.33

ug/l

1.40

798

Necrosis of pulp, including avohilmo

2297

22858

1.00

0.03

3.7

4.1

16.15

25.56

ug/l

1.11

1783

18063

Chronic suppurative otitis media, including avohilmo

239

2372

1.01

0.03

3.7

4.1

31.38

18.58

ug/l

0.30

183

1923

Helminthiases

491

0.98

0.03

4.0

3.19

32.89

ug/l

1.14

408

Burn and corrosion of hip and lower limb, except ankle and foot

591

0.98

0.03

2.8

4.4

3.68

31.92

ug/l

1.33

496

Intrahepatic Cholestasis of Pregnancy (ICP)

146

1446

1.01

0.02

4.7

3.6

35.47

37.30

ug/l

0.02

107

1012

Xanthelasma of eyelid

311

1.03

0.02

1.9

4.3

2.46

21.21

ug/l

0.79

262

Testicular hypofunction

751

0.98

0.02

4.7

5.1

20.39

25.73

ug/l

0.12

632

Pityriasis rosea

178

0.95

0.02

2.1

4.1

3.22

6.60

ug/l

1.07

137

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

268

2398

0.99

0.02

2.8

3.8

5.77

27.91

ug/l

0.74

183

1623

Neurological diseases

4084

20493

1.00

0.02

3.6

4.4

18.92

28.50

ug/l

1.22

3222

16316

Other spirochaetal diseases

1291

12884

1.00

0.02

3.7

4.1

13.90

24.17

ug/l

0.67

987

10420

Lichen planus

531

5292

1.00

0.02

3.3

4.0

32.96

23.37

ug/l

0.17

410

4314

Pustulosis palmaris et plantaris

144

1428

1.01

0.02

2.6

4.3

57.12

21.34

ug/l

0.44

114

1158

Migraine without aura, drug-induced

268

0.97

0.02

2.7

3.7

4.47

7.64

ug/l

0.59

214

Multiple gestation

222

2208

1.01

0.02

3.1

3.5

21.59

27.16

ug/l

0.10

156

1549

Biomechanical lesions, not elsewhere classified

171

1699

1.01

0.01

2.8

4.2

6.53

23.24

ug/l

2.06

142

1398

Postpartum haemorrhage due to anatomy

164

1651

0.99

0.01

3.2

3.4

40.84

34.48

ug/l

0.06

106

1090

Pedal cyclist injured in transport accident

749

7506

1.00

0.01

3.6

4.2

6.78

29.62

ug/l

3.72

597

5994

Atopic dermatitis, strict definition with reimbursement

841

8103

1.00

0.01

3.4

4.0

49.21

23.03

ug/l

0.52

653

6113

Plantar fascial fibromatosis

379

3778

1.00

0.01

3.2

4.3

37.34

36.22

ug/l

0.01

281

3002

Ethmoidectomy

438

4368

1.00

0.01

3.2

4.2

5.69

30.46

ug/l

2.41

355

3504

Blepharochalasis

1458

14563

1.00

0.01

3.5

4.1

17.90

20.63

ug/l

0.21

1163

11940

Twin gestation

212

2110

1.01

0.01

3.2

3.5

22.50

27.78

ug/l

0.09

149

1486

Infliximab

287

0.97

0.01

2.5

4.4

2.01

21.53

ug/l

0.69

227

Other extrapyramidal and movement disorders in other diseases

1027

10284

1.00

0.01

3.3

4.1

13.55

27.61

ug/l

1.55

817

8385

Blepharospasm

333

1.02

0.01

3.2

3.9

2.68

39.62

ug/l

0.93

279

Coxarthrosis, primary, with hip surgery

2447

22908

1.00

0.01

3.8

4.0

18.36

26.15

ug/l

0.76

2027

18918

Other specified transport accidents

114

1.06

0.01

2.7

4.9

6.90

9.38

ug/l

—

Noise effects on inner ear

127

1263

1.01

0.00

3.3

4.7

7.13

23.34

ug/l

1.50

1065

Acquired clawhand, clubhand, clawfoot and clubfoot

146

0.96

0.00

4.8

4.4

2.51

10.71

ug/l

—

127

Hypertrophic cardiomyopathy

140

1407

0.99

0.00

3.0

4.3

14.40

21.77

ug/l

0.39

124

1167

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

142

1427

0.99

0.00

3.5

4.2

61.63

19.11

ug/l

0.33

121

1165

Mastocytosis

166

0.96

0.00

2.3

4.7

2.98

9.22

ug/l

1.29

132

Ankylosis of joint

174

1.04

0.00

3.3

4.5

4.00

65.78

ug/l

0.97

160

Cutis laxa senilis

286

0.98

0.00

2.2

3.7

29.33

6.11

ug/l

0.67

237

Universal erythroderma, KELA reimbursement

424

1.02

0.00

3.5

4.7

10.22

39.95

ug/l

0.83

354

Paranoid personality disorder

464

1.01

0.00

2.3

4.3

25.86

36.58

ug/l

0.15

381

Contact with lifting and transmission devices, not elsewhere classified

486

0.99

0.00

4.6

4.8

5.69

42.93

ug/l

1.38

406

Third [oculomotor] nerve palsy

626

0.99

0.00

3.3

4.1

9.60

31.53

ug/l

0.89

525

Vascular dementia (mixed)

664

1.01

0.00

2.5

3.8

4.66

29.36

ug/l

1.38

565

Open wound of hip and thigh

836

0.99

0.00

3.3

4.7

4.14

29.78

ug/l

1.71

686

Generalized epilepsy

984

1.01

0.00

4.2

4.3

15.50

23.11

ug/l

0.30

784

Spirochaetal infections, other/unspecified

1285

12857

1.00

0.00

3.7

4.1

13.89

24.07

ug/l

0.66

983

10396

Trigeminal neuralgia

206

2054

1.00

0.00

3.0

4.1

19.30

21.97

ug/l

0.08

161

1637

Pedal cyclist injured in other and unspecified transport accidents

349

3484

1.00

0.00

3.7

4.1

8.54

23.05

ug/l

1.92

282

2800

Heterophoria

218

2184

1.00

0.00

3.7

4.1

4.07

21.85

ug/l

3.21

163

1717

Impacted maxillary molar

659

1.00

0.00

2.7

3.9

2.15

20.67

ug/l

1.04

457

Scissor bite

290

0.99

0.00

4.7

4.0

4.60

23.37

ug/l

0.60

216

Benign neoplasm: Connective and other soft tissue of head, face and neck

505

0.99

0.00

4.5

4.2

14.45

37.88

ug/l

0.70

418

Beningn neoplasm: Meninges, unspecified

526

1.01

0.00

3.2

4.0

11.53

15.91

ug/l

0.17

446

Congenital malformations of spine and bony thorax

128

1.02

0.00

3.2

3.9

3.63

43.22

ug/l

—

Nystagmus and other irregular eye movements

344

0.99

0.00

4.3

4.0

2.80

19.76

ug/l

0.76

282

178

1.01

0.00

2.6

4.5

7.41

33.81

ug/l

0.56

146

Clubfoot

198

1.01

0.00

1.9

4.9

61.11

6.75

ug/l

0.46

159

Other and unspecified trigeminal disorders

503

0.99

0.00

2.2

4.2

2.79

16.76

ug/l

0.98

410

Optic atrophy

507

1.01

0.00

3.7

4.5

186.20

34.04

ug/l

0.40

423

CR(E)ST syndrome

517

1.01

0.00

2.3

3.9

5.05

8.56

ug/l

1.12

417

Other disorders of breast and lactation associated with childbirth

232

0.99

0.00

2.6

3.9

2.20

9.29

ug/l

1.77

166

Optic atrophy

527

1.01

0.00

4.0

4.5

177.46

32.98

ug/l

0.40

439

Other lack of coordination

557

1.01

0.00

2.6

4.4

15.04

34.11

ug/l

0.52

469

Benign neoplasm: Short bones of lower limb

288

1.01

0.00

3.7

4.2

7.08

45.55

ug/l

0.77

237

Benign neoplasm of male genital organs

667

1.00

0.00

3.9

4.4

4.30

34.23

ug/l

1.61

561

Other spirochaetal diseases

1303

13026

1.00

0.00

3.7

4.1

13.81

24.00

ug/l

0.67

995

10534

Traumatic amputation of wrist and hand

136

1364

1.00

0.00

4.5

12.50

33.39

ug/l

1.20

115

1133

Disorder of the sleep-wake schedule

382

0.99

0.00

2.7

4.7

3.52

19.55

ug/l

0.79

307

Other eating disorders

685

0.99

0.00

2.4

3.9

45.94

22.81

ug/l

0.22

475

Pityriasis lichenoides chronica

119

1.01

0.00

2.3

4.5

704.10

62.42

ug/l

—

103

Contact with sharp object, undetermined intent

528

1.00

0.00

3.9

4.8

8.42

33.55

ug/l

0.87

430

Increased muscle tone

191

0.99

0.00

1.9

4.4

2.55

40.35

ug/l

0.56

162

Other intracranial haemorrhages

118

1182

1.00

0.00

4.0

51.38

30.63

ug/l

0.26

101

1000

Dislocation, sprain and strain of joints and ligaments of elbow

166

1662

1.00

0.00

3.4

4.2

15.58

25.17

ug/l

0.54

125

1311

KRA_PSY_EATING, excluding more controls

120

1192

1.00

0.00

2.5

3.7

27.61

43.46

ug/l

0.16

806

Frostbite

261

1.00

0.00

2.6

4.4

2.85

27.33

ug/l

0.86

214

Calcific tendinitis

331

1.00

0.00

2.3

5.2

7.00

49.38

ug/l

1.01

274

Use of rotigotine

389

1.00

0.00

2.8

4.1

2.29

41.51

ug/l

1.19

328

Adhesive middle ear disease

421

1.00

0.00

3.2

4.4

25.04

40.65

ug/l

0.29

352

Hypersensitivity pneumonitis due to organic dust

539

1.00

0.00

3.0

4.3

20.75

34.31

ug/l

0.30

455

Diffuse brain injury

109

1091

1.00

0.00

3.5

4.8

5.43

32.24

ug/l

2.25

894

Routine general health check-up of defined subpopulation

469

1.00

0.00

3.3

4.2

20.50

9.74

ug/l

0.32

348

Mumps

741

1.00

0.00

3.6

4.3

24.52

29.28

ug/l

0.08

596

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

227

2275

1.00

0.00

3.0

4.4

14.34

43.97

ug/l

1.01

176

1786

Polypectomy (DHB20)

228

2277

1.00

0.00

3.7

4.3

48.46

24.45

ug/l

0.47

180

1889

Mesial bite

167

1.02

0.00

2.4

4.4

4.29

34.58

ug/l

—

130

Vascular syndromes of brain in cerebrovascular disorders

175

1747

1.00

0.00

3.3

4.1

8.77

26.97

ug/l

1.63

152

1464

Contusion of ankle

913

1.00

0.00

2.6

4.1

38.20

22.17

ug/l

0.27

736

Diabetes insipidus

283

0.99

0.00

3.1

4.0

3.52

46.05

ug/l

0.89

235

Cleft palate

155

0.97

0.00

2.7

4.1

204.42

9.68

ug/l

—

119

Other deformities of toe(s)

135

1355

1.00

0.00

3.1

4.3

14.56

30.15

ug/l

0.77

104

1114

Carcinoma in situ of vulva

265

0.98

0.00

3.2

4.0

3.92

9.88

ug/l

1.45

213

Benign neoplasm: Bones of skull and face

305

1.02

0.00

3.3

4.2

167.71

41.66

ug/l

0.48

255

Isolated proteinuria with specified morphological lesion

345

1.02

0.00

3.3

4.1

4.20

39.24

ug/l

0.91

290

Other papulosquamous disorders

325

0.98

0.00

3.9

4.2

17.91

21.46

ug/l

0.08

271

Disorders of brain, other and unspecified

296

1.01

0.00

2.8

4.5

38.30

50.86

ug/l

0.11

247

Arteriovenous malformation of cerebral vessels

344

0.99

0.00

3.6

4.5

5.19

19.67

ug/l

0.61

283

Adult-onset Still disease

1.02

0.00

2.6

3.9

1.22

10.04

ug/l

—

Lipoprotein deficiency

0.90

0.00

4.2

4.5

2.68

6.02

ug/l

—

Megavitamin-B6 syndrome

0.00

0.0

5.6

—

3.04

—

Bullous disorders in diseases classified elsewhere

0.00

0.0

4.0

—

24.06

—

Arenaviral haemorrhagic fever

0.00

0.0

4.2

—

2.62

—

Rifle, shotgun and larger firearm discharge, undetermined intent

0.00

0.0

5.6

—

2.28

—

Epileptic seizures related to drugs

0.92

-0.00

1.4

3.9

2.66

6.94

ug/l

—

Contact with other sharp object(s)

153

1530

1.00

-0.00

3.5

4.4

10.53

20.16

ug/l

0.69

121

1223

Arthropathic psoriasis

395

3950

1.00

-0.00

3.1

4.2

29.84

22.99

ug/l

0.15

326

3191

Rheumatoid arthritis

1546

13861

1.00

-0.00

3.1

4.2

25.44

28.74

ug/l

0.14

1257

11263

Hereditary angioödema type 2

0.00

-0.00

0.0

7.6

—

2.09

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.89

-0.00

2.7

4.0

1.65

74.07

ug/l

—

Tetraplegia

210

1.00

-0.00

3.7

4.5

7.40

28.73

ug/l

0.51

169

Folliculitis decalvans

0.96

-0.00

2.8

3.6

2.20

13.81

ug/l

—

Paracoccidioidomycosis

0.00

-0.00

0.0

5.1

—

21.69

—

Peritonsillar abscess

661

6610

1.00

-0.00

4.5

4.2

20.69

29.61

ug/l

0.28

549

5203

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.93

-0.00

3.4

4.4

2.16

66.60

ug/l

—

Atrioventricular septal defect

0.89

-0.00

2.7

4.4

2.24

10.33

ug/l

—

Carcinoma in situ of penis

0.95

-0.00

2.2

5.1

2.62

75.74

ug/l

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS